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ABSTRACT 
Maternal morbidity is physical ill health related to pregnancy and childbirth or any 
maternal complication during pregnancy, labour and puerperium. Severe maternal 
morbidity is a life-threatening obstetric complication. The importance of severe 
maternal morbidity is that it precedes maternal mortality and is therefore critical in the 
understanding of the factors that influence maternal mortality. 
The overall aim of the study was to investigate risk factors associated with severe 
maternal morbidity and progression to maternal mortality in Mulago hospital, Kampala, 
Uganda. The study had two stages: Stage 1 was an unmatched case-control study of 
severe maternal morbidity and Stage 2 was a follow-up of all cases from Stage 1 to 
discharge or death. 
A total of 499 cases of severe maternal morbidity and 500 controls (women with normal 
deliveries and no severe maternal morbidity) were studied. Both the cases and controls 
were interviewed to obtain information on socio demographic factors, previous obstetric 
outcomes and present obstetric performance. Information on obstetric management was 
extracted from clinical notes. All cases and controls were tested for HIV, syphilis and 
haemoglobin level. A total of 39 of the 499 severe maternal morbidity cases died. 
The causes of SMM were severe pre eclampsia (25%), severe dystocia (31%) Post 
partum haemorrhage (19%), ante partum haemorrhage (14%) puerperal sepsis (5%) and 
medical diseases (6%). The main risk factors for severe maternal morbidity were low 
socio economic class, long distance from home to Mulago hospital, having specific 
medical conditions, having to request permission to attend health unit, having a long 
interval since the last birth, HIV positive status and poor quality of care during antenatal 
and delivery. Further details, plus separate analyses of specific causes of SMM 
(eclampsia, post partum haemorrhage, severe dystocia and ante partum haemorrhage) 
are presented. Determinants of progression to maternal death included low socio 
economic class, factors associated with management of labour, and HIV/AIDS. 
The main conclusion from this work is that improvements in the social and economic 
status of women, the level of HIV in the community, and the quality of care offered 
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during pregnancy will reduce the burden of severe maternal morbidity and mortality in 
Kampala, Uganda. It is likely that these results can be generalised to other areas of sub- 
Saharan Africa and usefully integrated into Safe-Motherhood Programs there. 
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CHAPTER ONE: INTRODUCTION, RATIONALE, AND 
OBJECTIVES OF THE STUDY 
1.1 SEVERE MATERNAL MORBIDITY 
Maternal morbidity is defined by the World Health Organization (WHO) as ill health in 
a woman who has been pregnant (regardless of the site or duration of pregnancy) from 
any cause related to or aggravated by the pregnancy or its management, but not from 
accidental or incidental causes'. Such morbidity may occur any time and continue 
beyond reproductive years. The term severe maternal morbidity (SMM) is used when 
the morbidity is a life threatening obstetric complication related to child bearing. Some 
authors have called "near-miss" morbidity in that the women only just narrowly death. 
Maternal mortality has been used as a standard measure of the success of obstetric 
interventions. However, there are few cases in developed countries which make it 
difficult to formulate guidelines on small numbers. SMM has been suggested as an 
alternative measure. The study of SMM has the advantage that cases are more common 
and can be interviewed about risk factors or circumstances that occurred before the 
episode of SMM. This interview can offer a better understanding of the causes of 
maternal mortality' . 
Documentation of events that take place when a patient develops SMM can be used to 
measure the quality of care offered and in addition monitor the quality of service 
delivery, within an institution5'6. Relatively -little epidemiological work has been 
conducted on the determinants of SMM, especially in developing countries, but factors 
found to predispose women to SMM are low socio economic stratus, lack of 
empowerment, lack of accessibility to health care facilities and past and current 
obstetric performance 3'4'6'7. 
MATERNAL MORTALITY 
Approximately 529,000 women die as result of childbirth each year worldwide 8,9 Over 
90% of these deaths occur in Africa and Asia and the majority are preventable8'9. 
The different levels of maternal mortality between developing and developed countries 
have been attributed to differences in the accessibility and type of care offered to 
13 
parturient mothers. While it is true that accessibility to health care is a problem in 
developing countries, the care offered in health units once the patient is there may not 
be optimal1°. That is why WHO has been designing appropriate technologies for 
developing countries to use in order to prevent the rising numbers of maternal deaths'°. 
Quality of care factors play a big role in the progression of SMM to maternal 
mortalitys. 6,11 The type of care offered in hospitals, especially intensive medical care, is 
very important in saving a woman's life and there by reducing on maternal mortality. 
1.2 THE UGANDAN SITUATION 
1.2.1 Severe Maternal Morbidity and Maternal Mortality in Uganda 
Uganda is one of the countries with high maternal mortality in Africa with over 10,000 
deaths per year9. The national maternal mortality ratio (MMR) is estimated as 504 per 
100,000 live births 12. This high maternal mortality has been partly attributed to 
economic turmoil the country has gone through and the impact of HIV/AIDS13''5. 
Because of high maternal mortality, SMM is also expected to be high too. 
The incidence and causes of maternal morbidity in Uganda have not been well 
documented but a small study conducted in Mulago hospital show a similar pattern of 
rates and causes to that found in other developing countries16. Results from one study 
of referred near-miss cases in Mulago hospital showed the main causes as: 
haemorrhage, severe dystocia and eclampsia7. Since the introduction of the safe 
motherhood programme in Uganda over a decade ago, there has been no significant 
decline in maternal mortality. This calls for more innovative measures to be put in 
place. 
1.2.2 HIV in Uganda 
HIV in Uganda was first reported in late1984 from the southern part of Uganda in the 
district of Masaka. '7 It started from a fish-landing site called Kasensero and the disease 
was thought to have come from Tanzania. The virus caused severe emaciation and 
hence became to be known as "slim". From this time the prevalence of the disease 
increased and by the early 1990's had encompassed the whole country. '7"8 
Data from HIV surveillance from sentinel antenatal sites, which are reliable and cover 
selected sites across the whole country, show that there is downward trend in HIV 
prevalence country-wide with a current average of 6%18. The decline in incidence has 
14 
been attributed to Uganda's openness about HIV, and encouraging change of behaviour 
and condom use19. In Uganda as a whole 33% of the deliveries are to adolescents 
20 and 
this is the group with high HIV prevalence 17. suggesting that the morbidity and 
mortality associated with HIV is likely to be large and urgently needs to be estimated. 
The growing demand on health systems is being underscored by the exploding 
tuberculosis epidemic in most countries with HIV. TB is becoming one of the major 
indirect causes of maternal deaths: in Uganda it contributed 10.1% compared to that in 
Zambia of 25%14'21"23 
In a study of risk factors for maternal deaths in 1995 in Mulago hospital, Kampala, HIV 
was estimated to contribute to 40% of the maternal deaths 14. The contribution of HIV to 
maternal mortality was assumed clinically but not confirmed using serology. In a small 
study conducted within Mulago hospital the prevalence of HIV-positivity was found to 
be 52.3% among maternal deaths compared to 15.2% in those who did not die22. This 
study, however, did not in identify whether HIV contributed to death or was an 
incidental finding and no study has been carried out on mothers with SMM. Generally, 
the information of HIV and its overall contribution to SMM and mortality as a direct or 
indirect cause is not well established. 
1.3 RATIONALE OF THE STUDY 
SMM and mortality are of major public health importance in Uganda and the world in 
general. The majority of studies on SMM to date have dwelt more on classification and 
audit2,24'25. Relatively few studies have investigated aetiological factors, and very little 
has been done with respect to the identification of individual and hospital-based risk 
factors for SMM in Africa, especially in Uganda. Additionally, factors that put a 
woman with SMM at risk of death have not been examined epidemiologically. The role 
of HIV in SMM cases and the progression to maternal mortality is of particular interest. 
Results from this study will contribute to strategies aimed at reduction of maternal 
morbidity and mortality in Mulago hospital, Kampala, and Uganda in general. The 
results will hopefully be incorporated in the safe motherhood program. 
1.4 AIMS AND OBJECTIVES 
The overall aim of the study was to investigate the risk factors associated with maternal 
mortality and SMM at Mulago hospital, Kampala, Uganda. Knowledge of risk factors 
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will facilitate the identification and prediction of those at risk of SMM and, in turn, help 
prevent both SMM and mortality. The intention is to incorporate the results into the 
national safe motherhood programme in order to improve maternal health and reduce 
the burden of disease associated with maternal morbidity and mortality. 
Specific objectives were: 
a. To determine the risk factors for SMM in women who deliver in Mulago 
Hospital, Kampala. 
b. To investigate the factors that put a woman with SMM at risk of death. 
c. To determine the contribution of HIV infection to SMM and progression to 
mortality. 
1.5 STRUCTURE OF THE THESIS 
This thesis presents the first African study to explore the risk factors for SMM and 
progression to mortality in a defined geographical setting. Chapter two reviews the 
definitions used in the selection of SMM cases world-wide and critically reviews the 
epidemiological literature associated with it. Chapter three defines maternal mortality, 
its causes and the factors that influence progression of SMM to maternal mortality. 
Chapter four describes the methods used in carrying out this study. . Chapter five 
presents the results of the study of SMM and the individual causes of SMM. Chapter 
six presents the results of the study of progression from SMM to death. Chapter seven 
discusses the results and chapter eight provides an overview, discusses the strengths and 
limitations of the study, and offers recommendations for the way forward. 
16 
CHAPTER TWO: REVIEW OF THE LITERATURE ON 
SEVERE MATERNAL MORBIDITY 
2.1 INTRODUCTION 
Maternal morbidity is the physical ill health of a woman during pregnancy, childbirth 
and the post partum period. Maternal morbidity has a broad spectrum covering minor 
ill health to life-threatening obstetric complications. Direct obstetric morbidity results 
from complications due to the pregnant state, from interventions, incorrect treatment, 
omissions, or from the chain of events resulting from them. Indirect morbidity results 
from a previously existing condition or disease, which was aggravated by physiological 
effects of pregnancy. Such morbidity may occur any time and continue beyond 
reproductive years. 
The main direct causes of SMM are haemorrhage, obstructed labour and ruptured 
uterus, hypertension and infection. These contribute approximately 80% of the causes 
of SMM and mortality 9. The indirect causes contribute 20% and the main conditions 
are anaemia, existing medical conditions and HIV/AIDS9. 
For a long time most countries have concentrated their efforts on the Confidential 
Inquiry into the causes and prevention of maternal deaths and little has been done on the 
inquiry of SMM. Most studies of SMM have examined self-reported morbidity, audit 
of cases in the hospital, or validation of self reported SMM episodes in the community. 
Little has been done with respect to the identification of etiological and quality of care 
risk factors for SMM in Africa, particularly in Uganda. 
2.2 DEFINITION OF SMM 
A number of terms have been used to describe complications of pregnancy for 
example critically ill patients, life threatening complications and SMM, the latter 
being used here. While the definition of maternal mortality is clear, what constitutes 
SMM varies by place, institution and investigator, with different definitions to suit the 
circumstances. Although obstetric complications are presented as an alternative to 
maternal mortality, maternal death is easy to measure because of its definite end 
point.: By contrast, maternal morbidity is a measure between two extremes of good 
health and maternal death. 
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Three sets of criteria have been used in the definition of SMM: 
1. Management based: These criteria depend on the management of the cases of severe 
morbidity. The management-based criteria include admission to an intensive care 
unit (ICU), delivery by caesarean section, hysterectomy, blood transfusion and 
anaesthetic accident. Admission to ICU has been used in developed countries 
because of the assumption that only severe cases are admitted to intensive care 
units25'26. This criterion is simple to use and it is easy to collect information. The 
only disadvantage is that the criteria for admission to intensive care unit may vary 
from country to country, depending on hospital capacity and location of the ICU25. 
The use of this criterion is limited in developing countries because ICU facilities are 
few and are located away from maternity units. Other management-based criteria 
include having caesarean section, hysterectomy, or depend on the amount of blood 
transfused and anaesthetic accidents or complications 2,27,28. These are prone to 
problems, for example in South Africa where hypovolaemia will require at least five 
units of packed cells or blood but the patient may not receive it: the threshold for 
blood transfusion is high but volume of blood given is low. Also in countries where 
there is a chronic shortage of blood (like Uganda) this criterion will not work. 
Another disadvantage of these criteria is that they usually use laboratory 
investigations which can be expensive and inaccessible to a number of developing 
countries. 
2. Clinical signs and symptoms: This set of criteria use clinical signs and symptoms 
generally built on obstetric complications, focusing on major causes of maternal 
mortality such as haemorrhage, sepsis and hypertension. These are easy to use and 
interpret. In developing countries where there are few facilities for ICU, shortage of 
blood and inadequate laboratory investigation capability, this criterion may be the 
most appropriate. The criteria depend on the consensus of the hospital or unit on the 
broad definition of cases of SMM. The main problem with this definition is 
comparison of cases across the world for example post partum haemorrhage (PPH) 
in a European setting has been defined as blood loss of 1500mis or more29, or blood 
loss of 1000mis or more in UK3° and in Benin as signs of shock31. The use of these 
criteria needs global standardisation by WHO for easy use and generalisability of 
results. 
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3. Organ- or system-based: The third set of criteria comprises an organ- or system- 
based definition which depends on the identification of organ or system dysfunction 
or failure. This definition depends on, for example, the fact that bleeding must 
cause vascular hypovolaemia and renal failure, or that sepsis leads to circulatory 
failure or respiratory failure, and eclampsia will lead to cerebro-vascular accident 
and brain dysfunction or renal failure, liver failure or coagulation failure 2,32. The 
dysfunction of an organ or system selects a specific end point which is very good for 
identification. But if prompt management is given the end point may not be 
reached. 
In general any of the above criteria can be used well in developed countries where there 
are facilities for management of these conditions but have big pitfalls in developing 
countries where many factors influence pregnancy outcome. 
2.3 INCIDENCE OF SMM 
WHO estimates that every year 529,000 women die from pregnancy related causes and 
80-99% cases occur in developing countries9. In real terms 90% of these maternal 
deaths occur in Asia and Sub Saharan Africa 9. WHO also estimates that for every 
maternal death there are 16.5 pregnancy related morbidities worldwide. This estimate 
was based on a small study carried out in a rural community in India in the 1980s and it 
may no longer be accurate33. Each year an estimated 20 million women suffer acute 
obstetric morbidity worldwide9. 
The reported incidence of SMM in UK for the years 1990-2001 was estimated to 
between 0.05% and 1.9% of all deliveries2,25,30,32,3a The differences in these reported 
rates have been attributed to the different definitions used for SMM, the facilities 
available and type of care offered in the institution. In Maryland State in USA a study 
carried out between 1984 and 1997 on risk factors for ICU admissions found 1,023 
women having been admitted to ICU out of 822,591 deliveries, making the rate of 
0.12%35. This figure compares well with the findings in the UK. 25,30,32. The results 
from USA are more representative than the UK because it was population based and yet 
the UK is mainly hospital based studies. Similarly in France, a study of a French 
administrative region using the ICU criteria found a rate of 0.36 %36. 
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In developing countries the situation is very different and estimates for the ratio of 
maternal morbidity to mortality have been put it at 105 morbidities per maternal death, 
making WHO estimates of 16.5 morbidities to one mortality appear a significant under 
estimate37. In a community study interviewing 3,600 rural and urban women in south 
India, an estimated 41% of pregnant women had reported at least one morbid condition 
and 15% had experienced severe morbidity. The commonest causes of morbidity were 
haemorrhage and convulsions (eclampsia) in the post partum period38. In South Africa, 
a study to test the application of clinical definitions of severe acute maternal morbidity 
identified 147 women with SMM and 30 maternal deaths among 13,429 deliveries, 
which gives an SMM rate of 5.2% and a ratio of maternal death to SMM of 1: 52. This 
SMM incidence is much higher than that reported in developed countries. 
A community study of direct obstetric causes of SMM in six West African countries 
(Burkina Faso, Ivory Coast, Mali, Mauritania, Niger and Senegal) found the overall 
incidence to be 6.2% but varied from city to city with the lowest at Bamako in Mali of 
3.1% and the highest in Senegal of 9.1%39 Similar studies of incidence of SMM 
found an estimate of 8% of deliveries in Benin31,6.5% of deliveries in Niger 39. 
These estimates are, however, difficult to compare directly because of differences in 
the methods of data collection. The West African study was a community based 
prospective cohort study whereas those from Benin and Niger were hospital based. 
Hospital based studies may not provide reliable estimates for incidence in the 
population. Another possible reason for differences in incidence from these studies 
could have been due to differences in the definitions used for "near-miss". 
The major causes of SMM in these studies were haemorrhage, sepsis, dystocia and 
eclampsia2'7'31,39'40. In a Kenyan study, a cohort of 4,768 pregnant women followed 
for four years estimated 17.4% of the women experienced at least one morbid 
condition during pregnancy41. However, this study was a follow up of children, and 
morbidity of women was collected incidentally and therefore not likely to provide a 
very reliable estimate of maternal morbidity. 
In Uganda the magnitude of morbidity is not known but a small hospital based study 
carried out in Mulago Hospital found the rate of morbidity for a six-month period in 
1999 was 6.1% and the ratio of maternal morbidity to mortality was 8 to 116. The 
morbidity rate in Uganda was very low compared to other African countries most likely 
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because some morbidity was not measured and the clinical definitions used were varied. 
2.4 RISK FACTORS FOR SMM 
Maternal mortality can be prevented in over 90% of cases42. Most of the maternal 
deaths occur during labour and in the immediate post partum period. The effective 
identification of factors that predispose a pregnant woman to complication, and 
preventing a complication from resulting in maternal death, is the major thrust in 
preventing maternal mortality43 
The primary obstetric factors that cause SMM can occur in the antenatal period, intra 
and post partum and puerperium. Some of the underlying factors to these primary 
causes of SMM start during childhood. Maternal under-nutrition and hard physical 
work predispose both the mother and foetus to increased morbidity and mortality44. 
Under-nutrition leads to poor development of pelvis predisposing to dystocia and its 
complications, and also causes anaemia which is a predisposing factor for SMM. Hard 
physical work strains the woman and leads to lack of adequate rest predisposing her to 
eclampsiaas 
A number of studies in developed countries have looked into factors that predispose 
women to SMM. In a cohort study of 33,251 women in Tennessee State in USA, the 
risk predictors for prolonged hospital stay were infection, hypertension-related 
complications and haemorrhage, regardless of mode of delivery. After adjusting for 
cofounders the risk factors for SMM in relation to vaginal delivery was only ethnicity 
and not related to young age46. Multiparity was a risk factor for haemorrhage only46 
In another study done in Maryland USA, risk factors associated with ICU admission 
were caesarean section, pregnancy-induced hypertension/eclampsia, and PPH. Using 35 
multivariate analysis, risk factors for admission to ICU were age more than 35 years, 
black ethnicity, referral from another hospital, but not marital status35. Similar findings 
have been reported in UK34. In a study of ICU admissions in Royal Victoria and 
Jewish General Hospital in UK the frequency of admissions to ICU was 0.3 per 100 
live births and the characteristics of admitted women were young age, multiparity, 
preterm delivery and admission post partum. The causes of their admissions were 
haemorrhage, hypertension, medical disease and infection47. However, all these studies 
are hospital based and care has to taken in with interpretation of results since there may 
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be variation in the levels of quality of care available in ICU and the selection criteria 
for admission to ICU. 
A study of women who delivered in hospital in Gujarat, India found that a 
haemoglobin level below 11g/dl, lack of antenatal care, primigravidity, age more than 
35, and those delivering babies with weight less than 2.5 kilograms, were associated 
with morbidity48. A low parity was associated with less morbidity48. In Senegal, in a 
study comparing maternal morbidity and mortality in two urban areas (this was part 
of the six country study in West Africa) the level of training and skill of health 
workers was proportional to level of monitoring and recording of morbidity27. The 
provision of antenatal care and management of morbidity depended on the level of 
training and skill of the provider. 
A study done to investigate quality of care factors determining admission to ICU in a 
large hospital in UK, found that sub-optimal care was a cause of SMM. The quality 
of care problems identified were failure of the organisation, lack of knowledge by 
health workers, failure to appreciate clinical urgency of the complications, lack of 
support supervision by seniors, and failure to seek advice5. This study suggested that 
quality of care is very important in preventing SMM and mortality. 
Risk factors for each individual cause of SMM are considered in the following sections. 
2.5 PRE-ECLAMPSIA AND ECLAMPSIA 
2.5.1 Definition 
Severe pre-eclampsia is a rare but potentially life threatening condition that must be 
diagnosed and treated promptly. Pre-eclampsia is defined as pregnancy induced 
hypertension which causes a multisystem disorder, characterised by hypertension and 
proteinuria49'50. The hypertension considered sufficient to make a diagnosis of pre- 
eclampsia is systolic blood pressure of 140mmHg or higher and a diastolic of 90mmHg 
or higher, in addition to significant proteinuria of urinary excretion of 0.3g or higher in 
a twenty four hour urine specimen or approximately equal to 2+ on urinary dipstick49.51. 
The Magpie trial (Magnesium sulphate for prevention of eclampsia) used a multisystem 
disorder, hypertension and proteinuria to diagnose pre-eclampsia; while the Australasian 
Society for the Study of Hypertension in Pregnancy (ASSAHP) used the Magpie 
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definition and twenty or more weeks of gestation49'51-53. 
Table 2.1: Definition of pre-eclampsia and eclampsia used in various trials 
Criteria of diagnosis Characteristics 
Pre-eclampsia (Magpie trial " Pregnancy 
definition) " Multisystem disorder of pregnancy 
" Proteinuria 
Pre-eclampsia (ASSHP) " Hypertension after 20 weeks 
" Proteinuria>300mg/24hours 
" Renal insufficiency 
" Liver disease 
" Neurological problems 
" Haematological disturbances 
" Foetal growth restriction 
Severe pre-eclampsia (Magpie " Diastolic BP >110mmhg 
trial) " Systolic BP >170mmhg on two separate 
measurements 
" Proteinuria 3+ 
OR 
" Diastolic BP >100mmhg 
" Systolic >150 mmhg 
" Two or more signs /symptoms: severe headaches, 
epigastric pain, blurred vision, hyperreflexia. 
Eclampsia (Collaborative trial) " Occurrence of one or more convulsions with 
syndrome of pre-eclampsia 
Magpie = Magnesium sulphate for prevention of eclampsia. 
ASSHP = Australasian society of the study of hypertension in pregnancy 
Source Martin Lew et al (2003)54 Emergency Medicine 15 page 362 
Pre-eclampsia can also occur before twenty weeks of pregnancy in conditions such as 
multiple pregnancies, hydatidiform mole, foetal triploidy, antiphospholipid syndrome, 
essential hypertension and renal disease55,56. Severe pre-eclampsia is pregnancy 
induced hypertension with a diastolic blood pressure of 110mmHg or more and systolic 
blood pressure of 160 mmHg or more on two separate measurements at least four hours 
apart with a proteinuria of 3+ (see table above). Eclampsia is the occurrence of one or 
49 more convulsions associated with the syndrome of pre-eclampsia . 
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2.5.2 Pathophysiology of pre-eclampsia and eclampsia 
Pre-eclampsia is thought to be due to abnormal placentation which means the presence 
of the placenta is necessary for pre-eclampsia to occur. It also occurs in extra-uterine or 
abdominal pregnancy, and in pregnancies without a foetus such as hyditiforme mole, as 
long as there is presence of placental tissue57. The other cause is thought to be the 
failure of remodelling of the maternal spiral arteries which take place in the first and 
second trimester of normal pregnancy secondary to trophoblastic invasion. Failure of 
second wave invasion of the trophoblast leads to abnormal placental trophoblastic 
infiltration of the uterine spiral arteries, leading to failure of the spiral arteries to 
transform to dilated flaccid tubes which are supposed to be four times the original 
diameter of spiral vessels. The failure of the dilation of spiral vessels leads to poor 
perfusion of the placenta resulting in utero placental ischemia which is responsible for 
pre-eclampsiasa, s6, sa>s9 The reduced perfusion to the placenta is associated with 
increased sensitivity of blood vessels to any pressor agents, with endothelial damage 
leading to activation of the coagulation cascade resulting in maternal micro thrombi 
formation and loss of fluid in the intravascular compartment. In pre-eclampsia it is also 
thought that there is an increased production of superoxide anion which may inactivate 
nitric oxide leading to reduced relaxation and increased vasoconstriction. This is 
supported by the observation of low levels of serum antioxidant status in pre-eclampsia 
and eclampsia60. The above factors cannot be the only causes of pre-eclampsia since 
women who deliver growth restricted babies have reduced placental perfusion and yet 
not all pre eclamptic women get growth restricted foetus. Other factors which are likely 
to play a role in the causation of pre-eclampsia include genetic, environmental and 
behavioural factors which interact with reduced perfusion of placenta and endothelial 
activation57,61 . The long term consequences of pre-eclampsia to the mother and baby 
are not well known, although there are suggestions to the effect that these mothers have 
increased insulin resistance, altered endothelial function and atherogenic lipid profile 
later in life when compared to women who had healthy pregnancies62. 
Eclampsia is characterised by convulsions, with hypertension and proteinuria during 
pregnancy or in post partum period. It occurs in 1 of 200 patients with pre-eclampsia 
and sometimes fatal if untreated5O, 56 Life threatening complications occur in up to a 
third of patients with eclampsia and involve multiple organs and systems54'63 The main 
complications of eclampsia are abruption placentae, HELLP syndrome (haemolysis, 
elevated liver enzymes, and low platelet count), coagulation failure resulting in PPH, 
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intra cerebral haemorrhage, cardio pulmonary failure, and renal failure. HELLP 
syndrome is more of an indicator of the severity of the disease than a complication and 
can sometimes occur without eclampsia. All these complications contribute immensely 
to SMM and mortality64. 
2.5.3 Incidence and risk factors for pre-eclampsia and eclampsia 
Pre-eclampsia affects 2-10% of pregnant women worldwide54,57 and eclampsia 0.03- 
0.05%54, The reported incidence of eclampsia in the Western world is between 1 in 
2000 to 1 in 3000 deliveries (0.03 to 0.05%)65. In Africa pre-eclampsia complicates 4- 
20 % of pregnancies66. The reported incidences of eclampsia in India, Kenya and 
Tanzania is between 0.1-0.2 per 100 deliveries67 and in Benin 1% 31,39, Niger 2.0% and 
Zaria Nigeria 2.3%68. Part of the explanation for these wide differences may be due to 
differences in the study methods and possibly the definitions used. All the African 
studies are hospital based and the incidence depended on the type of hospital, e. g. 
whether it was referral hospital, and on the selection of women who used the hospital 
facilities. Therefore, when comparing the incidences we have to be cautious when 
making conclusions because these incidences may not be a true reflection of occurrence 
of eclampsia at the population level in these countries. 
It is estimated that worldwide 13% of maternal mortality is caused by hypertensive 
disorders of pregnancy8 but this figure is much higher in developing countries where the 
estimates are between 22-35% in Latin America countries and 20-80% in Africa. 57°64,69 
The reported incidences of eclampsia in Africa and Latin America are from the review 
papers which have used mainly information from hospital based studies. This explains 
the wide range of reported incidence but also highlights the un reliability of hospital 
based studies in providing the incidences of this diseases. The morbidity and mortality 
as result of eclampsia increases with increasing age of patients and development of 
hypertension at an early gestational age70. 
The disease commonly affects primigravidae and women with pre-existing 
hypertension, or diabetes mellitus, or those with thrombophillies such as 
antiphospholipid syndrome. In addition, obstetric conditions which increase placental 
size such as multiple pregnancy and hyditiforme moles predispose to pre-eclampsia 
probably through the relative decrease in placental blood flow58. 
A number of risk factors for pre-eclampsia have been reported but epidemiological 
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studies using multivariate analysis have reported age of more than 34 years, obesity in 
pregnancy, body mass index of more than 24.2kg/m2, primiparity and urinary tract 
infection as the main independent risk factors69,71 In other studies age below 19 
years has been reported as a risk factor for pre-eclampsia but this may be confounded 
6a by nulliparity because the two factors are highly correlated, 
69,70 
Paternity change in multiparous women has been found to be associated with pre- 
eclampsia and women getting pregnant with new partners behave like nulliparous 
women72"75. Another factor associated with pre-eclampsia and eclampsia is a long 
birth interval of more than four years since the previous birth. The reason for is not 
76 well known but may be related to paternity change. 
In Mexico, low socio economic status of women, primiparity and high pregnancy 
weight doubled the risk of pre-eclampsia and eclampsia77. In Africa low socio 
economic class and lack of antenatal care attendance have been reported to be risk 
factor for eclampsia. 
A study in Australia found that working women had a higher risk of developing pre- 
eclampsia and eclampsia compared to non working women78. This may be related to 
the work stress but no study has yet demonstrated a relationship between specific 
types of job and eclampsia. This finding may be also associated with older 
primiparity. Cigarettes smoking has been shown to be associated with 30-40% 
decrease in the risk of pre-eclampsia but this benefit is cancelled by the negative 
effect of smoking on foetal growth and placental abruption79. Studies on risk factors 
for eclampsia carried out in the USA and UK have shown a higher prevalence of 
eclampsia among black women compared to white women and mortality was also 
higher in the black group70,80,8t The reason for this was not clear but may be related 
to social exclusion of black women and their unsatisfactory health seeking behaviour. 
A case control study carried out in Herman hospital in Texas USA reported older age 
(but not young age) and primigravidity were the major risk factors for eclampsia after 
controlling for antenatal care82. The major flaw of this study was the small sample 
size due to the rarity of eclampsia in Texas, and possible information bias due the 
method of data extraction from medical records. Another study in USA using data 
from the Centre for Disease Control, reported that the predictors for eclampsia 
mortality were age above 35 and black ethnicity70. 
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Another study of women in Bethesda in USA, using data from the collaborative 
perinatal project, found a high risk of recurrence among women who had 
hypertension in their first pregnancy83. The problem with this study was that it 
investigated women in their first and second pregnancies only so the results cannot be 
generalised to higher parity groups. However similar findings have been reported 
else where 84,85. In Singapore a study to assess the incidence and epidemiological 
factors for eclampsia found headache as a predictor for eclampsia, along with age 
below 25 and above 34 and Indian ethnicity86. The use of headache as a predictor is, 
however, subjective and unlikely to be reliable in clinical practice. 
Two studies have reported nausea and vomiting, epigastric pain, elevated liver 
enzymes, serum uric acid above 7.8mg/dl and urine protein of 4+ by dip stick as 
predictors of eclampsia87'88. However other studies have shown that use of serum uric 
acid levels are not a good predictor for eclampsia79'89. A urine protein, of 2+ can be 
used to screen women with borderline pre-eclampsia and confirm the diagnosis of 
pre-eclampsia although the test has a high degree of false negatives79. The platelet 
life span is much shorter in pre-eclampsia, especially when complicated with intra 
uterine growth retardation. But the distribution of platelets in pre-eclamptic and 
normotensive women overlap so much that the counts may not be a good predictor for 
early detection of pre-eclampsia in low risk women79. 
The modern use of uterine artery Doppler as a screening test for pre-eclampsia has 
shown encouraging results for the obstetrician and patients in that an abnormal 
Doppler result increases the likelihood of pre-eclampsia diagnosis by six times79. 
This test is specific but the major draw back is expense and is not used routinely for 
screening79. The problem with laboratory based investigations is that there is no 
single test which can be used to predict pre-eclampsia. Most of these laboratory tests 
cannot be used in Africa because of lack of the capacity to carry out these 
investigations. The simple urine test for protein is used because it is cheap, but it is 
not very accurate due to many false positives and only diagnoses an established pre- 
eclampsia. 
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2.6 POST PARTUM HAEMORRHAGE 
2.6.1 Definition 
Post-partum haemorrhage (PPH) is the main cause of maternal death world wide, 
especially in developing countries90 92. This complication remains the most challenging 
in obstetric practice. Prevention and early detection or recognition with prompt 
management is key to reducing morbidity and mortality due to PPH90'91'93. PPH is 
described as primary when it occurs within twenty fours of delivery of the baby and 
secondary when it occurs after twenty fours of delivery of the baby. 
The definition of post partum haemorrhage depends on the amount of blood loss 
(500mls or more) but clinical estimation of blood loss is inaccurate and little 
consideration is given to women with low haemoglobin93°9a The 500m1 cut off point is 
arbitrary because the mean loss of blood in a vaginal delivery and caesarean section is 
500 ml and 1000 ml respectively95. An alternative definition is a change of 10% in the 
haematocrit, but this must be assessed retrospectively9t, 96 This means that you have to 
know the haemoglobin level before delivery and not every patient has ante partum 
haematocrit. This method is useful in assessing the management process of the third 
stage for the purpose of recommendations and research; but for practicing midwives or 
doctors is not helpful for clinical management. 
The definition of PPH remains a subjective clinical assessment that includes any amount 
of blood loss that threatens a woman's heamodynamic stability. It remains subjective 
because some women will be compromised with a loss of relatively small amount of 
blood, including women with anaemia, hypertension and those with small stature. 
2.6.2 Clinical features of PPH 
PPH presents as excessive vaginal bleeding and the main causes are uterine atony (over 
80% of cases)97. The other causes are retained placenta or placental fragments, tears in 
the genital tract including ruptured uterus and coagulation failure9t'96'98'99. Uterine 
inversion although rare also causes PPH. The bleeding due to coagulation failure can be 
massive and complicated to manage. 
2.6.3 Incidence and risk factors for PPH 
PPH affects about 5-15% of women after child birth 91,96,99. Major PPH, or loss of more 
than 1000mis of blood, occurs in 5% of deliveries97. 
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A number of risk factors have been reported to be associated with PPH, but 
epidemiological studies have reduced on the traditional risk factors. In a USA study, 
using a criterion of ten units of haematocrit or more, the PPH rate was found to be 2.8% 
in vaginal deliveries and after regression analysis only prolonged third stage of labour, 
pre-eclampsia, previous PPH, twin pregnancy and arrest of descent of presenting part 
were the predictors of PPH96. Stone et al analysing parturient women in UK and using a 
definition of 1000mis loss of blood for PPH, found a rate of 1.3% and risk factors 
included placenta abruptio, placenta praevia, multiple pregnancy and obesity, but not 
multiparityloo Factors associated with management were retained placenta and induced 
labour. 
In Zimbabwe, using a criterion of loss of more than 600mls of blood, the study 
identified low parity, advanced maternal age and antenatal hospitalisation for anaemia 
as risk factors for PPH. There was a moderate correlation between poor obstetric 
history and PPH. Multiparity was not a risk factor1°' In Nigeria, an incidence of 
4.5% was found for PPH with risk factors of age more than 35 years and grand 
multiparity1°2. Multiparity is associated with fibrosis of uterine muscles which 
predisposes the uterus to uterine atony or failure of uterus to contract causing PPH. 
This phenomenon seems to be associated more with increasing age than multiparity. 
Another study in Nigeria found that prolonged second and third stages of labour and 
non use of oxytocics, were the main risk factors for PPH103 Although these two 
studies were based in similar settings - referral hospitals in Nigeria- the difference in 
the findings may result from the difference methodologies: the first study was a 
review of past cases using medical notes, where the cases were defined by visual 
estimation of blood loss; the second was a case-control study where cases were more 
accurately assessed using actual blood volume (collected blood) as well as visual 
estimation of blood loss using linen and swabs. Although the risk of non-use of 
oxytocics in third stage management has been reported, there are women who still 
prefer physiological management of the third stage (i. e. allows placenta to naturally 
separate and delivered). Retained placenta is a major cause of PPH and is associated 
with history of recurrence and previous caesarean section104. In Australia, while 
studying foetal macrosomia among Chinese migrants, Westerway et al found that 
foetal weight of more than 3.5kilogrames was associated with PPH1°5. Placenta 
praevia, abruptio placenta and hypertension have been also identified as risk factors 
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for PPH95,106 
The quality of care a woman receives while in labour plays a role in the risk of PPH. 
A study in the management of PPH in UK found considerable variation in 
management. Problematic areas included delay in identifying cases of PPH and late 
involvement of senior staff in management, both of which contributed to morbidity 
107. Similarly, a survey of quality of care in three French regions found that sub 
standard care contributed to the risk of PPH1°8. In Africa, and Uganda in particular, 
neglected care leading to obstructed labour, delivery at home or with TBAs, and 
failures in the referral system predispose women to PPH23. In Nigeria there was an 
association found between PPH and the level of training of delivery attendants, with 
births attended by doctors less at risk of PPH. 1°2. It has been urged that however good 
the health facilities are, unless women come to use them, morbidity and mortality 
cannot be reduced. In addition, delays by primary health staff to refer patients will 
increase the maternal morbidity and mortality due to PPH104. 
2.7 OBSTRUCTED LABOUR 
2.7.1 Definition 
Labour is the physiological process through which the uterus expels a foetus to the 
outside world. Labour is characterised by increased myometrial activity leading to 
regular uterine contractions, effacement and dilation of the cervix, and ultimately 
expulsion of the foetus. 
Dystocia is used to describe difficult or abnormal labour109. The terms prolonged and 
obstructed labour is often used interchangeably in the international literature. WHO 
defines prolonged labour as active labour lasting more than 12 hours in spite of good 
uterine contractions and cervical dilation. Other authors have suggested 24 hours to 
include primigravidae who usually have longer labours than multigravidae"O. The 
length of labour depends on the health status and parity of woman. Primigravidae and 
women with abnormal foetal presentation take longer time. The type of clinical 
management offered to a woman by the health providers can also determine the length 
of labour. 
WHO recommends the use of a partograph in monitoring of labourl". The partograph 
was started by Philpot in Zimbabwe as a tool for monitoring labour (see diagram 
below). 
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The partograph collects information on the progression of labour which can be used to 
recognise abnormalities and alert staffs to take appropriate action. The partograph is 
designed in such way that it can be used by all cadres of staff in all types of health units. 
Obstructed labour is a major cause of direct obstetric morbidity in Africa and poses a 
big public health problem. Among mothers who survive these complications, 40% 
suffer 1 ong t erm m orbidity42'" "2 d ue top uerperal s epsis and its c omplications, and or 
vesico or recto vaginal fistula which can cause psychosocial distress and divorce. 
2.7.2 Clinical features of obstructed labour 
In obstructed labour, the progress of labour is impaired by mechanical barriers in the 
birth canal and is defined as failure of descent of the presenting part despite good 
uterine contractions' 13,114 The causes of obstructed labour are classified as "passage", 
"passenger" and "powers". Passage problems include contracted pelvis, abnormal 
masses in the reproductive canal such as uterine fibroids and ovarian cysts; abnormal 
placental presentation, cervical dystocia and tight perineum. Passenger problems 
include a big baby, malpresentation such as breech and brow or congenital 
abnormalities in the baby. The causes of obstructed labour may overlap for example in 
a cephalo pelvic disproportion and a big baby. Most of the causes of obstructed are 
diagnosed during labour except abnormalities of the foetus and contracted pelvis which 
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should be detectable during pregnancy. However the lack of antenatal ultrasound in 
developing countries means the abnormalities such as hydrocephalus, or twins, are not 
picked until labour. 
Because of long labour, patients use up most of the energy and water in their body. The 
body then resorts to the metabolism of fat to produce energy and ketone bodies. Ketone 
bodies together with metabolism of pyruvate outside the Krebs cycle result in 
electrolyte imbalance. The woman experiences shortness of breath or tachypnoea which 
leads to respiratory acidosis. The loss of fluid through the skin and respiration, coupled 
with inadequate intake, will cause water electrolyte imbalance, severe dehydration, 
exhaustion and oliguria. Because the woman has laboured for long time with ruptured 
membranes, open cervix and with repeated vaginal examinations, infection can set in 
causing fever and foul smelling liquor. The infection is worse in mothers who labour in 
unorthodox places and are referred to hospitals for management? "ls 
The water and electrolyte imbalance in the mother can cause foetal distress. The strong 
uterine contractions reduce the oxygen supply to the foetus because of diminished 
intervals between contractions, resulting in foetal hypoxia. Similarly, uterine 
contractions compress the foetal head onto the pubic bones leading to grade three 
moulding of scalp bones with a risk of compression of the brain which can lead to 
cerebral damage and later death. The surviving baby may suffer cerebral palsy. 
The strong uterine contractions force the foetus onto the obstruction, causing the upper 
segment to pull on the lower segment of uterus which can result in a "bandl's ring" or a 
band of muscle between the lower segment and upper segment. In primigravidae the 
over stretching will cause the uterus to have gradual decrease in strength and frequency 
of uterine contractions (hypotonia), but in multigravidae the contractions tend to 
continue until the lower segment thins and rupture may result. Strong uterine 
contractions force the presenting part of the foetus to apply pressure on the urethra and 
bladder against the pelvic bones which can result in urinary retention and full bladder. 
Further pressure on bladder can lead to obstruction of the blood supply to the bladder 
which may cause necrosis, and later desloughing, leading to vesico vaginal fistula. 
Similarly, pressure on the rectum can lead to recto vaginal fistula and pressure on the 
sacral plexus may lead to paralysis of the sciatic nerve resulting in foot drop or other 
neurological problems. 
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Mothers who survive severe obstructed labour may also suffer from long term 
morbidities such as pelvic infection, infertility, ectopic pregnancy and chronic pelvic 
pain. The formation of fistula leads to total loss of bladder or bowel control or both. 
This has both physical and social problems in that the woman becomes socially 
excluded in the community. These fistulas do not heal by themselves and require 
surgical treatment. Expertise in this treatment in Africa is limited, which increases the 
misery of these patients because the community considers this an incurable 
condition68"6 
2.7.3 Incidence and risk factors for obstructed labour 
Prolonged labour, or obstructed labour, accounts for 8% of maternal deaths world- 
wide"7. In Nigeria it contributes 0.4-7.0%118. It is responsible for most of the 
primary caesarean sections carried out both in developing and developed countries. 
In Uganda, like other developing countries, because of the high proportion of 
adolescent pregnancy and under nutrition this condition is not uncommon20,119. In 
Uganda obstructed labour occurs in about 15 % of deliveries in Mulago hospita123 
Dystocia was found to contribute 2.0% of cases of SMM in Zaria Nigeria68,4.5% in 
Benin31 and 0.1 in Nigerao, i2o. Obstructed labour is complicated by uterine rupture 
and puerperal sepsis which are, in turn, associated with SMM and mortality' 19,121,122 
The complications can be prevented through a combination of adequate antenatal 
care, monitoring of labour using a partograph, availability of emergency obstetric care 
and an efficient referral system 122. 
One major predictor for obstructed labour is the height of the woman. Generally a 
height of 150cm or less is a risk factor for obstructed labour and such women need 
special attention during antenatal and labour. The critical height of 150cm needs to 
be tailored to individual communities because a number of studies have reported 
different cut off points123,124 The "old tale" of our midwives that a short woman and 
small size shoe is a predictor of operative delivery was confirmed by Kennedy et al 
that women with smaller feet tended to have more operative deliveries and the 
operative deliveries decreased with the increasing size of the foot12s'126. These criteria 
may be inappropriate to use in developed countries but appropriate for use in 
developing countries where resources are scarce. 
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The other predictor which has been used in antenatal clinics is the clinical assessment of 
the pelvis at 36 weeks of pregnancy in primigravidae. This requires the women to 
attend an antenatal clinic that gloves are available for the pelvic assessment, and that 
staff have clinical experience in assessing the pelvis. The drawback of this is the large 
patients to midwife (or doctor) ratio and also the lack of gloves and staff commitment 
carry the examination. The other drawback is that a number of women attending 
antenatal will not accept pelvic assessment because it is invasive, and also some who 
accept the examination when are told about delivery by caesarean section may not come 
for it. However, it is thought that in low resourced countries the use of anthropometric 
measurements and pelvic assessment will screen the majority of the women likely to 
have obstructed labour68,127 
In developed countries obstructed labour is almost non existent because of good social 
services and excellent medical care, but in developing countries it is still a major 
problem because of poor social infrastructure and poor medical services. In Uganda the 
general belief that every woman should deliver vaginally has contributed to the low use 
of maternal health services 128. Such beliefs contribute to the delay of women to seek 
medical attention, as alluded to in the three delays contributing to maternal mortality129 
Womens' attitude towards attending antenatal clinic in developing countries is 
influenced by socio-cultural factors which oppose orthodox antenatal care and hospital 
deliveries. This attitude has been shown to play a major role among the Hausa and 
Fulani communities in Nigeria 116. The low educational status of the women helps 
enhance these attitudes and maternal deaths due to obstructed labour were high in this 
' group t6 
Management of labour in health units should be make use of a partograph but few units 
in developing countries use this tool, despite its availability. In a study carried out in 
the Dominican Republic looking at quality of care in health units, a partograph was 
being used in only 40% of its units 130. The Uganda demographic health survey found 
incredibly low use of partograph of less than 5% 12. The low use has been attributed to 
low morale of staff, large number of patients and sometimes lack of the graph paper and 
knowledge130. This indicates that detection of poor progress of labour is later than it 
need be and referrals are thus delayed. Also when patients arrive at the referral centre 
there are further delays to initiate appropriate treatment. This is due to delay of staff 
response, or lack of staff, shortage of essential drugs and expendables, shortage of blood 
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and busy theatres. These delays have been reported in Dominican Republic130. It has 
been suggested that the waiting time from diagnosis to operative emergency delivery 
should be less than 30 minutes 131'132. Even in developed countries few centres have 
managed to achieve this standard and some centres have extended it to 45-60 
minutest3t, t32 The delay for operative delivery is much longer in developing countries 
which make obstructed labour more severe, increasing both maternal and perinatal 
morbidity and mortality. 
2.8 RUPTURED UTERUS 
2.8 1 Definition 
Ruptured uterus (a torn uterus) is the most devastating complication of obstructed 
labour to both the mother and the foetus133'134. When the obstruction is not relieved in 
time, it will end in a ruptured uterus. In primigravidae the uterus will usually stop 
contracting and will not rupture, although some primigravidae 
have ruptured their 
uterus135. Uterine rupture can be spontaneous (when there is no predisposing 
factor), 
traumatic (as a result of oxytocic induction of labour, internal podalic version, or 
rupture of scarred uterus following previous caesarean section or myomectomy)136. 
Some authors have reported spontaneous rupture as the most common 
137138 but others 
have reported rupture of scarred uterus as the most common 
139. The debate about the 
relative contribution of spontaneous and scar-induced rupture of the uterus has been 
ongoing for some time, and there is still no clear-cut answer as to which is the most 
common type of ruptured uterus. However with increasing caesarean section rates in 
developing countries and sub optimal maternity care, rupture due to scarred uterus will 
be prominent 140 
2.8.2 Clinical features of ruptured uterus 
Rupture of the uterus in a typical obstructed labour is due to excessive contraction of the 
upper uterine muscles resulting in stretching and thinning of the lower segment muscles. 
As the contraction of the uterine muscles continues to force the foetus through the 
obstruction, it exerts pressure on the thin lower uterine segment resulting in rupture. A 
previous caesarean section in the lower segment acts as a point of weakness and when 
there is sufficient degree of obstruction the scar will give way (scar dehiscence). The 
rupture can occur in the anterior, posterior or antero or postero lateral part of the uterus. 
Uterine rupture can be recognised during labour using clinical symptoms and signs. 
The symptoms of rhythmic pains of contractions are replaced by continuous abdominal 
pain with reduced or absent foetal movements. Studies examining the foetal heart rate 
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pattern prior to uterine rupture have been reported as the best predictor of uterine 
rupture. The foetal heart undergoes prolonged deceleration to less than 90 beats per 
minute that exceeds 1 minute without return to baseline. Prolonged deceleration alone 
or when proceeded by severe or variable deceleration of foetal heart was diagnostic of 
uterine rupture in over 70% of cases. This deceleration may be followed by terminal 
bradycardia and foetal death '41 This method is very reliable and practical in situations 
where there is continuous foetal monitoring during labour. However such monitoring is 
very rare in developing countries where the majority of ruptured uterus occur. 
2.8.3 Incidence and risk factors of ruptured uterus 
The incidence of ruptured uterus varies from country to country and is more common 
where maternal health is poor136,142'144 The incidence varies from 1 in 157 deliveries to 
1 in 865 deliveries '45148. Other studies have reported a lower incidence in developing 
countries of around 1 in 1000 (0.1%) deliveries or less with the majority occurring in 
women with a previous scar 149. 
The predisposing factors for ruptured uterus are maternal, including prolonged labour 
due to contracted pelvis, cephalo pelvic disproportion, or abnormal growths in the 
genital tract such as fibroids and ovarian cysts or previous operations on the uterus. 
Foetal factors are malpresentation or malposition of the foetus, big baby and 
abnormalities of the foetus such as hydrocephalus and hydropis foetalis. The mode of 
delivery such as vacuum extraction or forceps delivery or use of fundal pressure during 
breech delivery can also lead to uterine rupture. Induction or augmentation of labour 
using oxytocics has been shown to predispose a woman to ruptured uterus 133,141 . In one 
study, women on oxytocics were three times more likely to develop uterine rupture 
compared to those who were not133 and in another study it was four and half times more 
likelylat. , In a population study of uterine rupture among women who delivered under 
the care of an obstetrician, or a family doctor in consultation with an obstetrician, in the 
province of Nova Scotia in Canada, augmentation and induction of labour contributed to 
43% of complete rupture of the uterus and 40% of dehiscence of trial of scar149. Other 
predictors of uterine rupture are age and parity which may be a result of uterine muscle 
scaring leading to weakening of uterine wall muscles and resulting in rupture during 
136 childbirth°'so 
The risk of uterine rupture in women with a previous scar compared to women without 
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previous scar was 2.8 to 3.7 times as high'51. The incidence of scar dehiscence was 
estimated as 0.043 % of deliveries in Dublin and 0.16% of deliveries in Washington 
USA149. 
With the increasing rate of caesarean sections in developing countries and inadequate 
accessibility of emergence obstetric care, the rates of rupture of scarred uterus may be 
on the rise'36"40'142. Repeat caesarean sections in Africa will significantly increase the 
burden on the maternal health services available' 36°1s2, compromising the quality of 
maternity care and in turn increasing maternal morbidity and mortality. 
2.9 ANTEPARTUM HAEMORRHAGE 
2.9.1 Definition 
Ante partum haemorrhage (APH) is an obstetric condition characterised by bleeding 
from the genital tract that occurs during pregnancy from the time when the foetus is 
considered viable to delivery of the baby. The WHO now considers viability of the 
foetus to start from the gestational age of twenty four weeks because of better facilities 
for support for foetal viability. So the definition of APH has changed from bleeding 
from 28 weeks of gestation to delivery of baby, to bleeding from twenty four weeks'53. 
The major causes of APH are placental in origin and the most common causes are 
abruptio placenta and placenta praevia. Other causes of bleeding are vasa praevia, local 
vaginal and cervical lesions and bleeding of undetermined origin. Local causes of APH 
contribute 5% and rarely make any significant effect on pregnancy unless it is cervical 
cancer 153. APH complicates 2-5% of pregnancies worldwide'53. 
In developed countries maternal mortality due to APH has decreased tremendously over 
the last 50 years. In the UK only four maternal deaths due to ante partum haemorrhage: 
(one abruptio and three placenta praevia) were reported by a relatively recent 
confidential inquiry 154. In developing countries maternal mortality due to APH is still 
high because of prevalent anaemia, inadequate access to maternal health care, and 
shortage of blood. The confidential inquiry into maternal deaths in UK highlighted the 
issue of quality of care. Maternal morbidity and mortality due to APH is linked with 
inadequate resuscitation of the mother, inexperienced junior medical staff, delays in 
seeking assistance from experienced doctors and senior staff failing to respond quickly 
to calls'54. 
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This condition can become life threatening in a very short period and therefore needs 
prompt intervention. Placenta praevia can be diagnosed by routine ultrasound 
examination and magnetic resonance imaging which is advantageous for early 
treatment. But these facilities are not easily accessible in developing countries. It is 
therefore important that the risk factors for severe APH are investigated so that they can 
be used to prevent and manage these conditions, in turn reducing maternal morbidity 
and mortality due to APH. 
2.9.2 Clinical features of placenta praevia 
Placenta praevia is the implantation of the placenta entirely or in part in the lower 
segment of the uterus. Four grades of placenta praevia are recognised: grade one is 
when the placenta encroaches on the lower segment but lower edge does not reach the 
internal os, grade two is when the lower end of placenta reaches internal os but does not 
cover it, in grade three the placenta covers the internal os asymmetrically and in grade 
four the placenta closes internal os symmetricallylss Placenta praevia is now classified 
as minor and major. Minor placenta praevia is when the placenta does not reach the 
internal os and major is when the placenta touches or covers internal os. Placenta 
praevia presents with vaginal bleeding which is not painful after twenty four weeks 
gestation and before delivery of the baby 
113 The bleeding is usually mild and recurrent 
but sometimes can be massive and life threatening. 
2.9.3 Incidence and risk factors for placenta praevia 
The incidence of placenta praevia is 3-5 per 1000 pregnancies worldwide and is 
increasing because of rising caesarean section rate153,1ss-iss The incidence of low lying 
placenta is much higher at 20 weeks than at 36 weeks and above because as the upper 
segment enlarges and the lower segment is formed and the placenta moves with the 
upper segment. 
The major risk factor for placenta praevia is previous caesarean section delivery and the 
risk increases with the increasing number of caesarean sections. The incidence has been 
reported as 2% after one previous caesarean section, 4.1% after two and 22% after 
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three' Similarly, patterns of increased risk have been observed with dilation and 
curettage, evacuation of uterus and myomectomy'54,157. 
Placenta praevia is more common in older and multiparous womentsa, ts7, tsa The reason 
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for this is not clear but it may be associated with ageing of the vasculature of the uterus 
which causes placental hypertrophy and enlargement, hence increasing the likelihood of 
encroaching on lower segment 158 . 
The spacing of children is also associated with risk of placenta praevia. In a study 
carried out among Norwegian women it was found that spacing of more than four years 
was associated with increased risk of placenta praevia. This was associated with 
involuntary infertility which could be linked to other factors of placenta praevia such as 
scarring of the uterus or poor vasculature of the uterus associated with increasing age'58. 
The sex of a baby has been reported to be associated with placenta praevia, with a 
higher risk for male babies158-16o The reason for this is not known but it could be linked 
to maternal hormones or prematurity. Premature rupture of membranes occurs more 
commonly in women pregnant with male babies and placenta praevia is also more 
common in premature pregnancies than mature pregnancies. 
Recurrence of placenta praevia has been reported and is thought to be linked to 
defective decidual vascularisation which is similar to the explanation for previous 
placenta praevia, coupled with previous delivery by caesarean sectionlss, is9 Placenta 
abruptio is also reported to be associated with placenta praevia and vice versa. In 
Norway a doubling of risk was found for placenta praevia among women who had had 
abruptio placenta and this may have been due to shared aetiology. Both abnormal 
placentation and smoking have been attributed to abruptio placenta and placenta 
praevia'59. Poor invasion of the placenta in the lower segment is also associated with 
placental abruptio. 
Obstetric conditions like multiple pregnancies which have large placentas usually 
encroach on the lower segment of uterus causing placenta praevia though one study has 
disputed this'56. 
Management of placenta praevia depends on gestational age and the general condition 
of the woman. If the gestational age is 37 weeks and above immediate delivery is 
recommended. But if gestational age is below 37 weeks and the bleeding does not 
compromise the general condition of the mother, conservative management can be 
offered. However, if the bleeding is significant and the general condition of the woman 
is compromised immediate delivery is recommended. 
19 
Preventing maternal morbidity and mortality in this condition depends on how fast you 
intervene to manage the haemorrhage. Management of massive haemorrhage needs a 
well organised management protocol in maternity units. Antenatal supplement of iron 
and folate ensures that the woman is able to tolerate a mild to moderate blood loss. 
There should be enough blood to correct the loss, and doctors and anaesthetists should 
be available to deliver the woman when need arises. In developing countries where few 
women attend antenatal care, and where there is shortage of blood for transfusion and 
delays in operative delivery due to lack of doctors or anaesthetists, the risk of SMM and 
mortality due to placenta praevia is high. 
2.9.4 Clinical features of abruptio placenta 
Placental abruption is the premature separation of a normally sited placenta from the 
uterine wall before delivery. Abruptio placenta is initiated by haemorrhage into the 
decidua basalis from small abnormal uterine arterial blood vessels forming a small 
haematoma which may be self limiting or may continue to dissect through the decidual 
layers causing a split of the decidua. The decidual haematoma may remain within the 
deciduas or may also extravasate into the myometrium producing a couvelair uterus, 
(bleeding into uterine muscles), or cross placental membranes into the liquor. It may 
also dissect down toward the cervix manifesting as vaginal bleeding. The expanding 
haematoma may lead to compression of intervillous space resulting in reduced surface 
area for placental oxygenation. Reduced placental oxygenation compromises the foetal 
oxygenation. Foetal death will occur if 50% or more of placental surface area is 
reduced. 
The cause of abruptio placenta is unknown but hypotheses suggest placental or vascular 
abnormalities. Abnormal placentation, vascular malformations and increased fragility 
of vessels predispose to haematoma formation, leading to abruptio placenta 154. 
Haematoma formation with increased bleeding may precipitate disseminated 
intravascular coagulopathy (DIC). This hypercoagulable state is maintained by the 
release of thromboplastic materials into the circulation. The thromboplastic materials in 
blood circulation cause the formation of more haematoma or clots. The clot is broken 
down to micro thrombi, precipitating further formation of clot or thrombi. This process 
uses up most coagulation factors causing coagulation failure resulting in bleeding from 
different organs and surfaces with PPH being the most serious. 
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Treatment of abruptio placenta is individualised depending on evaluation of each 
clinical scenario. A trial of labour and a vaginal delivery is recommended as long the 
maternal and foetal pair can tolerate the process but there should be close monitoring. 
Placental abruptio which is severe enough to cause the demise of the foetus in the third 
trimester is an obstetrical emergency and delivery should be affected to halt onset of 
disseminated intravascular coagulation (DIC). DIC will occur within one or two hours 
of complete abruptio placenta. Serial maternal coagulation studies should be carried out 
and blood and its component should be given whenever necessary. The management of 
this condition needs specialised staff if the maternal and perinatal mortality associated 
with this condition is to be minimised, but in developing countries such specialised 
people are few. 
2.9.5 Incidence and risk factors for abruptio placenta 
Abruptio placenta occurs in 0.8 tol. 0% of all pregnancies161-164 and 1.2% of twin 
pregnancies world wide 165. Abruptio is a major cause of third trimester haemorrhage 
and perinatal death. The high maternal morbidity and mortality is due to severe 
haemorrhage which follows this complication. 
Maternal hypertension, especially pre-eclampsia and eclampsia is a major risk factor for 
abruptio placenta161'163°166,167 In patients with severe pre-eclampsia Anatha et al found 
a relative risk of 3.8 for placental abruptio and 2.8 for women with chronic hypertension 
with superimposed pre-eclampsia161 have an increased risk of intrauterine growth 
retardation (IUGR) and hence higher perinatal mortality16s, 166, i6e. Foetuses that are 
small for gestational age are at risk of abruption placenta but since IUGR takes time to 
develop, this observation suggests that the pathology starts early in pregnancy161. 
Abruptio placenta has been found to be an independent risk factor for perinatal 
death167,169 In another study previous second trimester bleeding, vertex presentation 
and placenta praevia were found to be risk factors for an abruption placenta 167. Low 
educational status and not cohabiting with the father of the expected infant has been 
reported to be associated with abruptio placenta but these findings may be confounded 
by factors like smoking, nutritional status and age. Maternal age and parity have been 
linked to abruptio placenta but recent studies have suggested increasing abruptio 
placenta with increasing parity only up to the age of 30. The highest link was seen in 
parity of 3 and age below 20 after adjusting for confounders 166. There was also an 
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elevated risk in multiple pregnancies when compared to singletons170 and the difference 
was attributed to placental under perfusion due to either smoking or hypertensive 
disorders in multiple pregnancies. The other possible reasons could be hydramnios, pre 
term labour and premature rupture of membranes. 
Chorioamnionitis is an independent risk factor for abruptio placenta 171. Idiopathic 
elevated serum alpha foeto maternal protein has been found among women with 
abruptio placenta166,172 The role of alpha feto protein in abruptio placenta is still being 
investigated but if the association is confirmed this may be useful in early prediction of 
women at risk. 
2.10 PUERPERAL SEPSIS 
2.10.1 Definition 
Puerperal infection occurs after childbirth because the mother's genital tract has a large 
raw surface area which can become infected. Infection may be limited to the cavity and 
wall of the uterus, the fallopian tubes, or it may spread beyond to cause peritonitis and 
septicaemia. Serious infections are rare in normal labour provided there has been no 
undue interference or interventions. 
2.10.2 Incidence and risk factors for puerperal sepsis 
The prevalence of puerperal sepsis in developed countries is low at around 0.6 per 
100,000 births but in developing countries is more than 1000 times this risk 173,174 . The 
reported incidence in Nigeria was 1.7% 175, Mulago 1.2% 16 and Burkina Faso 0.5%40 
These latter incidences are from cross-sectional hospital-based studies and may not 
represent the true incidence of the country because the women who use national referral 
hospitals are likely to be different from women in the general population. It is thus 
difficult to compare these estimates directly. Puerperal sepsis causes up to 8% of 
maternal deaths and 15% of intensive care admission worldwide8"73. In addition, severe 
maternal infections such as chorioamnionitis can cause cerebral palsy in children. 
Risk factors for- puerperal sepsis include caesarean section, chorioamnionitis, and 
premature rupture of membranes, repeated vaginal examination and instrumental 
delive ry 175 1" However, less than 10% of women who deliver vaginally develop 
puerperal infection even when the pregnancy is complicated by premature rupture of 
membranes 174 ., Caesarean section was associated with 13 fold increased risk among 
42 
asymptomatic women in developing endometritis in University of Texas 177 and trebling 
risk in Helsinki, Finland 176. Other factors which have been associated with puerperal 
infection are extreme reproductive age, anaemia and low socio economic class and 
sexually transmitted infections175,17g Factors such as retained products of conceptus, 
obstructed labour, prolonged rupture of membranes and medical diseases especially 
HIV/AIDS are the leading predisposing factors for puerperal sepsis in developing 
countries 175,179,180 In women with reduced resistance due to HIV, puerperal sepsis may 
progress to septicaemia and may be further complicated by septic shock and possibly 
death. 
Puerperal infection can be complicated by peritonitis, pelvic abscess, burst abdomen 
and septic shock which put a woman at risk of death. To prevent death, interventions 
with correct antibiotics and possibly laparotomy are the life saving procedures. This 
should be supported by blood and pus samples taken for culture and drug sensitivity 
tests conducted before antibiotic therapy. The type and choice of antibiotic treatment is 
important in saving the woman's life and also cutting on costs of hospital stays. 
However, in most developing countries there are few options for antibiotic choice and 
some laboratory back up is uncommon, leading to women who survive severe episode 
of sepsis ending up with infertility, ectopic pregnancy and chronic pelvic pain. 
2.11 MATERNAL MEDICAL DISEASES 
Co-existing medical diseases contribute about 10% of all causes of maternal mortality 
worldwide and are therefore a major cause of SMM8. The maternal medical conditions 
which cause SMM and mortality include chronic anaemia, cardiac diseases, diabetes 
mellitus, pulmonary infections and renal diseases 113'181. With the advent of HIV the co- 
existing medical conditions contribution to morbidity and mortality have accelerated 
due to opportunistic infections of HIV/AIDS sufferers. Tuberculosis (TB) is the main 
cause of morbidity and mortality as a result of HIV/AIDS. In South African states with 
high rates of HIV, TB has become one the leading cause of indirect cause of maternal 
morbidity and mortali 1182. y Other conditions associated with HIV/AIDS are 
Cryptococcus and bacterial meningitis, pneumocystis carinaii and Kaposi's sarcoma. 
Pulmonary oedema is the accumulation of fluid in pulmonary interstitial spaces and 
alveoli which prevents adequate diffusion of both oxygen and carbon dioxide. The 
predisposing factors are pre-eclampsia or eclampsia, use of tocolytic therapy, severe 
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puerperal infection or any other septicaemia condition, cardiac diseases and iatrogenic 
fluid overload' 83. Pulmonary oedema commonly occurs in the post partum period due 
to mobilization of fluids combined by 30% decrease of colloid osmotic pressure 183 
This condition is associated with risk of maternal and perinatal morbidity and mortality. 
2.11.1 Maternal anaemia 
WHO defines anaemia as haemoglobin of less than 11 grams per decilitre184 In 
developing countries a haemoglobin level of below 10 grams per decilitre is defined as 
anaemia. The physiological changes in pregnancy of increased plasma volume (by 
50%) and red blood cell mass (of 18-25%) cause a haemodilution resulting in 
physiological anaemia. This increases the prevalence of anaemia in pregnancy 185 
The prevalence of anaemia in sub Saharan Africa is estimated to be over 50% among 
pregnant women184 . The prevalence of anaemia among antenatal mothers was more 
than 90% in Malawi 186,54% in Ghana187,80% in India'88,48% in Uganda, (Kalisoke 
1985) and 76% in Kenya 189. Anaemia in all these countries was associated with 
Plasmodium falciparum malaria especially in primigravidae and adolescents. In 
addition, in Malawi anaemia was three times more common among unmarried mothers 
than married ones'90. The causes of anaemia are iron deficiency (in over 90% of 
cases)'85197, malaria, folic acid deficiency, sickle cell and HIV/AIDS184. Nutritional 
deficiency thus accounts for most anaemia even in malaria areas191 
The effects of anaemia in pregnancy are low birth weight, preterm delivery, intra uterine 
foetal death, abortion and PPH. Maternal mortality due to anaemia ranges from 27 per 
100,000 live births in India to 194 per 100,000 live births in Pakistan and is the leading 
indirect cause of maternal death in developing countries. 192. This indicates that anaemia 
related SMM is very high. In Siaya, Kenya, Hb of 6g/dl and below compared to those 
with Hb 7-8g/dl found the mortality rate was over eight times higher in those of Hb six 
or less compared to those with Hb 7-8 g per decilitre 193 and its contribution to observed 
mortality was 30% with or without blood transfusion. 
2.11.2 Maternal cardiac disease 
The incidence of cardiac disease varies from country to country depending on the 
affluence of the nation and has an estimated prevalence of 0.3-3.5% in pregnant 
women' 81. Cardiac diseases including congestive cardiac failure due to chronic anaemia 
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have been the main cause of indirect maternal morbidity and mortality 
worldwide 180,181,192,194 but with the advent of HIV/AIDS the pattern has changed. With 
improved management of congenital cardiac lesions in developed countries, more 
cardiac patients are risking pregnancy. In developing countries the majority of cardiac 
cases have rheumatic heart diseases and very few have congenital heart defects or other 
cardiomyopathies. Physiological adaptation during pregnancy can potentially worsen 
the prognosis of women with cardiac disease. 
The major problem with cardiac diseases in pregnancy is diagnosis of the disease 
condition in asymptomatic patients. This means that cardiac patients will present with 
complications such as congestive cardiac failure, arrhythmia or stroke. The predictors 
for developing unfavourable cardiac event are: previous history of cardiac failure or 
cyanosis, systemic ventricular dysfunction and development of hypertension' 81,19s The 
conditions that put a woman with cardiac disease at risk of SMM and mortality are 
bacterial endocarditis, pulmonary hypertension, severe anaemia and coarctation of aorta 
19s , 196. complicated by marfan's syndrome with aortic involvement 
2.11.3 Maternal diabetes mellitus 
The management of diabetes mellitus in pregnancy still presents a lot of challenges to 
obstetricians, physician and neonatologists. It is even more challenging in developing 
countries where these cases are managed by medical officers with inadequate laboratory 
facilities. Risk factors for diabetes mellitus include maternal obesity and familial 
history of diabetes mellitus, 197. With use of insulin the morbidity and mortality in the 
mother and foetus has reduced tremendously. However, poorly controlled glucose 
levels will result in foeto maternal complications such as hypoglycaemia or 
hyperglycaemia which leads to diabetic keto acidosis. Development of conditions such 
as hypertension, hydramnios and foetal macrosomia complicate the management of 
diabetes mellitus and predispose to maternal and neonatal morbidity 197. Hypertension 
and superimposed pre-eclampsia, abruptio placenta and hydramnios are complications 
of diabetes mellitus and these complications can predispose to PPH. Foetal macrosomia 
is usually associated with vaginal delivery complications, PPH; foetal trauma, 
hypoglycaemia and respiratory distress syndrome. 
2.11.4 Other medical diseases 
Other medical conditions include chronic renal diseases, infections and endocrine 
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conditions. Chronic renal diseases are usually silent and present in advanced stage. 
Chronic renal disease can cause recurrent abortion, premature delivery and 
hypertension. An advanced disease is also associated with reduced fertility. Maternal 
risk is linked to degree of renal insufficiency, which in turn associated with 
hypertension. Loss of protein in the urine causes nephrotic oedema. Pre-eclampsia 
super imposes on hypertension in 25-30% of cases, predisposing a woman to SMM and 
mortality. Endocrine conditions are a rare cause of SMM. 
Syphilis in pregnancy causes abortion, intra uterine growth restriction, intra uterine 
death, premature labour and congenital syphilis198. Syphilis and HIV are both sexually 
transmitted diseases and can co exist and lead to maternal morbidity. HIV can be a 
symptomatic or symptomatic. Patients present with generalised lymphodenopathy, 
body rash and signs and symptoms of opportunistic infections. The opportunistic 
infections include monilia infections, chest infection especially pneumocystis carinaii, 
and tuberculosis. HIV in pregnancy predisposes women to infectious morbidity and 
mortality, and risks are greater with low CD4 cell counts199,20o It has also been 
reported that HIV is associated with increased risk of PPH200 
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CHAPTER THREE: REVIEW OF THE LITERATURE ON 
PROGRESSION FROM SEVERE MATERNAL MORBIDITY 
TO MATERNAL MORTALITY 
3.1 DEFINITION AND MAGNITUDE OF MATERNAL MORTALITY 
The death of a woman during pregnancy or childbirth is a tragedy for the family and the 
nation. Pregnancy and childbirth kill an estimated 529,000 women each year worldwide 
8 and 98% of these deaths occur in the developing world. Over 99% of these deaths are 
preventable. 
A maternal death is defined by the World Health Organisation (WHO) as a death of a 
woman while pregnant or within 42 days of termination of pregnancy irrespective of the 
duration and site of the pregnancy, from any cause related to, or aggravated by, the 
pregnancy or its management but not from accidental or incidental causes'. A late 
maternal death is defined as death of a woman who has been pregnant from direct or 
indirect obstetric causes more than 42 days, but less than one year, after termination of 
pregnancy. The causes of maternal death can be considered under two main categories: 
direct and indirect. Direct refers to those resulting from complications of the pregnant 
state, labour and the puerperium, or from interventions, omissions, incorrect treatment 
or any chain of events resulting from any of the above. Indirect obstetric causes of 
death are those resulting from previous existing conditions that developed during 
pregnancy and were aggravated by the physiological effects of pregnancy. This 
classification system is useful but requires detailed medical information: for the 
majority of maternal deaths in developing countries such details are not available and 
the cause cannot easily be established. This can lead to under-reporting of maternal 
deaths. 
Maternal mortality in developed countries has reduced to less than 20 per 100,000 live 
births and in the UK the maternal mortality ratio (MMR) is 12.2 per 100,0009. 
However, in developing countries the MMR is estimated to be as high as 1,000 per 
100,000 live births8°42. The MMR for Uganda as a whole was estimated by the 
demographic health survey to be 504 per 100,000 in 200112 and for Mulago Hospital, 
Kampala, the figure was 729 per 100,000 in 200023 
47 
The disparity between the levels of maternal mortality in developed and developing 
countries is attributed mainly to socio differences especially related to poverty and the 
status of women 42,201 There is now increasing evidence that lack of access to optimal 
maternity care in obstetric emergencies is the main contributory factor to maternal 
mortality in developing countries". This was demonstrated when analysing the 
differences in the reduction of maternal mortality in the UK and Sweden: Improved 
economic performance in UK was not associated with a rapid decline of MMR, while 
improved maternity care in Sweden was associated with a rapid decrease of MMRII 
The standards of maternity care were the main determinants of reduction of maternal 
mortality in Sweden and later in UK202. Maternal mortality started reducing in the UK 
when the National Health Service was introduced and accessibility improved 
irrespective of social class. This suggests that universal access to comprehensive 
maternity care in the developing world could reduce maternal mortality. However in 
most parts of Africa, where there is only one midwife for every 15,000 deliveries, the 
level of obstetric care is very low and maternal mortality very high203. In Uganda the 
midwife to births ratio is estimated to be 1 to 700 per year and the doctor to population 
ratio is 1 to 18,700 per year204. With these alarming statistics the provision of 
comprehensive maternity care is poor and this explains the high levels of maternal 
mortality in Africa, and Uganda in particular. 
In 1987 the Safe Motherhood initiative was started with the aim of halving maternal 
mortality by the year 2000 and then by 75% by the year 2015205. Despite all the efforts, 
maternal mortality has continued to rise and the current figures for sub-Saharan Africa 
as estimated by WHO/UNICEF is about 1,000 deaths per 100,000 live births, and 
Uganda specifically is 880 per 100,0008°42. The reason for such persistent alarming 
rates could be due to the quality of emergency obstetric care provided. 
The majority of maternal deaths worldwide are attributed to direct obstetric causes, such 
as haemorrhage (24%), obstructed labour (8%), eclampsia (12%), unsafe abortion 
(13%), - sepsis (15%), and other causes such as ectopic pregnancy, embolism and 
complication of anaesthesia (8%)8. Indirect factors explain 20% of maternal deaths 
worldwide and these include anaemia, malaria, heart disease and HIV/AIDS 
complications. 
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In Uganda the causes of maternal death mirror the world pattern, and two sets of data 
from Kampala estimate that 22% of deaths are explained by haemorrhage, 20% by 
sepsis, 3% by eclampsia, 15% by unsafe abortion, 35% by complication of HIV/AIDS 
and 5% by other causes '4,23,206. If these estimates are representative of the country as 
whole, indirect causes of maternal mortality resulting from HIV/AIDS may be a very 
important cause of maternal mortality in Uganda. 
Haemorrhage is the major cause of death and has a high case fatality rate worldwide 
with range of 5-15% of cases dying of the condition94. In the UK haemorrhage due to 
ante partum haemorrhage caused four maternal deaths according to the latest 
confidential inquiry 154,207. In Nigeria the estimated case fatality due to haemorrhage 
ranges from 0.9% to 11.5%102. 
Eclampsia is a severe disease associated with high maternal and perinatal mortality. 
Maternal deaths are a result of cerebral haemorrhage, cardio pulmonary failure, renal 
and liver failure and post partum haemorrhage. The case fatality in hospitals in 
developing countries varies from 5 to 30%64,208-210The deaths have been reduced due 
to the use of anticonvulsants and anti hypertensive drugs. 
The proportion of maternal deaths due to obstructed labour varies from 10-30% in 
developing countries13'6s. The case fatality varies from 0.4-34% in developing countries 
depending on whether the hospital is referral or not, and the type of care 
offered' 17. lls'211. Ruptured uterus case fatality also varies by country with India 
reporting 10.5%137, Kenya 4.2%136, Ethiopia 11.1%144and Uganda 11%146. High 
mortality for cases of ruptured uterus is measure of the quality of services available in 
136 that hospital. 
The majority of puerperal sepsis maternal deaths follow obstructed labour and its 
complications. The advent of HIV has increased the complications due to puerperal 
sepsis. = Case fatalities for puerperal sepsis can be quite high especially in developing 
countries ý where there are unsafe abortions, unsafe delivery and lack of suitable 
antibiotic for treatment199,2 12. This was also demonstrated96 using data from Scotland 
where the proportion of cases. who died following puerperal sepsis was 1 in 200 
compared to -1 in 300 for eclampsia, 1 in 3000 for haemorrhage and 1 in 38,000 for 
dystocia213 
. In Benin the case 
fatality for puerperal sepsis was 21%3'. 
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3.2 HIV/AIDS IN RELATION TO MATERNAL MORTALITY AND 
MORBIDITY 
It was estimated that 45 million people in the world would be HIV-positive by the end 
of 2003, and in sub Saharan Africa that number would be 29.4 million214. In Uganda it 
is estimated that about 1.5 million people have been infected with HIV. UNAIDS 
estimates that this epidemic has increased the burden of disease by 15%, on top of the 
original burden the countries already had. 
HIV/AIDS has added a cruel burden on women in sub Saharan Africa. HIV is one of 
the most devastating pandemics in human history as it afflicts those in their most 
productive years. In sub Saharan Africa, AIDS has become one of the leading causes of 
pregnancy related death. Studies from Malawi, South Africa and Zimbabwe show that 
mortality during pregnancy or within six weeks post partum may have doubled during 
these years of HIV/AIDS pandemic, obliterating the gains which had been made in 
controlling maternal mortality215. Studies have shown 2-5 fold increased risks of dying 
during pregnancy and post partum for HIV infected women compared to uninfected 
women22'1 82'216 
AIDS related mortality in Zambia and South Africa has become one of the leading 
causes of maternal mortality21°217. Similar results have been reported in Kampala where 
indirect causes of maternal mortality were the leading causes of death in the 1990s'3"4. 
In Mulago hospital maternal mortality rose from 95 per 100,000 live births in 1972 to 
628 per 100,000 in 2001. This rise has been attributed to economic breakdown during 
the political unrest and turbulent years of the seventies and eighties leading to under- 
funding of health services, along with the rise of HIV/AIDS13'1s, 2i8, 
The increase in maternal deaths in countries affected by the HIV pandemic has led to 
questions whether HIV progression during pregnancy is accelerated, resulting in 
maternal death, or is just a reflection of the coexistence of this cause of death among 
women of reproductive age. HIV/AIDS can increase pregnancy related morbidity in 
many ways: First by suppressing immunity by depleting the CD4 cells or T helper 
lymphocytes which play a major role in cell mediated immunity, predisposing the 
woman to opportunistic infections or community infections219. Secondly, HIV can put a 
pregnant woman at a risk of infections, especially chorioamnionitis, puerperal infection 
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and urinary tract infections increasing her risk of death220 222. Another factor may be the 
effect of HIV on health systems affecting access to quality of obstetric care services. 
The burden the disease puts on reproductive health services is enormous and provision 
of essential care may be compromised, especially in terms of drugs that treat 
opportunistic infections. It is possible that HIV may be incidental during pregnancy, 
with pregnant or recently delivered women having the same risk of death as the HIV 
women who are in reproductive age. 
Epidemiological studies from developed countries have up to now failed to demonstrate 
the progression of the HIV disease during pregnancy or the period following the 
pregnancy200'223-227. A Meta analysis which was carried out on studies of HIV 
progression during pregnancy from published papers found that the odds ratio for HIV 
progression to AIDS in all studies was 1.41 (95%CI 0.85-2.33) and in developing 
countries was 3.71 (95% CI 1.82-7.75). The odds ratio for death was 1.80 (95% CI 
0.99-3.33)228. This preposition has been rejected in later studies carried out among 
American cohorts223 and a French cohort. The differences between the European and 
developing country populations was is that most of the European women were 
asymptomatic compared to those in developing countries who were in advanced disease. 
The outcome of women during pregnancy with HIV depends on the WHO stage of HIV 
and the CD4 cell count. Asymptomatic women seem to have a better outcome 
compared to symptomatic women22'227. 
The predictors for progression of HIV during pregnancy are the degree of anaemia, age 
more than 35 years and lymphopenia at sero conversion225. The laboratory predictors 
were CD4 cell count below 200/microliter, anaemia, and hypoalbuminaemia229,230. HIV 
RNA values were found to be good predictors of mortality: RNA values of 5,000- 
50,000 and greater than 50,000 copies per ml were strong predictors of death230. In the 
European studies there were no predictors for progression of HIV during pregnancy 
when patients were matched for CD4 cells and age223'22ý'231,2. 
Mode of delivery may predispose pregnant women with HIV to maternal complications. 
Emergency caesarean section has been reported to be associated with increased post 
partum morbidity such as endometritis, wound infection and pneumonia233. The 
morbidities associated with operative delivery were more severe and sometimes fatal in 
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those patients with advanced AIDS disease or those with low CD4 cell counts compared 
to women with asymptomatic HIV220'234 
The effect of HIV in the critically ill is not well-studied and as far as I know only one 
study in Ireland has examined its effect. In this study there was lower prevalence of 
infection in HIV positive women than non HIV positive women, and there were higher 
frequencies of complications in HIV negative groups as compared to the HIV 
positive235. Thus this study did not find HIV as a risk factor for severe morbidity235. 
However, this study did not report CD4 cell count and viral RNA copies in blood 
circulation despite the importance of these factors in the outcome of HIV critically ill 
obstetric patients during childbirth. 
3.3 QUALITY OF CARE AND MATERNAL MORTALITY 
It is known that delay in receiving care is crucial in the survival of the woman with 
morbidity236'237. Maternal mortality reduction has focused mainly on three delays: 
" The delay of the woman to seek medical care. 
" Delay to reach first referral facility 
" Delay in actually receiving care at the health facility'29. 
Accessibility of women to maternity services has been advocated by WHO. This 
means women in the community should be mobilised and sensitized for safe 
motherhood programmes. Following the sensitization, health units should offer 
quality care to women who attend the maternity services. The patients referred to 
referral hospitals should get treatment that can save them from severe morbidity and 
mortality. WHO has a set of clinical standards for practice in health units and 
hospitals, and these include management protocols for different obstetric 
conditions238'239. Each country is expected to make appropriate treatment guidelines 
to be used in their health institutions. Uganda has these guidelines but unfortunately 
these are not routinely used for a number of reasons such as shortage of staff, drugs 
and equipment. The process of providing treatment and monitoring of patients with 
SMM in particular in an environment with few or no intensive care units is likely to 
play an important role in the progression of SMM to maternal mortality. The delay in 
receiving care is critical in the survival of the women with SMM5,10,236,240. Quality of 
care factors usually identified in hospitals are delay to recognise an emergency 
condition, delay in starting treatment, poor judgement of the patients condition, late 
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involvement of the senior staff in case management, institutional deficiencies and 
staff attitude 217,241-243. Institutional deficiencies have been reported to be responsible 
for majority of maternal deaths in Sri Lanka242. Similar findings have been reported 
in South Africa and Tanzania21r, 244. Senior staff participation in the management of 
emergency cases sometimes comes too late to save the patients. This has been 
highlighted in the confidential inquiry of maternal deaths in the UK245 and South 
Africa217 In France SMM due to PPH was at risk of death when there was no 24 hour 
anaesthetist and obstetrician on duty108. Another study investigating quality of care 
factors before admission to ICU in a large hospital in UK identified sub-optimal care 
as major cause of severe morbidity. The care problems identified were failure of 
organisation, lack of knowledge by health workers, failure to appreciate clinical 
urgency, lack of supervision and failure to seek advice5. This study suggests that 
quality-of-care issues are very important aspects of prevention of SMM and mortality. 
In developing countries like Uganda, where 24 hour coverage is not strictly adhered to, 
shortage of staff at certain times of the day puts women at risk of death. This was 
highlighted in the study of maternal mortality in Kampala hospitals246. Shortage of staff 
and poor pays result in poor performance of staff and directly affects the outcome of 
patients, as has led to delays in attending to patients when they arrive with an 
. emergency. 
This has been reported in some developing countries130,247,248 
Management of patients during the labour period is important in detecting any warning 
signs for maternal morbidity. The partograph is a recommended tool for monitoring of 
women in labour and low prevalence of use suggests inadequate monitoring of patients. 
Low levels of patient monitoring have been reported to be associated with high maternal 
mortality217'248. 
The number of emergencies sent to a referral hospital depends on the capability of the 
neighbouring units in their provision of emergency obstetric care. When health units 
cannot offer emergency obstetric care they refer their patients to referral hospitals which 
can overwhelm it. It can lead to over-crowding and monitoring of patients becomes 
difficult because, for example, some patients are lying on the floor. This has been 
observed in Kenya249 The large numbers of patients with morbidity results in many 
emergency cases needing emergency operative deliveries. The waiting time for 
operative delivery should be is less than 30 minutes131 but a large case load often results 
in delay. The long waiting periods predisposes patients with morbidity to SMM and 
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mortality, as has been reported in Dominican Republic130and Sri Lanka242. Also, the 
large numbers of patients need expendables to be available both in the labour ward and 
the theatres, and yet these are usually in short supply. The availability of drugs is 
related to the numbers of patients and amount of money allocated to them. With 
budgetary constrains in most developing countries, there is shortage of essential drugs 
which are necessary for the survival of the patients. The lack of intravenous fluids and 
anaesthetic drugs also cause delay of operative deliveries. The shortage of drugs thus 
predisposes patients to SMM and mortality, as reported in East and West African 
countries241°247 
The advent of HIV has led to increased wastage of blood as a proportion donated blood 
is found positive. The blood banks suffer from chronic shortage of blood leading to 
increased waiting time for operation and transfusion. It is not uncommon for surgeons 
to carry out operations without adequate blood supplies, putting women at further risk 
of maternal morbidity'41. 
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CHAPTER FOUR: METHODS 
The Aims and Objectives of the study are presented in Chapter one. 
4.1 STUDY DESIGN 
The study had a two-stage design. Stage I was a prospective unmatched case-control 
study for risk factors for SMM. Stage 2 was a follow-up study of cases to investigate 
factors that put a woman with SMM at risk of progressing to maternal mortality. 
4.2 STUDY SITE 
The study was carried out in Uganda. Uganda is situated in the eastern part of Africa. 
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It lies astride the equator with a total surface area of 241,039 square kilometres. 
Uganda's population was estimated at 24.6 million by the end of 2003 with 52% of this 
being female. The rural and urban population is 86% and 14% respectively 12. The 
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Map of Africa showing the location of Uganda 
annual population growth rate is 3.2%. The life expectancy at birth is 48 years in 
females and 45 in males'2. The total fertility rate is 6.9 and contraceptive prevalence is 
estimated to be 23%12. Uganda is one of the poorest countries in the world with an 
estimated gross national product of 300 US dollars per capita per annum and only 12% 
is spent on health 250 
Map of Uganda showing the location of Mulago hospital complex in 
Kampala 
/ 
ý.. 
_, ý 
' ý7 UG DA 
- ... _.. _.. _.. ý 
ý'GAýlýý SUDAN i' 
r_ 
ý.. ý ý.. ý "-, ý KENYA r` 
.cs iii _. , 
Ii.: i. t ', 
. 
w-` 
''. 
Ki, 9ixiJo -'-_ Qü` 
/ KITGUM .,,,, r 
ýý 
''., DEMOCRATIC REPUBLIC ^-- , ---''--t ... 
-, `ý 
I 
öo'". N t. 
OF THE L.. ^VEBBI ý.... 
-ll \ ...,.. ý - 
CONGO ý' -- "" ö_r., r-"' ., ta< 
;o 
l 
nrnc LISA1 l) tn, r, es 
tiK tr. ýKwl 
r Moxuru 
z t<lý. .f" MASI\'PI ,., u - `ý , ýa I ,' All+frt ý`-1. ' 
oMrf, r, e, 
xuann ý L7_: 
I 
r'Soro I11t ONenrlu ý- 
. na! `. p 8unla i 
ý- 
_.. 
' LJ Ly 
. 
`' f 
{, 
I A. 1 u. n, * 
/ ; blr.. 'd1 . tilr `t 
ý"ysrýtr 
_tis^S' ý-+t" `ý'ýý A M! 
IK MiwI% 
,! Ht. IMA y\ýý 1. ý, 'Sý iPtrf, IRWA Uri, 
ý 
; 'ý 
ý' 
\ ý-" 
' s"'ý KfHCk: a '` 
_I 
' i. tt1(1Ltý' ý1': 1LLIýA omtw. 
ý-- 
.I ýC`ý K18ALE aKÖn. 
w L '` /ý}R. AL 
- 
OKaw 
i 
T. 
' ` ýlý P-ý 
"ý 
!, 1'. 
ý1C: ANt1A TO ._. 
'_. Zi° ~___ti if, fFý, ý^ 
iý. _ý_. rl-.. 
i^k ö+9e5' ro. w. A IBe^I0 
i 
,' KARANOi-E . ý'' 
°"A a. ' III 
I1NIA (C gu, , +ý_. ` Eleorat ý. 
_ 
(., S __ 
Kampala', rr n {RUBIA 
_. 
<KnýtýEiý.. rý 
ý_75ý`'v} MIfc: It. l, 
0 
5 
fýoý 
_ 
KENYA 
0 T. 
r 
t 1` tr ýSý D ý'ý v 
f 
_. _ ý.. yproa. 
aa 
1 
+19"., 
ýMAS Ä -sý -` 
`^'IC°rnw ý'Otol"" r ý- _-- 
J Ida. 
d. Iýrt. I SIIl '. 1 "MBAKAllA`'. .,. 
910 e ýv'ý 
jfI 
ý 
'ý 
Ji 
q a. 
ýý 
`' 
,o`, 
N`1x. %I ! 
"' 
-- KAI. ANGA LA 
I 
r' 
ý. ^ 
l_ I i} ý, r 
.i 
ý~_ R°r_ý LAKE VICTORIA -- ý, ý' 
- 
ý' 
l ýjoltewb ýKydlu ý- 
"`""- 
ý" 
_, "`ý: 
I0 National capital 
j UNITED REPUBLI 
r5o Town, village 
ý! OF . -""- International boundary RWANDA 
1 
H, n, wýe 
u«srsc 
, -_ `- 
RDA 
t boundary TANZANIA 
: 
ý. 
" aKl9ali e l. ý veorww Railroad 
'ý }"r Airport 
r "_, ý" ý -, 
ý. 
"ý+ 
'_ .r ý" 1 
^'`'ý 
_O 25 SO 75 t? O km 
7! w Cdi/MV, et NW MhMf fl, Wn Ngllwrý 
~-- 
i: \l 
ýB: 
ýRUNýý, Pfýd anOfNf rrwP do ýt"^iWy 
ýý 
25 50 7$ml 
The specific study site was Mulago Hospital, which is situated in the city of Kampala, 
Uganda. Mulago Hospital complex is a national referral and teaching hospital. It also 
acts as district hospital for Kampala City Council. 
Kampala city has a population of about two million people250 It covers an area of 250 
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square miles . Kampala City 
hosts the capital of Uganda. Kampala is a city of hills 
where you find most middle and above middle socio economic classes. The surrounding 
lower-lying areas are mainly populated by lower income people. This is the pattern in 
the whole Kampala city. It has a heterogeneous ethnicity. The majority ethnic group is 
Baganda contributing 63%, others are Banyankole, Bakiga, Batoro, Banyoro, Basoga, 
Bagisu, Iteso, Langi, Acholi and those tribes from West Nile part of Uganda250. The 
people have all levels of educational and economic status ranging from the lowest to 
the highest in the country. The majority of women in Kampala have middle and low 
level educational and economic status. About 30% of women in Kampala are involved 
in professional job and small scale commerce and the majority are peasant or full time 
house wives250. The 15 kilometre radius area used in this study covers the urban and 
peri urban areas of Kampala city and excludes rural areas. 
Mulago hospital has three labour wards: one for private paying patients only, and the 
other two for general patients (Old Mulago labour ward handling apparently low risk 
deliveries and run by midwives and the New Mulago ward handling both normal and 
complicated deliveries). Any pregnant woman in Kampala city is able to attend Mulago 
hospital for antenatal care and delivery. She is able to attend for delivery even if she did 
not attend the hospital before birth. The maternity services in these two labour wards are 
free to all. However there are sometimes shortages of essential drugs and expendables 
experienced by the hospital. Alternative places for delivery of women living in 
Kampala city are three Non-Governmental (private, paying) hospitals and 15 health 
centres with maternity care. The health centres provide basic maternity care, with 
midwives only. 
Most women who develop complications in and around Kampala city (15 Km radius) 
are referred and managed in New Mulago labour ward. These women will include 
those who had planned their delivery to be at Mulago as well as those who did not. 
Women who develop complications after twenty fours post partum are admitted to 5A 
Annex ward which is an emergency gynaecological ward. Mulago hospital has a 
twelve-bed intensive care unit, shared between the labour ward and other departments, 
and is situated in the department of anaesthesia. Admission to this unit is very 
competitive and the services are free except for renal dialysis. This means that most of 
severe maternal morbidity cases are managed in the labour ward. The hospital (all the 
three labour wards) delivered 22,927 women in 200223. Over one third of deliveries 
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(36%) are to those age below 20 years (adolescents), and the mean parity of women 
delivering in Mulago is 4.623. 
It has been estimated that 94% of all pregnant women in Uganda attend one or more 
antenatal visits, but only 37% deliver in hospital or health units 12. The Kampala birth 
survey studied all post partum women who delivered in August and September 1999 
and followed them for six weeks. The survey found that 96% of all pregnant women in 
the city of Kampala had attended antenatal care and 80% delivered in health units (43% 
in hospitals and 37% in other health units251 
In one small study carried out in Mulago hospital in 1998 to determine the prevalence of 
morbidity among the women who delivered in this hospital, 6.1 per 100 deliveries and 
7.9 morbidities per maternal death were recorded16. In 2001,148 women died of 
pregnancy related complications in Mulago hospital, making a maternal mortality ratio 
of 628 per 100,000 live births. This ratio was lower than that for 2000 which was 729 
per 100,000 live births. Both the ratios are far higher than that of the national estimate 
of 504 per 100,000 live births23,20s 
The national HIV prevalence from antenatal sentinel centres throughout Uganda the 
12 
. sites was 6.4% 
in 2002 and in Mulago hospital the prevalence was at 8.2%, 18 
4.3 ORGANISATION OF THE FIELD WORK 
Before the start of field work I obtained ethical approval for the study from Mulago 
Hospital, the Uganda National Council of Science and Technology, and the LSHTM. 
I recruited two study midwives, one laboratory technician, a pathologist, a 
microbiologist and one obstetrician who assisted me in data collection. I enlisted the 
service of one runner who transported specimens to the laboratory and collected results. 
These staff were trained and monitored (see pilot study 4.4 below). 
Meetings of the study team were held every fortnight for the first eight weeks and then 
every month for the rest of the study period. These meetings were to check on progress 
of study and answer any queries raised. 
During the study the pathologist carried out the post mortems and was attended by me 
or my assistant. He wrote a post mortem report which was put on file and sent back to 
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me for clinical note extraction. 
4.4 PILOT STUDY 
The pilot study was carried out between 25th October and 11th November 2001. The 
overall objective of the pilot was to test the study methods and logistics of data 
collection. Specific objectives were: 
1. To test the diagnostic criteria for selecting SMM cases. 
2. To translate the diagnostic criteria into operational definitions for SMM. 
3. To determine whether the sample size calculated could be achieved. 
4. To conduct interviews of cases and controls in order to assess the feasibility and 
acceptability of the questionnaire. 
5. To test the feasibility of the laboratory investigations and data exchange. 
6. To test the clinical record abstraction method. 
4.4.1 Planning meetings 
A half-day meeting was held with obstetricians and gynaecologists within the 
Department. I presented my draft case selection criteria for discussion. A consensus on 
criteria was achieved and a final document for selection of cases was drawn up. A 
second half-day meeting was held with all key players taking part in the study. Each 
person's role was defined and the day-to-day running of the study was explained 
including: the procedure for selecting cases and controls; carrying out interviews; taking 
off blood specimens; transport of specimens; examination of specimens; and record 
keeping. Asking for consent from patients, HIV pre- and post- test counselling, and 
ways of communicating with the research team was also discussed. 
4.4.2 Sensitization of staff 
The purpose and procedures of the study was explained to all ward staff to sensitize 
them to the study and to explain to them what to expect. It was explained to them that 
their co-operation was essential for the success of the study. 
4.4.3 Selection and interview of pilot subjects 
Ten cases and ten controls were recruited. I observed the selection of cases and 
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controls, interviews, and taking off blood. I verified the practicability of application of 
the selection criteria and verified their use and implementation by the assistant PI. 
Together we examined the cases, carried out data extraction from clinical files and 
followed up laboratory investigation processes. Analysis of the ten cases and controls 
was performed and the following corrections were made to the questionnaire: increasing 
some options for questions, dropping some questions because they were not relevant, 
and re-phrasing some questions. 
Some logistic changes were made, such as recruiting a runner to deliver all specimens to 
the laboratory and collecting results. Blood for screening for HIV was taken to a larger 
clinical research centre outside the hospital because it also had facilities carry out CD4 
cell counts. We also requested an assistant pathologist to be part of the team in case the 
senior pathologist was not available to carry a post mortems. We included the ten pilot 
cases in the main study database due to shortage of case numbers. 
4.5 STAGE ONE: CASE CONTROL STUDY OF SEVERE MATERNAL 
MORBIDITY 
4.5.1 Study population 
The study population was women of 24 or more weeks of gestation who delivered 
infants at Mulago hospital or arrived in puerperium between 15th November 2001 and 
30th November 2002 and who lived within a radius of 15 kilometres from the hospital. 
4.5.2 Definition of cases 
All cases were recruited after admission to the labour suite of New Mulago hospital and 
5A Annex ward. Cases of SMM were women who developed severe obstetric 
complications during pregnancy from 24 weeks of gestation to end of puerperium. 
Gestation was ascertained by weeks of amenorrhoea, clinical examination and whenever 
possible by ultrasound scan. 
Development of selection criteria 
The selection criteria were developed in the following way. Firstly, Medline was 
searched using the words: severe maternal morbidity, obstetric intensive care admission, 
near miss, HELLP syndrome, eclampsia, obstructed labour, ruptured uterus, post partum 
haemorrhage, abruptio placenta, placenta praevia, puerperal sepsis and medical diseases 
such as anaemia, cardio pulmonary failure, coma and renal failure. Those conditions 
that were difficult to diagnose, such as amniotic embolism, were excluded. 
Next, these published criteria were presented to a team of obstetricians and 
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gynaecologists from Mulago hospital. Each criterion was evaluated and agreed by the 
obstetric team. Key changes to the published criteria were the inclusion of some 
clinically-based and routinely measured events in Mulago hospital. The main changes 
were the amount of blood transfused, which was put at two units taking in consideration 
the shortage of blood, and two units of intravenous fluids for the same reason. For 
obstructed labour the presence of bandl's ring and maternal distress to dehydration was 
emphasized. For cardiac and lung diseases it was agreed that there must be clinical 
evidence of cardio pulmonary failure requiring resuscitation with oxygen. 
The following text lists the criteria as developed above: 
Severe pre-eclampsia 
The cases for severe hypertension had the following: 
" Hypertension of equal or more than 160/110 mmhg on two occasions at least 
four hours a part, and 
" Urine protein of 2+ on dipstick. 
Plus any two or more of the following: 
" Epigastric pain or right upper quadrant pain or tenderness, 
" Visual disturbances (flashing of light or blurring of vision), 
" Severe headache, 
" Oliguria defined as urinary out put of less than 100 mis during any four hour 
period of admission, 
" Pulmonary oedema clinically diagnosed, 
" An episode of jaundice diagnosed clinically. 
Eclampsia 
This was classified as: 
" Hypertension indicated by blood pressure of equal or more than 140/90mmhg, 
with 
" Convulsion or generalised fit during pregnancy or in first seven days post 
partum. 
Plus any two or more the following: 
" Urine protein of 2+ dipstick, 
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9 Increased aminotransferase of more than or equal to 40 U/I, 
" Serum uric acid of 6.0 mg or greater per dl. 
Postpartum haemorrhage 
This was classified as vaginal bleeding post partum of more than 500mls with any two 
of the following: 
" An episode of shock with a systolic blood pressure of equal to or less than 
90mmhg and a pulse rate of 100/min small volume or more, 
" An intravenous therapy of two or more units of blood, 
" An intravenous therapy of fluids of two or more litres. 
OR had one of the following emergency operations: 
" Evacuation of the uterus, 
" Manual removal of the placenta, 
" Cervical repair, 
" Laparotomy for hysterectomy or ligation of pelvic major vessels. 
Obstructed labour 
This was characterised by failure of descent of the presenting part despite strong uterine 
contractions because of mechanical obstruction due to either cephalo pelvic 
disproportion or soft tissue, or an abnormal presentation or lie. Additionally at least one 
of the following needed to be present: 
" Maternal distress characterised by dehydration, temperature of 38°C and 
restlessness, 
" Uterine signs of obstruction characterised by hypotonia of uterus in 
primigravidae and hypertonic uterus or bandl's ring, 
" Genital tract signs of obstruction as defined by infected liquor and vulva oedema 
or urinary haematuria. 
Ruptured uterus 
All cases diagnosed with ruptured uterus were recruited as cases of SMM. 
Placenta praevia 
This was classified as: 
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" Vaginal bleeding which is painless before delivery, with 
" An episode of shock with a systolic blood pressure of equal to or less than 
90mmhg and a pulse rate of 100 or more beats per min and of small volume. 
Additionally, one or more of the following was necessary: 
" An intravenous therapy of two or more units of blood, 
" An intravenous therapy of fluids of two or more litres. 
Abruptio placenta 
Was characterised by the following: 
" Vaginal bleeding or concealed bleeding, 
" Abdominal pain and abdominal tenderness, 
" An episode of shock with a systolic blood pressure of equal or less than 
90mmhg and a pulse rate of 100 or more beats per minute and of small volume, 
and 
" Retro placental clot at delivery of placenta. 
With any one of the following: 
" An intravenous therapy of two or more units of blood, 
" An intravenous therapy of fluids of two or more litres. 
Puerperal sepsis 
This was infection in current pregnancy, or recent pregnancy, with infection arising 
from genital tract characterised by: 
" Temperature of 38.5°C or more, or less than 36°C, 
" Evidence of shock with systolic blood pressure of less than 90mmhg and pulse 
rate of more than 100 beats per minute in absence other causes of hypotension, 
" White cell count of more than 1 5x 109 /L, and 
" Positive swab culture. 
'With any one of the following: 
" Acute alteration of mental state characterised by confusion or restlessness, 
" An episode of oliguria defined as urine output of less than 100mis in 4 hours, 
" Clinical jaundice, 
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" Uterine evacuation, 
" Laparotomy for pelvic abscess. 
Maternal anaemia 
This was characterised by haemoglobin level less than 7 grams per decilitre with any 
two or more of the following: 
" Diagnosed with heart failure, 
" Diagnosed to have haemolysis as evidenced by worsening pallor and jaundice, 
" Blood transfusion of two or more units of blood within 24 hours, 
" Sickle cell crisis. 
Maternal cardiac disease 
This was characterised by confirmed (diagnosed) cardiac heart lesion (pathology) with 
any one or more of the following: 
" Diagnosed with being in heart failure, 
" Fever of 38.0°C or more, 
" Blood pressure of more than 130/90mmhg, 
" Episode of jaundice, 
" Petichael haemorrhages. 
Maternal pulmonary disease 
This was characterised by evidence from clinical and chest x-ray of lung disease with 
acute respiratory failure needing oxygen with or without fever of 38°C or more. 
Maternal meningitis 
This was characterised by fever of 38°C, severe headache, neck stiffness and positive 
kerning's sign with or without comma or coma only. 
4.5.3 Selection and recruitment of cases 
All cases matching one or more of the criteria outlined above (and living within 15 km 
form the hospital) were included in the study. The cases were selected on a daily basis 
as they arose. One study midwife was based in the labour suite during the day to 
identify the cases and notify the PI for verification. The doctors and staff working in 
the labour suite would also notify the study midwife on duty in the labour suite, or the 
principal investigator (PI) or his assistant, either by sending a person or by phone about 
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a case in the labour ward. The PI or assistant checked the labour suite from time-to- 
time to identify any SMM cases admitted and to verify whether the identified cases 
satisfied the selection criteria. Figure 4.1 illustrates the selection of cases. 
Recruited cases were told about the study and asked to give consent. Most of the cases 
were too sick to give consent or be interviewed, and the husband, spouse, or the first 
relative were given information about the study and requested to give consent. The 
patients were asked for consent later when their conditions improved. For those whose 
condition did not improve we used the information from the spouse or relative and case 
records. 
4.5.4 Eligibility of controls 
Controls were selected from the study population of women of 24 or more weeks of 
gestation who delivered infants at Mulago hospital or in puerperium between 15th 
November 2001 and 30th November 2002 and who lived within a radius of 15 
kilometres from the hospital. Controls must have had a normal vaginal delivery to a 
singleton live baby, not had an episiotomy or tear of more than first degree, and the 
blood loss should have been normal. 
4.5.5 Selection and recruitment of controls 
The controls were selected on a daily basis during the time of study. Controls were 
unmatched and the aim was to obtain the same number of controls as cases. Two 
controls were selected daily by the study midwife. Every mid morning except Sunday a 
list of women who had had normal deliveries (as defined in 4.5.4 above) was used to 
choose two women to join the study. The two were selected randomly from the list 
using computer generated numbers. The selected women were told about the purpose of 
the study and, if they agreed to take part, the midwife used a checklist to ensure that 
they satisfied the selection criteria. Those who refused to join the study or did not 
satisfy the selection criteria were dropped and another woman, or women, selected. 
Figure 4.1 illustrates the selection of controls. 
Control women were told about the study and also given an information sheet about the 
study to read. The information sheets were in English and local dialect (Luganda). 
Those who could not read English were given the translated version of information 
sheet. For those who did not know how to read, the study midwife read the information 
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sheet to them in the local dialect. They were told about the laboratory investigations 
which were carried out. They were specifically counselled on voluntary testing for 
HIV. They were told about the option to know, or not to know, their HIV status. Those 
who accepted to know their results were given post HIV test counselling. They were 
then asked to give a written consent. 
4.5.6 Data collection 
Each case and control was assigned a unique study number. 
Interview of cases and controls using questionnaire 
The cases or the proxy and controls were interviewed using a pre-coded questionnaire 
(see Appendix A, Questionnaire A). Questions covered items of information on socio 
demographic factors, family social history, medical and surgical history, past obstetric 
performance and present obstetric outcomes. For those who are admitted when too sick, 
in a coma, or died soon after recruitment, the interview was conducted with the husband 
or the first relative. However those who recovered were interviewed before or on day of 
discharge. 
Note abstraction from medical records 
The following data was extracted from medical records for cases and controls by me or 
my assistant. Items of information included: 
" Medical history, 
" Clinical examination and management records, 
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A typical interview session in labour ward 
" Follow up records of patients until discharge or death, 
" Causes of morbidity and outcomes(cases only), 
" Admission to intensive care records (cases only). 
The data were recorded on the questionnaire. 
4.5.7 Laboratory investigations 
Taking blood specimens for laboratory investigations 
After the interview 10 mis of blood was taken off from the cubital area using a 
vacutainer under sterile procedure for laboratory investigations. Eight mis was put in 
the purple sequestreen bottles for HIV and syphilis testing and 2 mis put in red 
sequestreen bottles for full haemogramme. The bottles were labelled with the study 
number and taken to the laboratory with request forms. The following investigations 
were performed. 
Human immunodeficiency virus test 
The HIV screening test was carried out on daily basis on all cases and controls using 
Determine test (Abbott Laboratories, Abbott Park, IL). This was an 
immunochromatographic test for qualitative detection of HIV-1/2. The test was 
performed by applying 50u1 of serum to the test pad at the bottom of the strip. The 
sample then migrates, reconstitutes and mixes with the selenium colloid antigen 
conjugate. The mixture then continues to migrate through a sold phase until it reaches 
immobilized recombinant antigens and synthetic peptides in the patient window site. If 
antibodies to HIV are present, a red line forms in the patient window. If the antibodies 
to HIV 1/2 are absent, the antigen selenium colloid will flow past the patient window, 
and no red line is formed. The results of the strip were interpreted visually. A 
procedural control window is included on each strip where red line forms to ensure 
quality control of individual strips. 
Among the cases those whose HIV test was positive their blood was further analysed for 
CD4 and CD8 cell counts. ; 
The CD4 cell counts were carried out using a flow 
cytometer, (cyflowR). This test was carried out within 48 hours of getting the sample 
from 
. patients. 
The flow cytometer used volumetric absolute counting using 
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immunolabelling of the cells to obtain the absolute count of CD4 and CD8. 
Syphilis test 
The disease syphilis is caused by a spirochaete Trepanema Pallidum. This is a sexually 
transmitted infection but can also be transmitted through blood transfusion with infected 
blood. 
The tests used include VDRL carbon antigen and TPHA for confirmation from Biotech 
laboratories. The VDRL carbon antigen is a modified form of VDRL antigen 
containing micro particulate carbon to enhance visual reading of results. The reagent, 
non trepaonemal antigen, consists of cardiolipin lecithin which will flocculate when 
exposed to patient serum containing reagin found in syphilitic patients. The test is read 
microscopically. The tests which are reactive are further exposed to TPHA which uses 
preserved avian erythrocytes coated with antigens of Trepanema pallidum. When 
mixed with patients' serum which contains reagin there is haemoagglutination. 
Complete blood count 
We used a coulter R MAXM automated haematology counter from Beckman coulter. 
The instrument measured the white blood cell count and its differential, red blood cell 
count, haemoglobin concentration, haematocrit, mean corpuscular volume, and mean 
corpuscular haemoglobin concentration and platelet count. Those cases with 
haemoglobin level less than 10 grams per decilitre had a blood film to study the blood 
picture. 
Specific tests for diagnosis of SMM 
Specific investigations were done on certain cases to confirm the diagnoses. For severe 
hypertension and eclampsia blood was taken to assess serum uric acid and aspartate 
aminotransferase. Urine was tested for protein. In puerperal sepsis a high vaginal swab 
or abdominal swab was taken for culture and sensitivity. 
4.5.8 Daily follow up of cases and controls 
The controls were checked before they were discharged (usually the day after delivery) 
by a midwife. At discharge they were given post HIV counselling test and those who 
wanted to know their HIV status were told. Those who were anaemic or had syphilis 
were treated. 
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The cases were checked daily until discharge or death. The midwife checked on the 
general condition of patients, talking to relatives and checking ward reports on the 
performance of the patient and reported the findings to the PI or assistant. The PI or 
assistant did not carry out this follow-up of cases because it could have influenced on 
the management of patients. 
On the day of discharge, the cases who had not been interviewed because of they were 
too sick were interviewed. They were given post HIV test counselling and those who 
wanted to know their HIV status were told. Those who were anaemic or had syphilis 
were treated. The files were collected and information on quality of care was extracted 
by the PI and filled in the questionnaire. 
For the cases that progressed to death a post mortem was requested and carried out by 
the pathology team to confirm the cause of death. The post mortem findings and 
patients' case notes were given back to the PI for extraction of information on 
management of patients and final causes of death. 
4.6 STAGE TWO: FOLLOW-UP STUDY OF SEVERE MATERNAL 
MORBIDITY CASES 
4.6.1 Study population 
All women recruited as cases of SMM into the first (case-control) stage were followed 
up until discharge from hospital or death (See 4.5.8). 
4.6.2 Definition of outcome 
The outcome definition was maternal death. 
4.6.3 Data collection 
One obstetrician was trained to assist in data extraction from the clinical notes. At 
discharge or death information on the clinical management of the severe morbidity 
cases was extracted from the files using an extension of the Stage l (case-control) 
questionnaire (Appendix A Questionnaire B). The following information was extracted 
from the files: 
"' Waiting time for operation, 
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" Causes of delay to have operative delivery, 
" Time of examination of patient by obstetrician on duty, 
" Times of monitoring of vital signs of patients, 
" Frequency of checking for vaginal bleeding, 
" Availability of drugs and blood when needed, 
" Post mortem results. 
4.7 SAMPLE SIZE AND POWER 
4.7.1 Stage 1: Case-control study 
Sample size was calculated prior to the conducting the study using the estimated 
number of deliveries in Mulago hospital for the year 1999. In that year there were 
around 20,000 deliveries and 157 maternal deaths (7.9 per 1,000 deliveries)252. Since 
the study was restricted to women who lived within 15 kilometres from the hospital, the 
estimated number of deliveries was 60-70% of the total deliveries, making the estimated 
number of eligible deliveries 13,000. Maternal mortality was likely to be associated 
with distance from hospital (increasing risk the further away the woman lives), so to 
allow for the exclusion of women living over 15 kilometres from the hospital, a more 
conservative estimate of maternal mortality of 5.5 per 1,000 live births was used in 
these calculations, which is similar to the recent population estimate of 5.06 per 1,000 
204 live births for the whole country of Uganda in 1995 
Thus, around 72 maternal deaths in an estimated 13,000 deliveries among women living 
within 15 kilometres from Mulago hospital were expected in one year. Using the results 
of a small study done in Mulago16 and a West African study on SMM39, the expected 
ratio of SMM to mortality was estimated to be 7: 1. Thus with an estimated 72 maternal 
deaths among eligible women, approximately of 500 cases of SMM (all causes) could 
be recruited in one year in Mulago hospital. 
With 500 cases and an equal number of controls, and taking a risk factor with 
prevalence of 30% in the population (such as nulliparity), the case-control study was 
estimated to have over 99% power to detect odds ratio of 2 and 85% power to detect 
odds ratio of 1.5 at the level of 5% of significance (see table 4.1A). For a risk factor 
such as HIV infection, which has an estimated prevalence in the population of a round 
12%, the case-control study would have 95% and 55% power to detect odds ratio of 2 
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and 1.5 respectively. 
For individual causes of SMM the estimated numbers of cases were calculated from the 
prevalence reported in West Africa39 and in a small Mulago study 16. An average was 
calculated and used in the calculations (Table 4.1B). For cases with haemorrhage the 
estimated number was 143 cases. With 500 controls there was good power to detect a 
doubling of risk or higher (table 4.1 C) over a range of exposure prevalence. The 
estimated number of cases with eclampsia was only 65 cases, and with 500 controls, the 
study would have limited power to detect a doubling of risk (table 4.1D). 
4.7.2 Stage 2: Follow up study 
As described above the expected number of maternal deaths was 72 over the study 
period. A study with 72 maternal deaths and 428 survivors would have good power to 
detect an odds ratio of 3.0 and above (table 4.2) over the range of exposure prevalence 
expected. 
4.8 DATA PROCESSING AND ANALYSIS 
4.8.1 Data processing 
My role in data processing is described in appendix D. The data collected was checked, 
coded and double entered using Epi-Info software. The data was cleaned and 
transferred to Stata 8 where it was merged. 
4.8.2 Definition of outcomes for case-control study 
Cases were assigned a primary diagnosis, e. g. eclampsia or haemorrhage, and secondary 
diagnoses, as appropriate. The primary outcome was all-cause SMM and for this all 
women identified and recruited as cases were used and compared to the control women. 
Secondary outcomes were defined as: 
" Severe pre eclampsia and eclampsia, 
" Post partum haemorrhage, 
" Obstructed labour, 
"_ Ruptured uterus, 
" Abruptio placenta, 
" Placenta praevia. 
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For each secondary outcome the relevant subset of cases was compared with all 
controls. When categorising women as cases both primary and secondary diagnoses 
were taken into account, and thus women could be considered cases for more than one 
secondary outcome. 
4.8.3 Definition of exposures for case-control study 
The main exposures of interest were the socio demographic characteristics, social and 
family history, past obstetric history, and present obstetric performance and laboratory 
results. The majority of variables were pre-coded on the questionnaire (see Appendix 
A). Others required coding as follows: 
" Age of patients was grouped as below 20,20-29,30-34 and 35 or more years, 
" Distance from Mulago was grouped as five kilometres and under, more than five 
and less than ten kilometres, and between ten and fifteen kilometres, 
9 Tribe was grouped as Bantu and Nilotics, 
" Educational level was grouped according to the educational system in Uganda of 
nil, primary, secondary and post secondary, 
" Spouse and patient's jobs were grouped as employed and peasants (not paid), 
" Parity was grouped as primiparous, 2-5 and more than 5, 
" Birth interval was grouped as less than 36 months, 37-60 months and more than 
60 months, 
" Birth weight was grouped as below 2500,2500-3500 and more than 3500 grams. 
A hierarchy of exposures was developed to compare variables which may act at the 
same level. Variables were grouped together if they were thought to measure similar 
exposures: 
The first level included socio demographic exposures (variables in brackets were 
thought to be highly correlated and thus not independent): 
1. Variables measuring distance from hospital and nearest health unit (distance 
from Mulago to home and distance to the nearest health centre), 
2. Marital status (Married and living together), 
3. Social grouping (Tribe and religion), 
4. Socio economic class (type of house, utilities in the house, educational level, 
patient's job, husband's job, ownership of house, paying for health services), 
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5. Requesting permission (asking for permission before visiting health unit, who 
gives permission). 
The second level was Social, Family and Medical History: 
1. Familial diseases (Hypertension, Diabetes mellitus and epilepsy in family or 
self), 
2. Social behaviour (Drinking of alcohol, smoking). 
At the next level were variables associated with previous obstetric performance: 
1. Abortion, 
2. Bleeding during pregnancy, 
3. Bleeding in labour, 
4. Hypertension during pregnancy, 
5. Prolonged labour, 
6. Stillborn baby, 
7. Delivery by instruments (Caesarean section, vacuum extraction, forceps 
delivery), 
8. Postpartum haemorrhage, 
9. Retained placenta, 
10. Blood transfusion. 
At the next level were variables associated with present obstetric performance: 
1. Parity, 
2. Birth spacing, 
3. Antenatal attendance (booking time, number of visits, response to vaginal 
bleeding during pregnancy), 
4. Antenatal diagnosis of hypertension and anaemia, 
: 5. Referral, 
6. Length of labour, 
7. Mode of delivery, 
--'8. ., Birth weight and sex of baby. 
At the final level were variables associated with laboratory investigations: 
1. HIV test, 
2. Syphilis, 
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3. Complete blood count. 
4.8.4 Analysis of case-control study 
Univariate analysis 
Distributions of each exposure (number, percentage) were presented for cases and 
controls. Odds ratios were calculated and Chi-squared tests used to test the statistical 
significance. 
Logistic regression 
Logistic regression was used to establish the strength of association between exposure 
variables and SMM. Logistic regression uses the log odds ratio and all associations are 
presented as odds ratio with corresponding 95% confidence intervals. Odds ratios of 
greater than one represents an increased risk of SMM in that exposure compared to the 
baseline category. The significance of an association between an exposure factor and 
SMM was assessed using the likelihood ratio test253. The baseline level was usually the 
exposure level with the highest number of cases and controls. 
The objective of the study was to assess the independent contribution of exposure 
variables to SMM. Multiple logistic regression analysis was performed to identify 
independent exposure variables after controlling for other risk factors and potential 
confounders. Multiple logistic regressions is an analysis that takes into account a 
number of variables simultaneously, describing most efficiently the association between 
the exposures of interest and the disease254. 
A conceptual framework was used to identify variables within the hierarchical 
relationship of exposure risk factors described in 4.8.3 above. 
For socio demographic variables, which were grouped together according to the type of 
exposure, e. g. exposures measuring socioeconomic class, each factor within the group 
was tested using the likelihood ratio test to identify which explained the most variation. 
This would then be the chosen exposure variable to represent that group. Some factors 
which were not statistically significant but which were thought to be important in the 
conceptual framework were included in the final set of exposure variables representing 
socio demographic characteristics. 
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The multivariate modelling was an iterative process. Selection of variables into the 
initial multivariate model was based on a p-value of <0.25 obtained from bivariate 
analyses, as recommended by Hosmer and Lamesho255. Variables with such p-values 
were included in the analysis because, although the variable may be only weakly 
associated with the outcome by itself, it may become an important predictor of an 
outcome when taken together with other variables. Variables were taken out of the 
initial multivariate model one by one, and significance in the presence of all other 
variables in the model was assessed using the likelihood ratio test. Variables with a p- 
value of <0.1 were left in the model, and the model was then refitted. This process was 
repeated until all variables left in the model were either statistically significant at the 
95% level or were considered too epidemiologically important to leave out. 
The process of hierarchical selection and logistic regression was repeated for subsets of 
individual causes of SMM. 
4.8.5 Analysis of Stage 2: Follow up study 
Analysis of stage two followed the same pattern as stage one, the case-control study. 
The only difference was that the "cases" were those SMM patients who died and the 
"controls" were the SMM patients who survived. In the hierarchical analysis the quality 
of care exposure variables were included in this part of analysis. The quality of care 
factors were: 
1. Availability of blood, 
2. Use prophylactic antibiotics, 
3. Availability of drugs(magnesium sulphate and antibiotics), 
4. Coverage of labour ward by obstetricians on duty, 
5. Monitoring of patients, 
6. Time spent waiting for operation, 
7. Causes of delay of operation. 
4.9 Ethics and informed consent 
Permission was sought and granted from the ethical committees of London school of 
Hygiene and Tropical Medicine, Mulago Hospital and the Uganda national council of 
science and technology. Study participants were told about the study and written 
consent obtained. The patients were given voluntary counselling before being tested for 
HIV and a post HIV counselling session before being given the HIV results. For those 
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who were too sick to consent for HIV testing their husband or first relative consented 
for them and the patient's consent was sought after recovery or at discharge. For those 
who died consent was requested from the husband or first relative. 
$ .. 
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Table 4.1 Calculations of sample size and power prior to conducting the study: 
STAGE I Case-control study 
A. Power for all causes of SMM 
For 500 cases and 500 controls the power was as follows: 
Prevalence of exposure ODDS RATIO OF SMM 
1.5 2.0 2.5 3.0 3.5 4.0 
30% (e. g. nulliparity) >84% >99.5% 100% 100% 100% 100% 
12% (e. g. HIV) 57% 97.5% 99.5% 100% 100% 100% 
B. Estimated number of specific cases of SMM 
Cause of severe 
morbidity 
Expected percentage of causes 
of SMM among total deliveries 
Estimate 
used for 
Estimated number 
of individual cause 
Mulago 1999 Burkina Faso sample size 
calculation 
of SMM 
1999 
Haemorrhage 1.44 0.80 1.10 ( 13 ,000 x1 .10 )=1 
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Sepsis 1.24 0.50 0.80 (13,000x0.80)=104 
Eclampsia 0.33 0.64 0.50 (13,000x0.50)=65 
Dystocia 0.31 1.98 0.70 (13,000x0.70)=91 
Anaemia 0.42 - 0.42 (13,000x0.42)=55 
Other 42 
C. Power for specific cause of SMM: Haemorrhage 
For 143 cases and 500 controls the power is as follows: 
Prevalence of exposure ODDS RATIO HAEMORRHAGE 
1.5 2.0 2.5 3.0 3.5 4.0 
30% (e. g. nulliparity) >50% >93% 99.5% '99.5% 100% 100% 
12% (e. g. HIV) 30.5% 75% 94% 99% 100% 100% 
1). Power for specific cause SMM: Eclampsia 
For 65 cases and 500 controls the power is as follows: 
Prevalence of exposure ODDS RATIO ECLAMPSIA 
1.5 2.0 2.5 3.0 3.5 4.0 
30% (e. g. nulliparity) >28% >69% 91% >98.5% 99.6% 100% 
12% (e. g. HIV) 37.0% 69.5% 88.4% 96% 98.7% 99.5% 
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Table 4.2 Calculations of sample size and power prior to conducting the study: 
STAGE 2 Follow-up study 
For 72 maternal deaths and 428 survivors the power is as follows: 
Prevalence of exposure ODDS RATIO MATERNAL MORTALITY 
1.5 2.0 2.5 3.0 3.5 4.0 
50% e. g. Failure to get 
blood in 50% cases 
49% 69% 96% 100% 100% 100% 
10% e. g. Failure to get 
blood in 10% cases 
23% 64% 88.4% 91% 99% 100% 
Figure 4.1 Summary of recruitment of study participants 
All women delivering in Mulago 
hospital 
Women who satisfied the following criteria: 
" Within a radius of 15km from 
Mulago hospital 
" pregnancy of 24 weeks to 
puerperium 
" Consent to participate 
Cases: 
Women who satisfied selection 
criteria for each cause of 
severe morbidity 
Data collection 
" Interview 
" Blood for 
investigations 
" Treatment protocol 
Death II Alive at 
discharge 
Controls: 
" Normal delivery 
" Live birth 
" Singleton 
Data collection 
" Interviews 
" Blood 
investigations 
Alive at 
discharge 
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CHAPTER FIVE: RESULTS FROM STAGE 1 CASE- 
CONTROL STUDY OF SEVERE MATERNAL MORBIDITY 
Cases were recruited over a twelve and a half month period from 15`h November 2001 
to 30th November 2002. During this period Mulago hospital delivered a total of 22,827 
women and the caesarean section rate was 14.9%. There were 22,059 live births. The 
hospital had a total of 843 SMM patients recorded and there were 61 maternal deaths. 
5.1 RECRUITMENT OF CASES AND CONTROLS 
A total of 499 women satisfied the selection criteria as cases for the study and all these 
eligible cases were recruited. Five hundred and twelve women who satisfied the control 
selection criteria were selected as controls for the study. Twelve of these women 
declined to take part in the study because they did not want to be screened for HIV, 
leaving a total of 500 women successfully recruited as controls. 
5.2 CAUSES OF SMM IN CASES 
Causes of SMM were recorded for each of the 499 cases (table 5.1 and figure 5.1). The 
majority of cases (87%) had one cause recorded. The remainder (13%) had ä primary 
cause plus one or more additional causes recorded during the course of admission. A 
total of 565 individual causes were recorded (table 5.1 and figure 5.1). Severe pre- 
eclampsia and eclampsia, post partum haemorrhage, obstructed labour, abruptio 
placenta and puerperal sepsis appeared as both primary and secondary causes, but 
placenta praevia and ruptured uterus were only ever recorded as primary causes. The 
main primary direct causes of SMM were pre-eclampsia and eclampsia (25% of cases), 
obstructed labour and ruptured uterus (31%), post partum haemorrhage (19%), ante 
partum haemorrhage (abruption placenta and placenta praevia) (14%), and puerperal 
sepsis (5%). The indirect causes were anaemia (4%) and conditions such as meningitis, 
cardiac disease and pneumonia (2%) (see figure 5.2). The vast majority of cases thus 
had a direct obstetric cause (93%) related to a condition or conditions arising in 
pregnancy and only a minority (7%) of cases had an indirect cause. 
5.3 ANALYSIS OF ALL-CAUSE SEVERE MATERNAL MORBIDITY 
5.3.1 Characteristics of cases and controls (univariate analysis) 
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Table 5.2 describes the characteristics of all SMM (499 cases) and normal deliveries 
(500 controls). 
Socio demographic characteristics (table 5.2i) 
The majority of the controls (82%) lived within a radius of 5 kilometres from Mulago 
hospital compared to just under half the cases, and only a small proportion of the 
controls (2.2%) lived more than 10 kilometres from Mulago hospital in contrast to 15% 
of cases (table 5.2i) (crude OR for over 10 km compared to <= 5km =11.6,95% Cl 6. to 
22.3). The mean distance in kilometres from home to hospital for controls was 4.2 (SD 
2.5) km compared to the mean distance for cases of 6.7 (SD 3.66) km (P <0.001). A 
similar pattern was seen for the distance from home to the nearest health unit (crude OR 
=12.2,95% Cl 6.5 to 24.4). 
Both cases and controls were young compared to maternities in developed world, with 
30% below the age of twenty years. The mean age for the controls was 23.4 (SD = 5.7 
years) which was similar to the mean age of cases of 23.4 (SD = 4years, P>0.05). The 
vast majority (80%) of both cases and controls were below the age of 30 years. A 
similar proportion of cases and controls (81% and 85% respectively) were either 
married or lived as married. The educational level of both cases and controls was low, 
with 60% having no, or only primary, education. The mean years spent in school for 
cases was 7.6 (SD =2 years) and for controls 7.4 (SD = 2.6 years) (P>0.18). Only 6% 
of cases and with 3% of controls had spent more than 12 years in school. The low 
educational status was reflected in the type of jobs the cases and controls had: Over 
70% of both the cases and controls were peasants. However, 6% cases compared with 
3% controls had professional jobs (crude OR professional compared with peasant = 2.5, 
95% CI 1.3 to 4.6). 
Around two-thirds of both cases and controls were Anglicans or Catholics, but the 
proportion of Muslims was lower in cases (26%) than in controls (32%). Tribes in 
Uganda are categorized into two major groups using language and place of origin. The 
Bantu (Baganda, Basoga, Bagisu, Banyankole, Banyoro and Batoro) are tribes from the 
Southern and Western part of Uganda and Nilotics are tribes from the North and North 
Eastern Uganda. A higher proportion of cases (14%) than controls (9%) were Nilotics 
(crude OR =1.6; 95% CI 1.1 to 2.5). ,- 
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Overall, the controls lived in better housing than the cases, with 83% living in plastered 
brick houses with iron or tiled roofs compared to 51 % of the cases. Fourteen percent of 
cases and 3% of controls lived in poor quality houses of mud with or without iron roof 
(crude OR for poor housing versus better housing = 7.9,95% CI 4.3 to 14.2). 
A higher proportion of cases (33%) compared to controls (9%) asked for permission 
before they could attend a health facility (crude OR = 4.7,95% CI 3.3 to 6.7). Among 
those who asked for permission, more than 80% of both the cases and controls asked 
permission from their spouses and less than 20% from their parents or parents in law. 
The financial contribution to health care was mostly made by the spouse and patient 
together (84% in cases and 80% in controls). The other contributors were the patient's 
parents and relatives or the spouse's parents or relatives (crude OR for others paying = 
2.9,95% CI 1.9 to 4.2). 
Social, family and medical history characteristics (table 5.2ii) 
Approximately one fifth of cases (21%) drank alcohol compared to over one quarter 
(27%) of controls (crude OR = 0.7,95% CI 0.5-0.9). Those who drank alcohol had less 
than 14 units of alcohol per week. Smoking in Ugandan women is rare and as shown in 
this study group: Less than 0.5% of cases and controls reported smoking. The reported 
prevalence of familial hypertension and diabetes mellitus was similar in both the cases 
and controls: around 40% for hypertension and 12% for diabetes mellitus. Existing 
hypertension was reported in 23 cases (5%) but only 2 controls (0.4%) (crude OR = 
12.0,95% CI 2.8 to 51.3). 
Past obstetric performance (table 5.2iii) 
Three hundred and fourteen cases (63%) and 350 controls (70%) were multiparous 
(table 5.2iv). A previous history of evacuation or dilation of uterus was carried out on 
7% cases and 4% controls (crude OR = 1.8,95% CI 1.2 to 4.5). Also a higher 
proportion of cases had one or more caesarean section in a previous pregnancy (19%) 
compared to controls (4.0%) (crude OR = 5.4,95% CI 2.9 to 10.2). About 10% cases 
and 7% controls had had a stillbirth in a previous pregnancy (crude OR = 1.6,95% CI 
0.9 to 2.9) and 16 cases (5%) and 4 controls (1%) had been transfused in their previous 
pregnancies (crude OR = 4.7,95% CI 1.4 to 16.6). Fifteen percent of cases and 11% of 
the controls had bleeding in a previous pregnancy (crude OR = 1.5,95% CI 1.0 to 2.5). 
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Characteristics of current pregnancy (table 5.2iv) 
The mean parity of the controls was 2.8 (SD = 0.81) compared to 2.6 (SD = 0.76) for 
cases. About a third of cases and controls were primiparous (crude OR = 1.3,95% CI 
1.0 to 1.7), and 17% cases and 23% controls were grand multiparous (parity>5). About 
50% of SMM cases occurred in what was thought to be safe parity of two to five. 
In multigravida the interval between the last born and current pregnancy was longer in 
cases than controls. Twenty percent of cases reported an interval of more than 60 
months compared to 12% of controls (crude OR = 1.8,95% CI 1.1 to 2.8). The 
majority of cases and controls attended antenatal care but a high proportion of cases 
(12%) compared to controls (3%) never attended (crude OR = 4.5,95% CI 2.5 to 8.4). 
Although antenatal care attendance was high, 60% of controls and 55% of cases had had 
less than four antenatal visits. A third of both the cases and controls who attended 
antenatal care booked in the third trimester. When the cases and controls were asked 
about what they would do if they suffered vaginal bleeding during pregnancy, three 
quarters of cases but nearly all controls knew that they should go to hospital 
immediately (crude OR for not knowing compared to knowing = 8.7,95% 5.3 to 14.3). 
As expected, significantly higher proportions of cases than controls were diagnosed 
with hypertension (crude OR = 16.9,95% CI 7.7 to 36.9), anaemia (crude OR = 5.0, 
95% CI 1.7 to 14.7), and vaginal bleeding during pregnancy (crude OR = 4.8,95% CI 
1.4 to 16.7). 
Mulago hospital is a referral hospital and received 53% of cases compared to 17% of 
the controls as referred patients (crude OR for being referred patient = 5.5,95% Cl 4.1 
to 7.4). The reasons for referral in controls are shown in table 4 of appendix C. The use 
of a partograph was uncommon in both the cases (7%) and controls (9%) (crude OR for 
use = 0.8,95% CI 0.5 to 1.3). The majority of cases had longer first stage of labour 
(crude OR for > 18 hours = 2.7,95% CI 1.6 to 4.6) and third stages of labour (crude OR 
for > 25 minutes = 18.4,95% CI 3.8 to 89.6) compared to controls. 
Only 36% of cases had spontaneous vaginal delivery compared to 100% of controls. 
The remaining cases were delivered by caesarean section (51.5%), laparotomy (11.2%) 
and vacuum (1.2%). Babies born to cases were more likely to be of low birth weight 
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than babies born to controls. (crude OR =5.9,95% CI 3.8 to 8.8). A lower proportion of 
cases were given oxytocics soon after delivery (91%) than controls (98%) (crude OR for 
not receiving oxytocics = 5.7,95% CI 2.9 to 11.1). 
Laboratory results (table 5.2v) 
The HIV test was positive in 14% of cases and 9% of the controls (crude OR = 1.7,95% 
CI 1.1 to 2.5). The reactive syphilis test was positive for a similar proportion of both 
cases and controls (9%). Approximately 60% of cases and 15% of controls were found 
to be anaemic (crude OR for haemoglobin less than 10 mg/dl = 8.4,95% CI 6.3 to 
11.4). However, the mean corpuscular haemoglobin concentration (MCHC) was below 
33.0 g/dl in 87% cases and 83% controls, suggesting significant level iron deficiency 
anaemia. Thirty one percent of cases and 11% controls had a low platelet count (crude 
OR for <150109/1=3.6,95% CI 2.6 to 5.1). 
5.3.2 Adjusted analyses 
Factors found to be of importance in univariate analyses (table 5.2) were entered into a 
multivariate regression model using the methods described in section 4. Age was 
included in this model so as to be consistent with other studies. Table 5.3 presents a 
summary of the adjusted odds ratios for factors found to be independently statistically 
significantly related to the outcome. The factors used for adjustment are presented as 
footnotes. 
The further away the patient lived from the hospital the higher the risk of developing 
SMM (adj. OR >5-10km compared to <=5km = 2.6,95% CI 1.8 to 3.7 and OR >10km 
compared to <=5km = 7.3,95% CI 3.6 to 14.5). Having a professional job was also 
associated with increased risk (adj. OR for professional job compared to peasant = 2.5, 
CI 1.3 to 5.0). Socio economic status as assessed by the type of house patients lived in 
was related to risk: Women who lived in brick, not plastered and iron roofed houses 
(adj. OR = 3.3,95% CI 2.3 to 4.7), and those who lived in mud and with or without iron 
roofed houses (adj. OR = 4.5,95% CI 2.3 to 8.7) were at an increased risk of SMM 
compared to those who lived in brick, plastered and iron or tiled roofed houses. 
Women who depended on financial support from their relatives for up-keep in hospital 
compared to those who paid for themselves or by their spouse had an increased risk of 
developing SMM (adj. OR = 5.0,95% CI 2.9 to 9.8). Similarly, those who asked for 
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permission to attend hospital were at a higher risk of developing SMM compared to 
those who did not (adj. OR = 3.3,95% CI 2.2 to 4.9). 
Chronic hypertension before current pregnancy was a very strong independent risk 
factor for developing SMM (adj. OR = 11.8,95% Cl 2.6 to 54.4). A history of having 
had an evacuation and/or dilation and curettage of the uterus was associated with a 
doubling of risk (adj. OR = 2.0,95% CI 1.2 to 3.9), and women who had had a previous 
delivery by caesarean section compared to those who had only ever delivered vaginally 
had more than five times the risk of developing SMM (adj. OR = 5.6,95% CI 3.0 to 
10.4). 
Nulliparous women had one and a half times the risk of parous women (adj OR = 1.6, 
95% CI 1.1 to 2.3) and women with a long interval since the last birth had more than a 
doubling of risk (adj. OR = 2.6,95% CI 1.5 to 4.9). Women who never attended 
antenatal care had four times the risk of developing SMM compared to women who did 
attend antenatally (adj. OR = 4.0,95% CI 2.1 to 7.8) and those who had antenatal care 
but whose blood pressure was not checked at all had an increased risk compared to 
women whose blood pressure was checked (adj. OR = 2.6,95% CI 1.1 to 6.1) during 
antenatal visits. Hypertension, and anaemia diagnosed during pregnancy were, not 
surprisingly, associated with being a case (adj. OR hypertension = 12.3,95% CI 6.0 to 
25.2, adj. OR anaemia = 4.4,95% CI 1.3 to 14.4), as was premature rupture of 
membranes (adj. OR = 2.3,95% CI 1.7 to 3.3) and admission to hospital during 
pregnancy (adj OR = 1.9,95% CI 1,1 to 3,2). Women who did not know what to do if 
they bled during pregnancy were at increased risk of SMM compared to women who 
did know that they needed to seek urgent medical attention (adj. OR = 12.7,95% CI 7.4 
to 22.0). Women on trial of scar (adj OR=3.4,95% CI 1.8 to 6.9) and induced or 
augmented labour (adj 24.5,95% CI 9.1 to 99.6) had significantly associated elevated 
risks. Lack of receipt of oxytocics soon after delivery (adj. OR = 3.1,95% CI 1.4 to 
6.4), and prolonged third stage (adj. OR = 22.6,95% CI 3.6 to 120.6) were also 
significantly associated with increased risk. Cases were much more likely than controls 
to be delivered by a doctor than a midwife (adj. OR = 196.1,95% CI 96.1 to 396.9). 
SMM was associated with delivery of a low birth weight (<2500gm) infant (adj. OR = 
5.1,95% CI 3.3 to 8.1) and haemoglobin below lOg/dl (adj. OR 7.8,95% CI 5.6 to 
10.5). 
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Women who were tested HIV positive had a higher risk of developing SMM than 
women who were HIV negative (adj. OR =1.6,95% CI 1.0 to 2.5). 
The risk of SMM was associated with being a referred patient (adj. OR = 6.4,95% CI 
4.5 to 9.1). To investigate possible selection bias associated with referral, further 
analysis was conducted on the subset of 236 cases and 416 controls who were not 
referred. The results are presented in tables 1 to 4 in Appendix C and as a column in the 
summary table 5.10. Overall, the pattern of results was similar to that for all cases (see 
summary table 5.10), although a greater proportion of non-referred cases had had a 
previous caesarean section (adj. OR = 12.1,95% 5.7 to 25.9) and had bleeding during 
the current pregnancy (adj. OR = 7.1,95% CI 1.7 to 35.1). 
5.4 ANALYSIS OF SEVERE PRE-ECLAMPSIA AND ECLAMPSIA 
Severe pre-eclampsia and eclampsia was recorded as a primary or secondary cause of 
SMM in 143 women. There were sixty two cases (43.4%) with eclampsia and eighty 
one cases (56.6%) with severe pre-eclampsia. Severe pre-eclampsia and eclampsia 
cases were delivered by spontaneous vaginal delivery (52.4%), caesarean section 
(46.9%) and vacuum extraction (0.7%). These cases were compared with the 500 
control normal deliveries using similar methods to those used for all cases. Table B1 in 
Appendix B presents the univariate results, which will not be described in detail here. 
Adjusted analyses 
Table 5.4 presents a summary of the adjusted odds ratios for factors found to be 
statistically significantly related to the outcome. The factors used for adjustment are 
presented as footnotes in table 5.4. Factors found to be independently associated with 
the risk of severe pre-eclampsia and eclampsia after appropriate adjustment were, for 
the most part, similar to those found for risk of all SMM (table 5.3). But existing 
hypertension (adj. OR = 26.9,95% 4.3 to 170.4) and delivery of a low birth weight baby 
(adj. OR = 23.5,95% CI 10.4 to 52.7) produced stronger associations than for all cases 
(see summary comparison table 5.10). 
Risk factors specific to pre-eclampsia and eclampsia, and not found for all cases 
analysed together, were family history of hypertension (adj. OR = 1.9,95% CI 1.2 to 
2.9), history of hypertension in a previous pregnancy (adj. OR = 2.6,95% CI 1.0 to 6.6), 
previous history of abortion (adj. OR = 2.6,95% CI 1.3 to 5.1), and delivering a male 
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baby (adj. OR =1.5,95% CI 1.0 to 2.3) (table 5.4 and 5.10). 
Factors which were not found to be independently significantly associated with risk of 
pre-eclampsia and eclampsia, but were found to be risk factors for all cases, included 
bleeding in labour (adj. OR = 4.5,95% CI 0.9 to 12.1. ), prolonged third stage (adj. OR 
= 3.8,95% CI 0.4 to 38.4), not being given oxytocics (adj. OR = 4.1,95% CI 0.9 to 
16.7), and being HIV positive (adj. OR = 0.7,95 % CI 0.3 to 1.4) (see summary table 
5.10). The lack of association between risk of pre-eclampsia and eclampsia and factors 
related to labour may be explained by the fact that 46.9% of these cases were delivered 
by caesarean section. In addition, some of these analyses involved small numbers and 
hence lacked power to detect statistically significant effects. 
5.5 ANALYSIS OF POST PARTUM HAEMORRHAGE 
One hundred and six cases had severe post partum haemorrhage (PPH) as a primary or 
secondary diagnosis of SMM. The specific causes of PPH were: uterine atony (45.0%), 
tears in the genital tract (22%), coagulation failure (16%), and retained placenta (7%). 
These 106 cases were delivered by: spontaneous vaginal delivery (70.8%), vacuum 
extraction (4.7%), caesarean section (14.2%) and laparotomy (10.3%). These cases 
were compared to the 500 control normal deliveries using the method as that used for all 
cases. Table B2 in Appendix B presents the results of the univariate analyses. 
Adjusted analyses 
Table 5.5 presents a summary of the adjusted odds ratios for factors found to be 
statistically significantly related to the outcome, with factors used for adjustment 
presented as footnotes. The pattern of results was similar to that found for all cases and 
only the notable differences will be described. 
Women with PPH were more likely to have a previous history of PPH (adj. OR = 3.6, 
95% CI 1.1 to 11.8) than all cases. Not unexpectedly, bleeding during labour (adj. OR 
= 31.5,95% CI 10.6 to 93.3) and hospital admission during present pregnancy (adj. OR 
= 2.7,5% CI 1.2 to 6.5) also produced stronger associations than for all cases (see 
summary comparison table 5.10). Also, a higher proportion of PPH cases than all cases 
did not know what to do if there was bleeding during pregnancy (adj. OR = 17.3,95% 
CI 7.5 to 39.0). ý Risk of PPH was very strong for women with prolonged third stage of 
labour (adj. - OR = 49.1,95% CI 18.8 to 342.8) and a high proportion of women with 
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PPH had haemoglobin levels below 10 grams/dl (adj. OR = 17.3,95% CI 9.5 to 31.7 
Factors which were not found to be significantly associated with risk of PPH, but were 
found to be risk factors for all cases, included professional employment (adj. OR = 1.9, 
95% Cl 0.7 to 5.4), nulliparity (adj. OR = 1.2,95% CI 0.7 to 1.9) and premature rupture 
of membranes (adj. OR = 1.3,95% CI 0.8 to 2.1). In each of these examples, however, 
the direction of the effect was similar to that for all cases and the lack of statistical 
significance may be a result of small numbers and low power. Surprisingly, for 
previous evacuation and/or dilatation and curettage of the uterus (adj. OR = 0.5,95% CI 
0.2 to 1.2), the (non statistically significant) effect was in the opposite direction to that 
for all cases (negative association rather than positive association) (see summary table 
5.10). 
5.6 ANALYSIS OF OBSTRUCTED LABOUR 
One hundred and eight cases had obstructed labour as a primary or secondary cause of 
SMM. Figure 5.4 presents more detail on the causes of the obstructed labour: cephalo 
pelvic disproportion (59%), big baby (22%), transverse lie (9%), mento posterior (face) 
(5%), brow (3%) and hydrocephalus (2%). The majority of these 108 women were 
delivered by caesarean section (94%), vacuum extraction (2%), destructive operation 
(2%), and one hysterectomy (0.8%) was performed because the uterus was necrotic and 
could not be salvaged. The mean waiting time for operative delivery was 221.6 (SD = 
3.7) hours with a range of 30 to 960 minutes. Forty percent of cases waited for two or 
less hours, which was the expected waiting time for operation in Mulago hospital. The 
shortest hospital stay was less than 24 hours for 2% of cases, between 2-9 days for 75%, 
and 10 to 30 days for 23% of patients. The mean stay in hospital was 9.6 (SD = 5.3 
days). At discharge three (2.8%) patients had developed vesico vaginal fistula. 
These 108 cases of obstructed labour were compared with the 500 controls of normal 
deliveries, and the characteristics presented in Table B3 in Appendix B (univariate 
analysis). 
Adjusted analyses 
Adjusted analyses were performed using the same method as that used for the analysis 
of all cases and the results presented in table 5.6 with adjustment factors shown as 
footnotes. Significant factors associated with increased risk were similar to those found 
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for all cases, including: longer distance from home to hospital, low quality housing, 
requiring permission to attend hospital, being unable to pay for hospital upkeep, existing 
hypertension, previous caesarean section, long birth interval, lack of knowledge of what 
to do if bleeding in pregnancy, being a referred patient, and having haemoglobin below 
10 grams/dl. Nulliparity (adj. OR = 3.2,95% CI 1.6 to 6.3), premature rupture of 
membranes (adj 11.3,95% CI 6.4 to 20.0) and delivery of a male infant (adj. OR = 2.3, 
95% CI 3.8 to 10.8) showed stronger associations with risk of obstructed labour than 
with all cases (see table 5.10). Lack of antenatal care (adj. OR = 1.7,95% CI 0.5 to 5.0) 
and HIV positivity (adj. OR = 1.3,95% CI 0.7 to 2.7) did not reach statistical 
significance, but the direction of associations was similar to that for all cases. 
5.7 ANALYSIS OF RUPTURED UTERUS 
Fifty two women suffered a ruptured uterus. The causes were: cephalo pelvic 
disproportion (33%), previous scar (37%), malpresentation of foetus (15%), big baby 
(10%), retained second twin (4%), and hydrocephalus (1%). Two women presented 
with post partum rupture of uterus. There was no ruptured uterus due to oxytocin 
induction or augmentation. Six (12%) patients had ruptured uterus involving the 
bladder. 
The treatments offered were sub total hysterectomy in 44 (85%), repair of uterus and 
bilateral tubal ligation in 5(10%), and repair of uterus only for 3 (6%). The mean 
waiting time for operation after diagnosis was 202.4 minutes, the shortest being 60 
minutes and the longest 840 minutes. The mean operating time was 70 minutes and the 
range was 45 to 120 minutes. 
The length of stay of these patients in hospital ranged from less than twenty hours to 30 
days. The mean length of stay was 9.7 (SD = 3.7) days. Two (4%) patients stayed for 
less than twenty fours because they died of hypovolaemic shock due to haemorrhage. 
Twenty one (40%) patients had puerperal infection post operatively which resulted in 
prolonged hospital stay. One (2%) patient had developed vesico vaginal fistula at 
discharge. 
Out of 52 cases of ruptured uterus three died (case fatality 6%), two of hypovolaemic 
shock and third one of uraemic shock following a second operation with a urologist to 
relieve the ligated ureters on third day after first operation. Twenty four (46%) babies 
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born were live births and twenty eight (54%) were still births. 
Characteristics of the 52 cases of ruptured uterus and the 500 controls are shown in 
table B4, Appendix B. 
Adjusted analyses 
As previously, adjusted analyses were performed using the same method as that used for 
the analysis of all cases. Table 5.7 presents a summary of the adjusted odds ratios for 
factors found to be statistically significantly related to the outcome, with factors used 
for adjustment presented as footnotes. 
The pattern of results was similar to that found for all cases and only the notable 
differences will be described. In contrast to the findings for all cases, and specific 
causes discussed thus far, being young (<20 years) (adj. OR = 0.1,95% CI 0.1 to 0.4) 
and nulliparous (adj. OR = 0.1,95% CI 0.1 to 0.5) was found to be protective for 
ruptured uterus. Also, being of the Nilotics rather than Bantu tribe doubled risk (adj. 
OR = 2.4,95% CI 1.0 to 5.4). For parous women, previous caesarean section was a 
very strong risk factor for ruptured uterus in the current pregnancy (adj. OR = 22.3, 
95% CI 9.2 to 54.2). As expected, bleeding during labour (adj. OR = 27.9,95% CI 9.6 
to 81.3) and low haemoglobin level (<10 grams/dl) (adj. OR = 20.2,95% CI 9.3 to 43.7) 
were also very strongly associated with ruptured uterus. Cases with ruptured uterus 
were more likely than all SMM cases, and controls, to deliver a large baby (>3500 
grams) (adj. OR = 2.4,95% CI 1.2 to 4.7). Notably, HIV positive women had more 
than 3 times the risk of developing ruptured uterus than HIV negative women (adj. OR 
= 3.2,95% CI 1.5 to 7.2). 
5.8 ANALYSIS OF PLACENTA PRAEVIA 
There were 36 cases of placenta praevia: 80% major placenta praevia and 20% minor. 
All the minor placenta praevia were of type 2. The characteristics of these 36 cases 
were compared to the 500 controls, and the results presented in Table B5, Appendix B 
(univariate analyses). 
Adjusted analyses 
Adjusted analyses were performed using the same method as that used for the analysis 
of all cases and the results presented in table 5.8 with adjustment factors shown as 
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footnotes. This analysis was limited by the small number of cases, and wide confidence 
intervals, but it was possible to detect some differences in the results compared to all 
cases (see comparison table 5.10). Women with placenta praevia were found to be 
much more likely than controls (and all cases) to be living more than 10km from 
Mulago hospital (adj. OR = 21.4,95% Cl 7.4 to 63.7). Also, for parous women, 
previous caesarean section was a stronger risk factor for placenta praevia than for all 
cases, and controls (adj. OR = 19.9,95% Cl 6.4 to 61.7). Previous history of evacuation 
was strongly associated with placenta praevia (adj. OR = 3.6,95% CI 1.1 to 12.5). Not 
unexpectedly bleeding during current pregnancy (adj. OR = 9.9,95% CI 1.3 to 77.8) 
was also strongly associated with placenta praevia. Women with placenta praevia were 
highly likely to deliver a low birth weight baby (adj. OR = 18.9,95% CI 7.1 to 50.3). 
5.9 ANALYSIS OF ABRUPTIO PLACENTA 
Abruptio placenta was recorded as a primary or secondary cause of SMM in 45 women. 
The characteristics of these 45 cases and the 500 controls are shown in table B6 in 
Appendix B (univariate analysis). 
Adjusted analyses 
Adjusted analyses were performed using the same method as that used for the analysis 
of all cases and the results presented in table 5.9 with adjustment factors shown as 
footnotes. Like placenta praevia described above (section 5.8), this analysis was limited 
by the small number of cases, and consequent wide confidence intervals, but it was 
possible to detect some differences in the results compared to all cases and other 
specific causes of SMM (see comparison table 5.10). As for all cases, long distance 
from home to Mulago hospital, low quality housing, and requesting permission to attend 
hospital were associated with increased risk (table 5.9,5.10). Existing hypertension 
(adj. OR = 56.8,95% CI 9.0 to 358.5) was a very strong risk factor, and parous women 
who had experienced a previous stillbirth (adj. OR = 3.1, CI 95% 1.1 to 9.1) or a 
previous caesarean section (adj. OR = 7.3,95% CI 1.8 to 29.7) had increased risk of 
abruptio placenta. Not surprisingly, bleeding during pregnancy (adj. OR = 26.7,95% 
CI 8.6 to 85.4) and bleeding during labour (adj. OR = 18.2,95% Cl 3.8 to 88.4) were 
clearly associated with being a case, as was being diagnosed with hypertension during 
pregnancy (adj. OR = 22.7,95% CI 7.4 to 69.7). Nearly half of all infants delivered to 
cases were of low birth weight (adj. OR = 24.6,95% CI 9.2 to 65.9). Somewhat 
surprisingly, cases were more likely than controls to deliver male babies (adj OR = 1.9, 
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95% CI 1.0 to 3.8). Being HIV positive was not found to be associated with risk (adj. 
OR = 1.0,95% CI 0.3 to 2.9) (table 5.10). A high proportion of women with abruptio 
placenta (80%) had a haemoglobin level below 10grams/dl (adj. OR = 35.5,95% CI 
13.6 to 92.6). 
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fable 5.1 Primary and secondary causes of severe maternal morbidity in cases 
Cause of SMM Primary 
n (%) 
Primary and 
secondary cause 
n(%) 
Severe pre-eclampsia and eclampsia 125(25.1) 143(25.3) 
Post partum haemorrhage 95(19.0) 106(18.8) 
Obstructed labour 102(20.5) 108(19.1) 
Ruptured uterus 52(10.4) 52(9.2) 
Abruptio placenta 33(6.6) 45(8.0) 
Placenta praevia 36(7.2) 36(6.4) 
Puerperal sepsis 25(5.0) 34(6.0) 
Anaemia 20(4.0) 25(4.4) 
Other medical conditions 11(2 2) 16(2.8) 
Total 499(100) 565(100) 
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Table 5.2 Characteristics of all SMM cases and controls 
(i) Socio-demographic characteristics 
Characteristic Stratum Cases Controls Crude odds ratio P 
N (%) N( %) (95% C1) value 
Distance from home to 0-5 246 (49.3) 408 (81.6) 1.0 (- ) 
Mulago(km) 6-10 176 (35.3) 81 (16.2) 3.6 (2.7-4.9) 0.00 
11-15 77 (15.3) 11 (2.2) 11.6 (6.1-22.3) 
Distance to nearest 0-5 408 (81.8) 491 (98.2) 1.0 (-) 
health unit (km) .5 91 (18.2) 9 (1.8) 12.2 (6.1-24.4) 0.00 
Age(years) 14-19 145 (29.1) 155 (31.0) 0.9 (0.7-1.3) 
20-29 282 (56.5) 262 (52.4) 1.0 (- ) 
30-35 50 (10.0) 52 (10.4) 0.7 (0.4-1.2) 0.45 
35+ 22 (4.4) 31 (6.2) 0.8 (0.6-1.4) 
Marital status Married 405 (81 2) 425 (85.0) 1.0 (-) 
Single 94 (18.8) 75 (15.0) 1.3 (0.9-1.8) 0.12 
Tribe Bantu 428 (85.8) 454 (90.8) 1.0 (- ) 
Nilotics 71 (14.2) 46 (9.2) 1.6 (1.1-2.5) 0.01 
Religion Protestant 164 (32.9) 141 (28.2) 1.0 (- ) 
Catholic 165 (33.1) 173 (34.6) 0.8 (0.6-1.2) 
Muslim 127 (25.5) 160 (32.0) 0.7 (0.5-0.9) 0.03 
Seven day II (2.2) 5 (1.0) 1.9 (0.6-5.6) 
Saved 32 (6.4) 21 (4.2) 1.3 (0.7-2.4) 
Education level of No schooling 25 (5.0) 22 (5.0) 1.2 (0.1-2.2) 
patient Primary 266 (53.3) 277 (55.4) 1.0 (((. 8-1.3) 0.18 
Secondary 180 (36.1) 186 (37.2) 1.0 (-) 
College 28 (5.6) 15 (3.0) 1.9 (1.0-2.2) 
Patients job Commerce 111 (22.2) 114 (22.8) 1.0 (0.8-1.4) 
Professional 32 (6.4) 14 (2.8) 2.4 (1.3-4.6) 0.02 
Peasant 356 (71.3) 372 (74.4) 1.0 (- ) 
Spouse job Commerce 233 (46.7) 205 (41.0) 1.0 (- ) 
Professional 82 (16.4) 106 (21.2) 0.7 (0.5-1.0) 0.08 
Peasant 184 (36.9) 189 (37.8) 0.9 (0.7-1.1) 
Type of house * Brick, cemented 258 (51.7) 417 (83.4) 1.0 (- ) 
Brick only 173 (34.7) 69 (13.8) 4.1 (2.9-5.6) 0.00 
Mud only 68 (13.6) 14 (2.8) 7.9 (4.3-14.2) 
Facility in house Electricity and 183 (36.7) 261 (52.2) 1.0 (- ) 
water 
Electricity or 149 (29.8) 14(1 (28.0) 1.5 (1.1-2.0) 0.00 
water only 
Neither 167 (33.5) 99 (19.8) 2.4 (1.8-3.3) 
Need to request 
permission to visit 
health Unit/hospital 
Yes 
No 
163 
336 
(32.7) 
(67.3) 
47 
453 
(9.4) 
(90.6) 
4.7 
1.0 
(3.3-6.7) 
(-) 0.00 
Who gives permission Spouse 138 (84.3) 42 (88.5) 1.0 (- ) 
to attend I lealth Other 25 (15.7) 05 (11.5) 1.4 (1.0-2.2) 0.08 
Unit/hospital 
Who pays for Self and spouse 400 (80.2) 460 (92.0) I. 0 (_ ) 
treatment Others 99 (15.8) 40 (8.0) 2.9 (1.9-4.2) 0.00 
*Brick, cemented: brick, well cemented house and floor with iron roof or tiles 
Brick only: brick, not cemented floor and walls and iron roof 
Mud only: Mud walls and floor with iron roof 
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(ii) Social, family and medical history characteristics 
Characteristic Stratum Cases Controls Odds ratio P value 
N (%) N (%) (95% CI) 
Taking alcohol Yes 105 (21.0) 137 (27.4) 0.7 (0.5-0.9) 0.02 
No 394 (79.0) 363 (72.6) 1.0 (- ) 
Smoking Yes 3 (0.6) II (2.20) 0.3 (0.2-2.4) 0.75 
No 496 (99.4) 489 (97.8) 1.0 (- ) 
Family Yes 196 (39.3) 194 (38.8) 1.0 (0.8-1.3) 0.87 
hypertension No 303 (60.7) 306 (61.2) 1.0 (- ) 
Family diabetes Yes 63 (12.6) 62 (12.4) 1.1 (0.2-1.4) 0.75 
mellitus No 436 (87.4) 437 (87.6) 1.0 (- ) 
Hypertension (self) Yes 23 (4.6) 2 (0.4) 12.0 (2.8-51.3) 0.00 
No 476 (95.4) 498 (95.6) 1.0 (- ) 
Use of Yes 201 (40.3) 219 (43.8) 1.0 (- ) 
contraceptives No 298 (59.7) 281 (56.2) 1.2 (0.9-1.5) 0.26 
(iii) Past obstetric performance * 
Variable Stratum Cases Controls Odds ratio P value 
N (%) N (%) (95% CI) 
Previous abortion Yes 44 (14.0) 43 (12.3) 1.1 (0.7-1.9) 0.50 
No 270 (86.0) 307 (87.7) 1.0 (- ) 
Previous evacuation Yes 35 (7.0) 20 (4.0) 1.8 (1.2-4.5) 0.00 
of uterus and No 464 (93.0) 480 (96.0) 1.0 (- ) 
curettage (all women) 
Bleeding in previous Yes 48 (15.3) 37 10.6 1.5 (1.0-2.5) 0.07 
pregnancy No 266 (84.7) 313 (89.4) 1.0 (- ) 
Bleeding in labour Yes 33 (10.5) 37 (10.6) 1.0 (0.6-1.6) 0.99 
No 281 (89.5) 313 (89.6) 1.0 (- ) 
Labour lasting more Yes 
than 18hrs No 
Still birth Yes 
No 
Previous caesarean Yes 
section No 
Vacuum or forceps Yes 
No 
Post partum Yes 
haemorrhage No 
Retained placenta Yes 
No 
Hypertension in Yes 
pregnancy No 
Blood transfusion Yes 
During pregnancy No 
54 (17.2) 77 (22.0) 
260 (82.8) 273 (78.0) 
35 (10.1) 25 (7.1) 
279 (88.9) 325 (92.9) 
61 (19.4) 15 (4.0) 
253 (80.6) 335 (96.0) 
6 (1.9) 5 (1.4) 
308 (98.1) 345 (98.6) 
17 (5.4) 14 (4.0) 
297 (94.6) 336 (96.0) 
8 (5.5) 9 (12.6) 
306 (94.5) 342 (97.4) 
23 (7.4) 19 (5.4) 
291 (93.3) 331 (94.6) 
16 (5.1) 4 (1.1) 
298 (94.9) 346 (98.9) 
0.7 (0.5-1.1) 0.12 
1.0 (-) 
1.6 (0.9-2.9) 0.07 
1.0 (-) 
5.4 (2.9-10.2) 0.00 
1.0 (-) 
1.4 (0.4-5.1) 0.62 
1.0 (-) 
I. 4 (0.6-3.0) 0.38 
1.0 (-) 
1.0 
I. 0 
(0.3-2.9) 
(-) 
0.98 
1.4 (0.7-2.7) 0.31 
1.0 (-) 
4.7 (1.4-16.6) 0.00 
H) (-) 
* Women with previous pregnancies only 
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(iv) Characteristics and outcome of the current pregnancy 
Variable Stratum Cases Controls Odds ratio P value 
N (%) N (%) (95% Cl) 
Parity 1 185 (37.1) 150 (30.0) 1.3 (1.0-1.7) 0.02 
2-4 227 (45.5) 237 (47.4) 1.0 (- ) 
5-14 87 (17.4) 113 (22.6) 0.8 (0.4-0.9) 
Birth spacing 1-36 173 (55.0) 216 (61.9) 1.0 (- ) 
In months* 37-60 81 (25.9) 91 (26.0) 1.1 (0.8-1.6) 0.05 
>60 60 (19.1) 43 (12.1) 1.8 (1.1-2.8) 
Attended antenatal Yes 438 (87.8) 485 (97.0) 1.0 (- ) 
care No 61 (12.2) 15 (3.0) 4.5 (2.5-8.0) 0.00 
Booking time for <28 297 (68.6) 332 (68.6) 1.0 (- ) 
antenatal (weeks) 28-36 137 (31.4) 153 (31.4) 1.0 (0.1-1.3) 0.99 
Number of antenatal 4+ 197 (45.0) 195 (40.1) 1.0 (- ) 
visits <4 240 (55.0) 291 (59.9) 12 (0.9-1.6) 0.13 
Having blood No 103 (24.0) 93 (19.2) 2.7 (1.7-7.6) 0.02 
pressure checked Yes 325 (76.0) 392 (80.8) 1.0 (- ) 
during antenatal 
Response to vaginal Go to hospital 371 (74.5) 481 (96.2) 1.0 (- ) 
bleeding during Don't know 128 (25.5) 19 (3.8) 8.7 (5.3-14.. 3) 0.00 
pregnancy 
Bleeding during this Yes 14 (2.8) 3 (0.6) 4.8 (1.4-16.7) 0.01 
pregnancy No 485 (97.2) 497 (99.4) 1.0 (- ) 
I lypertension in this Yes 93 (18.6) 7 (1.4) 16.9 (7.7-36.9) 0.00 
pregnancy No 406 (81.4) 493 (98.6) 1.0 (-) 
Anaemia in this Yes 20 (4.0) 4 (0.8) 5.0 (1.7-14.7) 0.00 
pregnancy No 479 (96.0) 496 (99.2) 1.0 (- ) 
Loss of weight during Yes 50 (10.0) 34 (6.8) 1.5 (I. 0-2.4) 0.06 
pregnancy No 449 (90.0) 466 (93.2) 1.0 (- ) 
Admission during Yes 50 (1O. 0) 37 (7.4) 1.4 (0.9-2.2) 0.14 
pregnancy No 449 (92.6) 463 (92.6) 1.0 
Referral from other Yes 263 (52.7) 84 (16.8) 5.5 (4.1-7.4) 0.00 
centres No 236 (47.3) 416 (83.2) 1.0 
Premature rupture of Yes 174 (34.9) III (22.3) 1.9 (1.4-2.5) 0.00 
membranes No 324 (65.1) 386 (77.7) 1.0 l-) 
Missing 1 
Bleeding in labour Yes 98 (19.5) 6 (1.20) 20.1 (8.4-51.4) 0.00 
No 400 (80.5) 493 (98.8) 1.0 (- ) 
Use of partograph Yes 35 (8.2) 44 (8.8) 1.0 (-) 0.32 
No 394 (91.8) 456 (91.2) 0.8 (0.5-1.3) 
Missing 5 
Type of labour Normal 330 (76.0) 481 (96.2) 1.0 (-) 0.00 
'T'rial of'scar 34 (7.8) 15 (3.0) 3.3 (1.7-6.5) 
Augment/induced 70 (16.2) 4 (0.8) 25.5 (8.9-82.9) 
Length of first stage =<I8hours 317 (72.7) 435 (87.2) 1.0 (- ) 
in hours >18 117 (27.3) 65 (12.8) 2.7 (1.61-4.63) 0.00 
No labour 65 
Length of third stage =<25 401 (88.3) 497 (99.4) 1.0 (-) 
in minutes. ** >25 54 (11.7) 03 (0.6) 18.4 3.8 -89.6 0.00 
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Variable Stratum (uses 
N (%) 
Controls Odds ratio I' value 
N (%) (95% CI) 
Mode of deliver) Sport ý ag 180 (36.1) 500 (I l)0) 
Vacuum 6 (1.2) 0 (-) 
Caesarean section 257 (51.5) 0 (-) 
l. aparotomq 56 (11.2) 0 (-) 
Sex of baby Female 233 (47.4) 252 (50.2) 1.0 (- ) 
Male 259 (52.0) 248 (49.6) 1.1 (0.8-1.5) 0.33 
Missing 7 
Birth weight in < 2500 121 (25.6) 13 (2.6) 5.9 (3.9-8. g) 0.00 
kilograms 2500-3500 246 (52.0) 317 (63.4) 1.0 (- ) 
>3500 106 (22.4) 170 (34.0) 1.0 (0.7-1.4) 
Missing 9 
Level of delivery Midwife 125 (25.6) 482 (96.4) 1.0 (- ) 
attendant Doctor 344 (71.1) 18 (3.6) 73.7 (43.1 - 0.00 
TRA 19 (3.3) 0 (0) - 127.6) 
Given Oxytocics **Yes 408 (90.7) 489 (97.8) 1.0 (- ) 
No 44 (9.8) 11 (2.2) 5.7 (2.9-11.1) 0.00 
* Multiparous women only ** ruptured uterus with hysterectomy excluded 
(v) Laboratory results 
Variable Stratum Cases Controls Odds ratio P value 
N (%) N (%) (95% Cl) 
HIV status Negative 429 (86.0) 455 (91.0) 1.0 (- ) 
Positive 70 (14.0) 45 (9.0) 1.7 (1.1-2.5) 0.01 
Syphilis Negative 456 (91.4) 454 (90.8) 1.0 (- ) 
Positive 43 (8.6) 46 (9.2) 0.9 (0.6-1.4) 0.75 
Haemoglobin <10 298 (59.8) 75 (15.0) 8.4 (6.3-I1.4) 
gm/dI =>10 201 (40.3) 425 (85.0) 1.0 (-) 0.00 
Mean corpuscular <33.0 436 (87.4) 412 (82.4) 1.5 (1.0-2.1) 0.03 
haemoglobin >33.0 63 (12.6) 88 (17.4) 1.0 (-) 
concentration in g/dI 
Platelets x 109/1 <150 152 (30.5) 52 (10.8) 3.6 (2.6-5.1) 0.00 
=>150 347 (69.5) 448 (89.2) 1.0 (- ) 
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Table 5.3 Risk factors for Severe Maternal Morbidity 
Variable Stratum Cases Controls Crude odds Adjusted odds P 
N (oho) N (oýý) ratio ratio value 
(95% Cl) (95% CI) 
Distance Irom - *5 246(49.3) 408(81.6) 1.0(- ) 1. () (-) 0.00 
home to Mulago (km) >5-)0 176 (35.3) 81(16.2) 3.6 (2.7-4.9) 2.6 ( 1.8- 3.7)a 
>10-15 77 (15.3) 11(2.2) 11.6 (6.1- 22.3) 7.3 (3.6 -14.5)a 
Distance to nearest health <=5 408 (81.8) 491 (98.2) 1.0(-) 1.0(-) 0.00 
unit (km) >5 91 (18.2) 9(1.8) 15.4 ( 5.5- 42.7 6.2 ( 2.31-20.9 )a 
Patients job Commerce 111 (22.2) 114 (22.8) 1.0 (0.8 - 1.4) 1.0 (0.7 - I. 4)a 0.02 
Professional 32(6.4) 14(2.8) 2.4 (12.5 - 4.6) 2.5 (1.3 - 5.0)a 
Peasant 356 (71.4) 372 (74.4) 1.0(-) I. 0 (- ) 
Type of house Brick, plastered 258 (51.7) 417 (83.4) 1.0 ( -) 1.0 (-) 0.00 
Brick only 173(34.7) 69 (13.8) 4.1 (2.9 - 55.7 3.3 (2.3 -4.7 )" 
Mud only 68(13.6) 14(2.8) 7.9(4.3-14.2) 4.5(2.3-8.7)a 
Need to request for Yes 163(32.7) 47(9.4) 4.7 (3.3 - 6.7) 3.3(2.2-4 . 
9)a 0.00 
permission to visit I It No 336 (67.3) 453 (90.6) 1.0(-) 1.0(-) 
Who pays for treatment Self and spouse 420 (84.2) 460 (92.0) 1.0 (-) 1.0 (-) 0.00 
Other 7905.8) 40 (8.0) 3.3( 19.8- 5.6) 5.0 (2.9 - 9.8)a 
Admission during Yes 50(10.0) 37(7.4) 1.4(0.9-2.2) 1.9(1.1-3.2)a 0.03 
pregnancy No 449(90.0) 463(92.6) 1.0(-) 1.0(-) 
Previous evacuation of Yes 35 (7.0) 20 (4.0) 1.8 (1.2 - 4.5) 2.0 (1.2 - 3.9)a 0.01 
uterus or curettage No 464 (93.0) 480 (96.0) 1.0 (-) ºA 
Hypertension (self) Yes 23(4.6) 2(0.4) 12.0 (2.8- 51.3) 11.8 (2.6 - 54.4)' 0.02 
No 476(95.4) 498 (99.6) 1.0(-) 1.0(- 1 
Previous caesarean section Yes 61 (19.4) 15( 4.0) 5.6(2.9 - 10.2) 5.6(3.0 - 10.4)b 0.00 
(women with previous No 253 (80.6) 335(96.0) 1.0 (-) 1.0 (-) 
pregnancies only) 
Birth spacing in months 1-36 173 (55.0) 216 (61.9) 1.0 (-) 1.0 (-) 0.01 
(women with previous 37-60 81 (25.9) 91 (26.0) 1.1 (0.8 - 1.6) 1.1 (0.7 - 1.7)` 
pregnancies only) >60 60(19.1) 43 (12.1) 1.8 (1 1.1 - 2.8) 2.6 (1.5 - 4.9)` 
Number of pregnancy 1 185(37.1) 150(30.0) 1.3 (1.0-1.7) 1.6(1.1-2.3)' 0.00 
2-4 227(45.5) 237(47.4) 1.0 (-) (-) 
3-14 87(17.4) 113(22.6) 0.8 (0.6-1.1) 0.6 (0.3-1.0)` 
Antennal care attendance Yes 438 (87.8) 485 (97.0) I. 0 (-) (-) 0,00 
No 61(12.2) 15(3.0) 4.5(2.5-8.1) 4.0(2.1-7.8)` 
I laving blood pressure Yes 325(76) 39 (80.8) 2.7(1.7 - 7.6) 2.6(1.1 - 6.1 0.04 
checked during antenatal No 103 (24) 93 (19.2) 1.0 (-) 1.0(-) 
Response to vaginal Go to hospital 371 (74.3) 481 (96.2) 1.0 (-) l. 0 (-) 0.00 
bleeding during pregnancy Don't know 128 (25.7) 19(3.8) 8.7 (5.3 - 14.3) 12.7(7.4 - 22.0 )` 
Having hypertension in Yes 93 (18.6) 7(1.4) 14.7 (7.6-28.4) 12.3( 6.0-25.2)` 0.00 
this pregnancy No 406 (81.4) 493(98.6) 1.0 (- ) 1.0 (- ) 
I laving anaemia in Yes 20(4.0) 4(0.8) 4.9(1.7-14.7) 4.4(1.3-14.4)` 0.00 
pregnancy No 479(96.0) 496(99.2) 1.0( -) l. 0 (- ) 
Referral from other health Yes 263(52.7) 84(16.8) 5.5 (4.1-7.4) 6.4(4.5-9.1 0.00 
units No 236 (47.3) 416(83.2) 1.0 (-) 1.0 (-) 
Premature rupture of Yes 174(34.9) 11 1 (22.3) 1.9(1.4-2.5 ) 2.3 (1.7- 3.3)` 0.01 
membranes No 324(65.1) 386 (77.7) 1.0 (-) 1.0 (- ) 
Bleeding in labour Yes 98 (19.5) 6(1.20) 20.1 (8.4-51.4) 7.0 (2.3-16.0)` 0.00 
No 400(80.6) 493(98.8) I. 0 (-) l. 0 (- ) 
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Variable Stratum lases onirols ( rude odds Adjusted odds I' 
N (%) N (%) ratio ratio value 
(95% CI) (95% CI) 
Type of labour Normal 330(76.0) 481(96.2) 1. O(-) I. 0(-) 0.00 
Trial of scar 34(7.8) 15(3.0) 3.3 (1.7-6.5) 3.4 (1.8-6.9) 
Augment/ induced 70(16.2) 4(0.8) 25.5 (8.9-82.9) 25.5 (89.1-86.4) 
Length of third stage in =<25 401(88.3) 497(99.4) 1A (-) Im (-) 0.00 
minutes. >25 54(1 1.7) 03(0.6) 18.4 (3.8-89.6) 22.6 (3.9-120.7)` 
Level of delivery Midwife 124 (24.0) 484(96.8) LO (-) LO (-) 
attendant Doctor 356 (70.9) 16(3.2) 111.0 (60.4-03.9) 196.1 (96.9- 396.9)` 0.00 
IRA 16(2.0) ()(0) 
Given oxytocics Yes 408 (90.7) 489 (97.8) 1.0(-) 1.0 ( -) 
No 44(9.3) 11(2.2) 5.7 (2.9 - II. I) 3.1 (1.4 - 6.4)c 0.00 
Birth weight < 2500 121( 25.6) 13(2.6) 5.9 (3.9 - 8.1) 5.1 (3.3-8.1)c 0.00 
In kilograms 2500-3500 246(52.0) 317(63.4) I. 0 (-) 1.0 (- ) 
>3500 106(22.4) 170(34.0) 1.0(0.7 - 1.4) 1.1 (0.7-1.6)` 
HIV Negative 429(86.0) 455(91.0) 1.0(-) 1.0 (- ) 
Positive 70 (14.0) 45 (9.0) 1.7 (1.1-2.5) 1.6 (1.0- 2.5)c 0.04 
haemoglobin <I (1 298(59.8) 7(15.0) 1.0 (-) 1.0 (-) 
gm/dI =>10 201 (40.3) 425(85.0) 8.4 (6.3- 11.4) 7.8 (5.6-10.5)` 0.00 
a: Adjusted for age, distance from home to hospital, patients job, type of house she lived in, requesting for 
permission to attend health unit or hospital, person paying for hospital upkeep and taking of alcohol 
b: Adjusted as in (a) plus previous evacuation or dilation and curettage, and chronic hypertension. 
c: Adjusted as in (b) plus delivery by caesarean section. 
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fable 5.4 Risk factors for severe pre-eclampsia and eclampsia 
Variable Stratum Cases Controls Crude odds Adjusted odds p 
N (%) N (%) ratio ratio value 
(95% Cl) (95% Cl) 
Distance from home to 0-5 55 (38.5) 333 (66.0) l. 0(-) 1.0(-) 
Mulago in (kni) 5.1-10 57 (39.9) 139 (27.8) 2.5 (1.6-3.8) 1.8 (1.1-2.9)° 0.00 
>10 31(21.6) 28(5.6) 6.7(3.7-12.0) 3.8 (1.9- 7.7)a 
Patients job Commerce 24 (16.9) 104(22.8) 1.3(0.8-2.1) 1.9(1.0- 3.7)a 0.00 
Professional 17(11.8) 14(2.8) 5.7(2.5-13.1) 8.3(3.0-23.1)a 
Peasant 102(71.3) 372(74.4) 1.0(-) I. 0(-) 
Type of house Brick, plastered 78(54.5) 417 (83.4) l. 0(-) 1.0(-) 
Brick only 48(33.6) 69(13.8) 3.7(2.4-5.9) 4.5(2.7-7.5)a 0.00 
Mud only 17(11.8) 14(2.8) 6.5(3.1-13.9) 7.6 (3.9-26.9)a 
Requesting for Yes 46(32.2) 47(9.4) 4.6(2.9-7.3) 3.1(1.7-5.3)a 0.00 
permission to visit I IU No 97(67.8) 453 (90.6) 1.0 (-) 1.0(-) 
Who pays for Self and spouse 110(77.5) 460(92.0) 1.0(-) ). 0(-) 
treatment Others 33(22.5) 40(8.0) 4.4(2.6-7.3) 5.6( 2.5-12.6)a 0.00 
Family hypertension Yes 75(52.5) 194(38.8) 1.7(1.2- 2.5) 1.9(1.2- 2.9)° 0.00 
No 68(47.5) 306(61.2) 1.0(-) 1.0(-) 
Existing hypertension Yes 11(7.7) 2(0.4) 20.8(4.5- 94.8) 26.9(4.3-170.4)' 0.00 
No 132(92.3) 498(99.6) I. 0(-) 1.0(-) 
Previous hypertension Yes 10(1 1.9) 19(5.4) 1.9(0.9-4.2) 2.6(l. 0-6.6)h 
in pregnancy No 74(88.1) 331(94.6) 1.0(-) 1.0(-) 0.05 
Previous abortion Yes 21(25.0) 43 (12.3) 1.9(1.0-3.2) 2.6(1.3- 5. I )h 0.00 
No 63(75.0) 307(87.7) 1.0(-) I. 0(-) 
Previous caesarean Yes 11(13.1) 15(4.0) 3.4(1.48.2) 3.8(1.6-9.1)b 0.00 
No 73(86.9) 335(96.0) I. 0(-) (-) 
Number of pregnancy 1 59(41.2) 150(30.0) 1.5(1.0-2.1) 2.2(1.2-4.3)` 0.02 
2-5 74(51.8) 237(47.4) l. O(-) 1.0(-) 
>5 10(7.0) 113(22.6) 0.5(0.3-1.0) 0.4( 0.1- 1.0)` 
Birth spacing in <37 39(46.4) 216 (61.9) 1.0(-) 1. ()(-) 0.00 
months 37-60 22(26.3) 91(26.0) 1.4(0.7- 2.6) I. I(0.4-2.9)` 
>60 22(26.3) 43(12.1) 2.91(1.5- 5.8) 8.3(2.6-26.4)` 
Antenatal care Yes 128(89.5) 485(97.0) I. 0(-) 1.0(-) 
No 15(10.5) 15(3.0) 3.8(1.8-8.0) 3.4(1.4-8.5)` 0.00 
Booking time for <28 91 (71.6) 332(68.6) 1.0 (-) I. 0(-) 0.05 
antenatal (weeks) 28-36 37(28.4) 153(31.4) 0.3(0.2-0.7) 0.4(0.2- 1.0)` 
Having hypertension Yes 71(52.6) 7(9.0) 77.7(34.2- 176.1) 81.8(32.9- 203.5)` 0.00 
during pregnancy No 64(47.4) 490(88.5) l. 0(-) 1.0(-) 
I laving blood pressure No 21(14.7) 93(19.2) 2.2(1.1-4.5) 2.5(1.2-5.2)` 0.00 
checked during Yes 121(85.3) 392(80.8) I 1.0(-) 
antenatal 
Admission to hospital Yes 20(14.0) 31(6.2) 2.5 (1.4- 4.5) 3.1 (1.5-6.4)` 0.00 
No 123(86.0) 469(93.8) 1.0(-) 1.0(-) 
Referral Yes 63(44.1) 84(16.8) 3.9(2.6-5.8) 5.2(3.0-8.9)` 0.00 
No 80(55.9) 416(83.2) 1.0(-) 1,0(-) 
Sex Male 86(6.1) 248(49.6) 1.5(1.0-2.2) 1.5(1.0-2.3)` 
Female 57(39.9) 252(50.4) 1.0(-) 1.0(-) 0.05 
Birth weight in grams <2500 67(46.9) 317(63.4) 22.9(11.9-44.1) 23.5(10.4-52.7)` 
2500-3500 63(40.0) 13(3.0) 1.0 (-) 1.0(-) 0.00 
>3500 13(9.1) 170(34.0) 0.3(0.2-0.7) 0.3(0.2-0.7)` 
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Variable Stratum Cases Controls (. 'rude odds Adjusted odds l 
N (%) N (%) ratio ratio value 
(95% Cl) (95% Cl) 
Haemoglobin in <10 49(34.3) 75(15.0) 3.0(1.9-45.1) 2.7(l. 6- 4.4)' 0.00 
g/decilitre =>10 94(65.3) 425(85.0) 1.0 (-) 1.0(-) 
Platelets <150 51(35.7) 54(10.8) 4.6(2.9- 7.1) 4.5(2.7-7.7)` 0.00 
=>150 92(64.3) 446(89.2) 1.0(-) 1.0(-) 
a: Adjusted for distance from home to Mulago hospital. patients job, type of house they were living in. person paying 
for treatment, age. asking for permission and family hypertension. 
h: Adjusted as in (a) plus existing hypertension 
c: Adjusted as in (h) plus previous scar and abortion 
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Table 5.5 Risk factors for post partum haemorrhage 
Variable Stratum Cases Controls Crude odds Adjusted odds P 
N (%) N (%) ratio ratio value 
(95% Cl) (95% Cl) 
Distance from home 0-5 53 (50.5) 333 (66.0) I. 0 (. ) LO (-) 
to Mulago in (km) 5.1-10 37 (34.3) 139 (27.8) 3.4 (2.1 - 5.5) 2.0 (1.0- 3.7)a 0.00 
>10 16(15.2) 28 (5.6) 7.7(3.7-14.5) 4.8 (1.9- 7.7)a 
Type of house Brick, plastered 44(41.5) 417 (83.4) 1.0 (-) I. 0(-) 
Brick only 51(48.1) 69(13.8) 6.9 (4.3- 11.1) 5.3 (3.0- 9.2)a 0.00 
Mud only 11(10.4) 14(2.8) 7.5 (3.2-17.4) 3.3 (1.1-9.9)° 
Requesting for Yes 30(28.6) 47(9.4) 4.4(2.7- 7.4) 3.2(1.7-9.2)a 0.00 
permission to visit No 76(71.4) 453 (90.6) 1.0(-) 1.0(-) 
Ilu 
Who pays for Self and spouse 84(80.0) 460(92.0) 1.0(-) 1.0(-) 
treatment Others 22(20.1) 40(8.0) 2.8(1.6-5.0) 3.6(1.8-7.2)a 0.00 
Existing hypertension Yes 4(3.8) 2(0.4) 9.8(1.8- 54.0) 9.3 (1.7- 51.7)a 0.01 
No 102(96.2) 498(99.6) 1.0 (-) 1.0(-) 
Previous PPI1 Yes 6(8.7) 14(4.0) 2.1 (0.8- 5.6) 3.6(1,1- 11.8)b 0.03 
No 63(91.3) 336(96.0) 1.0 (-) I. 0(-) 
Previous caesarean Yes 15(21.7) 15(4.0) 6.2 (2.6-12.4) 7.5 (3.5-14.3)6 0.00 
No 54(78.3) 335(96.0) 1.0 (-) l. 0(-) 
Birth spacing in <37 37 (53.2) 216(61.9) 1.0 (-) (-) 0.00 
months 37-60 14(21.0) 91(26.0) 0.9 (0.5- 1.9) 1.3(0.6 - 3.0)c 
>60 18(25.8) 43(12.1) 1.5(1.2- 5.0) 5.2(2.1- 13.0)c 
Antenatal care Yes 92(86.8) 485(97.0) 4.9(2.9- 10.5) 4.7(1.8- 12.4)` 
No 14(13.2) 15(3.0) I. 0(-) I. 0(-) 0.00 
Bleeding in labour Yes 21(19.8) 6(1.2) 20.3(8.0-51.8) 31.5(10.6-93.3)` 0.00 
No 85(80.2) 493(98.2) I. 0(-) 1.0(-) 
Type of labour Normal 68(64.4) 496(99.2) 1.0(-) 1.0(-) 0.00 
Induced/augmented 38(35.8) 4(0.8) 17.1(4.3-67.5) 18.4(3.6-93.5)` 
having hypertension Yes 10(9.7) 7(9.0) 7.5(2.8- 20.2) 3.1(1.0- 10.5)` 0.01 
during pregnancy No 93(90.3) 490(88.5) I. 0(-) I. 0(-) 
Having anaemia in Yes 5(4.7) 4(0.8) 6.4(1.4-27.7) 6.1(1.1-35.4)` 0.05 
pregnancy No 101(95.3) 496(99.2) 1.0(-) 1.0(-) 
Admission to hospita l Yes 10(9.4) 31(6.2) 1.6(0.8-3.3) 2.7(1.2-6.5)` 0.02 
No 96(90.6) 469(93.8) I. 0(-) 
Referral Yes 59(55.7) 111(22.3) 6.1(3.97- 9.7) 6.5(3.8-11.2)° 0.00 
No 47(44.3) 386(77.7) 1.0(-) I. 0(-) 
Length ofthird stage <26 82 (79.3) 494(98.8) 1.0(-) 1.0(-) 0.00 
in minutes >25 22(20.7) 6(1.2) 28.3(6.6 - 78.9) 49.1(8.8-342.8)` 
Missing 2 
Level of delivery Midwife 51(48.1) 482(96.4) I. 0(-) 1.0(-) 0.00 
attendant Doctor 49(46.2) 18(3.6) 34.9(17.4-70.2) 65.6(26.8- 
I RA 6(5.7) 0 267.9)c 
Birth weight in gram s <2500 13(12.8) 317(63.4) 5.1(2.2- 11.4) 6.1(2.2 - 16.7)` 
2500-3500 63(62.4) 13(3.0) 1.0 (-) 1.0(-) 0.00 
>3500 25(24.8) 170(34.0) 0.7(0.4- 1.2) 0.8(0.4- 1.4)` 
Given Oxytocics Yes 84(80.8) 489(97.8) I. 0(-) 1.0(-) 0.00 
No 20(19.2) 11(2.2) 11.0(4.8-23.3) 12.2(5.0-21.3)` 
Missing 2 
haemoglobin level in <10 79(76.6) 75(15.0) 17.5(10.5-8.9) 17.3(9.5-31.7)` 0.00 
g/decal =>10 25(24.0) 425(85.0) I. 0(-) 1 n1-' 
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Variable Stratum Cases Controls Crude odds Adjusted odds P 
N (%) N (oha) ratio ratio value 
(95% CI) (95% CI) 
Platelets 150 70(66.0) 54(10.8) 4.3(2.6- 6») 4.2(2.3- 7.6)` 0.00 
=>150 36(34.0) 446(89.2) 1.0(-) 1.0(-) 
a: Adjusted for distance from home to Mulago hospital, patients job, type of house they were living in, person paying 
for treatment, age, asking for permission and family hypertension. 
b: Adjusted as in (a) plus existing hypertension 
c: Adjusted as in (b) plus previous scar and previous PPI I. 
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Table 5.6 Risk factors for obstructed labour 
Variable Stratum Cases Controls Crude odds Adjusted odds P 
N (%) N (%) ratio ratio value 
Distance from home to 0-5 34(31.5) 333 (66.0) I. 0(-) I. 0(-) 
Mulago in (km) >5-10 45(41.7) 139 (27.8) 3.2(1.9- 5.2) 2.2(1.3- 3.9)a 0.00 
>10-15 29(26.9) 28(5.6) 10.1(5.4-19.0) 6.7(2.6-17.1)a 
Distance to nearest 0-5 95 (88.0) 491(98.2) I. 0(-) 1.0(-) 0.00 
health unit 6-15 13(12.0) 9(1.8) 7.5(3.1- 18.0) 5.5(1.2 -24.5)a 
Type of house Brick, plastered 59(54.6) 417(83.4) 1.0(-) I. 0(-) 
Brick only 38(35.2) 69(13.8) 3.6(1.1 - 11.6) 2.9(1.7- 5.0)a 0.00 
Mud only 11(10.2) 2.8(5.55) 5.6(2.4- 12.8) 3.1(1.2 - 8.0)' 
Requesting for Yes 25(23.2) 47(9.4) 3.2(1.6- 6.4) 2.2(1.1 -4.1 0.01 
permission to visit HU No 83 (76.9) 453(90.6) 1.0(-) I. 0(-) 
Who pays for Selfand spouse 85 (78.7) 460(92.0) 1.0(-) 1.0(-) 0.02 
treatment Other 31(21.3) 40(8.0) 2.9(1.7 -5.2) 2.3(1.2 -4.4)a 
Previous caesarean Yes 8(16.0) 15(4.3) 4.5(1.8- 13.9) 4.7(2.0-14.8)b 0.00 
No 42(84.0) 335(95.7) 1.0(-) I. 0(-) 
Number of pregnancy 1 58(39.8) 150(30.0) 2.5(1.6 -3.8) 3.2(l. 6-6.3)' 
2-5 43(53.7) 272(54.4) 1.0(-) 1.0(-) 0.00 
6-14 7(6.5) 78(15.6) 0.6(0.3 - 1.3) 0.5(0.2 - 1.3)` 
Birth spacing 1-36 21 (42.3) 195(61.9) I. 0(-) 1.0(-) 0.01 
In months >36 29(57.7) 120(38.1) 2.1(1.2 - 4.0) 2.8(1.4 - 5.7)` 
Referral Yes 77(71.3) 84(16.8) 2.2(1.3-3.6) I1.5(7.0-19.7)` 0.00 
No 31(28.7) 416(83.2) 1.0(-) I. 0(-) 
Premature rupture of Yes 76(70.4) 111(22.3) 8.3(5.2- 13.1) 1 1.3(6.4 - 20.0)c 0.00 
membranes No 32(29.6) 386(77.7) 1.0(-) I. 0(-) 
Length of first stage of =<18 16(14.8) 435(87.2) 1.0 (-) 1.0(-) 
labour in hours >18 92(85.2) 65(12.8) 5.6(2.4-13.0) 3.3(1.1- 10.2)` 0.05 
Sex of baby Female 35(32.4) 252(50.4) 1.0(-) 1.0(-) 
Male 73(67.6) 248(49.6) 2.1 (1.4- 3.8) 2.3(1.3- 4.0)` 0.00 
Haemoglobin <10 49(45.4) 75(15.0) 6.8(4.3- 10.7) 6.4(3.8- 10.8)1 0.00 
gm/dl =>10 59(54.6) 425(85.0) I. 0(-) I. 0(-) 
a: Adjusted for distance from home to Mulago hospital, patients job, type of house they were living in, person paying 
for treatment. age, asking for permission and family hypertension. 
b: Adjusted as in (a) plus existing hypertension 
c: Adjusted as in (h) plus previous scar and previous I'M 1. 
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Table 5.7 Risk factors for ruptured uterus 
Variable Stratum Cases Controls Crude odds Adjusted odds P 
N (%) N (%) ratio ratio value 
(95% Cl) (95% Cl) 
Distance from home to 0-5 18(34.6) 333(66.0) 1.0(-) 1.0(-) 0.00 
Mulago in (km) 6-10 22(44.3) 139(27.8) 2.9(1.5- 5.6) 2.0(1.0- 4.2)' 
11-15 12(23.0) 28(5.6) 8.6(3.8- 19.3) 6.7(2.1- 21.2)" 
Age 14-19 5(9.6) 155(31.0) 0.1(0.0-0.4) 0.1(0.0-0.4)a 0.00 
20-29 36(69.2) 262(52.4) 1.0(-) 1.0(-) 
30+ 11(21.2) 83(16.6) 0.9(0.6-1.9) 0.8(0.4-I. 8)a 
Tribe Bantu 42 (80.8) 454(90.8) 1. ()(-) I. 0(-) 0.01 
others 10(19.2) 46(9.2) 2.4(1.1 -5.0) 2.4(1.0- 5.4)a 
Type of house Brick. plastered 30 (57.7) 417(82.6) 1.0(-) 1.0(-) 0.05 
Brick only 16(30.8) 69(14.6) 3.6(1.1- 11.6) 2.5(1.2- 7. I )a 
Mud only 6(11.5) 14(2.8) 2.6(1.4- 5.3) 2.0(0.5- 7.4)a 
Requesting for Yes 15(28.8) 47(9.4) 1.0(-) 2.5(1.2- 5.4)" 0.02 
permission to visit I IU No 37(71.2) 453(90.6) 3.2(1.6- 3.2) 1.0(-) 
Who pays for Self and spouse 47(90.3) 460(92.0) 1.0 (-) 2.2(1.1- 4.3)a 0.01 
treatment Others 5(9.7) 40(8.0) 1.8(0.8- 4.2) 1.0(-) 
Previous labour lasting Yes 14(31.1) 77(22.0) 2.0(1.0- 3.8) 2.3(1.5 - 4.9) b 0.07 
more than 18hrs No 31(68.9) 273(78.0) 1.0 (-) 1.0(-) 
Previous caesarean Yes 19 (41.3) 15(1.0) 18.6(7.7- 40.9) 22.3(9.2- 54.2)h 0.00 
Section No 27(58.7) 355(99.0) 1.0 (-) I. 0(-) 
Number of pregnancy 1 7 (13.5) 150(30.0) 0.3(0.1- 0.7) 0.1(0.1 -0.5)` 0.011 
2-5 39(75.0) 272(54.4) 1.0 (-) 1.0(-) 
6-14 6(11.5) 78(15.6) 0.52(0.21- 1.27) 0.6(0.3- 1.3)` 
Birth spacing in 1-36 27 (59.6) 216(61.9) 1.0 (-) 1.0(-) 0.02 
months 37-60 8(17.0) 91(26.0) 0.7( 0.3- 1.6) 0.9(0.4-2.0)` 
More than 60 II( 23.4) 43(12.1) 2.0 (0.9- 4.4) 3.4(1.4- 8.1 
Antennal care Yes 47(90.4) 485(97.0) 1.0(-) 1.0(-) 0.00 
attendance No 5 (9.6) I5(3.0) 3.4(1.2- 9.7) 4.7(1.6-I3.7)` 
Response to vaginal Go to hosp 40 (76.9) 481(96.2) I. 0 (-) I. ll(-) 0.00 
bleeding Don't know 12 (23.1) 19(3.2) 7.6(2.2- 29.6) 7.3(2.9- 18.3)` 
Referral Yes 27 (51.9) 84(16.8) 5.1(2.9- 9.3) 3.4 (1.8- 6.8)` 0.00 
No 25(48.9) 416(83.2) 1.0(-) I. 0(-) 
Bleeding in labour Yes 20 (38.5) 6(1.2) 49.8(18.7-98.4) 27.9(10.6-120.3)` 0.00 
No 32(61.5) 493(98.8) 1.0(-) I. 0(-) 
Length of labour first x=18 12(23.1) 435(87.2) 1.0(-) I. 0(-) 0.00 
stage in hours -18 40(76.9) 65(12.8) 22.2(10.6-47.6) 32.1(4.6-165.4)` 
Birth weight in grams < 2500 3 (5.9) 35(7.0) 1.1(0.3-3.7) 1.7(0.46- 6.0)` 0.05 
2500-3500 28(54.9) 350(70.0) 1.0 (-) 1.0(-) 
>3500 20(39.2) 115(23.0) 2.2(1.2- 4.0) 2.4(1 2-4.7)` 
111V Negative 42 (80.8) 455(91.0) I. 0 (-) 1.0(-) 0.02 
Positive 10(19.2) 45(9.0) 2.4(1.1- 4.2) 3.2(1.5-7 2)` 
I laemoglobin <I() 12 (23.1) 75(15.0) 19.4 (9.7-38.5) 20.2(9.3- 43.7)` 0.00 
gm/dI =>I0 40(76-9) 425(85.0) I. 0(-) 1. p(-) 
a: Adjusted fier age, type of house, the type of transport used, the distance from home to Mulago hospital, permission 
to attend health unit, and person paying for hospital upkeep. 
b: Adjusted as in (a) plus existing hypertension. 
c: Adjusted as in (b) plus previous delivery by caesarean section. 
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Table 5.8 Risk factors placenta praevia 
Variable Stratum Cases Controls Crude odds Adjusted odds P 
N (%) N (%) ratio ratio value 
(95% Cl) (95% Cl) 
Distance from home to 0-5 12 (33.3) 333(66.6) 1.0(-) 1.0(-) 
Mulago in km 6-10 11(30.6) 139(27.8) 2.2(0.9 - 5.4) 2.4(1.0- 5.7)" 0.00 
11-15 13 (36.1) 28(5.6) 12.9(5.4-30.9) 21.4(7.4 - 63.7)a 
Patients job Employed 16 (45.5) 128(25.6) 2.6(1.3 - 5.2) 2.3(1.0- 5.2)a 0.05 
Peasant 20(55.5) 372(74.0) 1.0 (-) 1.0(-) 
Requesting for Yes 11(30.6) 47(9.4) 5.4(2.6 -11.5) 3.2(1.3- 7.5)a 0.00 
permission to visit IIU No 25 (69.4) 453(90.6) 1.0(-) 1.0(-) 
Evacuation of uterus Yes 5(13.9) 20(4.0) 3.9(1.4 - 11.1) 3.6(1.1- 12.5)" 0.04 
(all patients) No 32(86.1) 480(96.0) 1.0(-) 1.0(-) 
Previous caesarean Yes 10 (27.8) 15(4.3) 12.4 (5.8,30.5) 19.9(6.4- 61.7)b 0.00 
section No 19(72.2) 335(95.7) 1.0(-) 1.0(-) 
Bleeding during this Yes 6 (16.7) 3(0.6) 26.7(6.1 - 117.0 ) 9.9(1.3-77.8)b 0.00 
pregnancy No 30(83.3) 497(99.4) 1.0 (-) 1.0(-) 
Response to vaginal Go to hospital 29(80.8) 481(96.2) 1.0(-) 1.0(-) 0.00 
bleeding during Don't know 7(19.4) 19(3.8) 6.1(2.4 - 15.7) 7.3(2.4- 22.0)° 
pregnancy 
Birth weight in grams < 2500 14(38.9) 13(2.6) 21.3(8.6 - 52.8) 18.9 (7.1 - 50.3)' 0.00 
2500-3500 16(44.4) 317(64.3) 1.0(-) 1.0(-) 
>3500 6(16.7) 170(34.0) 0.7(0.2- 1.2) 0.5 (0.1 -1.9)` 
I laemoglobin in gm/dl <10 7(19.4) 75(15.0) 23.5(9.9 - 55.5) 32.2(10.8- 96.0)` 0.00 
>9.99 29(80.6) 425(85.0) I. 0(-) I. 0(-) 
a: Adjusted for age, distance from home to hospital, patient's job. and asking for permission to visit a hospital. 
b: Adjusted as in (a) plus evacuation of uterus. 
c: Adjusted as in (b) plus previous caesarean section. 
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Table 5.9 Risk factors for abruptio placenta 
Variable Stratum Cases Controls Crude odds Adjusted odds P 
N (%) N (%) ratio ratio value 
(95% Cl) (95% Cl) 
Distance from home to 0-5 14(31.1) 333(66.6) I. O(-) I. 0(-) 0.00 
Mulago in km 6-10 21(46.7) 139(27.6) 3.1(1.8-7.3) 2.7(1.3-5.7)a 
11-15 10 (22.2) 28(5.6) 8.5 (3.5-20.9) 4.3(1.6- 11.4)a 
Type of house Brick, plastered 20 (43.5) 417(83.4) I. 0(-) 1.0(-) 0.00 
Brick only 17(37.0) 69(13.8) 5.1(2.6 - 10.3) 3.7(1.8-7.8)a 
Mud only 9(19.0) 14(2.8) 13.4(5.17-34.7) 10.5(3.8-29.2)8 
Requesting for Yes 14(31.1) 47(9.4) 3.4(1.65- 7.01) 2.3(1.0- 5.2)a 0.02 
permission to visit I IU No 31 (68.9) 458(90.6) 1.0(-) 1.0(-) 
Taking alcohol Yes 6(13.3) 137(27.4) 0.4(0.2- 0.9) 0.3(0.1-0.9)' 0.03 
No 39(86.7) 368(72.6) l. 0(-) 1.0(-) 
Hypertension (self) Yes 6(13.3) 2(0.4) 38.3(7.5- 196.1) 56.8(9.0- 358.5)" 0.00 
No 39(86.9) 498(99.6) 1.0(-) 1.0(-) 
Previous still birth Yes 6 (15.6) 26(7.4) 2.8(1.1- 7.0) 3.1(1.1- 9.1)h 0.04 
No 27(84.4) 324(92.6) I. 0(-) 1.0(-) 
Previous caesarean Yes 7 (8.7) 15(4.3) 6.0(2.0- 17.1) 7.3(1.8-29.7) 0.00 
No 26(81.3) 335(95.7) I. O(-) 1.0(-) 
Antennal care Yes 39(86.7) 485(97.0) I. 0(-) 6.5 (2.0-21.2)` 0.00 
attendance No 6(13.7) 15(3.0) 6.2(1.8- 13.5) 1.0(-) 
Bleeding during this Yes 6(15.3) 3(0.6) 25.5(6.1 - 105.9) 26.7 (8.6- 85.4)` 0.00 
pregnancy No 39(86.7) 497(99.4) I. 0(-) I. 0(-) 
Having hypertension in Yes 16(35.0) 10(5.6) 22.5(1 1.6 - 84.6) 22.7(7.4- 69.7)` 0.00 
this pregnancy No 29(64.4) 490(94.4) 1.0 (-) 1.0(-) 
Referral Yes 27(60.0) 84(16.8) 7.4(3.9,14.1) 7.0(3.4 - 14.5)` 0.00 
No 18(40.0) 416(83.2) 1.0(-) 1.0(-) 
Bleeding in labour Yes 34 (75.6) 6(1.2) 254.0(88.6- 728.4) 18.2(3.8- 88.4)` 0.00 
No 11(24.4) 493(98.8) LOH 1.0(-) 
Sex of baby Male 32(71.1) 252(50.2) 2.2(1.2-4.9) I. 9(I. 0-3.8)` 0.05 
Female 13(28.9) 248(49.6) 1.0(-) I. 0(-) 
Birth weight in grams < 2500 21 (46.7) 13(2.6) 30.1(12.9-70.2) 24.6(92- 65.9)` 0.00 
2500-3500 17(37.8) 317(63.4) 1.0(-) 
>3500 7(15.6) 170(34.0) 0.8(0.3- 1.9) 0.6(0.4 -2.4)` 
Haemoglobin <10 36(80.0) 75(15.0) 22.67(10.5- 49.0) 35.5(13.6- 92.6)c 
gm/dl =>10 9(20.0) 425(85.0) I. 0 (-) I. 0(-) 
Platelets <150 19(41.3) 54(10.8) 11.7(6.1- 22.5) 8.6(4.2- 17.6)c 0.00 
>=150 27(58.7) 446(89.2) 1.0(-) 1.0(-) 
a: Adjusted for age, distance from home to Mulago, type of house and asking for permission to attend health unit. 
h: Adjusted as in (a) plus hypertension. 
c: Adjusted as in (b) plus previous delivery by caesarean section and previous still birth. 
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Figure 5.2 Primary causes (%) of SMM in 499 cases 
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CHAPTER SIX: RESULTS FROM STAGE 2- STUDY OF 
PROGRESSION FROM SEVERE MATERNAL MORBIDITY 
TO MATERNAL MORTALITY 
Mulago hospital delivered a total of 22,827 women, with total live births of 22,059 and 
a caesarean section rate of 14.9% during the year of study. The hospital recorded a total 
of 843 SMM patients, giving a ratio of SMM to deliveries 1 to 27.1, and a ratio of SMM 
to live births 1 to 26.2 for all the hospital data. There were 61 deaths in total over the 
study period, giving a ratio of SMM to mortality 13.8 to 1, maternal mortality index of 
7.2% and a maternal mortality ratio of 276.5 per 100,000 live births for the hospital 
data. 
6.1 NUMBERS IN STUDY 
The study followed up 499 severe morbidity cases recruited as part of the case- control 
study. Of these, 460 survived and 39 died. The ratio of SMM to maternal mortality in 
this dataset was 12.8 to 1 and the maternal mortality index was 7.8%. 
6.2 CAUSES OF MATERNAL MORTALITY 
The causes of death were: haemorrhage in 12 cases (31%); eclampsia in 5 (13%); 
obstructed labour and ruptured uterus in 4 (10%); puerperal sepsis in 5 (13%); anaemia 
in 6 (15%); anaesthesia in 1 (23%); and medical diseases in 6 (15%) cases and there 
were no deaths due to tuberculosis. More than two thirds of deaths (69%) were as a 
result of direct obstetric causes and around one third (31%) the result of indirect causes 
(see table 6.1 and figure 6.1). 
Cause specific mortality (table 6.1) 
Looking across the rows of table 6.1, the proportion of cases who died by cause was 7% 
for haemorrhage, 4% for severe pre-eclampsia and eclampsia, 3% for obstructed labour 
and ruptured uterus, 24% for puerperal sepsis, 30% for anaemia, and 64% for other 
medical diseases. 
6.3 CHARACTERISTICS OF WOMEN IN THE STUDY (univariate analysis) 
Table 6.2 describes the characteristics of women with SMM who died (n=39) and those 
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who did not die (n=460). 
Socio demographic characteristics (table 6.2i) 
Approximately one third of the women who died and one half of those who survived 
lived less than 6 kilometres from the Mulago hospital, but 26% of those who died and 
14% of the survivors lived more than ten kilometres away (crude OR = 2.9,95% CI 1.2 
to 7.0). 
The majority of women who died were between the ages of 20 and 29 years (77%), 
compared to just over half (55%) of the survivors. About 90% of women who died and 
85% of those who survived were aged below 30 years. Overall, the mean age for the 
survivors was 22.3 (SD=2.3 years) and was similar to those who died was 23.6 (SD = 
4.7 years). 
The educational level was similar, with 95% of those who died and 92% of survivors 
spending twelve or less years in school. A lower proportion of women who died were 
employed (13%) compared to 70% of survivors (crude for peasant versus employed OR 
= 0.3,95% CI 0.1 to 0.9). In contrast, the proportion of spouses who were employed 
was higher for women who died (82%) than for women who survived (79%), but not 
significantly so (crude OR = 0.8,95% Cl 0.3 to 2.3). There was no clear evidence for a 
difference in the type of housing for the two groups of women (crude OR for the lowest 
quality housing = 0.5,95% CI 0.1 to 1.7). A higher proportion of women who died 
needed to ask for permission to attend the health unit (51%) compared to women who 
survived (31%) (crude OR = 2.4,95% 1.2 to 4.5) but the proportion of women who 
relied on others to pay for medical treatment differ significantly in both groups (crude 
OR = 0.7,95% CI 0.3 to 1.8). 
Social, family and medical history characteristics (table 6.2ii) 
Three-quarters of women who died had a history of familial hypertension compared 
with 52% of those who survived (crude OR = 2.7,95% Cl 1.2 to 6.0). In addition, those 
who had a history of existing hypertension was higher (10%) in those who died 
compared to those who survived (4%) (crude OR = 2.7,95% CI 0.9 to 8.2). Admission 
to hospital at any time in during the present pregnancy was more common in women 
who died (18%) compared to women who did not die (9%) (crude OR = 2.6,95% CI 
1.1 to 5.9). 
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Past obstetric performance (table 6.2iii) 
The proportions of subjects with a history of previous abortion were similar in groups, 
14% in those who died and 14% in the survivors. Similarly, there were no significant 
differences in the proportions of women who died and women who survived with 
respect to other adverse obstetric events, including bleeding, stillbirth, long labour, 
hypertension or blood transfusion. However, some of these analyses were based on 
very small numbers of deaths. The proportion of women who delivered by caesarean 
section in previous pregnancy was 24% in those who died and 22% in survivors (crude 
OR = 1.6,95% CI 0.7 to 4.0). 
Characteristics of the current pregnancy (table 6.21v) 
A lower proportion of women who died (28%) compared to survivors (38%) were 
nulliparous (crude OR = 0.4,95% CI 0.2 to 0.9) or grand multipara (8% of women who 
died and 18% of survivors (crude OR = 0.2,95% CI 0.0 to 1.0). The majority of 
women who died (64%) were gravidae two to five. 
Antenatal clinic attendance was more common in those who survived (90%) than those 
who died (56%) (crude OR = 5.9,95 %CI 3.0 to 11.9) and when women were asked 
what they would do if they had vaginal bleeding during pregnancy, about half (49%) 
cases and (24%) controls did not know what to do (crude OR = 2.9,95% CI 1.2 to 7.0). 
The proportion of referrals was similar for those who died (49%) and those who 
survived (51%) (crude OR = 0.8,95% CI 0.4 to 1.6). The proportion of deliveries by 
laparotomy was higher in those who died (16%) compared to those who did not die 
(11%) (crude OR = 1.1,95% CI 0.4 to 3.2). A high proportion of women who died 
delivered male babies (75%) compared to those who survived (51%) (crude OR = 2.9, 
95% CI 1.3 to 6.3). 
Type of care received while on ward (Quality of care factors table 6.2y) 
One third of women who died did not get oxytocics after delivery compared to only 9% 
of survivors (crude OR = 4.8,95% CI 2.1 to 11.6). Senior obstetricians cover the labour 
ward on twenty four hour basis. The obstetrician on duty reviewed 62% of women who 
died and 68% women who survived within one hour of diagnosis of the complication 
and there was no statistical difference between these two proportions (P> 0.39). The 
proportion of patients who were reviewed by an obstetrician six hours or more after 
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diagnosis of the complication was 28% of women who died and 13% women who 
survived (P< 0.011). 
Patients who had operative delivery waited on average 245 minutes with a range of 20 
to 860 minutes. One quarter of women who died compared to approaching one half of 
women who did not die were delivered within two or less hours after the decision to 
operate had been made. Sixteen percent of deaths compared to 7% survivors waited for 
more than ten hours for operation (crude OR = 4.1,95% CI 0.9 to 18.3). The length of 
the operation was similar in both groups with a mean time of one hour. It was not 
uncommon for the hospital to run out of drugs such as magnesium sulphate, antibiotics, 
intravenous fluids and blood. Sixty four percent of women who died compared to 10% 
of survivors did not receive blood when most needed due to shortage (crude OR = 13.9, 
95% CI 7.9 to 33.6), and one quarter of deaths compared to 5% of survivors had to rely 
on relatives to buy drugs because of hospital shortage (crude OR = 7.1,95% CI 3.0 to 
17.1). Monitoring of patients after diagnosis of SMM was one of the most important 
requirements of the management. The monitoring carried out was of blood pressure, 
pulse, respiratory rates and vaginal bleeding. A higher proportion of women who died 
were monitored less than six times (13%) compared to those who did not die (8%) 
(crude OR for monitoring <6 times compared to 6 to 13 times = 6.5,95% Cl 1.4 to 
30.6). Similarly, a low frequency of vaginal monitoring (less than 4 times in 24 hours) 
compared to more frequent monitoring (greater than 8 times in 24 hours) was more 
common in women who died than in women who survived (crude OR = 6.5,95% CI 1.4 
to 30.1). 
Laboratory results (table 6.2vi) 
The HIV test was positive in 39% of the women who died and 12% of the women who 
survived (crude OR = 4.6,95% CI 2.2 to 9.3). Also CD4 cell count of less than 200 per 
109/litre in HIV positive patients was more frequent in those who died (80%) compared 
to those who survived (46%) (crude OR = 4.8,95% CI1.2 to 18.9). Thirteen percent of 
women who died where syphilis test positive compared to 8% of survivors (Crude OR = 
1.7,, 95% CI 0.5 to 4.7). Seventy four percent of deaths and 59% survivors had a 
haemoglobin level of less than l Og/dl (crude OR = 2.1,95% CI 0.9 to 4.6). 
6.4 ADJUSTED ANALYSES 
Factors found to be of importance in univariate analyses (table 6.2) were entered into a 
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multivariate regression model using the methods described in Chapter 4. Age was 
included in this model so as to be consistent with other studies. Table 6.3 presents a 
summary of the adjusted odds ratios for factors found to be independently statistically 
significantly related to risk of death. The factors used for adjustment are presented as 
footnotes. Cause of morbidity was included as an extra adjustment factor in a second 
series of analyses, the results also presented in table 6.3 (final column). 
Puerperal sepsis and medical disease was associated with three times and eleven times 
higher risk of death respectively than post partum haemorrhage (adj. OR = 3.4,95% CI 
1.0 to 11.2 and OR = 11.3,95% CI 2.7 to 46.6 respectively). The further the severe 
morbidity patient lived a way from the hospital the higher the risk of progressing to 
maternal mortality: Women who lived between more than 10 and 15 kilometres had 
more than treble the risk of death compared to those who lived five or less kilometres 
from the hospital (adj. OR 3.1,95% CI 1.0 to 9.3). Being employed was a protective 
factor (adj. for employed versus peasant OR = 0.2,95% CI 0.1 to 0.7) and having to ask 
for permission to visit the hospital or health unit was associated with a trebling of risk 
(adj. OR = 3.2,95% CI 1.4 to 7.0). A previous history of admission to hospital for any 
medical reason increased the risk of progressing to maternal mortality (adj. OR = 3.8, 
95% CI 1.1 to 10.5) as did previous delivery by caesarean section (adj. OR = 2.7,95% 
CI 1.0 to 7.8). 
Women who did not attend antenatal care and who did not know what to do if vaginal 
bleeding occurred had higher risks of dying than women who did attend and who did 
know that they needed to seek medical advice (adj. OR = 4.0,95% CI 1.3 to 9.2 and adj. 
OR = 4.3,95% CI 1.2 to 7.0, respectively). Patients who were diagnosed with anaemia 
during the antenatal period had more than seven times the risk of progressing to 
maternal mortality compared with women who did not have anaemia (adj. OR = 6.7, 
95% 1.4 to 31.3). 
Not getting oxytocics soon after delivery of the baby was associated with a four fold 
increased risk of death compared to those who did receive them (adj. OR = 4.0,95% CI 
1.7 to 9.7). Patients who delivered male babies also had a four times the risk of 
progressing to maternal mortality compared to those who delivered female babies (adj. 
OR= 4.0,95% CI 1.6 to 10.1). 
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When patients developed an SMM complication and were not seen by the obstetrician 
on duty within six hours of diagnosis there was an increased risk of death. (adj. OR = 
2.2,95% CI 1.1 to 4.6). Fifty eight percent of severe morbidity patients had operative 
deliveries. Those who waited for operative delivery for ten or more hours had an 
increased risk compared to those who waited for under two hours (adj. OR = 4.6,95% 
CI 1.1 to 39.6). Lack of an essential drug or blood at a time when it was needed was 
also associated with an increased risk of progressing to maternal mortality (adj. OR = 
3.6,95% CI 1.1 to 11.3 and adj. OR = 10.1,95% CI 94.2 to 24.3). Women whose pulse 
and blood pressure was monitored infrequently post partum had increased risk of 
mortality compared to those who were monitored more often (adj OR for monitoring 
less than six times compared to more than 13 times = 5.6,95% CI 1.2 to 25.7). 
Similarly, mortality was dramatically higher for women who were monitored 
infrequently for vaginal bleeding in the first 24 hours following delivery (adj OR for 
monitoring less than 4 times compared to monitoring more than 9 times = 27.3,95% CI 
4.1 to 182.6). 
Mortality was five times higher in HIV positive women compared to HIV negative 
women (adj. OR = 5.1,95% CI 2.0 to 12.8). Similarly, HIV positive patients with CD4 
cell counts less than 200x109 per litre had almost six times the risk of death compared to 
HIV positive women with CD4 cell counts at or above 200x109 per litre (adj. OR = 5.9, 
95% CI 2.5 to 72.1). Further analysis of excluding puerperal sepsis and medical 
condition in the multivariate model reduced the odds ratio of HIV (adj. without 
puerperal sepsis and medical disease cases OR = 3.8,95% CI 0.9 to 12.5). 
When cause of mortality was included in the models the adjusted odds ratios were 
generally similar to those discussed above (see last column of table 6.3). The exception 
to this was the result for vaginal monitoring of patients where the risk of progressing to 
mortality reduced from more than 27 times increased risk for monitoring less than 4 
times in 24 hours (compared to monitoring more than 9 times) to four times increased 
risk (adj. OR = 3.9,95% CI 1.2 to 12.5). This decrease in effect reflects the fact that 
women with bleeding are more likely to be checked vaginally, and adjusting for cause 
of morbidity made suitable allowance for this. 
Causes of delay for operation 
Two hundred and seventy eight women with SMM, 25 who died and 259 who did not, 
116 
had an operation during delivery (see table 6.2). Of these, 20 (79.9%) of the women 
who died, and 187 (55%) of the women who survived, waited more than two hours to 
have the operation. The most common cause of the delay for operation was a busy 
theatre due to other obstetric emergencies, which was reported for 60% of the survivors 
and 45% of the deaths (table 6.4). The noticeable difference in reason for operative 
dealt in the women who died compared to the women who survived was shortage of 
blood (23% of the women who died and 6% of women who survived). 
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Table 6.1 Cause of severe maternal morbidity and mortality in study 
Primary cause of SMM SMM Cases Deaths Case fatality 
N (%) N (%) rate (%) 
Severe pre-eclampsia and eclampsia 125 (25.1) 5 (12.8) 4.0 
Post partum haemorrhage 95 (19.0) 
Abruptio placenta 33 (6.6) 12 (30.6) 7.3 
Placenta praevia 36 (7.2) 
Obstructed labour 102 (20.4) 
Ruptured uterus 52 (10.4) 
4 (10.3) 2.6 
Puerperal sepsis 25 (5.0) 5 (12.8) 20.0 
Anaemia 20 (4.0) 6 (15.3) 30.0 
Others medical diseases 11* (2.2) 7 (17.9) 63.6 
Total 499 (100) 39 (100) 8% 
* Medical conditions: Cardiac disease (3), Meningitis (2), Pneumonia (3), pulmonary 
embolus (2) and Cerebral malaria (1) 
Medical conditions: Pulmonary embolus (2), Broncho pneumonia (2), Meningitis 
(2) and Cardiac disease (1) 
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Table 6.2 Characteristics of women with SMM who died and women with SMM 
who survived 
(i) Socio-demographic characteristics 
Characteristic Stratum Deaths Survivors Crude odds ratio P value 
N( %) N( %) (95% Cl) 
Distance from home 0-5 12 (30.8) 324 (50.9) 1.0 (-) 
to Mulago (km) 6-10 17 (43.6) 159 (34.6) 2.1 (1.0-4.5) 0.03 
11-15 10 (25.6) 67 (14.6) 2.9 (1.2-7.0) 
Distance to nearest 0-5 5 (12.8) 152 (33.0) 1.0 (-) 0.00 
health unit (km) >5 34 (87.2) 308 (67.0) 3.4 (1.2- 10.0) 
Age (years) 14-19 5 (12.8) 140 (30.4) 0.3 (0.1-0.8) 
20-29 30 (76.9) 252 (54.8) 1.0 (-) 0.16 
30+ 4 (10.2) 68 (14.8) 0.4 (0.1-1.5) 
Marital status Married 35 (89.7) 370 (80.4) 1.0 (-) 0.16 
Single 4 (10.3) 90 (19.6) 0.5 (0.2-1.4) 
Tribe Bantu 35 (89.7) 393 (85.4) 1.0 (-) 0.44 
Nilotics 4 (10.3) 67 (14.6) 0.7 (0.2-2.0) 
Religion Protestant 13 (33.3) 151 (32.8) 0.8 (0.4-1.9) 
Catholic 16 (41.0) 149 (32.4) 1.0 (-) 
Muslim 8 (20.5) 119 (25.9) 0.6 (0.2-1.6) 0.73 
Seven day 0 (0.0) 11 (2.4) - - 
Saved 2 (5.1) 30 (6.5) 0.6 (0.1-3.1) 
Education level of No schooling 1 (2.6) 24 (5.2) 0.7 (0.1-6.1) 0.52 
patient Primary 25 (64.0) 241 (52.4) 1.6 (0.1-5.6) 
Secondary 11 (28.2) 169 (36.7) 1.0 (-) 
College 2 (5.1) 35 (7.6) 1.2 (0.6-7.0) 
Patients job Employed 5 (12.8) 320 (69.6) 0.3 (0.1-0.9) 0.01 
Peasant 34 (87.2) 140 (30.4) 1.0 (-) 
Spouse job Employed 32 (82.1) 365 (79.3) 1.0 (-) 
Peasant 7 (17.9) 95 (20.7) 0.8 (0.3-2.3) 
Type of house Brick plastered 22 (56.4) 236 (51.3) 1.0 (-) 
Brick only 14 (35.9) 159 (34.6) 0.9 (0.5-1.9) 0.45 
Mud only 3 (7.7) 65 (14.1) 0.5 (0.1-1.7) 
Facility in house Electricity and 18 (46.2) 158 (34.3) 1.0 (-º 0.0 
piped water 
Water or electricity 18 (46.2) 137 (29.8) 1.2 (0.6-2.4) 0 
only 
Neither 3 (7.6) 165 (35.9) 0.2 (0.0-0.5) 
Need to request Yes 19 (48.7) 317 (68.9) 2.4 (1.2-4.5) 0.00 
permission to visit No 20 (51.3) 143 (31.1) 1.0 (-) 
Health Unit/hospital 
Who gives permission Spouse 17 (81.0) 267 (84.2) 1.0 (-) 0.66 
to attend Health Unit/ Other 4 (19.0) 50 (15.8) 1.3 (0.4- 4.0) 
hospital 
Who pays for Self and spouse 33 (74.6) 367 (79.8) 1.0 0.6 
treatment Others 6 (25.4) 93 (20.2) 0.7 (0.3-1.8) 7 
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(iv) Characteristics and outcome of the current pregnancy 
Variable Stratum Deaths Survivors Odds ratio P value 
N (%) N (%) (95% Cl) 
Number of pregnancy I 11 (28.2) 174 (37.8) 0.4 (0.2-0.9) 0.02 
2-4 25 (64.1) 202 (43.9) 1.0 (-) 
5-14 3 (7.7) 84 (18.3) 0.2 (0.0-1.0) 
Birth spacing 1-36 21 (75.9) 152 (53.3) 1.0 (-) 
in months* >36 8 (24.1) 133 (46.7) 0.3 (0.1-0.8) 0.00 
Attended antenatal careYes 22 (56.4) 416 (90.4) 1.0 (-) 
No 17 (43.6) 44 (9.6) 5.9 (3.0-11.9) 0.00 
Booking time for <28 18 (81.8) 279137 (67.1) 1.00 (-) 
antenatal (weeks) 28-36 4 (19.2) (30.9) 1.2 (0.6-2.7) 0.64 
Number of antenatal 4+ 11 (40.7) 186 (47.1) 1.0 (-) 
visits <4 16 (59.3) 220 (52.9) 1.2 (0.6-2.7) 0.64 
Response to vaginal Go to hospital 20 (51.3) 351 (76.5) 1.0 (-) 
bleeding during Don't know 19 (48.6) 109 (23.5) 2.9 (1.2-7.0) 0.02 
pregnancy 
Bleeding during this Yes 2 (5.1) 12 (2.6) 2.0 (1.0-3.5) 0.06 
pregnancy No 37 (94.1) 448 (97.4) 1.0 (-) 
Hypertension in this Yes 3 (7.7) 89 (19.3) 0.2 (0.1- 0.9) 0.01 
pregnancy No 36 (92.3) 371 (80.7) 1.0 (-) 
Anaemia in this Yes 8 (20.5) 12 (2.6) 6.7 (2.7-16.8) 0.01 
pregnancy No 31 (79.5) 448 (97.4) 1.0 (-) 
Loss of weight Yes 8 (20.5) 45 (9.8) 2.4 (1.0-5.5) 0.06 
During pregnancy No 31 (79.5) 418 (90.9) 1.0 (_) 
Referral from other Yes 19 (48.7) 244 (53.0) 0.8 (0.4-1.6) 0.60 
centres No 20 (51.3) 216 (47.0) 1.0 (-) 
Premature rupture of Yes 10 (25.6) 164 (35.7) 0.6 (0.3-1.3) 0.21 
membranes No 29 (74.4) 295 (64.3) 1.0 (-) 
Bleeding in labour Yes 7 (18.0) 91 (19.6) 0.9 (0.2-6.4) 0.89 
No 32 (82.0) 369 (80.2) 1.0 (-) 
Type of labour Normal 19 (52.8) 228 (50.2) 1.0 
Augmented 17 (47 2) 226 (48.8) 0.9 (0.5-1.8) 0.77 
or induced 
Use of partograph Yes 5 (13.2) 30 (6.6) 1.0 (-) 
No 33 (86.8) 426 (93.4) 0.5 (0.2-1.5) 0.13 
Missing I 4 
Mode of delivery SVD 18 (47.4) 160 (34.8) 1.0 (_) 
Vacuum 1 (2.6) 5 (1.1) 1.8 (0.2-14.1) 0.09 
Caesarean 13 (34.2) 244 (53.2) 0.5 (0.2-1.0) 
Laparotomy 6 (15.8) 50 (10.9) 1.1 (0.4-3.2) 
Undelivered I I 
Sex of baby Female 9 (25,0) 223 (49.1) 1.0 
Male 27 (75.0) 231 (50.9) 2.9 (1.3-6.3) 0.01 
Missing 2 7 
Birth weight < 2500 8 (19.4) 117 (25.8) 0.5 (0.2-1.3) 0 17 In kilograms 2500-3500 25 (69.4) 231 (51.2) 1.0 (-) 
. 
>3500 4 (11.1) 105 (23.0) 0.4 (0.1-1 0) 0 06 Missing 2 7 . . 
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Variable Stratum Deaths Survivors Odds ratio P value 
N (%) N (%) (95% Cl) 
Level of delivery Midwife 12 (3I. 5) 113 (24.9) 1.0 
attendant Doctor 24 (63.2) 323 (71.3) 0.6 (0.3-1.3) 0.32 
TBA 2 (5.2) 17 (3.8) 1.3 (0.3-6.6) 
Missing I I 
* For women with at least one previous pregnancy 
(v) Quality of care factors 
Characteristic Stratum Deaths Survivors Crude odds ratio P value 
N (%) N (%) (95% Cl) 
Given oxytocics* Yes 26 (70.3) 37733 (91.4) 1.00 (-) 
No Il (29.7) (8.6) 4.8 (2.1-11.6) 0.00 
Use of prophylactic Yes 19 (26.6) 130 (29.3) 1.0 (-) 0.93 
antibiotics No 25 (71.4) 314 (70.7) 1.0 (0.5-2.3) 
Patient seen by senior Yes 24 (61.5) 311 (67.6) 1.0 (-) 
within Ihr No 15 (38.5) 149 (32.4) 1.4 (0.7-2.7) 0.39 
Patient seen by senior Yes 28 (71.8) 402 (87.5) 1.0 (-) 
within 6hrs No 11 (28.1) 58 (12.5) 2.8 (1.3-5.8) 0.01 
Waiting for operation in 1-120 5 (26.3) 150 (44.5) 1.0 (-) 
minutes ` 121-600 11 (57.9) 165 (49.0) 2.0 (0.8-5.9) 0.07 
601+ 9 (15.8) 22 (6.5) 4.1 (0.9-18.3) 
Time taken operating in <60 15 (75.0) 285 (86.9) 1.0 (-) 
minutes + >60 5 (25.0) 43 (13.1) 2.2 (0.8-6.4) 0.14 
Delay to operate + Yes 20 (80.0) 187 (54.1) 3.2 (1.1-10.0) 0.1 
No 5 (20.0) 150 (45.9) 1.0 (-) 
Shortage of blood or its Yes 25 (64.0) 45 (9.8) 13.9 (7.9-33.6) 0.00 
products No 14 (35.9) 415 (90.2) 1.0 (-) 
Shortage of drugs Yes 10 (25.7) 21 (4.6) 7.1 (3.0-17.1) 0.00 
Relative to buy No 29 (74.3) 432 (95.4) 1.0 (-) 
Number of times <6 5 (12.8) 35 (7.6) 6.5 (1.4-30.6) 0.02 
monitored: blood 6-13 28 (71.8) 198 (43.0) 3.4 (-) 
pressure pulse, >13 6 (15.3) 227 (49.3) 1.0 (1.1-12.0) 
respiratory rate in 24 hrs 
Number of times <4 5 (12.8) 33 (7.4) 6.5 (1.4-30.1) 0.02 
monitored: vaginal 5-8 28 (71.8) 253 (56.00 3.4 (1.1-12.0) 
bleeding >8 6 (15.3) 165 (36.6) 1.0 (-) 
First 24hrs 
* Hysterectomy for ruptured uterus excluded 
In those requiring operation 
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(vi) Laboratory Results 
Variable Stratum Deaths Survivors Odds ratio P value 
N (%) N (%) (95%CL) 
HIV status Negative 24 (61.5) 405 (88.0) 1.0 (-) 
Positive 15 (38.5) 55 (12.0) 4.6 (2.2-9.3) 0.00 
CD cell count * <200 12 (80.0) 25 (45.5) 4.8 (1.2-18.9) 0.03 
=>200 3 (20.0) 30 (54.5) 1.0 (-) 
Syphilis Negative 34 (87.2) 422 (91.7) 1.0 (-) 
Positive 5 (12.8) 38 (8.3) 1.7 (0.5-4.7) 0.33 
Haemoglobin <10 29 (74.4) 269 (58.5) 2.1 (0.9-4.6) 0.05 
Gm/dl =>I0 10 (25.6) 191 (41.5) 1.0 (-) 
Platelets <150 18 (46.1) 134 (29.1) 2.1 (1.0-4.2) 0.02 
=>150 21 (53.9) 326 (70.9) 1.0 (-) 
* In HIV positive women 
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Table 6.3 Risk factors for progression from SMM to maternal mortalih' 
Variable Stratum Deaths Survivors Crude odds Adjusted odds Adjusted P value 
N (%) N (%) ratio ratio including all 
(95% Cl) (95% CI) causes of 
mortality in 
model d 
Causes of maternal I laemorrhage 12(30.8) 152(33.0) 1.00 1.0(-) 
morbidity and F: clampsia 5(12.. 8) 120(26.1) 0.5(0.2-1.4) 0.4(0.1-1.3)a 0.00 
mortality pystocia 4(0.2) 150(38.5) 0.4(0.1-1.2) 0.4(0.1-1.3)a 
Sepsis 6(15.4) 19(4.1) 4.7(1.5-14.3) 3.4(1.0-11.2)' 
Anaemia 6(15.4) 14(3.4) 4.2(1.4-12.6) 2.9(0.9-9.2)' 
Other medical 6(15.4) 5(1.1) 12.5(3.4-45.1) 11.3(2.7-46.6)' 
Distance from 0-5 12(30.8) 152(33.0) 1.0 1.0(-) 1.0(-) 0.00 
home to Mulago 5.1-10 17(43.6) 201(43.7) 2.1(1.0-4.1) 2.0(0.8-5 . 
00)a 1.5(0.7-3.5) 
>10 10(25.6) 107(23.3) 2.9(l. 2 - 7.0) 3.1(1.0 -9.3)' 2.9(1.0-5.5) 
Patients job Fmployed 5(12.8) 320(69.6) 0.3(0.1-0.9) 0.2 (0.1-0.7)a 0.2 (0.0-0.7) 0.00 
Peasant/nil 34(87.2) 140(30.4) I. 0(-) 1.0(-) 1.0(-) 
Requesting Yes 19(48.7) 317(68.9) 2.4(1.2.4.5) 3.2(l. 4-7 O)a 2.6 (1.2-5.8) 0.00 
permission to visit No 20(51.3) 143(31.1) 1.0(-) 1.0 (-) 1.0(-) 
}IU 
Admission to Yes 8 (18.0) 42(8.7) 2.6(1.1- 5.9) 3.8(1.1- 10.5)a 2.5(1.0-6.6) 0.01 
hospital No 31(82.0) 418(91.3) 1.0(-) 1.0(-) 1.0(-) 
Previous delivery Yes 7(18.0) 64(13.9) 1.6(0.7-3.9) 2.7(1.0 - 7.8)b 2.0(0.8-5.4) 0.06 
by caesarean No 32(82.0) 396(86.1) 1.0(-) 1.0(-) 1.0(-) 
section 
Birth spacing 1-36 21(75.9) 152(53.3) 1.0(-) l. 0(-) 1.0(-) 0.05 
in months 1 >36 8(24.1) 133(46.7) 0.3(0.1 -0.8) 0.4(0.1- I. 0)` 0.3(0.1-1.2) 
Antennal care Yes 22(56.4) 416(90.4) I. 0(-) 4.0(1.3- 9.2)` 3.9(1.7-9.1) 0.00 
attendance No 17(43.6) 44(9.6) 5.9(3.0- 11.9) 1.0 (-) 1.0(-) 
Response to Go hospital 20(51.3) 351(76.5) 1.0(-) I. 0(-) I. 0(-) 
vaginal bleeding Don't know 19(48.6) 109(23.5) 2.9(1.2 - 7.0) 4.3(1.2- 7.0)` 3.2(1.4-7.0) 0.00 
during antenatal 
Anaemia in Yes 8(20.5) 17(3.7) 6.7(2.7-16.8) 6.7(1.4-31.3)` 6.2(2.4-32.1) 0.02 
antenatal No 31(79.5) 443(96.3) 1.0(-) 1.0(-) I. 0(-) 
Bleeding during Yes 2(5.1) 12(2.6) 2.0(1.0 -3.5) 5.9(1.0- 33.4)` 3.2(0.6-17.3) 0.04 
this pregnancy No 37(94.1) 448(97.4) 1.0(-) I. 0 (-) 1.0(-) 
Sex of baby Female 9(25.0) 223(49.1) 1.0(-) I. 0(-) 1.0(-) 0.00 
Male 27(75.0) 231(50.9) 2.9(1.3-6.3) 4.0(1.6- 10.1)` 4.5(1.6-11.7) 
(liven oxytocics Yes 26(70.3) 377(91.4) 1.0(-) 1.0 (-) 1.0(-) 0.00 
No 11(29.7) 33(8.6) 4.8(2.1-11.6) 4.0(1.7-9.7)` 4.0(1.5-10.9) 
Patient seen by Yes 28(71.8) 402(87.5) 1.0(-) 2.2(1.1- 4.6)` 3.7(1.5-9.2) 0.05 
senior within 6hrs No 11(28.1) 58(12.5) 2.8(1.3.5.8) 1.0(-) 1.0(-) 
Waiting for 1-120 5(26.3) 150(44.5) 1.0(-) 1.0 (-) 1.0(-) 
operation in 121-600 11(57.9) 165(49.0) 2.0(0.7 - 5.9) 2.1(0.8- 9.0)1 2.4(0.7-8.4) 0.05 
minutes - 601+ 9(22.0) 22(6.5) 4.1 (0.9- 18.3) 4.6(1.1 - 39.6)° 5.8(2.3-109.2) 
Shortage of blood Yes 25(64.0) 45(9.9) 5.5(2.7-10.9) 10.1(4.2-24.3)° 10.1(4.2-24.3) 0.00 
No 14(35.9) 411(90.1) 1.0(-) 1.0(-) l. 0(-) 
Shortage ofdrugs Yes 10(25.7) 21(4.6) 7.1(3.0-17.1) 3.6(1.1- 11.3)` 2.9(1.0-9.3) 0.00 
Relative to buy No 29(74.3) 432(95.4) 1.0(-) 1.0 (-) I. 0(-) 
Number oftimes 6-13 28(71.8) 222(49.1) 3.4(1.1-12.0) 3.1(12-10.9)` 3.8(1.1-13.0) 0.00 
monitored: blood >13 6(15.4) 196(43.4) 1.0(-) 1.0(-) 1.0(-) 
pressure/pulse post <6 5(12.8) 34(7.5) 6.5(1.4 - 30.6) 5.6(1.2-25.7)` 5.6(1.2-25 7) partum . 
Number of times 4-8 28(71.8) 253(56.0) 3.4(1.1 -12.0) 16.2(3.6-73.0)` 13.1(0.7-14.5) 0.00 
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(ii) Social, family and medical history characteristics 
Characteristic Stratum Deaths Survivors Odds ratio P value 
N (%) N( %) (95 % CI) 
Family Yes 29 (74.4) 240 (52.2) 2.7 (1.2-6.0) 0.00 
hypertension No 10 (25.6) 220 (47.9) 1.0 (-) 
Family diabetes Yes 9 (23.1) 54 (11.7) 1.8 (0.6-5.3) 0.31 
mellitus No 30 (76.9) 406 (88.3) 1.0 (-) 
Hypertension (self) Yes 4 (10.3) 19 (4.1) 2.7 (0.9-8.2) 0.09 
No 35 (89.7) 441 (95.9) 1.0 (-) 
Admission to Yes 8 (18.0) 42 (8.7) 2.6 (1.1-5.9) 0.03 
hospital No 31 (82.0) 418 (91.3) 1.0 (-) 
Use of Yes 13 (33.3) 188 (40.9) 1.0 (-) 0.12 
contraception No 26 (66.7) 272 (59.1) 1.4 (0.7-2.9) 
(iii) Past obstetric performance 
Variable Stratum Deaths Survivors Odds ratio P value 
N (%) N % (95 % Cl) 
Previous abortion Yes 4 (13.8) 40 (14.0) 1.2 (0.4-3.6) 0.74 
No 25 (86.2) 246 (86.0) 1.0 (-) 
Bleeding in Yes 3 (10.3) 45 (15.7) 0.8 (0.2-2.6) 0.70 
previous pregnancy No 26 (89.7) 241 (84.3) 1.0 
Bleeding in labour Yes 2 (6.9) 31 (10.8) 0.8 (0.2-3.4) 0.69 
No 27 (93.1) 255 (89.2) 1.0 (-) 
Labour lasting Yes 5 (17.2) 49 (17.1) 1.2 (0.5-3.3) 0.68 
more than 18hrs No 24 (82.8) 237 (82.9) 1.0 
Still birth Yes 5 (17.2) 30 (10.5) 2.1 (0.8-5.6) 0.15 
No 24 (82.8) 256 (89.5) 1.0 (-) 
Previous caesarean Yes 7 (24.1) 64 (22.4) 1.6 (0.7-4.0) 0.28 
section No 22 (75.9) 222 (77.6) 1.0 (-) 
Hypertension in Yes 4 (13.8) 19 (6.6) 2.7 (0.9-8.2) 0.09 
pregnancy No 25 (86.2) 267 (93.4) 1.0 (-) 
Blood transfusion Yes 1 (3.4) 15 (5.2) 0.8 (0.1-6.1) 0.23 
during pregnancy No 28 (96.6) 271 (94.8) 1.0 (-) 
* women with previous pregnancies only 
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Variable Stratum Deaths Survivors Crude odds Adjusted odds Adjusted P value 
N (%) N (%) ratio ratio including all 
(95% Cl) (95% Cl) causes of 
mortality in 
model d 
monitored: vaginal >9 6(15.4) 165(36.6) 1.0(-) 1.0 (-) I. ()(-) 
bleeding <4 5(12.87) 33(7.4) 6.45(1.40- 30.06)27.3(4.1- 182.6)` 3.9(1.2-12.5) 
First 24 hours 
HIV status Negative 24(61.5) 405(88.0) LO (-) (1.0) 1.0(-) 0.00 
Positive 15(38.5) 55(12.0) 4.60(2.18.9.30) 5.1(2.0-12.8)` 4.1(1.7-11.4) 
5.8(2.1-12.9)r 
CD cell count <200 12(80.0) 25(45.5) 4.8(1.22,18.93) 5.9(2.5,72.1)' 4.8(1.00-63.2) 0.00 
>200 3(20.0) 30 (54.5) 1.0(-) 1.0 (-) 1.0(-) 
Haemoglobin in <l() 29(74.4) 269(58.5) 2.06(0.94.4.64) 2.6(1.1-6.4)` 2.9(1.0-9.7) 0.03 
gm/dl =>I0 10(25.6) 191(41.5) I. 0(-) 1.0 (-) 1.0(-) 
a: Adjusted for: distance from home to Mulago, patient's job. requesting for permission and previous delivery by 
caesarean section. 
b: Adjusted for: distance from home to Mulago, patients job. requesting for permission and previous delivery by 
caesarean section and admission to hospital. 
c: Adjusted for: distance from home to Mulago, patients job. requesting for permission and previous delivery by 
caesarean section, admission to hospital, birth spacing, parity, antenatal care. hypertension, anaemia, bleeding and 
sex of baby. 
d: Adjusted in c plus causes of SMM. 
e: Adjusted as in d plus sexually transmitted infections and mode of delivery 
I In those with at least one previous pregnancy 
2 In those requiring operation 
3 In 111V positive women 
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Table 6.4 Causes of delay for 207 women* who waited more than two hours for a 
caesarean section 
Cause of delay of 
operation* 
SMM cases who 
survived 
N (%) 
SMM cases who 
died 
N (%) 
Total causes of 
delay 
N (%) 
Busy theatre 131 (60.0) 10 (45.5) 141 (58.1) 
Delay by doctors 38 (17.4) 4 (18.2) 42 (17.5) 
Delay of anaesthetist 15 (6.9) 1 (4.5) 16 (6.7) 
Shortage of expendables 16 (7.0) 0 (-) 16 (6.7) 
Delay of nursing staff 6 (2.6) 0 (-) 6 (2.5) 
Lack of blood 8 (3.5) 5 (22.7) 13 (5.4) 
Lack of instruments 2 (0.9) 0 (-) 2 (0.8) 
Sterilization failure 1 (0.4) 1 (4.5) 2 (0.8) 
Patient refused to consent 1 (0.4) 1 (4.5) 2 (0.8) 
Total 218 (100) 22 (100) 240 (100) 
* Same patient may appear twice in the table as more than one cause could have been reported 
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Figure 6.1 Relative distribution of severe maternal morbidity and mortality 
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CHAPTER SEVEN: DISCUSSION 
7.1 SEVERE MATERNAL MORBIDITY 
This is the largest study yet conducted to investigate risk factors for SMM in sub- 
Saharan Africa. The study looked at all causes of severe maternal morbidity unlike 
many other studies restricted to direct causes of SMM. It was a carefully designed and 
controlled epidemiological study which paid particular attention to the role of HIV 
status and quality of care factors as determinants of SMM. Because of the study setting, 
it was able to examine risk factors for more severe causes of SMM such as ruptured 
uterus, post partum haemorrhage, eclampsia, and abruptio placenta. Although there was 
some concern regarding possible selection bias in controls a the design stage of the 
study, the prevalence of HIV positivity in controls was similar to that of the general 
population of Kampala, providing strong evidence that the controls were representative 
of the population. 
This study confirmed most of the known risk factors for SMM which have been 
reported in the literature, again indicating a thorough and high-quality study. It also 
identified new risk factors which have not been reported in the literature before. The 
study confirmed the role of HIV in SMM and progression to maternal mortality. 
7.1.1 Causes of SMM 
Ninety three percent of the SMM cases in this study had direct obstetric causes and 7% 
indirect. Obstetric haemorrhage overall (33%) was the main cause of SMM in this 
study, as it was in Mulago hospital overall over the study period. This is the pattern in 
most low-income countries 39,256, but is in contrast to developed countries where the 
leading morbidity is hypertensive diseases24, i5,29. 
Hypertensive diseases were more prevalent here than the previously reported 
contribution of less than 10% of SMM cases in the hospital23'252. This increase may be 
related to the large number of primigravidae who delivered at the hospital over the study 
period. This apparent increase of hypertensive disease in Uganda is similar to reported 
trends in South Africa and Zimbabwe where the leading cause of SMM is now 
hypertensive disease 2'3'6,248 . The high proportion of cases in our study with obstructed 
labour and ruptured uterus suggests that the quality of maternal care was low. Indeed, 
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low quality of care was evident in the infrequent use of a partograph for monitoring 
patients: less than 10% of study participants were monitored in this way. Only 5% of 
cases had puerperal sepsis as a primary cause, which was a lower proportion than was 
anticipated at the design stage of the study. This could be due to early treatment 
resulting in reduction of the number of cases presenting with a severe episode. Another 
reason may be that over 80% of the women in Kampala deliver in health units under 
skilled attendants with knowledge of aseptic conditions 251 
7.1.2 Risk factors for all cause SMM 
This study did not find age, either younger than 20 or older than thirty four, was a risk 
factor for severe morbidity, as had been reported in other studies 34,35,257 However the 
majority of patients in this study had a mean age of 23, and over 80% of both the cases 
and controls were below the age of thirty years which limited the power of the study to 
detect older age effects. 
The study found that the further away the patients lived, the higher the risk of 
developing SMM. A lower proportion of cases (81%) compared to controls (98%) lived 
five or less kilometres from a health unit, which is the WHO requirement for good 
accessibility to health services258. Since the majority of patients fulfilled the WHO 
requirement of access to health services, we would expect fewer maternal 
complications. Referral from other health units was associated with an increased risk of 
developing SMM. This finding was similar to that for a study of referred patients in 
Mulago hospital as a whole, which showed a large proportion of "near-miss" cases were 
referrals7. Similar results have also been reported in Nigeria and Guinea' 15,259. Referral 
was a strong risk factor most probably because of time delays and the process of 
transferring patients being harmful, especially in circumstances where there is no 
ambulance service. Because of the importance of referral as a risk factor, the analyses 
were repeated using non-referred women only. The pattern of results was not greatly 
altered by this restriction, indicating the independent effect of the other determinants of 
SMM in this study. The general issue of bias, and the possible effects of bias on the 
results of this study, will be discussed in Chapter 8. 
Women who reported professional jobs had an increased risk of developing SMM 
compared to women who classified themselves as peasants. This somewhat counter- 
intuitive finding may relate to increased stress and lack of adequate rest79. Or it may 
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indicate a degree of selection bias, as these women recognized the importance of 
coming to hospital. Socio economic status was mainly assessed using housing type. 
Those of lower social economic status (living in mud or brick houses with iron roofs) 
had 3 to 4 times the risk of SMM after adjustment for confounding factors compared to 
those of higher socio-economic level (who lived in plastered brick houses with iron or 
tiled roofed houses). Low socio-economic class and poverty have been reported to be 
important underlying factors in both SMM and maternal mortality34,201,26o Women who 
said that they needed to ask for permission (from their husband or other family 
members) before attending a health unit or hospital had increased risk of developing 
SMM compared to those who did not need to ask for permission. This suggests that 
when a complication (signs and symptoms) occurs the woman cannot make a decision 
to attend a health unit until the spouse or family member gives permission, resulting in 
delay. Requesting permission is also a manifestation of women's poverty because they 
depend financially on their spouses. Indeed, patients who depended on others for 
financial support while they were in hospital had increased risk of developing SMM 
after controlling for confounders. Poverty has been reported to be associated with SMM 
and mortality in both developed and developing countries34,26o, 
z6l. Poverty is associated 
with poor nutrition, low education status and low or non use of antenatal care. 
With regards previous reproductive history, gravid patients with a history of having had 
an evacuation and dilation and curettage had twice the risk of SMM compared to those 
who did not. This finding has not been reported in the literature to date and may be 
explained by the fact that previous history of evacuation or dilation and curettage is 
associated with adverse obstetric events such as ante partum haemorrhage. Women 
with a poor obstetric history are at increased risk of an adverse event in the current 
pregnancy. Parous women who had delivered by caesarean section in a previous 
delivery also had higher risk of developing SMM compared to those who had only ever 
delivered vaginally. In a similar argument to that presented for previous abortion and/or 
evacuation of the uterus, previous caesarean section may simply be a marker for 
previous morbidity. Or it could be a measure of the quality of obstetric performance in 
Mulago hospital in that timely intervention was not offered to these women when need 
arose and they ended up with severe complications. Indeed, women on trial of scar had 
thrice the risk of developing SMM. The other explanation could be the desire for 
vaginal delivery among African women such that those with a previous scar will delay 
attending medical care in an attempt to avoid a repeat caesarean6s, i2s, ia2. 
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Chronic hypertension, as well as hypertension in previous pregnancies, was associated 
with a considerably increased risk of developing SMM. Chronic hypertension has been 
found to be an important risk factor for SMM in studies carried out in USA, UK and 
South Africa6°34°35Previous history of admission to hospital for medical (non-obstetric) 
reasons during pregnancy was associated with an increased risk of SMM. Admission 
was most probably for pre-existing hypertension, urinary tract infection or anaemia, 
which can predispose women to SMM. This has been observed in the UK34. 
A very long interval since the last pregnancy ended (more than five years) was 
associated with an increased risk of developing SMM, but analyses comparing birth 
intervals of less than 18 months with those between 18 and 36 months did not reveal 
any statistically significant variation in risk (results not presented in analysis). This 
suggests that frequent births are not associated with SMM, a finding reported in other 
studies262'263 The reason for the effect of long birth interval on SMM is not clear but 
previous studies have shown an association between birth intervals of more than 4 years 
and the risk of pre-eclampsia and eclampsia69'76. In addition, a prolonged birth interval 
of more than 5 years could be associated with development of uterine fibroids among 
Africans 264 which can predispose to malposition of foetus resulting in obstructed labour 
or cause reduced blood supply to the placenta leading to ante partum haemorrhage. 
The mean parity in both cases and controls was 2.6 (SD = 0.8), with a range of 1 to 14. 
Nulliparity but not high parity was associated with the risk of developing SMM after 
adjusting for confounders. High parity has been reported to be associated with risk of 
maternal mortality in developing countries 265and an association with SMM was 
expected, but not demonstrated in this study. The morbidity and mortality risk due to 
high parity may be a measure of the risk associated with advanced age (over 34 years), 
and we did not have a large number of study subjects within this age group in our study. 
Overall, antenatal care attendance was high in cases (88%) and in controls (97%) and 
was similar to the national figure of 94%12. But the patients who did not attend 
antenatal care at all had, as expected, increased risk of developing SMM after 
controlling for confounding factors compared to those who attended at least once. This 
confirmed what other research studies have found266. Although the attendance was 
relatively high, a third of cases and controls booked-for antenatal care in the third 
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trimester, and in both cases and controls over 55% of women attended less than four 
times. An antenatal attendance of less than 4 times is considered inadequate by WHO 
standards which recommend at least 4 visits spread over the 3 trimesters267. Thus, 
although there was a high level antenatal care attendance overall, patient observation 
over the course of the pregnancy was not adequate for staff to detect abnormalities. In 
addition, the quality of antenatal care was limited: among patients who attended 
antenatal clinic almost one quarter of cases compared to almost one tenth of the controls 
did not have their blood pressure checked. This was associated with a clear increased 
risk of developing SMM. Failure to measure blood pressure when a woman attends 
antenatal clinic is a serious omission and demonstrates inadequacies in antenatal care 
provision. 
When study participants were asked what they would do if they developed vaginal 
bleeding in their current pregnancy one quarter of cases did not know what to do 
compared to 4% of the controls. Bleeding during pregnancy is one of the most serious 
signs/symptom which pregnant women should recognize and act on by seeking medical 
attention immediately. Knowledge about what a woman should do when she bleeds 
during pregnancy tests not only whether a woman has attended antenatal clinics, but 
also whether the health education messages given during such visits were understood. 
A higher proportion of cases than controls failed to absorb the message regardless of 
whether they attended antenatal care. 
Anaemia during pregnancy was associated with a clear increase in risk. Anaemia in 
pregnant women has been estimated to be about 40-80% in developing countries 185,268 
and the levels are known to be associated with, and aggravated by, the degree of malaria 
infection '86"87"89. Several studies have reported an association between anaemia and 
risk of maternal morbidity and mortality in Africa269,270. We found a haemoglobin level 
of less than 10 grams per decilitre was a risk factor for SMM. A limitation of this result 
is that all the control samples were taken after delivery, but a proportion of case samples 
were taken during delivery, making it difficult to disentangle the role of bleeding during 
delivery and antenatal anaemia. 
During labour, premature rupture of membranes (membranes ruptured before start of 
labour) increased risk of SMM. This is explained by the fact that premature rupture of 
membranes is associated with chorioamnionitis, which in turn is an underlying cause of 
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abruptio placenta and puerperal infection162°176 Premature rupture of membranes is also 
associated with cephalo pelvic disproportion and abnormal presentation of the foetus 
which put a woman at risk of developing SMM if intervention to deliver her was not 
provided in time. 
Bleeding during labour as expected was clearly associated with increased risk of SMM. 
Bleeding during labour is a serious warning sign which needs evaluation and 
appropriate management. With good monitoring of labour SMM could be avoided by 
prompt management. This result suggests that there was inadequate monitoring of 
patients or delay in reaching hospital or offering appropriate treatment. 
Active management of the third stage is the recommended practice that has been 
shown to prevent post partum haemorrhage. 98. Normal third stage should last not 
more than 30 minutes because the risk of post partum haemorrhage increases with a 
time 271. Study participants whose third stage lasted more than 25 minutes had a 
remarkably high risk of SMM. In addition, women who did not receive oxytocics 
soon after delivery of their babies had higher risks of developing SMM compared to 
women who did receive it. This confirms an earlier finding that administering 
oxytocics soon after delivery of the baby reduces the incidence of PPH99,106. The 
reason for not getting oxytocin may be due to shortage of syringes, lack of the drugs, 
or lack of staff knowledge. 
Having SMM resulted in higher risks of delivery of low birth weight babies (babies 
weighing less than 2500 grams). This finding relates to the fact that low birth weight 
is associated with pre-eclampsia, ante partum haemorrhage and medical disease 172. 
Low birth weight also results from premature termination of pregnancy due to the 
severity of SMM. 
In our study sample the test for Syphilis was positive in 9% of both cases and controls. 
This is within the reported prevalence estimated between 4-15% among pregnant 
women in Sub Saharan Africa193'272'274. Syphilis was not associated with the risk to 
SMM. 
HIV. in sub Saharan Africa has claimed many lives including pregnant women. HIV 
prevalence rates in Uganda have reduced from 30% in the early 1990's to 8% in urban 
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areas and 4% in rural areas with an overall average of 6.5% in the early 2000s18. 
Fourteen percent of cases and 9% controls tested HIV positive in this study: HIV 
positivity was associated with twice the risk of developing SMM. HIV infected women 
have a degree of immunodeficiency and are thus expected to have significant increase 
of morbidity when compared to the HIV negative women. Reported conditions 
associated with HIV include chorioamnionitis, puerperal sepsis, ante partum 
haemorrhage, post partum haemorrhage and chronic anaemia199'200One study in 
Ireland reported no influence of HIV on the clinical course of critically ill obstetric 
patients235. The type of care women receive during pregnancy and delivery and the 
stage of HIV disease may account for the difference in this result and the findings of our 
study. Other studies have shown that pregnancy does not influence the progression of 
the HIV disease 223°231. Studies from Rwanda reported increased risks of post operative 
complications among HIV positive mothers compared to HIV negative mothers275. It is 
thought that post partum morbidity is determined by maternal CD4 lymphocyte count 
and stage of maternal HIV disease233. The HIV positive patients in Mulago hospital 
only received niverapine peripartum to prevent vertical transmission of HIV. No 
woman was on antiretroviral treatment for HIV/AIDS in the study pre-partum. 
In conclusion, the main risk factors identified for all types of SMM were residential 
distance from hospital, low socioeconomic status of women, lack of empowerment, 
history of hypertension and previous adverse events in pregnancy, being referred, type 
of care offered to women during pregnancy and delivery, and HIV status. The 
improvement of maternal care offered to women during the antenatal period and 
delivery, coupled with an improved referral system, could potentially reduce the burden 
of SMM in Kampala. Prevention of HIV transmission will also reduce SMM. In the 
community, mobilization of women for safe motherhood, improvement of social status 
of women and empowerment of women economically are likely to contribute to the 
reduction of SMM. 
This study has confirmed the following risk factors previously reported in the 
literature: 
" Residential distance from health unit 
" Nulliparity 
" Pre-existing medical conditions 
" Low socio economic class and low social status 
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" Non attendance of antenatal care 
" Referred from another health unit during labour 
" Admission prior to delivery for medical reasons. 
This study did not confirm the following findings previously reported in the literature: 
" High parity as a risk factor for SMM 
" Young and older mothers being at increased risk of SMM. 
This study reports the following new associations not previously reported in the 
literature: 
" Birth spacing of more than five years was associated with an increased risk of 
SMM 
9 HIV positivity was associated with an increased risk of SMM 
" Previous delivery by caesarean section was associated with an increased risk 
of SMM 
" Previous uterine evacuation was associated with an increased risk of SMM 
9 Lack of knowledge of what to do when bleeding starts during pregnancy was 
associated with increased risk of SMM. 
7.2 RISK FACTORS FOR INDIVIDUAL CAUSES OF SMM 
7.2.1 Risk factors for severe pre-eclampsia and eclampsia 
Severe pre-eclampsia and eclampsia are potentially life threatening conditions. The 
management aims at reduction of high blood pressure, preventing and controlling 
convulsions and ultimately termination of pregnancy. Severe pre-eclampsia and 
eclampsia contributed 25% as primary causes of SMM. 
In this study the characteristics of these cases were compared the characteristics of the 
controls in a separate case-control analysis. Living a further way from the hospital, 
being a referred patient, lack of knowledge about what to do if there was bleeding in 
pregnancy, and low socio-economic and social status were significant risk factors for 
eclampsia and severe pre-eclampsia, and for all SMM cases as described in 7.1.2. Poor 
socio economic status and poverty may lead to a lack of some essential dietary elements 
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such as vitamin E and other antioxidants. These micronutrients have been postulated to 
decrease the production of monocyte tumour necrosis factor alpha which is likely to 
play a role in athrogenic events and is a potent endothelial activating factor playing a 
role in the pathogenesis of pre-eclampsia276. The relationship between pre-eclampsia 
and maternal age has been described as J shaped where hypertension is raised in the 
young ages, decreases, and then begins to rise above age of thirty four years69. Maternal 
age (young or old) was not found to be risk factor for severe pre-eclampsia and 
eclampsia in this study although other studies have reported it77'79. This may have been 
because of majority women delivered in Mulago hospital were below thirty years. 
Women who were employed had increased risk of developing pre-eclampsia and 
eclampsia compared to peasant women after controlling for potential confounders such 
as age, and professionals had the highest risk within the employed group. Similar 
results were reported from the Mexico where working women had twice the risk of pre- 
eclampsia compared to non-employed women77. Two other studies, from Australia, 
showed similar associations between working and pre-eclampsia78 77,277,278. It has been 
suggested that the association between pre-eclampsia and working during pregnancy is 
related to strain and different levels of physical activity at work but not to socio 
economic status Ugandan women who participate in commercial and professional work 
probably did not get enough time to rest and this may predispose them to pre-eclampsia. 
Family history of hypertension doubled the risk of developing pregnancy induced 
hypertension. Familial hypertension may be associated with pre-eclampsia because pre- 
eclampsia could be the first manifestation of later development of chronic 
hypertension50. And, perhaps not surprisingly, study women with pre-existing chronic 
hypertension had a very high risk of pre-eclampsia and eclampsia compared to those 
without. This confirms findings from recent studies that both familial hypertension and 
chronic hypertension are risk factors for pre-eclampsia and eclampsia51,65,69,73, 
Similarly, the current study confirmed previous reports of increased risk associated with 
a history of pregnancy-induced hypertension45, ss, 7i, 79 In addition, previous history of 
admission to hospital for medical (non-obstetric) reasons during pregnancy was 
associated with a trebling of the risk. Admission was most probably for pre-existing 
hypertension or urinary tract infection which can predispose a woman to pregnancy 
induced hypertension. 
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Women with a previous history of abortion had an increased risk of developing pre- 
eclampsia or eclampsia. Previous studies have reported that women who have had 
abortion are at risk of pre-eclampsia when the next pregnancy is not with the same 
partner278. Any pregnancy following an abortion or term pregnancy with the same 
partner is thought to be protective because of the immune theory of pre-eclampsia 
which suggests that second invasion of trophoblast is protective 71,278,279. Many studies 
have reported nulliparity as a risk factor for severe pre-eclampsia45,54,74,82,280,28' and this 
study confirmed the finding. How the mother reacts to the first invasion of the 
trophoblast or placenta will determine the risk of pre-eclampsia. Failure of the normal 
invasion of trophoblastic cells leads to mal-adaptation of the spiral arterioles thought to 
be related to the causation of pre-eclampsia56. The protective effect of multiparity 
which disappears on change of paternity have lead some authors to suggest that it is 
primipaternity, rather than primigravidity, which is a risk factor for pre-eclampsia282 
Results from a Norwegian population study have confirmed the role of paternity in the 
determination of pre-eclampsia72. We did not ask about paternity in our questionnaire 
and were thus unable to examine the change of partner. Indeed, grand multiparity was 
found to be protective for developing severe pre-eclampsia. Because grand multiparity 
is associated with increasing age, it was expected to be associated with increased risk 
for pre-eclampsia but this was not observed. In our study majority of the patients were 
below thirty years which suggests age rather than grand multiparity is a risk factor for 
pre-eclampsia. 
We found that pregnancies with a long birth interval of over 5 years had over 8 fold 
greater risk of developing severe pre-eclampsia compared to pregnancies with birth 
intervals of thirty six or less weeks. The reason for this association is not known but 
could be due factors such as sub fecundity and other risk factors associated with 
76,283_ paternal change which may act together to predispose to pre-eclampsia 
Women who had no antenatal care had a higher risk of developing severe pre- 
eclampsia. Antenatal care is an important component of maternity care which screens 
women who are at risk or have developed pre-eclampsia so that they can be managed 
early to prevent complications. Effectiveness of the screening of the women depends on 
the quality of antenatal care, the booking time and the number of visits by the patients. 
Among those who did attend antenatal care, there was evidence that cases had their 
blood pressure checked less often than controls over the course of the pregnancy, a 
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serious omission in antenatal care. The hypertensive mothers would have had signs and 
symptoms suggestive of hypertension and could therefore have been identified and 
managed to prevent the development of severe pre-eclampsia or eclampsia. 
Once diagnosed, women with pre-eclampsia should ideally be followed up using uric 
acid levels which are good predictors of severity of established pre-eclampsia. Delivery 
can then be carried out at an appropriate time to prevent further complications. 
Measurement of serum uric acid and creatinine levels are limited in developing 
countries because of cost, and are not used routinely in Mulago hospital. Urinary 
protein measurement as used in Mulago is cheap and readily available but picks up 
cases late and has false negatives79. With inadequate laboratory facilities to monitor the 
progress of pre-eclampsia, as is the case in developing countries, many women will end 
up with severe maternal and perinatal morbidity. 
Women with pre-eclampsia and eclampsia delivered a significantly higher proportion of 
male babies compared to women without these conditions. The explanations for this in 
not clear but similar results were reported by Basso and Olsen283. Other studies 
however have found no statistical difference in total testosterone and free estriol values 
between women with pre-eclampsia and those without suggesting that sex of foetus 
does not play a role in causation of the pre-eclampsia284. 
Hypertension in pregnancy causes intra uterine foetal growth restriction. However not 
all pre-eclamptic mothers deliver growth restricted babies, and the effect depends on the 
initiation of the disease. Pre-eclampsia is more severe when it starts early in pregnancy 
but has minimal effect on the foetus when it starts late pregnancy45. In this study low 
birth weight babies were much more likely to be delivered by women with severe pre- 
eclampsia and eclampsia, indicating that the disease was initiated early in pregnancy or 
that there was premature termination of pregnancy as result of severity of disease. 
This study did not find a statistically significant association between HIV and risk of 
severe pre-eclampsia and eclampsia. In our study we must note that the numbers were 
small and so the study lacked power to detect a statistical significant difference even it 
had been present, so we must be cautious about concluding no effect. 
The platelet life span is shorter in pregnancy induced hypertension especially when 
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complicated by growth restriction of the foetus. This study found a greater risk of 
thrombocytopenia (less than 150 x 109 per litre) in women with severe pre-eclampsia 
and eclampsia. Fifteen (10%) of cases had platelet counts less than 100 x 109 cells per 
litre and were complicated with HELLP syndrome. However the distribution of 
platelets among women with hypertension and those without overlap too much for 
platelet count to be used as a predictor for severe pre-eclampsia. 
In conclusion, this study found the main risk factors for severe pre-eclampsia and 
eclampsia were: residing further away from hospital, being referred, being a 
professional woman, having familial or co existing hypertension, nulliparity, birth 
interval of more than five years, previous abortion, and delivery of male babies. 
Prevention of this disease will depend on quality of care offered to women during 
antenatal and labour and support of laboratory investigations. 
In summary this study has confirmed the following as risk factors for severe pre- 
eclampsia already reported in literature: 
" Nulliparity 
" Stress of job 
" Antenatal care 
" Chronic and familial hypertension 
" Previous hypertension in pregnancy 
" Birth interval of more than four years 
" Male babies 
" Low socio economic status. 
" Being a referral patient 
The study found the following as risk factors not previously reported in the literature: 
9 Previous abortion. 
7.2.2 Risk factors for post partum haemorrhage 
Post partum haemorrhage (PPH) is the leading causes of maternal morbidity and 
mortality in developing countries8. It contributed 19% of primary causes of SMM in 
this study. 
The background to the PPH cases were uterine atony (45%), retained placenta or 
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placental tissue (16%), coagulation failure (16%) and genital tract tears (15%). Uterine 
atony is a common cause of PPH due to high parity and age-related changes which take 
place in the uterine connective tissue and muscles resulting in reduced contractility and 
retraction of uterine muscles after delivery. Other contributory factors to uterine atony 
are prolonged labour, over-distension of the uterus in multiple pregnancy and 
hydramnios, non use of oxytocics soon after delivery and anaesthesiato2,2ss In 
industrialized countries induction of labour, operative delivery and epidural anaesthesia 
107 are major risk factors for PPH. 
Women who lived further away from Mulago hospital, in poor quality housing, being 
unable to pay for hospital upkeep, and needing to ask for permission to visit a health 
unit or hospital had increased risks of PPH after adjusting for confounders, results 
which were similar to those described for all SMM cases (7.1.2. ). Asking for 
permission causes delay of the mother to reach health unit/hospital but also may 
encourage them to deliver at home and present to hospital with PPH. This is further 
reinforced by the low socio economic status of the women which hinder women from 
using health facilities because of failure to afford transport and cultural beliefs that 
12s , 2s6. encourage them to deliver at home 
Patients with chronic hypertension had a greater risk of developing PPH compared to 
those without. Hypertension predisposes to pre-eclampsia and abruptio placenta which 
are also risk factors for PPH91°99,106 Women with a past obstetric history of PPH had a 
higher risk of developing severe PPH after controlling for confounders. This was 
similar to Hall's finding of a3 fold increase among patients with previous history of 
PPH287. In Zimbabwe there was moderate association of previous history of PPH with 
risk for PPHIOI Previous history of PPH seems to be a good predictor of subsequent 
PPH, but the limitation is validation of the reported history of PPH288 
Women who delivered by caesarean section in their previous pregnancy had a much 
higher risk of developing PPH after adjusting for confounders. When previous scar was 
further adjusted for mode of delivery the effect persisted. This was similar to Coombs 
findings, although the effect of previous scar disappeared after controlling for induction 
of labour96. The explanation for previous scar being a risk factor is possibly related to 
recurrent factors such as previous ante partum haemorrhage and hypertension which are 
underlying risk factors for PPH. It may also be related to prolonged labour and its 
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complications resulting in PPH. 
Birth intervals of more than five years increased the risk of PPH after adjusting for 
confounders. Previous work has shown that prolonged birth interval may be associated 
with increasing age and low parity, both of which have been reported to be associated 
with PPH101,239 However, our estimate was adjusted for parity so that is not a likely 
explanation in these data. Long birth interval is associated with conditions such as pre- 
eclampsia and ante partum haemorrhage which are known risk factors for PPH113 
Patients who did not attend antenatal care had increased risk of developing PPH. 
, Studies have reported a strong relationship 
between lack of antenatal care and PPH13,285 
but one study in Nigeria showed no relationship between lack of antenatal care and risk 
for PPH102. The association between lack of antenatal care and PPH is related to 
management: women at risk of PPH are offered advice on where to deliver, and doctors 
prepare for these women by taking blood for haemoglobin level and grouping. When 
they arrive in labour blood is booked and a drip set up in anticipation of bleeding. But 
women without identifiable risk factors also get PPH, so delivery attendants need to 
have the skill and knowledge to manage these conditions if the morbidity, and 
associated mortality, is to be prevented. Women who lack knowledge about what to do 
if there was bleeding in pregnancy had increased risk of developing PPH. Previous 
work has reported that ante partum haemorrhage which usually presents with bleeding is 
a risk factor for PPH'°7. 
Bleeding in labour, as expected, was associated with a much greater risk of developing 
severe PPH. This was because the majority of women who bleed during labour are 
likely to have ante partum haemorrhage or ruptured uterus which are risk factors for 
PPH98'107. Women who bleed during labour should be managed in anticipation of PPH. 
Patients diagnosed with hypertension during pregnancy were also at greater risk of PPH. 
Hypertension is associated with disseminated intravascular coagulation which 
predisposes patients to PPH due to coagulation failure95. 
Referred patients to Mulago hospital had higher risk of developing severe PPH. This is 
explained by the fact that some women labour out of hospital and only come to Mulago 
when they have failed to deliver and have complications or have delivered at home and 
have a retained placenta. Similar results have been reported in previous studies from 
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Mulago and elsewhere 7,285. Women who had induced or augmented labour had a 
markedly increased risk developing PPH, as has been reported in other studies95,107. 
Women who did not get oxytocics soon after delivery had increased risk of developing 
PPH. The majority of these patients were referred to Mulago after delivery. The 
recommended management of third stage is by active management: utero tonics are to 
be given at delivery of the anterior shoulder of foetus or within one minute of delivery 
of baby, followed by delivery of placenta by controlled cord traction. Conservative 
management allows the placenta to be delivered physiologically by waiting for placental 
separation then delivery with or without administration of utero tonics. Active 
management of third stage has been demonstrated to reduce on the incidence of 
PPH95,107,271 The loss of blood is minimal within the first 30 minutes, but the increases 
three fold for longer third stages271. In our study those who stayed in the third stage for 
25 or more minutes were at very high risk of PPH compared to those who spent less 
than 25 minutes after adjusting for confounders. Other studies have shown that 
9s prolonged third stage predisposes to PPH, ioi, to3, toý 
The patients delivered by a doctor had markedly increased risk of PPH compared to 
those delivered by midwives. This may be partly explained by the fact that patients 
delivered by doctors were women who are were already at risk of PPH, or attended 
hospital with existing PPH. However a study in Nigeria showed reduction of PPH in 
women delivered by doctors102 
Women with PPH delivered a higher proportion of babies weighing less than 2500 
grams compared to women without SMM. This was because conditions that cause low 
birth weight also cause PPH. PPH was not found to be associated with the delivery of 
big babies in this study, although some studies have reported increased incidence of 
PPH due to big babies as result of over distension of the uterus, which affects the 
contractility and retraction of the uterine muscles", 102. 
In conclusion, risk factors for PPH were found to be residential distance from hospital, 
being referred, and low socio economic status of women, existing hypertension and 
anaemia, past history of PPH, lack of antenatal care and management of third stage of 
labour. Proper management of labour using skilled attendants at delivery and use of 
oxytocics during the third stage remains the hall mark in the prevention of PPH. 
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In summary, this study confirmed the following as risk factors for PPH already reported 
in the literature: 
" Low socio economic class 
" Lack of antenatal care 
" Being referred patient 
" Prolonged third stage 
" Hypertension 
" Induction or augmentation of labour 
" Previous history of PPH. 
The study found the following risk factors for PPH not previously reported in the 
literature: 
" Previous delivery by caesarean section 
" Lack of knowledge of what to do when bleeding occurs in pregnancy 
" Birth spacing of more than five years. 
7.2.3 Risk factors for obstructed labour 
Obstructed labour and its consequences was the most frequent sub group of SMM in 
this study. This complication is a life threatening obstetric emergency but when 
recognized early and managed by caesarean section usually carries few or no 
complications. 
Women who lived further away from Mulago hospital, in poor quality housing, being 
unable to pay for hospital upkeep, who did not know what to do if bleeding in 
pregnancy, and who needed to ask for permission to visit a health unit or hospital had 
increased risks of severe obstructed labour after adjusting for confounders. Low socio 
economic class has been reported as a risk for obstructed labour 13,117,118,217,289. The 
majority of our patients lived within five kilometres from the nearest health unit and 
therefore the risk of obstructed labour should be minimal if the units had comprehensive 
maternity services and a functional referral system. In order to reduce maternal 
morbidity and mortality due to obstructed labour, a referral system should have a 
transport component to transfer patients to referral hospitals in order to reduce the 
delay290. Indeed women who were referred had eleven fold risk for developing 
obstructed labour. Sometimes, even when the referral system is working, if the midwife 
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or delivery attendant does not make a decision to refer a patient promptly, the patient 
will remain at risk of obstructed labour. 
The vast majority (91%) of women with obstructed labour were below the age of thirty 
years compared to 83% of controls. Although a young age was a statistically significant 
factor for obstructed labour in the univariate analysis, the effect disappeared after 
adjusting for confounders. In Gombe hospital in Sokoto Nigeria age below thirty years 
was associated with increased risk of obstructed labour211. Other work in developing 
countries has indicated that under-nutrition may cause poor development of pelvises 44 
and this, coupled with pregnancies in teenagers who are still growing, put them at risk 
of obstructed labour if their labour is not well managed44,118,135,211,289. We found that 
primigravidae had increased risk of developing severe obstructed labour compared to 
multigravidae. The majority of the primigravidae were teenagers who are expected to 
t 
. be at 
higher risk of cephalo pelvic disproportion, as reported in Nigeria 
Parous patients who had delivered by caesarean section in a previous pregnancy had 
increased risk of developing severe obstructed labour compared to those who had only 
previously delivered vaginally. This suggests the existence of a recurrent cause of 
obstructed labour, but that timely delivery was not offered in the current pregnancy. 
Another explanation may be the desire for vaginal delivery among African women. As 
mentioned previously, they tend to avoid a repeat caesarean section by labouring at 
home and only turn up in hospital when vaginal delivery has failed. Similar 
observations have been reported in Nigeria and Uganda 128,142,207. This risk, then, should 
be interpreted cautiously because it may be a measure of health seeking behaviour of the 
women (in that they delayed to come to hospital) or quality of care (in that the 
intervention to deliver was delayed) rather than a direct effect of previous delivery by 
caesarean section. 
Although some studies have reported lack of antenatal care as a risk factor for 
obstructed labour 17.289. We did not find a statistically significant association in this 
study., : The effect estimate, however, was above one, and the lack of significance may 
be related to lack of power resulting from the small number of cases. 
Monitoring of labour using a partograph was low in both cases (11%) and controls (9%) 
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in this study, suggesting there was poor monitoring of labour which resulted in failure to 
detect prolonged labour. If obstructed labour is not terminated in time it will progress to 
severe obstructed labour. The mean waiting time for a patient to have caesarean section 
from diagnosis to operation should be less than 30 minutes131 but in this study the 
average waiting time for caesarean section was 211 minutes (3.5 hours). Only 46 (43%) 
of the patients with obstructed labour were operated on within two or less hours of 
diagnosis, which was the target of the hospital, and only 3 (3%) met the international 
standard of having caesarean section done in less 30 minutes. The reason for the long 
waiting times was a busy operating theatre (with other obstetric emergencies) and 
delays by staff. A similar finding of busy theatre not coping with obstetric emergencies 
has been reported in Dominican Republic13o 
Parous women with birth intervals of more than 36 months had higher risks of 
developing severe obstructed labour after adjusting for confounders. The reason for this 
was not clear but may be associated with previous obstructed labour which recurred. It 
is also possible that the effect of a previous delivery was traumatic and resulted in a 
longer waiting time to next pregnancy291. Women who presented with premature 
rupture of membranes had much higher risk of developing severe obstructed labour. 
Cephalo pelvic disproportion, malpresentation, malposition and abnormal lie are 
associated with premature rupture of membranes and these conditions predispose to 
obstructed labourlo9 
As expected, patients who laboured for more than 18 hours were more likely to develop 
severe obstructed labour compared to those who did not. The mean length of labour in 
cases of obstructed labour was 25.2 (SD = 16.2 hours) and this was in excess of the 
suggested 24 hours which indicate that a woman's life may be in danger. Obstructed 
labour was associated with the delivery of male babies which are likely to be heavier 
than the female babies292. 
In conclusion, risk of severe obstructed labour was associated with residential distance 
from hospital, referral, low socio economic status of women, nulliparity and the type of 
care offered during labour. Monitoring of labour using a partograph is key to 
preventing obstructed labour. 
In summary, this study confirmed the following risk factors for obstructed labour 
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previously reported in the literature: 
" Low socio economic class 
" Living further a way from hospital 
" Asking for permission 
" Referral 
" Parity 
" Prolonged labour. 
The study found the following risk factors not previously reported in the literature: 
" Birth spacing of more than 36 months 
" Previous caesarean section scar 
" Delivery of a male baby. 
7.2.4 Risk factors for ruptured uterus 
Uterine rupture is one of the most dangerous obstetric emergencies which have serious 
consequences for the mother and foetus. It is one of the main causes of maternal death 
in sub-Saharan Africa 136. Uterine rupture is a catastrophic event to a woman because 
she may loose her future fertility due to hysterectomy or repair of uterus with bilateral 
tubal ligation293. 
Ruptured uterus contributed 10% of the primary causes of SMM in this study. The 
background causes were: cephalo pelvic disproportion (33%), previous scar (37%), 
malpresentation of the foetus (15%), big baby (10%) and others (5%). This pattern was 
similar to studies in other developing countries136°las, t7s, 29a. The treatment offered was 
subtotal hysterectomy (85%), repair of uterus and bilateral tubal ligation (10%) and 
repair of uterus only (4%). Scar dehiscence with no other complication is better 
managed by uterine repair. Hysterectomy cases performed better post operatively than 
those whose uteruses were repaired. Six (12%) of patients had uterine rupture involving 
the bladder. This was similar to that reported in Ethiopia and Nigeria '42,295. The main 
worry with offering subtotal hysterectomy in Uganda is the risk of developing cancer of 
cervix later in life. 
Women who lived further away from Mulago hospital, in poor quality housing, being 
unable to pay for hospital upkeep, who did not know what to do if bleeding started, and 
who had to ask for permission to visit a health unit or hospital had increased risks of 
ruptured uterus after adjusting for confounders, similar results to those described for all 
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SMM cases (7.1.2. ). Low socio economic status has been reported previously as a risk 
factor for ruptured uterus 68,136,142 
Teenage women had a lower risk of developing ruptured uterus as did nulliparous 
136 women. Other studies have reported similar findings, 14s, 146 It is known that when 
mechanical obstruction to labour occurs in primiparous women uterine contractions 
gradually weaken and stop without uterine rupture, but in multigravidae contractions are 
more likely to continue until delivery or rupture of uterus296. 
Uganda has two major tribal groupings: the Bantu who are the majority and the Nilotics. 
The Nilotics had an increased risk of developing ruptured uterus compared to the Bantu. 
Most of the Nilotics are displaced persons due to civil war in their region and have 
come to live in Kampala. As result of civil war it is possible that some women could 
have had fracture of the pelvis or lower limbs resulting in cephalopelvic disproportion 
and predisposing them to uterine rupture. There also could be poor health seeking 
behaviour of these women and a strong desire for vaginal delivery. 
We found that women with a history of previous labour lasting more than 18 hours had 
a higher risk of ruptured uterus after adjusting for confounders. This was likely to be 
associated with previous scar because women labouring for more than 18 hours were 
more likely to have been delivered by caesarean section. The main draw-back with 
such information is the recall and measurement bias of number of hours in labour. Our 
finding of a strong association between previous scar and ruptured uterus was similar to 
that found by several other studies 134,139,143,148,297. Some authors have demonstrated 
increased risk of rupture with increasing number of caesarean sections. The risk of 
uterine rupture in relation to previous scar varies from country to country, type and site 
of uterine scar (either in upper segment or lower segment, transverse or vertical scar) 
and post-operative outcome of the mother. It has been reported that post operative fever 
increases the risk of scar dehiscence by 4 times in the next trial of labour141,217. 
Birth spacing of more than 5years was associated with an increased of ruptured uterus 
compared to birth intervals of 36 or less months. The possible explanation for this 
could be a result of the women's health seeking behaviour of attempting vaginal 
delivery at home and coming to hospital when delivery has failed. It is also possible 
that there was delay of operative delivery resulting in ruptured uterus. 
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Lack of antenatal attendance was a clear risk factor for ruptured uterus. A similar result 
has been reported in studies in Kenya 136, Ethiopia'', Sudan 140 and in Nigeria 142 . 
However, over 50% cases of ruptured uterus were referred to Mulago hospital and 
referral was associated with risk. These patients laboured outside the hospital and when 
they had failed they were referred, or self referred, to Mulago. Similar findings have 
been reported from Mbale regional hospital in Uganda. 297, in Ethiopia'44 and in 
Ghana298. These results suggest that there was low quality of care in peripheral 
maternity units and that referred patients may have suffered undue delay to Mulago 
hospital, possibly because of lack of transport. 
Women with ruptured uterus were more likely to deliver babies weighing more than 
3500 grams. Big babies cause obstructed labour when delivery is not terminated in time 
to prevent rupture296. 
HIV positive women had increased risk of uterine rupture. There were 10 cases of 
ruptured uterus who were HIV positive and 4 of these had previous scar. It is possible 
that these 4 cases were asymptomatic HIV in a previous delivery by caesarean section 
and had poor uterine wound healing due to sub clinical infection. This could not be 
investigated further in this study as we did not have information of the patient's 
previous HIV status. This finding needs to be urgently investigated further. 
In conclusion, risk factors for ruptured uterus were found to be residential distance for 
the hospital, referral, and poor socio economic status, previous scar, type of care offered 
during pregnancy and labour, and HIV. Early diagnosis and management of prolonged 
labour are likely to reduce the risk of ruptured uterus. 
In summary this study confirmed the following risk factors for ruptured uterus as 
previously reported in literature: 
" Previous caesarean section 
" Low socio economic status 
" Lack of antenatal care 
" Multiparity 
" Referral 
" Older age 
148 
" Birth weight more than 3500 grams. 
This study identified the following risk factors not previously reported in the literature: 
" Birth interval of more than five years 
" HIV positive status 
" Nilotics group of tribes in Uganda. 
7.2.5 Risk factors for placenta praevia 
Placenta praevia is a major cause of obstetric haemorrhage in the third trimester and is 
associated with severe maternal complications and adverse perinatal outcomes. 
Placenta praevia is very important because the condition can become life threatening 
within a short period and if not managed promptly mortality due to this condition is 
very high. 
Distance of residence from Mulago hospital and asking for permission before attending 
a health unit or hospital were risk factors for developing severe ante partum 
haemorrhage due to placenta praevia. As mentioned above, this condition is life 
threatening and occurs within a short time. If patients have to travel a long way or have 
to ask for permission to attend hospital valuable time will be lost. Referred patients 
were also an increased risk, probably also because of crucial time delays. 
Many studies have reported an association of placenta praevia with increasing age and 
high parity'57,158,299 . There was some evidence from our data that younger women and 
nulliparous women had lower risks but the results were not statistically significant: we 
had very few numbers of women in the strata to test this adequately. 
Women who were employed had a higher risk of placenta praevia after adjusting for 
confounders compared to peasant women. As mentioned in a previous section (7.2.1) 
employed women may spend less time resting, predisposing them to haemorrhage since 
bed rest is one way of managing placenta praevia. No study as far as I know has ever 
reported an association between socioeconomic factors and risk of placenta praevia. 
A history of evacuation and or dilation and curettage of the uterus was associated with 
an increased risk, as has been reported previously157,158,299,300, Evacuation is related to a 
history of abortion ' but abortion was 'a not found to be a risk factor in this study. 
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Evacuation is associated with scarring of the uterus leading to under-perfusion which 
may predispose to placenta praevia. Scarring of the uterus has been reported as a risk 
factor for placenta accreta in other studiesls7, iss, 3oi 
Patients who had previous delivery by caesarean section were at increased risk of 
placenta praevia after adjusting for confounders compared to those who did not, a 
finding which has been reported in the literature previously' 58,299. A meta analysis of 
over 170,000 pregnant women found a dose-related risk of placenta praevia with 
increasing number of caesarean section deliveries3o1. The reason for this finding is 
thought to be damage and scarring of the uterus during caesarean section predisposing 
to low implantation of the placenta. Another explanation is the attraction and adherence 
of the placenta to the caesarean section scar3o"305Scarring of the uterus may also 
retard the physiological development of the lower uterine segment and interfere with the 
placental migration within the upper segment as the pregnancy grows. The history of 
evacuation of the uterus may be acting in the same way as previous scar on the 
uterus 299,301 . Recently, manual removal of placenta has been reported to be a risk factor 
for placenta praevia, a finding also thought to act through scarring of uterus 157 
When women were asked what they should do when bleeding starts during pregnancy, a 
higher proportion of cases than controls did not know that they needed to seek urgent 
medical attention. Bleeding in the present pregnancy was associated with an increased 
risk of placenta praevia. This was likely to be due threatened abortion or early 
presentation of placenta praevia. Vaginal bleeding due to placenta praevia is likely to 
occur when the lower segment of the uterus begins to form at thirty two weeks of 
pregnancy. 
Eleven percent of cases compared to 3% of controls did not attend antenatal care. After 
adjusting for confounders the effect of lack of antenatal care on the risk of severe 
placenta praevia disappeared. Antenatal care would be effective if there was a routine 
ultrasound examination on all women who attended, or at least all those who have 
vaginal bleeding to identify cases with placenta praevia and plan for their management. 
The cost and maintenance of ultra sound machines may be too much for developing 
countries for it to be routine. 
Women with placenta praevia were much more likely than controls to deliver low birth 
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weight babies. This may be largely explained as severe haemorrhage leading to 
premature delivery, but chronic hypoxia due to placenta praevia may also cause intra 
uterine growth retardation 158 
In conclusion, the study identified risk factors for major placenta praevia as residing 
further away from Mulago hospital, being referred, and previous evacuation of the 
uterus or dilation and curettage, previous scar, recurrent bleeding and having 
employment. Prevention of severe haemorrhage due to placenta praevia is by use of 
ultrasound for at-risk patients in the antenatal period and offering prompt treatment 
when necessary. 
In summary this study confirmed the following risk factors as reported previously in the 
literature: 
" Previous history of evacuation 
" Previous history of caesarean section 
" Being referred patient 
" Vaginal bleeding during pregnancy. 
This study identified the following risk factors not previously reported in the literature: 
" Having some employment. 
7.2.6 Risk factors for abruptio placenta 
Abruptio placenta is known to be an important cause of SMM and mortality worldwide. 
It is associated with high perinatal morbidity and mortality. Abruptio placenta 
contributed 7% of primary causes of SMM. 
Women who lived further away from Mulago hospital, in poor quality housing, being 
unable to pay for hospital upkeep, and needing to ask for permission to visit a health 
unit or hospital had increased risks of severe abruptio placenta after adjusting for 
confounders. Poor education has been reported to he rick f 'tnr fnr 
placenta 163,165"72 but in'this study no strong effect of education was observed after 
adjusting for other markers of socio-economic status. 
Teenage pregnancy has been reported to be associated with abruptio placenta172 as has 
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advanced age163'165,166. These trends were not demonstrated in this study but, again, the 
number of cases was small and the power of the study to detect small effects was low. 
We found that women who had a stillbirth in a previous delivery had an increased risk 
of abruptio placenta. This is likely to be a measure of recurrence of abruptio placenta 
because the majority of women in Mulago hospital who develop severe abruptio 
placenta ended up with stillbirth. Previous abruptio placenta had been reported as a risk 
factor in the literature306. Patients who delivered by caesarean section in their previous 
pregnancy had greater risk of developing abruptio placenta after adjusting for 
confounders. A previous study of history of delivery by caesarean section did not show 
an association with abruptio placenta163 Our finding may suggest similar aetiology of 
abruptio placenta and placenta praevia. 
Women diagnosed with chronic hypertension or hypertension during pregnancy had 
very much higher risks of abruptio placenta compared to women who did not. This is in 
agreement with previous reports of hypertension as a risk factor for abruptio 
placenta 163,165,166,172 The patho physiology of hypertension and abruptio placenta is still 
not well understood. However, in a study which evaluated 445 patients with severe pre- 
eclampsia and eclampsia, the severity of blood pressure elevation and proteinuria was 
not predictive of abruptio placenta, suggesting a more complex aetiology of abruptio 
placenta than a simple casual link with hypertensive disorder307. 
Women who did not attend antenatal care had a higher risk of developing abruptio 
placenta. This is despite the fact that diagnosis of abruptio placenta in the antenatal 
clinic is difficult, even with use of ultrasound 166. Not surprisingly, patients who 
presented with repeated vaginal bleeding of small amounts of blood during the present 
pregnancy had a very high risk of developing severe abruptio placenta. These are the 
type of patients would benefit from ultrasound166 As expected patients who presented 
with vaginal bleeding during labour had much higher risks. Interestingly, a previous 
study has found that although 65-80% of abruptio placenta present with vaginal 
bleeding, 20-35% is concealed308. These cases would not be picked up on simple 
examination or questioning about vaginal bleeding. 
Delivery of a male baby was more common in cases than controls, a finding which has 
been reported previously163,166,167,169,172The explanation may be related to the 
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association between pre-eclampsia and male babies. Women with severe abruptio 
placenta were highly likely to deliver low birth weight infants through premature 
delivery, an observation previously reported by Katherine et al'66. The still birth rate for 
the case was 52%. This was very high but within the estimated perinatal mortality in 
abruptio placenta of 4.4% to 67.3% reported by previous studies 166. The incidence of 
stillbirth is associated with the degree of separation of placenta with separation 
exceeding 50% making mortality is inevitable3os 
In conclusion, the risk factors identified for abruption placenta were residing further 
away from Mulago hospital, referral, hypertension, recurrent vaginal bleeding, previous 
delivery with caesarean section, lack of antenatal care and low socio economic status. 
Prevention of severe abruptio placenta is by offering prompt management when 
abruption occurs. 
In summary, this study confirmed the following risk factors for abruptio placenta 
previously reported in the literature: 
" Low socio economic status 
" Recurrence 
" Hypertension 
" Being a referred patient 
" Vaginal bleeding during labour 
" Lack of antenatal care 
" Further away the patient lived from Mulago hospital. 
" Delivery of male babies 
The study found the following risk factors not previously reported in the literature: 
" Repeated vaginal bleeding during pregnancy 
" Previous caesarean section 
" Previous still birth. 
7.3 PROGRESSION FROM SEVERE MATERNAL MORBIDITY TO 
MORTALITY 
7.3.1 Ratio of SMM cases and deaths 
The ratio of SMM to mortality was 12.8 to 1, which was similar to the ratio reported by 
the hospital during the study period of 12.7 to 1. The ratio was similar to that reported 
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in Benin of 12: 131, and in Nigeria of 10: 1309, but higher than that reported in India of 
7: 1310 and in South Africa of 5: 12. Higher ratios have been reported in Jamaica 25: 1311. 
The difference in the reported ratios was due to differences in the definitions used in 
selecting the SMM cases and the quality of care the cases received. The better the 
quality of care received the fewer deaths and the higher the ratio of SMM to 
mortality2,36,248 
7.3.2 Causes of maternal mortality and case fatality 
The distribution of death by cause was similar to that reported before in Uganda 23 and 
other studies in sub Saharan Africa839,136,209 The relatively higher proportion of deaths 
due to haemorrhage may be due to shortage of blood and the quality of care the cases 
received. This will be discussed further in section 7.3.3 below. A high proportion of 
women with puerperal sepsis and medical diseases died compared to other causes of 
mortality and this was similar to findings from West Africa39 and Scotland213. The high 
proportion of deaths in puerperal sepsis cases may be related to HIV/AIDS and quality 
of care offered in the hospital. This will also be discussed in the next section. 
7.3.3 Risk factors for progression to maternal mortality 
Age was not found to be related to risk of death in SMM. This finding was in contrast 
to previous findings of young age being associated with death in Uganda 23.312 and older 
ages also being linked to death following SMM elsewhere248. However, the study had 
very little power to investigate age as only 5 women who died were under 20, and only 
4 were over 30 years. 
Living more than ten kilometres, compared to under 5 kilometres, from Mulago hospital 
was a clear risk factor for death. It may be that these women took longer to reach 
hospital following development of obstetric complications and arrived in hospital in a 
critical condition which was difficult to salvage7, lls, 313,314. Another factor possibly 
related to delay was that some women had to ask for permission before attending a 
health unit or hospital. Asking for permission is a manifestation of lack of 
empowerment of Ugandan woman whereby they cannot make an independent decision. 
We have shown here that this is significantly associated with risk of death following 
SMM. As an example, one woman in this study was unable to make a decision, and 
refused a caesarean section, until the husband came and consented; by which time she 
had ruptured her uterus. 
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Employment was associated with a lower risk of death. Employed women have better 
education, are more likely to attend antenatal clinic, and are most probably empowered, 
resulting in a lower risk of progressing to maternal mortality. Low educational status, 
poverty and lack of empowerment of women have been reported to be associated with 
2oi maternal mortality in previous studies, 3i2,315,316 
Admission to hospital during the pregnancy for any condition other than pregnancy was 
associated with a higher risk of death. These were women admitted for medical 
conditions such as malaria, hypertension, urinary tract infection and anaemia and these 
results provide evidence that these medical conditions predisposed women with SMM 
to progress to death. Further evidence for this comes from the case fatality mortality 
where over 55% of SMM cases attributed to medical conditions died. 
Our data showed that women who reported a previous caesarean section had a higher 
risk of death, although the result was of borderline statistical significance. Any delay in 
delivering patients with previous scar will put them at risk of morbidity and mortality 
because the uterus can rupture. Delay may result from the recognized desire of patients 
to deliver vaginally and late attendance in order to avoid a repeat section. Additionally, 
the hospital may have delayed offering operative delivery. In Mulago hospital, the 
mean waiting time for operative delivery was 245 minutes (4 hours) because of busy 
theatre; hence patients with a previous scar carried high risk of mortality. This is 
discussed further in section 7.3.4. 
Multigravida women with birth interval of more than 36 months since the last delivery 
had a reduced risk of dying compared to those with lower birth intervals. Longer birth 
intervals may have enabled women to rest and recover from previous pregnancy217. 
Further analysis of the data comparing women whose previous birth interval was 14 or 
less months compared to 24-36 months showed no increased risk of progression to 
maternal mortality (results not shown in analysis). This suggests that very frequent 
births do not predispose women to maternal mortality, as has been noted in a previous 
stud y262, although the statistical power of our analysis was limited. 
Women who did not attend antenatal clinics had increased risk of death. Hopefully, 
women who attend antenatal care are screened for obstetric risk factors, managed, and 
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given advice where to deliver. For antenatal care to be effective patients should book in 
the first trimester and attend regularly as prescribed by the health provider, but of those 
who did attend, about 60% of those who died and 55% of those who survived booked in 
third trimester. About the same proportion attended fewer than 4 times. This type of 
antenatal care does not give a health worker enough time to screen the patients for 
possible risk factors. Furthermore, regarding the quality of antenatal care provided, 9% 
of those who died compared to 6% of those who survived had attended antenatal but 
had never had their blood pressure checked at all. This suggests that the quality of 
antenatal care was low, possibly due to lack of equipment and or shortage of staff. In a 
review carried out on effectiveness of antenatal care in a number of countries, in the UK 
15% of women who had a previous history PPH were not identified and in Java one in 
four of women with a previous stillbirth were not identified by trained health workers, 
which calls in question the quality and effectiveness of antenatal care offered. 317. 
Bleeding during pregnancy is a sign of an obstetric emergency which needs to be 
evaluated and appropriate management offered. It is known that early reporting to 
hospital with vaginal bleeding can reduce on the risk of dying from haemorrhage 113. 
This study found that lack of knowledge about what to do if there was vaginal bleeding 
during the pregnancy was related to increased risk of death. Cases diagnosed with 
anaemia in pregnancy had an increased risk of dying compared to cases who did not 
have anaemia. This finding is similar to previous reports of anaemia being a known 
cause of maternal mortality in developing countries270'31s. Patients with haemoglobin of 
less than 10 grams per decilitre had 3 times the risk of progressing to maternal mortality 
compared to those with haemoglobin above 9g/dl after adjusting for confounders. This 
finding is complicated by the fact that the haemoglobin level was measured in some 
patients post delivery and therefore it is difficult to disentangle from antenatal anaemia. 
The high rate of anaemia brings in question whether these women received haematinics 
during antenatal visits and, if they did, whether the compliance to taking the drugs was 
high. Also, it is possible they received haematinics but because majority came in the 
third trimester there was not enough time for the haematinics to have an impact on the 
haemoglobin level. The anaemia finding may also be confounded by underlying factors 
such as nutritional status which was not measured. 
The women who delivered male babies had higher risk of death. This finding is most 
probably related to the fact that male babies are bigger than female babies292'319 and 
could have predisposed to severe dystocia. In addition, male babies have been linked to 
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increased risk of severe pre-eclampsia and eclampsia, and abruptio placenta. However, 
the mechanism whereby the sex of the baby in a woman who has SMM can influence 
the risk of death is not entirely clear. 
7.3.4 Type of care offered for SMM patients 
The partograph has been shown to be an efficient tool in monitoring labour and in 
identifying women who need obstetric interventions. Patographs were used in 13% of 
those patients who died compared to 7% of those who survived. The generally low use 
of the partograph suggests that monitoring of patients was not adequate. Although 
Patographs may not have been used on critically sick patients because they needed 
special observations or because they did not labour, low usage could have been due to 
poor patient to staff ratio, low morale among staff or lack of knowledge regarding its 
use. 
The majority of SMM patients were delivered by doctors, as expected, but 2 cases (5%) 
who died and 17 cases (4%) who did not die were delivered by TBAs. These numbers 
were too few to allow meaningful statistical analyses, but the finding it is of potential 
importance. Most of the SMM patients delivered by TBAs were patients who came in 
with PPH and puerperal sepsis post delivery. TBAs in Uganda still play a role in 
delivering mothers but the major concern is can they recognize signs of danger and refer 
the patients to hospital for further management on time? One study in Senegal 
comparing women who delivered by trained TBAs and professional midwives showed 
that maternal mortality was higher in TBA-assisted deliveries compared to midwife 
assisted deliveries and it was postulated that the midwives were able to detect and refer 
more complications than TBAs27. 
Patients who did not get oxytocics soon after delivery of their baby had higher risk of 
progressing to maternal mortality compared to those who did. It is known that the use 
of oxytocics soon after delivery prevents PPH99°320. 
Mulago hospital labour ward is managed on a 24 hour basis by a team of two 
obstetricians (Consultant and senior registrar), 4 senior house officers (registrars), four 
junior house officers and a team of midwives. The patients who developed SMM, or 
were referred with this condition, and not seen by the obstetrician on duty within 6 
hours of diagnosis of the severe morbidity condition had higher risks of death compared 
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to those who were seen within 2 hours. The time of day when a patient is admitted or 
develops a severe complication may be important: Patients who developed 
complications between midnight and early morning were less likely to be seen by the 
obstetrician because they do not stay in hospital through the night and when called some 
do not turn up because of lack of transport. Another explanation may be the low morale 
among the obstetricians because of low pay, driving them to attend private practice 
when they are supposed to be in hospital. The old practice of carrying out labour ward 
rounds every 6 hours also contributed to delays. The consultant obstetrician on duty is 
crucial because the SHO needs him or her for decision making or management of the 
patients at a critical time. If they were not available this may predispose the woman 
with SMM to progress to maternal mortality. 
Overall, 52% of the SMM patients were delivered by caesarean section: 34% of the 
patients who died and 53% of the patients who survived. It has been recommended that 
the waiting time for operative delivery (time from decision making to time of operation) 
in emergency caesarean section should be at less than 30 minutes 131,132. As mentioned 
previously the mean waiting time for operation in this study was 4 hours 5 minutes with 
a range of 20 to 860 minutes. The patients who waited for more than 10 hours had 5 
times the risk of progressing to death compared to those who waited for less than 2 
hours. The reasons for long waiting times for operation (more than 2 hours) were: busy 
obstetric theatre with emergencies (58%), delay by doctors (18%), delay by anaesthetist 
(7%), lack of expendables and failure of sterilization (8%) and lack of blood (5%). The 
hospital was overwhelmed by obstetric emergencies that needed to be delivered but the 
theatre had only 2 operating tables to handle both obstetric and gynaecological 
conditions. The large numbers of emergencies was because neighbouring health 
facilities did not have capacity to handle emergency caesarean section. The other 3 
NGO hospitals are paying hospitals. This resulted in large numbers of patients being 
referred to the Mulago hospital. Similar demand caused by obstetric emergencies has 
been reported in Dominican Republic130. The hospital was in process of addressing this 
problem by renovating and turning part of labour ward into a theatre and hopefully 
reducing waiting times. 
The large numbers of emergencies over stretches the resources of the hospital which is 
under funded by government, leading to shortages of expendables and instruments. 
Staff delays were due to the' morning audit meeting which lasted at least 45 minutes 
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daily, followed by handing over rounds in the labour ward lasting at least 1 hour. The 
other cause of delay was in the evenings when staff handed over to the night staff, more 
especially in theatre where it involved counting of instruments. The anaesthetists were 
understaffed and had only 2 shifts in 24 hours and change over in the evening caused a 
lot of delays for operation because of late arrival of the night anaesthetist. In France it 
has been found that lack of 24 hour anaesthetists was associated with maternal mortality 
due to PPH108. The delays and shortages of staff and lack of equipment and drugs, 
experienced in Mulago hospital put women at risk of mortality. This was also reported 
in a study carried out in Dakar Senegal which found the type of staff on duty, and the 
equipment available at the time of admission of a patient, were predictors of surviva1321. 
Similar findings have been reported in other Kampala hospitals2°6. 
Monitoring critically ill patients was crucial, especially in Mulago hospital where 
intensive care facilities are limited. The hospital has only one 12-bed intensive care 
unit. This meant that most of the critically ill patients were nursed in the labour ward, 
increasing the demands on staff in an already under-staffed unit. The study analysed 
patient monitoring in the first 24 following diagnosis of a SMM condition. Those 
whose blood pressure, pulse, and respiration were monitored less than 13 times had 
increased risk of dying compared to those who were monitored more than thirteen 
times. Of course, less monitoring in the women who died may be explained by the fact 
of death itself, but it is unlikely to explain the whole effect. The monitoring of blood 
pressure, pulse and respiration for very ill patients generally was every 15 minutes. 
This is less frequent than in places with good facilities where there would have been 
continuous monitoring. 
Lack of regular and frequent monitoring of vaginal bleeding was also associated with 
risk of death. In a normal delivery, using a partograph, vaginal bleeding should be 
checked every half hour for first 4 hours and those with PPH checked on more 
frequently for at least 24 hours. A lower proportion of women who died were checked 
for vaginal bleeding more than 8 times in the first 24 hours following diagnosis of SMM 
than cases who survived. 
One of the causes of delay. of operation was lack of blood for transfusion and perhaps 
not surprisingly, we found that patients who needed blood for transfusion, but where it 
was unavailable, had high risk of death. Lack of blood has been reported as one of the 
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factors that have increased the maternal mortality in Mulago hospital since the advent of 
HIV in early 1980s7,15,23 The shortage has been made worse by the high HIV 
prevalence in Uganda in that a high proportion of donated blood needs to be discarded. 
Similar shortage of blood and its effect on maternal deaths has been reported in Nakuru 
provisional general hospital in Kenya322. 
Puerperal sepsis contributed about 6% of the maternal deaths in this study. Puerperal 
sepsis can be reduced by having skilled delivery attendants and carrying out delivery in 
a clean, aseptic environment323. We found that those patients who needed specific 
antibiotics, or magnesium sulphate for managing their condition, but did not receive 
them because they were not available, were more likely to progress to mortality than 
patients who either did not need medication or needed them and received them 
promptly. When the hospital did not have the required drugs, relatives were asked to 
buy them, especially antibiotics and magnesium sulphate. This delayed the required 
treatment or resulted in failure to obtain the required treatment. The budgetary 
constrain of the hospital was responsible for this situation. 
Three patients died due to poor surgical skills and lack of supervision by the 
obstetricians on duty. The 2 patients who had a window on the uterus post operatively 
raises questions about the supervision of the post graduate students (SHO) by the 
consultants on duty. If there was adequate supervision and consultation these deaths 
could have been prevented. One woman had her ureters ligated during hysterectomy 
and this also demonstrates inadequate skills. However, in this latter case, the delay of 
urologist to intervene led to woman's death. These 3 cases demonstrate lack of 
adequate knowledge and skill of the surgeons who carried out the operations and failure 
of the consultant on duty to provide support supervision. It also shows weakness in 
communications across the teams on duty in the hospital in general. 
7.3.5 HIV and progression to maternal mortality 
Since the advent of HIV in Uganda and sub Saharan Africa in general, mortality due to 
the HIV/AIDS has continued to rise. HIV has been attributed to the rising numbers of 
maternal deaths 182,215 This study found HIV positive women with SMM had 5 times 
the risk of progressing to death compared to HIV negative women with SMM. When 
we adjusted for the cause of death the point estimate for HIV decreased, indicating that 
some of the causes may be more strongly related to HIV than others. The risk of death 
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following ruptured uterus showed the strongest association with HIV. Further analysis 
showed that when puerperal sepsis and medical conditions were removed from the 
multivariate model, the estimate decreased, suggesting that the risk of dying associated 
with HIV may also act through these conditions. Majority of women with medical 
condition could have had HIV related conditions. The majority of those HIV positive 
patients who died also had CD4 cell counts below 200, and a CD4 Cell count below 200 
was highly significantly associated with risk of death. However, 3 HIV positive 
patients with CD4 cells above 200 died due post partum haemorrhage. HIV has been 
reported to increase the risk for PPH in critically ill obstetric patients who are HIV 
negative200. The results of this study confirm what other studies in sub Saharan Africa 
that have shown: HIV predisposes pregnant women to mortality. The uniqueness of this 
study is that it has demonstrated that critically ill obstetric patients who are HIV positive 
are at increased risk of death compared to critically ill patients who are HIV negative. 
This study did not investigate patients with tuberculosis, which is a major cause of 
mortality in HIV/AIDS, because of the selection criteria used. Our odds ratio of 
progression to maternal mortality was higher than the reported odds of 1.80(95% CI 
0.99-3.33) for HIV positive in maternal deaths compared to the general population in 
fairly recent met analysis228 but similar to results of population based studies from 
Uganda216. One study in Ireland which investigated the role of HIV in SMM, showed 
no effect of HIV on outcome of SMM cases. 235 The difference between the Irish study 
and this study may be due to the type of care offered, and stage of HIV/AIDS in the 
study patients. The asymptomatic HIV cases have a better outcome. All our patients 
were not HAART but some of them had received the niverapine peripartum to prevent 
transmission of HIV by the mother to the child. The peripartum dose may not have 
affected the link between HIV and progression to maternal mortality, but it has been 
reported that the patients on HAART were at lower risk of death230. 
In conclusion, the risk factors for progression to maternal mortality were low socio 
economic class, distance from home to Mulago, type of care offered, organization of 
health system and HIV. Improvement of quality of care in the period during antenatal 
and labour and reorganization of management of labour ward and theatre is likely to 
reduce maternal mortality. The control of HIV will also reduce the burden of maternal 
mortality. Long term strategies to improve women's education, incomes and 
empowerment are also expected to reduce maternal mortality. 
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In summary, this study has confirmed the following risk factors for progression to 
maternal mortality as reported in literature: 
" Lack of antenatal care 
" Distance from hospital 
" Low socio economic class 
" Delay to reach hospital 
" Treatment deficiency 
" Shortage of blood 
9 HIV (general risk for maternal mortality) 
" Lack or delay of senior support 
" Inadequate monitoring of patients. 
This study found the following risk factors for progression to death from SMM not 
previously reported in the literature: 
9 Lack of blood 
" HIV status (specially within SMM patients) 
" Delay of operative delivery. 
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CHAPTER EIGHT: LIMITATIONS, CONCLUSIONS, AND 
RECOMMENDATIONS 
This is the largest study yet conducted to investigate risk factors for SMM and 
progression to maternal mortality in sub-Saharan Africa. It paid particular attention to 
the role of HIV status and quality of care factors as determinants of SMM and maternal 
death. The results have been reported and discussed in previous chapters, and before 
moving on to the conclusions and recommendations emerging from this work the 
limitations of the study need to be addressed. 
8.1 LIMITATIONS 
8.1.1 Statistical Power 
During the design phase of the study we predicted that a sample size of 500 cases and 
500 controls would provide the case-control study with very good power to detect at 
least a doubling of risk associated with most risk factors if such associations existed in 
the population. Since we were able to achieve these numbers (albeit taking a little 
longer than the estimated 12 months) we are confident that the case-control study of all 
cause SMM was well powered. The individual causes of SMM achieved a reasonable 
sample sizes in 4 of the 9 primary causes: eclampsia and pre-eclampsia; post-partum 
haemorrhage; obstructed labour and ruptured uterus. Although individual analyses were 
conducted for ante partum haemorrhage and placenta praevia, the small numbers limited 
their statistical power, as was pointed out in the discussion. For puerperal sepsis and 
anaemia the numbers were too small (25 or less) to allow meaningful analyses to be 
carried out. 
Regarding Stage 2, the study of progression from SMM to death, the study ended up 
with fewer deaths (39) than anticipated at the design stage of the study (72). These 
analyses thus had less power than originally predicted. However, we considered that 
the estimated 80% power we had to detect an odds ratio of 3.5 or more over the range of 
exposures was reasonable and the analyses were conducted, keeping in mind the less- 
than-ideal power when interpreting the results. 
8.1.2 Bias 
The potential for selection bias in Stage 1 of the study was recognised at the design 
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stage. Since Mulago hospital is a referral hospital we expected that SMM cases would 
come from a wider geographical area than controls. The controls may thus not have 
been representative of the population from which the cases originated, resulting in 
selection bias with respect to exposure distribution. In order to limit this bias we 
restricted the study area for both cases and controls: they had to live 15 or less 
kilometres from Mulago hospital. The fact that residential distance from the hospital 
emerged as a consistent risk factor in the study despite this restriction emphasises the 
importance of our original decision to limit the study population to 15km. 
Referral also emerged as an important risk factor for SMM, raising the possibility that 
referred patients (who tended to be cases) may be fundamentally different from non- 
referred patients with regards other exposures, introducing a form of selection bias. In 
fact, when we compared the results for all cases and controls with that for only non- 
referred cases and controls there were no clear differences in the pattern of risk factors, 
indicating the absence of major selection bias associated with referral. However, 
referral is clearly a risk factor for SMM (after adjustment for distance) and the 
explanation may be the time taken for patients to travel from health unit to Mulago 
hospital. Unfortunately time was not measured, largely because of difficulties in 
recalling time by the patients. 
Once they appeared in the hospital, selection bias of cases was minimised by using 
trained midwives and using selection criteria and processes which had been tested in the 
pilot study. In addition, the selection and recruitment of controls was highly regulated. 
The selection of cases and controls was certified by the principal investigator or his 
assistant on daily basis before they were included in the study. For stage 2, the 
mortality study, all SMM cases who died, and all SMM cases who survived until 
discharge, were included in the analysis. It is recognised that SMM cases who died 
after hospital discharge would have been misclassified as "survivors" in this study. 
However, this misclassification would most likely have tended to move the estimates of 
effect (of exposures) towards the null. 
Information biases arising during the interviews of patients must also be considered, 
especially for those very sick patients where the interview was by "proxy" with the first 
relative or the spouse. Hopefully information bias was kept to a minimum by careful 
training of interviewers, and by interviewing the survivors at time of discharge. But for 
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the SMM patients who died, there remains the possibility of exposure misclassification. 
In order to limit the possibility of both differential and non-differential (random) error 
the author used the antenatal record information whenever available to check 
information and fill in missing information from proxy respondents. 
Another possible source of information bias was data extraction from clinical notes. In 
some records observations or procedures may have been carried out but not recorded, 
possibly because they were considered "routine". Since the study depended on recorded 
information this could have resulted in misclassification of these exposures. However, 
since observations and procedures are more likely to be recorded for cases than for 
controls, any effect of missing data would have attenuated the effects found, rather than 
giving spurious results. Since we have interesting findings linking quality of care, or 
the lack of it, to increased risk of outcome, we can be reasonably confident that these 
results were not simply the result of recording errors. 
Recall by study participants of other exposures, such as age and previous obstetric 
history, could have been a problem especially among multi parous women. Whether 
this was different in the cases than the controls, leading to biased estimates, is difficult 
to estimate. However, even if it was present it is unlikely to explain the major pattern of 
results reported here. 
8.1.3 Confounding 
This study was as comprehensive as possible and many social and economic factors 
were asked about as well as obstetric and medical details of previous pregnancies. 
However, potential confounding factors such as nutritional status, stature, height and 
weight were not measured and it must be recognised that there may be some 
uncontrolled confounding in this study. Having said that, the author does not consider 
this a major limitation since most factors previously reported in the literature were 
included. 
During the adjustments for confounders I took into consideration the factors that existed 
before pregnancy such as socio demographic and economic factors, social and family 
history, existing medical conditions and past obstetric performance. All analyses were 
adjusted for these pre pregnancy factors only. This was because I was conscious that 
further adjustment with factors acting during pregnancy and delivery may interfere with 
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my understanding of factors in the causal pathways and could lead to over adjustment. 
8.2 CONCLUSIONS 
Factors that predispose women to SMM and progression to mortality are not only 
obstetric but interlinked with social, economic and gender factors. These factors act 
together and are responsible for the high maternal mortality found in many parts of the 
developing world. 128,180,324 This means that the reduction of maternal mortality and 
morbidity is complex and needs programs that address issues like poverty, nutrition, 
education of the girl child, improvement of communication, empowerment of women 
and quality of care in health institutions. These programs need government and political 
commitment, money, and mobilisation and sensitization of the people for it to have 
effect on maternal mortality. 
A holistic approach to addressing SMM and maternal mortality using both obstetric and 
community factors will yield better and sustainable results. Obstetric and hospital based 
factors are amenable to change and this is where the emphasis has to be put whilst long- 
term programs that address socio economic and cultural factors are implemented. 
8.2.1 Distance and transport factors 
The further away the patients lived from Mulago hospital the greater the risk of SMM 
and progression to maternal mortality. As with referral, distance is probably a proxy for 
time and is associated with the difficulty in affording transport to Mulago hospital. This 
matter was made worse by lack of ambulance services for the referred patients from the 
health units. 
8.2.2 Socio-economic factors 
From this study it is evident that low socio economic class (poverty) as demonstrated by 
people living in low quality houses (mud and brick only) were risk factors for SMM 
overall, all primary causes of SMM, and progression to maternal mortality. The level of 
poverty in society affects maternal mortality and consequently SMM in that women will 
not be able to afford to educate their children, afford the cost of health services, or 
transport to hospital. Poverty also leads to not having enough food to eat and living in a 
poor health environment such as slums in this study. All these factors have an effect on 
26t , ý2a-326. SMM and mortality and have been reported elsewhere 
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Poverty is linked to poor nutrition which can cause women to have poorly developed 
pelvises and, together with adolescent pregnancy, predisposes to obstructed labour and 
ruptured uterus. Poverty was also exhibited by patients who depended on relatives for 
financial help. Lack of personal finance makes patients less able to afford transport to 
hospitals or health units leading to non attendance or poor compliance of antenatal care 
and later delay in reporting to hospital for delivery. In addition, it may encourage 
women to deliver at home, as has been reported in Nigeria309 
The women who had jobs were at increased risk of SMM, and this I thought may be due 
to lack of adequate rest. However, employment among women with SMM was 
protective for progression to maternal mortality. This may be the result of ability to 
afford to buy drugs in circumstances where drugs were unavailable, or that the women 
attended hospital in good time for adequate treatment. 
8.2.3 Gender issues 
Women who needed to ask for permission from their spouses or relatives before 
attending hospital were at higher risk of SMM and progression to maternal mortality. 
This finding is a reflection of the lack of empowerment of women in important decision 
making processes. Lack of empowerment is associated with low education status, 
poverty, and cultural beliefs that a husband is the decision maker'16,128.205,309,327. In this 
study almost all the women spent twelve or less years in school and about one third 
were peasants. Low levels of education, poverty and traditional beliefs predispose 
women to delays in seeking medical attention and strengthen their resolve in delivering 
at home 116. Furthermore, traditional birth practices and beliefs are that pregnancy is a 
test of endurance of a woman and maternal death is a sad, but normal, event in Ugandan 
communities 128. Such traditional beliefs lead to use of primary health care units and the 
referral hospital, including when complications have occurred, only as a last resort. 
Such traditional beliefs may also explain why the Nilotics compared to Bantu tribes 
were at higher risk of ruptured uterus. Men should be encouraged to be more supportive 
of their wives and look at them as partners rather than baby factories, and should be 
encouraged to take control of their family rather than allow relatives to dictate to them 
what is good for them and their wives. 
8.2.4 Medical factors 
Admissions to hospital for medical reasons, having chronic hypertension, and having 
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anaemia and hypertension during pregnancy, were predictors for SMM and progression 
to maternal mortality. These findings were similar to those reported in UK and South 
Africa2'34. These are patients who should have benefited from antenatal care and 
medical management, but clearly did not. 
8.2.5 Age, parity and birth interval 
Adolescent pregnancy has been reported in other studies as a major cause of maternal 
morbidity and mortality because of abortion related complications, dystocia and 
eclampsia in sub Saharan Africa 13'42. However this was not demonstrated in this study. 
Adolescents, or age below 20 years, were in fact protective in ruptured uterus, although 
this effect is difficult to disentangle from nulliparity. Age above 34 has been reported to 
be a predictor of SMM and maternal mortality2'34; again, this study did not demonstrate 
this effect because the majority of women who delivered in Mulago were below the age 
of 30 years. 
Primigravidae was a predictor for SMM and this was driven by increased risk for severe 
pre-eclampsia and eclampsia and severe dystocia. In Uganda grand multiparity (GMP) 
or parity above 5 usually occurred by the age of thirty. GMP was not a predictor for 
SMM and progression to maternal mortality in this study but was associated with 
reduced risk of severe pre-eclampsia. There are conflicting submissions about grand 
multiparity: that it is not a risk factor for maternal morbidity and mortality328'329 and that 
is it330,331 Clearly the influence of GMP on risk is related to the type and quality of care 
available. 
A long birth interval of more than 5 years was found to be a determinant of SMM and 
its primary causes such as eclampsia and pre-eclampsia, PPH and dystocia. The 
explanation is not clear but may be due to the women's health seeking behaviour or the 
type of care these patients received. However there may be some underlying factors 
causing this phenomenon which need further investigation. As expected, birth intervals 
of more than 3 years were protective for progression to maternal mortality, emphasising 
332 importance of family planning in prevention of maternal mortality. 
8.2.6 Quality of care 
Good quality care offered to women when pregnant and during labour can prevent the 
majority of complications associated with childbirth. We found evidence that sub- 
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optimal care predisposed to SMM and mortality. Although over 90% of the study 
women attended antenatal care, the booking time was late (on average 25 weeks) and 
over 50% attended less than four times. Late booking for antenatal care, coupled with 
few visits, perhaps does not give the provider time and opportunity to manage 
pregnancy complications or to refer, appropriately. This may be a reflection of the 
health seeking behaviour of women as alluded in traditional beliefs and practice 
128 or 
poor screening during antenatal care as demonstrated by non-measurement of blood 
pressure in over 20% of the women. Non measurement of blood pressure may also be 
reflection of staff shortage or lack of equipment in health facilities. 
The use of a partograph was low suggesting that monitoring of labour was poor. 
Monitoring of labour is important because impending complications can be identified 
and managed early to avert severe maternal morbidity. For example patients who had 
vaginal bleeding or prolonged labour would have been identified and managed. 
Similarly patients who were monitored less were at higher risk of progressing to 
maternal mortality. The low levels of monitoring may be associated with shortage of 
staff, inadequate staff knowledge, or poor staff moralel30. Lack of intensive care 
facilities has been found in previous studies to be associated with progression from 
SMM to maternal mortality2. However, monitoring of patients in the wards could be 
improved by addressing the patient to midwife ratio. Unfortunately in Mulago hospital 
there is over-crowding in the labour ward with some patients sleeping under the beds, 
making monitoring of patients extremely difficult. Similar results were reported in 
Kenyatta hospital Kenya249. 
Previous caesarean section scar was a predictor for SMM and all its primary causes but 
not for progression to maternal mortality (although the numbers of cases were few). 
Previous scar is, of course, an indicator of previous morbidity. With adequate care 
patients with previous scar should not develop SMM: clearly in this hospital those on 
trial of scar did not getting timely intervention when the need arose. Also, delays of 
such patients reaching hospital (for both deliberate and logistical reasons) and delays in 
operative delivery once they arrived, added to the problem and highlights the 
significance of the importance of timely treatment to avoid SMM. 
Prolonged third stage and non use of oxytocics was predictive of SMM and progression 
to maternal mortality, especially for PPH. The role of a skilled attendant delivery is 
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very important in avoiding morbidity and mortality associated with this condition since 
a good proportion of women who develop PPH have no warning signs. 
We found that delays of specialists to review SMM cases increased risk of death. The 
consultants should see patients more regularly and be available for consultation when 
needed. The cases that had surgical problems leading to death may be the tip of the ice 
berg in that a number of patients admitted to the labour ward may spend many hours 
before being reviewed by a consultant. This causes delay in decision making and 
consequently delay in getting the right treatment to avoid death. Our results suggest 
that the supervision by consultants of SHOs may have been inadequate and may indeed 
be affecting the training of obstetricians as evidenced by the surgical errors which 
resulted in mortality. However, the surgical problems encountered could also be treated 
as adverse events in the management of patients 333'334. Interdisciplinary communication 
was not functioning efficiently as evidenced by a woman with ligated ureters who died 
due to uraemia. In the organisation of the hospital, emergency teams on duty should be 
able to consult across other teams in the hospital so that such delays, and errors, are 
avoided. 
Drugs in Mulago Hospital are, in theory, free and available to patients. But in some 
instances drugs such as antibiotics and magnesium sulphate were not available. When 
these shortages occurred, patients or their relatives were asked to buy the drugs, or were 
given a less effective alternative. Shortage of drugs put women at risk of death, 
especially those with severe pre-eclampsia and eclampsia and sepsis. A drug such as 
magnesium sulphate is critical in the management of eclampsia and is so cheap that it 
should always be available. Shortage of this drug in particular suggests that the 
planning and supply of drugs and equipment to the labour ward is far from adequate. 
Shortage of blood for transfusion was also associated with mortality following diagnosis 
of SMM. Blood shortages in Uganda have been exacerbated by HIV and similar 
shortages have been observed in Nakuru provisional hospital in Kenya322. 
8.2.7 HIV and AIDS 
This study found out that HIV positivity was a predictor for SMM. The specific type of 
SMM associated with HIV status was ruptured uterus and this may be related to the 
healing of caesarean section scar in asymptomatic HIV women in a previous delivery. 
This is a new observation which needs further investigation. 
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The study confirmed that critically ill patients who were HIV positive had an increased 
risk of progressing to maternal death, a finding which has been reported 
elsewhere. 13,200,215,216,248 The increase in pregnancy related mortality in populations 
affected by HIV could be due either to pregnancy induced acceleration of HIV disease 
or simply the result of coexistence of the HIV disease amongst women in reproductive 
age taking its toll. Maternal death as result of HIV seen in sub Saharan Africa has put 
into question the quality of care offered in hospitals as well as poverty among the 
women, nutritional deficiencies and the prevalence of HIV related disease in the general 
population. The increased burden that HIV places on medical services in developing 
countries has lead to over-stretching of the resources available for health care and 
compromises in the quality of care. This has resulted in shortage of hospital beds, 
drugs, blood and staff. The effect of some of these quality of care factors on maternal 
mortality have been identified, and quantified, in this study. 
8.2.8 Implication of the study to safe motherhood 
The aim of this study was to identify the risk factors that predispose a woman to SMM 
and progression to maternal mortality so that these factors can be used to screen and 
predict women at risk in the antenatal period and labour. The aim is to be able to offer 
appropriate management in order to reduce maternal mortality. However, statements 
from WHO say that every pregnant woman is at risk of a maternal complication and 
thus risk assessment or screening does not work335. In developing countries, where 
access to maternity care and resources are limited, risk assessment still has a role to 
play, especially in setting priority for management of patients. If the 94% pregnant 
women who attend antenatally in Uganda could deliver in maternity clinics, priority 
setting would be necessary because of the large numbers versus the available facilities. 
Advocacy for women to deliver in health units is top on the agenda of safe motherhood, 
but whether developing countries can cope with this influx is in doubt. In Uganda about 
40%12 and in Kampala about 80%251, women deliver in health facilities but the type of 
care offered is generally low quality. Staff numbers are limited and those that are 
working have reduced morale since equipment and resources are scarce. Only 12% of 
GNP is spent on health250 so it is perhaps not surprising that SMM and maternal 
mortality remain a major problem in Uganda, and sub Saharan Africa overall. 
The decision making processes of women need to be addressed at the community level, 
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along with traditional birth practices and beliefs, in order to reduce the delay of women 
seeking medical services. The participation of the men as partners in reproductive 
health will go along way in addressing this issue. The current movement towards 
universal primary education in Uganda is one step forward in addressing decision 
making processes for women but this must be accompanied by improvement of the lives 
and incomes of women. 
While over 90% of both cases and controls lived five kilometres or less from a health 
unit, lack of ambulance services to transport patients from these health units to hospitals 
is a major draw-back. The majority of women with morbidity who were referred to 
Mulago hospital used public transport and this must have resulted in delay. Well- 
functioning maternity units can contribute to the reduction of maternal mortality when 
the referral system has one or more working ambulances. 
Besides the delay in reaching hospital, we found that patients faced further delays while 
waiting for operative delivery and appropriate consents. Ideally, peripheral health units 
should be able to offer emergency obstetric care instead of referring most of their cases 
to Mulago hospital. This calls on government and Kampala city council to upgrade 
both staff and equipment in these units. This would cut down on transport delays and 
also over-crowding and expenditure so that Mulago could function efficiently as a 
national referral centre. 
The advent of HIV in sub Saharan Africa was another curse to the poor population. 
This study has demonstrated increase risk of SMM and mortality as result of HIV. The 
situation is made worse by lack of drugs including antibiotics and anti retroviral and 
shortages of blood for transfusion. The prevention of HIV, along with adequate 
management of existing cases, will hopefully reduce the extra deaths in pregnancy 
attributed to HIV. 
In conclusion, the findings from this study suggest that the most urgent factors to be 
addressed in order to reduce SMM and maternal mortality are: mobilisation and 
sensitization women for safe motherhood, prevention and management of HIV, and the 
provision of quality care to parturient women. 
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8.3 RECOMMENDATIONS 
8.3.1 Further research: extending the study 
" Further research is needed to follow up the SMM cases who survive to evaluate 
the effect of morbidity on health. The progression and outcome of any following 
pregnancy would be particularly important. The length of follow up would 
depend on the amount of research funding available, but should be at least one 
year following delivery. 
" The role of HIV needs to be further evaluated, especially regarding the role in 
rupture of uterus, previous scar and eclampsia. 
"A study of quality of care in Mulago hospital is necessary to quantify its 
magnitude and effect on maternal and perinatal morbidity and mortality. The 
study should first develop practical, reproducible and nationally agreed tools for 
measurement of quality of care in Mulago hospital and Uganda in general. 
" Intervention studies that address social, cultural and religious factors influencing 
decision making by women need to be put in place. Such programs will aim at 
changing women's decision making processes and discourage traditional beliefs 
and birth practices that are harmful. This intervention should also address the role 
of the spouses in reproductive health. 
" An intervention study to assess the impact of stocking blood for blood transfusion 
in labour wards on maternal mortality in Mulago hospital is recommended. 
"A pilot intervention study to offer support supervision to neighbouring health units 
in the provision of comprehensive obstetric care would be useful. The effect of 
this intervention on the number and outcome of SMM patients attending Mulago 
hospital, and the impact on the type of care offered in Mulago, would be assessed. 
" More research is needed to study the effect of anaemia on SMM and maternal 
mortality, in particular the role of HIV in the causation of anaemia in pregnancy. 
8.3.2 Policy issues 
Economic: Low socio economic class was a predictor for both SMM and progression to 
maternal mortality. 
" The government should put in place programs that are aimed at alleviating 
poverty. Programs such universal education for all school children and rural 
finance schemes for women to take credit and start income-generating activities 
are recommended. 
9 At the village level government should finance societies that co-ordinate the 
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buying and selling of local produce to enable village people to receive adequate 
payment for their goods. 
Decision making: Decision making was one of the main predictors of SMM and 
maternal mortality. Empowerment of women is a significant component in addressing 
SMM and mortality. 
9 Education of the girl child should be promoted as this will improve the status of 
women in society, improve decision making, and reduce adolescent pregnancy 
rates. 
" At the community level, women should be encouraged to organise into groups 
where they can learn about reproductive health issues: about their bodies, sex, 
pregnancy and delivery and universal rights for women regarding reproductive 
health and other rights in general. 
" Sensitize and involve men to play a big role in reproductive health matters. 
Distance and referral: The further way a woman lived the higher the risk of SMM and 
progression to maternal mortality. 
" Kampala city council, with assistance from government and NGOS, should put in 
place an ambulance service to transfer patients form health centres to referral 
hospitals. 
" The government, in collaboration with Kampala city council, should upgrade 
some health units so that they can offer comprehensive obstetric services in order 
to reduce congestion in Mulago hospital. 
Antenatal care: Lack of antenatal care was predictor for SMM and progression to 
maternal mortality: 
" Staffing of antenatal clinics should be in proportion to the number of patients they 
serve so that they can offer quality care. Staff should be regularly updated on 
current concepts of management of women in antenatal clinics. 
Management of patients in labour: The type of care offered to patients in the labour 
ward was a predictor of SMM and progression to maternal mortality. 
" Monitoring of patients in labour should be by use of a partograph. The hospital 
should employ more staff to ensure the staff-to-patient ratio is adequate to 
facilitate the use of the partograph. Staff should be given refresher courses on its 
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use. 
" The Intensive Care Unit should be expanded to accommodate more obstetric 
cases. 
" Programmes to develop and implement treatment guidelines for managing 
obstetric cases in the labour ward should be initiated. 
" Consultants should be on duty in the labour ward for the full 24 hours and actively 
participate in the management of patients. 
" Consultation across emergency teams on duty in different disciplines should be 
improved and strengthened. 
" The hospital should create another theatre in the labour ward to handle the large 
numbers of emergencies and reduce on waiting time for operation. 
" The level of anaesthetist staffing should be improved so that they can work an 8 
hour shift instead of 12 and hence be available to handle emergencies. 
" The government should increase on the funding of the hospital so that more drugs 
and equipment can be bought. 
" The blood bank should organise more blood donor exercises to collect more blood 
and should prioritise the labour ward in its blood allocation. 
8.3.3 Political Issues 
Government level: 
" Politically formulate and enhance policies that promote safe motherhood at 
government and community levels. 
" Increase funding to health institutions especially Mulago hospital complex. 
" Continue supporting and promoting programs which reduce and prevent HIV 
spread. 
" Incorporate of some of the risk factors identified in safe mother hood programmes. 
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APPENDIX A: QUESTIONNAIRES 
Questionnaire A 
Please fill in the appropriate responses by ticking or filling in the required information 
Interviewer's initials: 
Date and time of interview: 
Date: m/mTITTý 
Time (24 hr clock): 
b Stu dy num er: 
Who is being interviewed - the patient herself, or a representative? 
I The patient herself Q 
2= The patient 's husband or partner 
3= The patient's mother, sister or close female relative 
4= other (please specigv here): 
9 Not known 
I am first going to ask some general questions about you (/your wifeletc) 
1. How old are you? 
k ' (Ag s represenative does not now, estimate and tick e in years: if patient patient 
box) 
2. Where do you live? 
3. What is the distance from your home to this hospital in 
kilometres? (Distance /from hospital in km; ; Aot known 99) 
4. What is the distance from your home to the nearest Health Unit 
in kilometres? (Distance /rom health unit in km; Not known (99) 
5. What is your tribe? 
I Ganda Q 
2 Nkole 
3 . 
Sofia 
4 Nyarwanda 
5 Acholi 
6 Teso 
7 Gisu 
8 Other (please specify here): 
99 Not known 
6. What is your religion? 
/ Protestant Q 
2 Catholic 
3 Muslim 
4- 7rh Da v Adventist 
5 Other (please specify here): 
9- Not known 
7. Have you ever been to school? Q 
I Yes 
2 No (-# skip to question 10) 
9 Not known 
8. 
(V 
For how many years did you attend school? 
choolin : A'ot known 99 r a/ y ) u. of g; ea s s 
9. What is the highest level of school attended? 
/ Primary 
2 Secondary 
3 = College / University 
9 = Not known 
192 
10. What is your job? 
1= Commerce Q 
2= Agriculture 
3= Artisan 
4= Professional 
5= Peasant 
9= Not known 
11. Are you currently married or in stable union, single, 
separated, divorced or widowed? Q 
1= Married/stable union 
2= Single 
3= Separated 
4= Divorced 
5= Widowed 
6= Other (please specify here): 
9= Not known 
-i skip to question 13 i not married or in a stable union) 
12. Are you living under the same roof as your husband or partner? 
1=Yes Q 
2= No 
9= Not known 
13. What is your husband or partner's job? 
I= Commerce Q 
2 =Agriculture 
3= Artisan 
4= Professional 
5= Peasant 
6= Does not have paid employment 
9= Not known 
14. What is the highest level of school attended by your husband or 
partner? Q 
1= No formal education 
2= Primary 
3= Secondary 
4= College /University 
9= Not known 
15. Who is the owner of the house you live in? 
I= You and husband/partner Q 
2= Husband or partner 
3= You 
4= Parents/ husband's (partner's) parents 
5= Landlord (renting) 
9- Not known 
16. What type of house do you live in? 
I= Mud with or without iron roof Q 
2= Brick, not plastered and iron roof 
3= Brick plastered and iron roof 
4= Brick; plastered and tiled roof 
5= Other (please specify here): 
9= Not known 
17. What facilities does the house you live in have? 
I= Electricity in house and tap water or bore hole Q 
2= Electricity and piped water in house 
3= Tap water or bore hole only 
4= Electricity only 
5 =No electricity or tap or piped water 
9= Not known 
18. What type of transport did you use when coming to hospital? 
1= Came on foot 
2 =Bicycle 
Q 
3= Motor bicycle 
4= Public vehicle 
S= Personal car 
6 -Ambulance 
9= Not known 
19. Do you ask for permission to visit health care unit or hospital 
when you have a health problem? Q 
I- Yes 
193 
'= , 
Nn (-# skin In aupstion 21 
9 Not known 
20. From whom do you ask permission? 
I= Husband or partner 
2= Mother-in-law 
3= Your parents 
4- Other (please specify here). 
9 Vol known 
21. Who pays for health care for pregnancy and delivery in your 
household? F] 
I= Self and husband/partner 
2= Husband or partner 
3= You 
4= Parents / husband's (partner's) parents 
5 Other (please specify here). 
9= Not known 
Now I am going to ask about all your previous pregnancies 
22. How many pregnancies have you carried in total? 
(. No 
. of pregnancies; 
Not known 99) 
if no previous pregnancies (i. e. this is their first pregnancy) -+ skip to question 
23. When did you have each pregnancy? m 
I" Month Year 
m 
2nd Month Year 
III 
3rd Month Year 
m 
4'h Month Year 
511 Month Year 
m 
6"' Month Year 
m 
7'h Month Year 
m 
8'h Month Year 
(add Hinre on hack ýe i neccýcary 
24. Were any of your pregnancies multiple pregnancies? la, Q Put a code for each pregnune_t': 
/ No, singleton 2nd Q 
2- Yes, twin 
3= Yes, triplet 3rd Q 
4- Yes, higher number of'babies 
9 Sot known 4th 
5`h F-I 
6'h F-I 
7'h F-I 
8'n 
M 
(add more on back page if necmsary) 
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25. How did each of your previous pregnancies end? " (You may need to explain the outcomes) I 
Q 
Put a code . 
16r each pregnancy: 2nd 
Q 
I live born baby or babies 
2 stillborn baby or babies 3rd 
Q 
3 
. 
Miscarriage 
4 -- Planned termination of pregnancy 4`h 
Q 
5 Ectopic pregnancy 
cth 
Q 
7 /tydatidiform mole 
8 Other (please specify here): _ __ bin 
Q 
99 - Not known 
7th 
Q 
8th Q 
(add more on back page i necessary 
26. Did you have to have an operation or other procedure during the 1, 2,7 or 9 Procedure delivery of any of your pregnancies? 
(You may have to explain what is meant by this) I3ý 
I- Yes (-º ask which pregnancies, and what was done) 
2- No (-º skip to question ... ) 
2"A Q Q 
9= Not known 
3rd Q Q 
Procedures: 
ti C 
4, h Q Q 
on aesarean sec I 
2 I'acuum extraction 5th Q Q 
3- Forceps delivery 
4- Repair of uterus 6th Q Q 
5 Other (please specify here): 
9 Not known 7'n 
Q Q 
8Ih Q Q 
(add Hinre on back page if nececcarV) 
27. Do you know why you had to have this operation/operations or 
procedure/procedures? 
(li rite reasons below for each pregnancy, labelling the reason wall ihr 
pregnancy number) 
99 = Not known 
Have you had any of the following problems during any of your previous pregnancies, 
i. e. during the pregnancy, delivery or in the time following the delivery? 
28. Bleeding during the pregnancy? Q 
/ )cs 
2 
. 
AO 2nd 
9= Not known 
3rd Q 
4'h 
5'n Q 
7 th 
gbh Q 
(add Hinre on back Date if neceis 
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29. Bleeding during labour? 
1= Yes 
2=No 
9= Not known 
Q lit 
2nd 
Q 
3rd 
Q 
4th 
Q 
Q 5tb 
6th 
Q 
7th 
Q 
8th 
Q 
(add more on back page if necessary) 
30. Excessive bleeding after delivery? Q lit 1= Yes 
2= No 2nd 
Q 
9= Not known 
3'd 
Q 
4th 
Q 
5th 
Q 
6th 
Q 
7th 
Q 
gth 
Q 
(add more on back page if necessary) 
31. Delay of placenta to come out for more than 60 minutes after Q ? 1`t li er d v e y 
I= Yes Q 
2 =No 
2oa 
9= Not known 3rd Q 
4th 
Q 
5tb Q 
6th 
Q 
7th Q 
8th Q 
(add more on back page if necessary) 
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32. Labour lasting more than 18 hours? Ist Q 
1= Yes 
2= No 2"d D 
9= Not known 
3rd 
4th FI 
5th Q 
6'h El 
. nth 
Q 
8th Q 
(add more on back Page i nec s 
33. High blood pressure? ist 
I= Yes 
2 =No 2nd 7 
9= Not known 
3'd 7 
4th 
5th 
6'h F-I 
7th 
Q 
8th El 
(add more on back page iYnectwary) 
34. Pus discharge from your vagina during pregnancy or after ist Q delivery? 
1= Yes 2°d El 
2 -No 
9= Not known 3rd El 
4`h El 
5th El 
6'h El 
7th 
8th 
(add more on back page if neaecs 
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35. Blood transfusion? Q 
I= Yes 
2= No 2nd Q 9= Not known 
3rd 
Q 
4th F1 
5th 
6'h 
7th Q 
8th Q 
(add more on back page if necessary) 
36. Admission to hospital? 
I= Yes (# ask which pregnancies, and wiry they were admitted write 
f "Z or 9 ?? ICD10 
answers helow) Q code 
l, t 2 No 
9 Not known Q 
2nd 
Reason for admission (label each reason with the relevant pregnancy number): 3rd 
4th 
Q 
5'h 
6'h 
th 
F] 
7 
8 th 
add more on hack ýe i ncce'sart 
Now I am going to ask about your current pregnancy 
37. Did you plan for this pregnancy? 
/ Yes Q 
2 Vo 
9 Vot known 
38. How old is your last born? 
(Put age in years and months) 
QQ 
Years Months 
39. Do you remember when your had your last normal menstrual 
eriod? p 
(Put (late, or 01 01 2025 i cannot remember date) 
40. What was the expected delivery date? 
01 0/ 2025 i b , f cannot remem (Put date, or er date) 
41. How many weeks of ammenorrhoea is she now? 
42. During this pregnancy did you attend antenatal check up? 
Yes Q 
2 %Io (-º skip to question -/4) 
9 =- Not known 
43. How many times did you go for antenatal check up? 
I One to three 
2 Four or more 
9 Not known 
44. How many months was the pregnancy when you went for the 
first antenatal check up? Q 
/ Less than four months 
2 Between four and seven months 
3- More than seven months 
199 
9 Not known 
45. During your antenatal period: 
(you need in explain the condition and confirm frone records) 
i) Were you told you have hypertension? 
)'es 
2 NO 
9 . Vol 
known 
ii) Did You have vaginal bleeding during this pregnancy? F-I I }'es 
2 NO 
9 A'ot known 
iii) Were you told you had anaemia or lack of blood? 1-1 
I }es 
2 Au 
9 Not known 
iv) Did you have water coming out your vagina? (Pre term rupture F-I of membranes) 
I =Yes 
2 No 
9 Not known 
46. Were you admitted during this pregnacy? (The reason for 
admission was medical disease such as UTI, hypertension, F-I malaria, Anaemia) 
I Yes 
2 No 
47. Have you had any of the following complications during this Q 
pregnancy: 
i) Abnormal vaginal discharge? I Yes, 2- No, 9 Vol . known 
ii) Blurring of vision? I Yes, 2 No, 9 Vol . 
known 
iii) Painful and frequent urination? I- Yes, 2 No, 9 Not known 
iv) Frequent fevers? I Yes, 2 No. 9= Not known 
v) Cough lasting a month or more? I Yes, 2 -- No, 9 .\ of known 
vi) Loss of weight? / Yes, 2 No, 9 Vol . 'known 
vii) Body rash? I)e. S, 2- No, 9 Not known 
viii) Swelling of the body? I- Yes, 2 No, 9 Not known 
ix) Epigastric pain? / Yes, 2> No, 9- Not known 
x) Excessive weight gain? / -= Yes, 2ý No, 9 Vol known 
xi) Severe headache? / Yes, 2= No, 9 Vol known 
xii) The baby stopped moving? / -- Yes, 2 No, 9 . 
\'ot known 
xiii) Other (please give details) / Yes, 2 -- No, 9 Vol known 
Now I am going to ask you questions about diseases of the reproductive system, 
and about contraception 
48. Have you ever had any of the following infections in the last one 
year? 
(You need to explain the symptoms of the S%'/) 
i) Gonorrhoea? ! Yes, 2 No 
,9= Not known 
ii) Syphilis? I Fes, 2= No, 9 Not known 
iii) Chlamydia? / Yes, 2- No, 9 Not known 
iv) Bacterial vaginosis? ! Yes, 2 No, 9- Not known 
v) Candidiasis (thrush)? I Yes, 2o, 9 Not known 
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vi) Chancroid? I= Yes, 2= No ,9 =Not known 
vii) Other sexually transmitted infection (please give details) 
1= Yes, 2= No, 9= Not known 
49. Have you ever had any of the following operations on your 
reproductive system? 
(You may need to describe what these are) 
i) Evacuation? I= Yes, 2= No, 9= Not known 
ii) Dilatation and curettage ("D and C") 1= Yes, 2 =No, 9= Not known 
iii) Myomectomy? I= Yes, 2= No, 9= Not known 
iv) Operation on cervix? I= Yes, 2= No, 9= Not known 
v) Repair of the uterus? 1= Yes, 2= No, 9= Not known 
vi) Other operation on your reproductive system (please give 
details) I= Yes, 2= No, 9= Not known 
50. Which contraceptive method did you last use in the six months 
before becoming pregnant this time? 
1= Permanent 12 = None 
m 
2= Injection depo 99 = Not known 
3= Norplant 
4= Intrauterine contraceptive device 
5= Condom 
6= Spermicides 
7= Oral contraceptive pills 
8= Rhythm 
9= Vaginal jellies 
10 = Emergency contraception 
11 =Other 
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This section is on medical and surgical conditions 
51. Have you ever been told that you have any of these medical 
conditions? 
V 9 Y 1 2 N k i es , o- , ot nown on i) Essential hypertens 
N =2 t i Y 1 N k -9 i h C o nown yper ens on es , , ot hron c ii) 
iii) Renal disease }es 1, No 2, Not known =9 
iv) Sickle cell disease }'es -1, No=2, Not known =9 
v) Herpes zoster Yes =1, No=2, Not known =9 
vi) Tuberculosis Yes 1, No=2, Not known -9 
vii) Diabetes mellitus Yes 1, No=2, Not known -9 
viii) Bronchial Asthma Yes -1, No-2, Not known-9 
ix) Cardiac Disease Yes 1, No 2, Not known 9 
x) Others 
State 
52. Have you ever had fractures of the lower limbs, spine or pelvis? 
Yes 1, No -2, Vol . 
known 9 
Q 
53. Have you ever been given blood? 
Yes 1, No 2 
Q 
54. What was the reason for blood transfusion? 
Bleeding during pregnancy 1 
Lack of blood -2 
Don't know - 99 
Other State 
Q 
This section is about your family and social history 
55. Do you take alcohol? 
Yes -I No-2(1fnogotono57) 
Q 
56. How much alcohol do you take per week? 
I/O I 
2 11-14 
3 15-21 
4 21 
Q 
57. Do you smoke? 
Yes 1 Vo -2 (1/ no go to no 59) 
Q 
58. How many sticks of cigarettes per day? Q 
59. Do you have any of your relatives who have the following 
conditions? 
i) Hypertension Yes - I, No -- 2, Not known -- 99 
ii) Diabetes mellitus Yes - 1, No = 2, Not known -- 99 
iii) Sickle cell disease Yes - 1, No 2, Not known 99 
iv) Epilepsy Yves 1, Vo 2, Vot known 99 
v) Other 
State 
This section is about labour and delivery 
60. This is about your referral. 
i) Were you referred? Yes = 1, No -2 (If not referred go to no 60) 
ii) State the reason for referral: 
Q 
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61. Did your membranes rupture before getting labour pains? That Q 
is you have draining of water from your vagina 
Yes 1, Ao 2 (IJ no skip no 62) 
62. If yes how many hours ago before delivery? 
63. Did you have vaginal bleeding before delivery? 
Yes I, No =2 (1f no go to no 64) 
63. If yes how much blood did she loose in mil litres? 
At the end of No 64 go ahead and take blood. 
This section is on clinical examination. This is for abstraction from the clinical notes. 
The following questions refer to the time of at recruitment. 
64. State general condition of the patient (see appendix4) Q 
I poor 
2 Jair 
3 good 
65. State degree of pallor 
mild Q 
2= moderate 
3 severe 
66. Does she have jaundice? 
Yes 1, Ao-2 
Q 
67. State the degree of oedema 
l= mild 
2- moderate 
3 severe gross 
4 Nil 
68. In the cardio vascular system QQQ 
1. Pulse 
2. HP El F 3. Murmurs Yes 1, No 2 
69. In respiratory system Q 
1. Respiratory rate 
2. Added sounds: Yes /, No 2 LL II F-1 3. Consolidation: Yes 1, No 2 
70. In central nervous system 
1. Coma. Yes _ 1, No 2 
Q 
2. Neck stiff Yes 1, No 2 
3. Kerning's: Yes = 1, No -2 
Obstetrical examination at recruitment 
71. Fundal height estimation in centimetres if not delivered QQ 
72. What was the presentation of foetus'? 
I cephalic 
2 breech 
3 shoulder 
4 brow 
5 Jace 
6 other 
State 
73. What was the foetal heart rate? 
74. What was the lie of foetus? 
I longitudinal F1 
2 transverse 
3- oblique 
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75. State any abnormalities observed or elicited on abdominal 
examination F 
I tenderness 
2= Bandl s ring 
3 easily palpable foetus 
Q 
4= others 
State 
Vaginal examination findings 
76. What was the appearance of external genitalia 
I normal 
2 tears 
3= oedematous 
4- other 
State 
77. Describe the discharge 
l= blood 
2- pus or infected liquor 
4= mucoid bloodstained (chow) 
78. State the presenting part 
I cephalic F-I 2- brow 
3 =face 
4 shoulder 
5- breech 
79. What was the mode of delivery? I st 2nd 
/= spontaneous vertex delivery 
hd db l e ivery 2 assiste reec 
3 Caesarean section 
4 vacuum 
5 -forceps 
6 laparotomy 
Other wate 
80. State the indication of caesarean section or laparotomy or 
instrumental delivery. 
81. What type of labour was it 
I normal labour 
2 trial of labour 
3 trial of scar 
4 induction of'labour 
5 Augmented labour 
82. 
a) What is/was the out come of baby 
i) Sex: Male 1, Female 2 
it) Weight 
LLLLI 
iii) Apgar Score 
iv) Still birth: Fresh= 1, Macerated 2 (if twins fill in 82b too) Q 
82. 
b) For second twin delivery 
What is/was the out come of delivery 
i) Sex: Male 1, Female 2 
ii) Weight 
iii) Apgar Score 
iv) Still birth: Fresh 1, Macerated=2 Q 
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83. What was the total blood loss during third stage in millilitres 
84. State total length of labour in hours 
1. First stage in hours 
2. Second stage in hours 
3. Third stage in minutes 
This section is about the postpartum period 
85. Has the placenta been delivered? res I. . Aa 2 (i/ no, c'o to 90) Q 
86. Is the placenta complete? Yes 1, No 2 Q 
87. If the whole or part of placenta was retained, How was it 
removed? Q 
I -Manual removal of placenta 
2= Evacuation 
3= Hysterectomy 
Other State 
88. Did she get post partum haemorrhage? Yes I, No 2 Q 
89. State the cause of post partum haemorrhage. 
I Vaginal tear Q 
2 Cervical tear 
3 Episiotomy site 
4 Uterine tear 
5= Uterine atony 
6 Coagulation failure 
Other State 
90. Does the patient have fever during the puerperium? Yes 1, No 2 Q 
91. Does the patient have foul smelling/pus like lochia? Yes 1, No 2 Q 
92. Was she operated on in puerperium? ]'e., 1. No 2 Q 
if no go to no 96 
93. Which operation was done? 
I Laparotomy 
Q 
2 C'olpotomy 
3 Closure of hurst abdomen 
4- Evacuation 
Other State 
94. What was the indication of of operation in puerperium? 
State 
95. Admission to intensive care unit. 
it d d i i h W 
Q 
m te ea to ntens as s ve care unit? Yes 1, No 2 i) 
ii) Number of days in ICU in days 
96. State the final diagnosis of patient at discharge: 
97. Describe the state on patient at discharge 
I Jair Q 
2 dead (Continue with the ahstraction) 
98. State total stay in hospital in days 
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99. State the cause of death 
100. Was post mortem done? Yes = 1, No =2 Q 
101. What is the cause of death from post mortem? 
Questionnaire B 
This questionnaire is on quality of care 
Interviewer's initials: m 
Date and time of interview: ýIml® 
Date: 
Time (24 hr clock): mm 
Study number: 
1. Did she attend antenatal care? 
b 3 N 2 (fno go to num er ) o Yes=1, 
2. Did you attend health talks during antenatal clinics? 
Yes=1, No=2 
3. Did she have the following tests done during antenatal? 
i) Syphilis Yes = 1, No =2 
ii) Haemoglobin level Yes =1, No =2 
11 
iii) Urinalysis Yes =1, No =2 
U 
4. Was her blood pressure checked during antenatal period? 
I= Never checked 
Q 
2= Less than four times 
3= More than four times 
Question 5 and 6: Ask the patient at discharge. 
5. State what you should do when you get vaginal bleeding during 
antenatal period. 
1 =I don't know 
2= Go to hospital immediately 
6. Did you get tetanus immunisation during antenatal period? 
No=2 Yes=1 
Q 
, 
7. Were you given an injection ergometrine soon after delivery of 
your baby? Explain this to her. Q 
Yes=1, No=2, Not known=9 .. 
8. Was the labour monitored using a partograph? 
Yes=1, No =2 
9. How many times was she observed after diagnosis of severe 
maternal morbidity complication in the first 24 hours? 
I. BLOOD PRESSURE/PULSE/RESPIRATORY 
ii. VAGINAL BLEEDING POST DELIVERY 
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10. Was she given prophylactic antibiotics during labour? 
Yes 1, No 2 
Q 
11. What is the level of training of delivery attendant? 
I= Midwife 
2- Clinical officer 
F1 
3- Intern Doctor 
4 Doctor/SHO 
5 Specialist 
6 TBA 
7= None 
12. State time of diagnosis of operative delivery 
13. State time of start of operation? 
14. How long was the waiting time in hours? 
15. How long was the operation in minutes? 
16. Was there any delay in doing the operation? Q 
Yes 1, No -2 
17. If yes state the reason of delay Ist -)a 
I= Delay of nursing staff 
2= Delay of doctors 
QQ 
3 Delay of anaesthetist 
4= Lack or shortage of instruments. 
5= Power failure 
6 Failure of sterilisation 
7= Lack of expendables 
S Theatre was husy with obstetric emergency 
18. Did the doctor call his/her senior when faced with complications? 
Yes 1, No 2 
Q 
19. 
i) When the senior was called did he/she come to give support to El 
the junior? Yes / . Va 2 
ii) If no state the reason for not coming 
20. When this patient was admitted/diagnosed with severe maternal 
morbidity condition was she seen by the senior (Obstetrician) six 
Q 
or more hours of diagnosis? 
Yes 1, No 2 
21. When the severe morbidity patient was admitted/ diagnosed did 
senior (Obstetrician) see her one or less hours of admission? 
Q 
Yes 1, No 2 
22. This to be answered by P/ or Assistant 
i) Were relevant laboratory investigations carried out? Yes = 1, No -- 2 
Q 
ii) Are the results available? Yes No -- 2, Some 3 
23. 
i) Did she get the right treatment within thirty minutes of diagnosis Q 
of severe maternal morbidity condition? Yes 1, \0 2 
ii) Did she get blood for transfusion when she needed it? 
Yeti 1, No 2 
Q 
iii) Was she given definitive antibiotic for treatment of her 
condition? Yes 1. : Ao 2 
Q 
iv) Was magnesium sulphate available for treatment of her 
condition? Yes 1, .Ao 
Q 
24. Were relatives asked to buy drugs for patients' treatment? 
Yes 1, No 2, Not known 171 
Criteria to assess clinical performance for severe maternal morbidity 
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GENERAL ACTIONS TAKEN 
25. Was the patient's complete history documented in clinical notes? 
i) Identification of patient Yes 1, No =2 
ii) Present obstetric history Yes 1, No -2 
iii) Past obstetric history Yes 1, No =2 
iv) Reason for referral Yes 1, No 2 
v) Gynaecological history Yes = 1, No =2 
FI 
vi) Medical history Yes 1, No =2 
26. Clinical Examination 
Full clinical state of patient at admission. Q 
Yes 1, No 2 
You need to go to relevant section for that morbidity. 
This section is for post ante partum haemorrhage 
THE ACTIONS TAKEN 
27. Management of patient. Were the following done? 
i) Intravenous access achieved Yves 1. Vo ' 
F] 
ii) Patient's Haemoglobin or haematocrit was carried out Yes -- I, No 2 
iii) Typing blood and cross matching was carried out Yes - 1, No 2 
F] 
iv) Coagulation test performed Yes 1, No 2 F] 
v) Crystalloid/colloids were infused until X-matched blood is available FI 
Yes 1.. v o2 
vi) Clinical monitoring of patients was done every quarter an hour Q 
for at least twelve hours was carried out to detect deterioration of 
the patient. YCs 1. au 2 
vii) Urine out put monitored hourly Yes 1. Va 2 
viii) Experienced staffs were involved in the management of life 
F 
threatening condition within ten minutes of admission Yes 1, No 2 
ix) Theatre available within thirty minutes of diagnosis Yes 1, No 2 
x) Coagulation test performed Yes 1, . Ar o2 
This is on actions taken on eclanipsia 
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28. Were the following management offered to the patient? 
i) Treatment or prophylaxis for seizures was with magnesium Q 
sulphate Yes = 1, No =2 
ii) Anti hypertensive was given to the patients within two hours of Q 
diagnosis Yes = 1, No =2 
iii) Respiratory rate and tendon reflexes were monitored when 
nesium sul ma hate was in use Yes =1 No =2 
Q 
g p , 
iv) Ante partum and post partum fluid chart were maintained 
Yes=1, No=2 
Q 
v) Haematological and renal investigations should be done at least Q 
once (bleeding, clotting time, platelet count and urine albumin) Yes 
=1, No=2 
vi) Delivery was achieved within twelve hours Yes =1, No =2 Q 
vii) Monitor urine out put, pulse, blood pressure carried out for at Q 
least 48 hours after delivery Yes = 1, No =2 
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I7us section is on post purtuni haemorrhage 
29. I n the management of patient were the following carried out. 
i) Intravenous access achieved Yes 1, Vo 2 Q 
ii) Patient's Haemoglobin or haematocrit should be checked Q 
Yes 1, No 2 
iii) Typing blood and cross matching Yes = 1, No -2 
Q 
iv) Coagulation test performed )is 1, NO 2 
Q 
v) Crystalloid/colloids were infused until x-matched blood is 
Q 
available f es 1, No -2 
vi) Clinical monitoring of patients done every quarter an hour for 
Q 
at least two hours was carried out to detect deterioration of 
patient ) es /, A0 2 
vii) Urine out put should be measured hourly Yes 1, . \n 2 
Q 
viii) Experienced staff should be involved in the management of life Q 
threatening condition within ten minutes of admission Yes 1, No 2 
ix) Theatre available within thirty minutes of need Yes 1, No 2 
Q 
x) Coagulation test performed Yes /, .\o2 
Q 
xi) Oxytocics are used )es 1, , Ao 2 
Q 
Criteria to assess clinical performance 
for obstructed labour 
ACTIONS TAKEN. Were the following actions carried out? RESPONSE 
30. 
i) Resuscitation of patient was carried out Yes 1, No 2 
Q 
ii) Typing and cross matching of blood done ) cs /.. \ 02 
Q 
iii) Delivery of the foetus carried out within two hours of diagnosis Yes 1. No 2 
Q 
iv) Urinary bladder should be drained and rested Yes 1, . \0 
Q 
v) Broad-spectrum antibiotics given Frs 1. \o 2 Q 
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This section is on ruptured uterus and actions taken 
31. 
i) 
Were the following actions carried out? 
Resuscitation of patient was done }"es 1, : Va 2 
ii) Typing and cross matching of blood carried out }es 1, va 2 
EI 
iii) Emergency surgery performed within two hours of diagnosis }"es - 1, No 2 
Q 
iv) Urinary bladder drained and rested Yes = 1, No -2 
Q 
v) Broad-spectrum antibiotics given Yes 1, No 2 Q 
vi) Clinical monitoring of patients done every quarter an hour for at least two F-I 
hours should be carried out to detect deterioration of patient }'es 1, NO 2 
This section is for puerperal sepsis 
i) Resuscitation of patients was done Yes 1, : Ao 2 
ii) Typing and cross matching of blood was carried out }'es 1. No 2 F-I 
iii) Clinical monitoring of patient done every half hour for at leasst twenty four 
hours to detect detoriation of patient? }es 1, . \a 
2 
iv) Broad spectrum antibiotics were given Yes 1, NO 2 
v) Was culture and sensitivity of swab carried out within 24 hours of admission? F] 
vi) 
Yes 1, No 2 
Was any surgery carried out on this patient? }'es No -2 
Q 
Fill in all laboratory results here 
Stu dy number: 
32. Haematological tests: 
a) Fib Level 
b) Mean corpuscular volume 
- MCHC 
Blood Film 
c) Platelet count 
d) Other 
33. HIV screening test 
a) CD 4 
b) CD8 
34. Syphilis test 
35. Liver function tests 
a) Serum glutamate-oxalate transaminase (SGOT) 
b) Serum glutamate pyruvate transaminase (SGPT) 
C) Lactate dehydrogenase (LDH) 
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36. Renal function tests 
a) Urine Protein 
b) Serum Uric level 
_ 
c) Serum creatinine 
37. i) Pus culture. (State the site .................................................... .. ) 
a) Bacteria cultured 
b) Antibiotic sensitivity 
ii) Sputum culture. 
a) Bacteria cultured 
b) Antibiotic sensitivity 
iii) Blood culture 
a) Bacteria cultured 
b) Antibiotic sensitivity 
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APPENDIX B: UNIVARIATE TABLES FOR SPECIFIC 
CAUSES OF SEVERE MATERNAL MORBIDITY 
Table B1 Characteristics of severe pre eclampsia and eclampsia cases and controls 
(i) Socio-demographic characteristics 
Characteristic Stratum Cases Controls Crude odds ratio P 
N (%) N (%) ( 95% Cl) Value 
Distance from hone ()-ý 55 (38.5) 409 (51.6) I. )) 
to Mulago (km) 6-10 57 (39.9) 81 (16.2) 2.5 (1.6-3.8) 0.00 
II-I5 31 (21.6) II (2.2) 6.7 (3.7-12.0) 
Distance to nearest 0-5 113 (81.8) 491 (98.2) 1.0 (-) 
health unit in (km) >5 30 (18.2) 9 (1.8) 14.5 (6.7-31.4) 0.00 
Age in years 14-19 49 (34.3) 155 (31.0) 1.1 (0.7-1.6) 
20-29 78 (54.5) 262 (52.4) 1.0 (-) 
30-35 10 (7.0) 52 (10.4) 0.7 (0.3-1.3) 0.32 
35+ 6 (4.2) 31 (6.2) 0.7 (0.3-1.6) 
Marital status Married 112 (78.3) 425 (85.0) 1.0 (-) 
Single 31 (21.7) 75 (15.0) 1.6 (1.0-2.5) 0.05 
Tribe Bantu 135 (94.4) 454 (90.8) 1.0 (-) 
Nilotics 8 (5.6) 46 (9.2) 0.6 (0.3-1.3) 0.17 
Religion Protestant 44 (30.8) 141 (28.2) 1.0 (-) 
Catholic 50 (35.0) 173 (34.6) 0.9 (0.6-1.5) 0.10 
Muslim 38 (26.6) 160 (32.0) 0.8 (0.5-1.2) 
Seven day 2 (1.4) 5 (1.0) 1.3 (0.2-6.8) 
Saved 9 (6.3) 21 (4.2) 1.4 (0.6-3.2) 
Education level of Primary and nil 74 (51.8) 299 (59.8) 0.9 (0.6-1.3) 
patient Secondary 54 (37.8) 186 (37.2) 1.0 (-) 0.0)) 
College 15 (10.5) 15 (3.0) 3.4 (1.3-7.1) 
Patients Job Commerce 24 (16.9) 114 (22.8) 1.3 (0.8-2.1) 
Professional 17 (11.7) 14 (2.8) 5.7 (2.4-13.1) 
Peasant 102 (71.3) 372 (74.4) 1.0 (-) 0.00 
Spouse job Commerce 24 (16.9) 205 (41.0) 1.0 (-) 
Professional 17 (11.7) 106 (21.2) 1.2 ((). 8-1.9) 0.31 
Peasant 102 (71.3) 189 (37.8) 0,8 ((). 4-1.3) 
Type of house Brick, plastered 78 (53.2) 417 (83.4) I. 0 (-) 
- 
Brick only 48 (33.6) 69 (13.8) 3.8 (2.4-5.9) 0.01) 
Mud only 17 (11.8) 14 (2.8) 6.5 (3.1-13.9) 
Facility in house Electricity and 
piped water 56 (39.2) 261 (52.2) 1.00 (-) 
I-; lectricity or 
Tap water 40 (28.0) 140 (28.0) 0.6 ((). 3-I. 0) 0.00 
Neither 47 (32.8) 99 (19.8) 2.9 (2.0-4.5) 
Need to Request Yes 46 (32.2) 47 (9.4) 4.6 (2.9-7.4) 11. (1(1 
permission to visit Pu' No 97 (67.8) 453 (90.6) 1.0 (-) 
Health Unit/hospital 
Who gives permission Spouse 84 (94.7) 401 (98.5) I 0 (-) 
to attend Iýealth 
Unit/hospital 
Other 13 (15.3) 52 . (I1.5) 1.4 ((1.8-2.6) 0.23 
Who pays for Self and spouse 110 (77.5) 403 (80.6) I. )) (_) 
treatment Others 33 (22.5) 97 (19.4) 4.4 (2.6-7.3) O. UO 
(ii) Social, family and medical history characteristics 
Characteristic Stratum Cases Controls Odds ratio P. 
N 
-- -- 
ý! "ý (95% CI Value 
f aking alcohol YC. 27 (1 . Y) 137 (27.4) 0.0 (0.4-1.0) 0.04 No 116 (81.1) 363 (72.6) 1.0 1_1 
Smoking Yes (1 - 11 (2.20) 
No 143 (47.5) 489 (97.9) 
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aniilý hýhertension ý k: ý (32.5) I`I-I ( 1.7 Lb-i. _il 
U. UU 
No 68 (47.5) 306 (61.2) 1.0 (-) 
Family diabetes Yes 11 (7.7) 62 (12.4) 1.6 (1.0-2.6) 0.00 
mellitus No 132 (92.3) 437 (87.6) 1.0 (-) 
Hypertension (self) Yes 11 (7.7) 2 (0.4) 20.8 (4.5-94.8) 0.00 
No 132 (92.3) 498 (95.6) 1.0 (-) 
Admission to hospital Yes 20 (14.0) 31 (6.2) 2.5 (1.4-4.5) 0.00 
No 123 (86.0) 469 (93.8) 1.0 (-) 
Use of contraception Yes 20 (14.0) 219 (43.8) 1.0 (-) 0.00 
No 123 (86.0) 281 (56.2) 2.5 (1.4-4.5) 
(iii) Past obstetric performance* 
Variable Stratum Cases Controls Odds ratio P 
N 
-- 
(%) N (%) 
- 
95% Cl) Value 
---- - -- Previous abortion Yes 21 (25.0) 43 (12.3) 1.9 (1.0-3.1) 
No 63 (75.0) 307 (87.7) 1.0 (-) 0.03 
Bleeding in previous Yes 20 (23.8) 37 10.6 2.0 (1.1-3.6) 0.02 
pregnancy No 64 (76.2) 313 (89.4) 1.0 (-) 
Bleeding in labour Yes 15 (17.9) 37 (10.6) 1.5 (0.8-2.8) 0.23 
No 69 (82.1) 313 (89.6) 1.0 (-) 
Labour lasting more Yes 5 (6.0) 77 (22.0) 0.2 (0.1-0.5) 0.00 
than l8hrs No 79 (94.0) 273 (78.0) 1.0 (-) 
Still birth Yes 15 (17.9) 25 (7.1) 1.7 (0.8-3.4) 0.07 
No 69 (82.1) 325 (92.9) 1.0 (-) 
Previous caesarean Yes 11 (13.1) 15 (4.0) 3.4 (1.4-8.2) 0.00 
section No 73 (86.9) 335 (96.0) 1.0 (-) 
Vacuum or forceps Yes 1 (1.2) 5 (1.4) 0.7 (0.1-6.0) 0.74 
No 83 (98.8) 345 (98.6) 1.0 (-) 
Post partum Yes 2 (2.4) 14 (4.0) 0.5 (0.1-2.2) 0.35 
haemorrhage No 82 (97.6) 336 (96.0) 1.0 (-) 
Retained placenta Yes 3 (3.6) 9 (12.6) 1.2 (0.3-4.5) 0.82 
No 81 (96.4) 342 (97.4) 1.0 (-) 
I lypertension in Yes 10 (11.9) 19 (5.4) 1.9 (0.9-4.2) 0.74 
pregnancy No 74 (88.1) 331 (94.6) 1.0 (-) 
Blood transfusion Yes 06 (7.1) 4 (1.1) 5.4 (1.5-19.5) 0.01 
During pregnancy No 78 (92.9) 346 (98.9) 1.0 (-) 
* Women with previous pregnancies only 
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(iv) Characteristics and outcome of the current pregnancy 
Variable Stratum 
N 
Cases 
(%) 
Controls 
N (%) 
Odds ratio 
(95% Cl) 
P 
Value 
Number of pregnancy I 59 (41.2) 150 (30.0) 1.5 (I. 0-2.1) (1.110 
2-4 74 (51.8) 237 (47.4) 1.0 (-) 
5-14 10 (7.0) 113 (22.6) 0.5 (0.3-1.0) 
Birth spacing 1-36 39 (46.4) 216 (61.9) 1.0 (-) 
in months* 
37-60 22 (26.3) 91 (26.0) 1.4 (0.7-2.6) 
>60 22 (26.3) 43 (12.1) 2.9 (1.5-5.8) 0.02 
Attended Antenatal 
care 
Yes 
No 
128 
15 
(89.5) 
(10.5) 
485 
15 
(97.0) 1.0 (-) 
(3.0) 3.8 (1.8-8.0) 0.00 
Booking time for <28 91 (71.6) 332 (68.6) 1.0 (-) 
antenatal (weeks) 28-36 37 (28.4) 153 (31.4) 0.3 (0.2 -0.7) 0.00 
Number of antenatal 4+ 71 (55.9) 195 (40.1) 1.0 (-) 
visits <4 57 (44.6) 291 (59.9) 1.2 (0.8-1.7) 0.42 
Having blood No 21 (14.7 ) 93 (19.2) 2.2 (1.1-4.5) 0.00 
pressure checked Yes 121 (85 . 3) 392 (80.8) 1.0 (-) during antenatal 
Response to vaginal Go to hospital 11033 (76.9) 481 (96.2) 1.0 (-) bleeding during Don't know (23.1) 19 (3.8) 7.6 (4.2-13.9) 0.00 
pregnancy 
Bleeding during this Yes 3 (2.1) 3 (0.6) 3.4 (0.7-I7.8) 0.01 
pregnancy No 140 (97.9) 497 (99.4) 1.0 (-) 
Hypertension in this Yes 71 (52.6) 7 (1.4) 77.7 (34.2-176.1) 0.00 
pregnancy No 64 (47.4) 493 (98.6) 1.0 (-) 
Anaemia in this Yes 1 (0.7) 4 (0.8) 0.9 (0.1-7.0) (1.91 
pregnancy No 142 (99.3) 496 (99.2) 1.0 (-) 
Referral from other Yes 63 (44.1) 84 (16.8) 3.9 (2.6-5.8) 0.00 
centres No 80 (55.9) 416 (83.2) 1.0 (-) 
Length of first stage -<l8hours 139 (97.2) 435 (872) I 0 (-) in hours 18 
no labour 
1 
2 
(0.7) 
(1.4) 
65 (12.8) 
. 0.1 O OO (0.0-0.3) 
Sex of baby Female 86 (60.1) 248 (50.2) 1.0 (I. 0-2,2) 
Male 57 (39.9) 252 (49.6) 1.5 (-) 
(l (14 
Birth weight in grams ` 2500 67 (46.9) 13 (2.6) 22.9 (11.9-44.1) (). OO 
2500-3500 63 (44.0) 317 (63.4) LO (-) 
>3500 13 (9.1) 170 (34.0) 0.9 (02-0.7) 
* For women with at least one previous pregnancy 
(v) Laboratory Results 
Variable Stratum Cases Controls Odds ratio P 
N 5% Cl) ý Value 
ItIV status cg itiý c ý 
Nýý 134 93.7 155 (91.0) _- -- I (lu 1-1 
Positive 9 6.3 45 (9.0) 0.7 (0.3-1.4) 0.31 
Syphilis Negative 135 94.4 454 (90.8) (-) 1.0 
Positive 8 5.6 46 (9.2) 0.6 ((). 3-I. 3) 0.17 
Haemoglobin <10 49 34.3 75 (15.0) 3.0 (1.9-45.1) 
grams/decilitre ->10 94 65.3 425 (85.0) 1.0(_) 0.00 
Platelets x 10°/litre <150 51 35.7 52 (10.8) 4.6 (2.9-7.1) 0 00 
=>150 92 64.3 448 (89.2) 1. ) 1-) 
. 
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Table B2. Characteristics of post partum haemorrhage cases and controls 
(i) Socio-demographic characteristics 
Characteristic Stratum Cases Controls Crude odds ratio p 
N (%) N (%) (95% Cl) Value 
Distance from home 0-5 54 (50.5) 408 (81.6) 1.0 (-) 
to Mulago (km) 6-10 36 (34.3) 81 (16.2) 3.4 (2.1-5.5) 0. U0 
11-15 16 (15.2) 11 (2.2) 11.2 (4.9-25.4) 
Distance to nearest 0-5 87 (82.1) 491 (98.2) 1.0 (-) 
health unit (km) >5 19 ( 17.9) 9 (1.8) 17.5 (5.6-54.9) 0.00 
Age (years) 14-19 32 (30.2) 155 (31.0) 0.9 (0.6-1.5) 
20-29 58 ( 54.7) 262 (52.4) 1.0 (-) 0.94 
30+ 16 (15.1) 83 (16.6) 1.0 (0.4-2.0) 
Marital status Married 87 (82.5) 425 (85.0) 1.0 (-) 
Single 19 ( 17.9) 75 (15.0) 1.3 (0.7-2.2) 0.31 
Tribe Bantu 94 (88.7 ) 454 (90.8) 1.0 (-) 
Nilotics 12 ( 11.3) 46 (9.2) 1.3 (0.6-2.6) 0.50 
Religion Protestant 40 (35.9) 141 (28.2) 1.0 (-) 
Catholic 32 (31.1) 173 (34.6) 0.7 (0.4-1.2) 
Muslim 24 (22.6) 160 (32.0) 0.6 (0.3- 1.0) 0.08 
Other 10 (9.4) 26 (5.2) 1.2 (0.5-2.8) 
I? ducation level of No schooling 6 (5.7) 22 (4.4) 1.4 (0.5-3.7) 
patient Primary 58 (54.7) 277 (55.4) 2.1 (0.8-5.7) 
Secondary 36 (34.0) 186 (37.2) 1.0 (-) 0.64 
College 6 (5.7) 15 (3.0) 1.1 (0.7-1.7) 
Patients job Commerce 28 (26.4) 114 (22.8) 1.3 (0.8-2.2) 
Prolcssional 06 (5.7) 14 (2.8) 1.9 (0.7-5.4) 0.31 
Peasant 72 (67.9) 372 (74.4) 1.0 (-) 
Spouse job Commerce 64 (62.1) 205 (41.0) 1.0 (-) 
Professional 24 (21.4) 106 (21.2) 1.0 (0.6-1.8) 0.44 
Peasant 18 (16.5) 189 (37.8) 0.7 (0.4-1.3) 
Type of house Brick, plastered 44 (41.5) 417 (83.4) 1.0 (-) 
Brick only 51 (48.1) 69 (13.8) 6.9 (4.3-11.1) 0.00 
Mud only 11 (10.4) 14 (2.8) 7.5 (3.2-17.4) 
Need to request Yes 30 (28.6) 6) 47 (9-4) 3.9 (2.3-6.4) 
permission to visit No 76 (71.4) 453 (90.6) 1.0 (-) 0 00 Ilealth Unit/hospital . 
Who gives permission S Spouse 25 (82.9) ý 42 (Hx. Sý 1.0 (-) 
to attend I lealth Other 05 (17.1) 05 (11.5) 1.7 (0.4-7.4) 0.44 Unit/hospital 
Who pays for Self and spouse 84 (80.0) 403 (80. )) 1. (1 (-) 
treatment Others 21 (20.0) 97 ( 19.4) 1.0 (2.7-7.4) 0.0(I 
215 
(ii) Social, family and medical history characteristics 
Characteristic Stratum Cases Controls Odds ratio P 
N (%) N (%) (95% CI) Value 
Taking alcohol Ye. 23 (21.7) 137 (27.4) 0.7 (0.4-1.2) 0.22 
No 83 (72.6) 363 (72.6) I. ll (-) 
Smoking Yes 1 (0.9) II (2.20) 0.4 (0.1-3.3) 0.41 
No 105 (99.1) 489 (97.8) 1.0 (-) 
Family hypertension Yes 47 (44.3) 194 (38.8) 1.4 (0.1-2.1) 0.07 
No 59 (55.7) 306 (61.2) 1.0 (-) 
Hypertension (self) Yes 4 (3.8) 2 (0.4) 9.8 (1.8-54.0) 0.00 
No 102 (96.2) 498 (95.6) 1.0 (-) 
Use of contraception Yes 39 (43.8) 219 (43.8) 1.0 (-) 
No 67 (63.2) 281 (56.2) 1.3 (0.9-2.1) 0.10 
(iii) Past obstetric p erformance* 
Variable Stratum Cases Con trols Odds ratio P 
N (%) N (%) (95% Cl) Value 
Previous abortion Yes 9 (13.1) 43 (12.3) I. O (0.1-2.1) 0.97 
No 60 (86.9) 307 (87.7) 1.0 (-) 
Bleeding in Yes 10 (14.5) 37 (10.6) 1.3 (0.6-2.7) 0.49 
previous pregnancy No 59 (85.5) 313 (89.4) 1.0 (-) 
Bleeding in labour Yes 6 (8.7) 37 (10.6) 0.8 (0.3-1.8) 0.53 
No 63 (91.3) 313 (89.6) 1.0 (-) 
Labour lasting Yes 12 ((7.4) 77 (22.0) 0.7 (0.4-I. 3) 0.43 
more than 18hrs No 57 (82.6) 273 (78.0) 1.0 (-) 
Previous caesarean Yes 15 (21.7) 15 (4.0) 6.2 (2.6-12.4) 0.00 
section No 54 (78.3) 335 (96.0) 1.0 (-) 
Post partum Yes 6 (8.7) 14 (4.0) 2.1 (0.8-5.6) 0.14 
haemorrhage No 63 (91.3) 336 (96.0) l. O (-) 
Retained placenta Yes 3 (4.3) 9 (12.6) 0.5 (0.4-6.0) 0.67 
No 66 (95.6) 342 (97.4) 1.0 (-) 
I lypertension in Yes 7 (10.1) 19 (5.4) 1.8 (0.7-4.4) 0.21 
nreenancv No 62 (89.9) 331 (94.6) 1.0 (-) 
* Women with previous pregnancies only 
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(iv) Characteristics and outcome of the current pregnancy 
Variable Stratum Cases Controls Odds ratio P 
N (%) N (%) (95 % Cl) Value 
Number of pregnancQ I 37 (34.9) 150 (30.0) 12 (0.7-I. 9) 0.4(( 
2-4 57 (53.8) 237 (47.4) 1.0 (-) 
5-14 12 (11.3) 113 (22.6) 0.7 (0.4-1.4) 
Birth spacing 1-36 37 (53.2) 216 (61.9) 1.0 (-) 
In months (in 37-60 14 (21.0) 91 (26.0) 0.9 (0.5-1.9) 0.03 
multigravida) >60 18 (25.8) 43 (12.1) 2.5 (1.2-5.0) 
Attended Antenatal Yes 92 (86.8) 485 (97.0) 1.0 (-) 0.00 
care No 14 (13.2) 15 (3.0) 4.9 (2.9-10.5) 
Booking time for <28 58 (63.0) 332 (68.6) 1.0 (-) 0.23 
antenatal (weeks) 28-36 34 (37.0) 153 (31.4) 1.3 (0.8-2.1) 
Having blood pressure No 83 (78.3) 93 (19.2) 1.0 (-) 0.31 
checked during Yes 23 (21.7) 392 (80.8) 0.8 (1.4-1.3) 
antenatal 
Response to vaginal Go to hospital 82 (77.4) 481 (96.2) 1.0 (-) 0.00 
bleeding during Don't know 24 (22.6) 19 (3.8) 7.4 (3.9-14.1) 
Bleeding during this Yes 4 (3.8) 3 (0.6) 6.5 (1.4-29.5) 0.03 
pregnancy No 102 (96.2) 497 (99.4) 1.0 (-) 
I lypertension in this Yes 10 (9.4) 7 (I. 4) 7.5 (2.9-9.7) 0.00 
pregnancy No 96 (90.6) 493 (98.6) 1.0 (-) 
Anaemia in this Yes 5 (4.7) 4 (0.8) 6.1 (1.4-27.4) 0.00 
te nancy No 101 (95.3) 496 (99.2) 1.0 (-) 
Admission to hospital Yes 10 (90.6) 469 (93.8) 1.6 (0.7-3.3) 
No 96 (9.4) 31 (6.2) 1.0 (-) 0.25 
Referral from other Yes 59 (55.7) 84 (16.8) 6.1 (4.0-9.7) 0.00 
centres No 47 (44.3) 416 (83.2) 1.0 (-) 
Premature rupture of Yes 3 (2.8) 111 (22.3) 1.3 (0.8-2.1) 0.27 
membranes No 103 (97.2) 386 (77.7) 1.0 (-) 
Bleeding in labour Yes 21 (19.8) 6 (1.2) 20.3 (8.0-51.8) 0.00 
No 85 (80.2) 493 (98.8) 1.0 (-) 
Type of labour Normal 68 (64.2) 496 (99.2) 1.0 (-) 
Induced or 38 (35.8) 4 ((). 8) 69.2 (20.7-2411.6) 0.00 
augmented 
Use of partograph Yes 11 (10.4) 44 (8.8) 1.0 (-) 
No 95 (89.6) 456 (91.2) 1.2 (0.6-2.4) 0.61 
Length of first stage <=18 hours 13 (12.3) 77 (22.0) 1.0 (-) 0.03 
>l8hours 93 (87.7) 273 (78.0) 0.6 (0.3-1.0) 
Length ofthird stage in - 76 84 (79.2) 494 (98.8) I. )) (-) 
minutes =25 22 (20.8) 6 (1.2) 28.3 (6.6-78.9) 0.00 
Sex of baby Female 58 (54.7) 252 (50.2) 1.0 (-) 
Male 48 (45.3) 248 (49.6) 11.8 (0.5-1.2) 0.34 
Birth weight < 2500 13 (12.8) 13 (2.6) 5.0 (2.2-11.4) 
In kilograms 2500-3500 63 (62.4) 317 (63.4) I. O (-) 11.1)(1 
; 3500 25 (24.8) 170 (34.0) 0.7 2 
_1 (0.4-1.2) missing 5 
Level of delivery Midwife 51 48.1 482 (96.4) 1.0 (-) 0.00 
attendant I)octor 49 46.2 18 (3.6) 34.9 (17.4-70.2) 
WA 6 5.7 O (0) 
Given Oxytocics Yes 85 (80.2) 489 (97.8) I. 3 (-) 
No 21 (19.8) 11 (2.2) 11.0 (4.8-23.3) 0.00 
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(v) Laboratory Results 
Variable Stratum Cases Controls Odds ratio P 
N (%) N (%) (95% Cl) Value 
IIIV status Negative 93 (87.7) 455 (91.0) 1.0 (-) 
Positive 13 (12.3) 45 (9.0) 1.4 (0.7-2.7) 0.30 
Syphilis Negative 98 (87.7) 454 (9O. 8) 1.0 (-) 0.59 
Positive 8 (12.3) 46 (9.2) 0.8 (0.4-1.8) 
1laemoglobin <10 79 (74.5) 75 (15.0) 17.4 (10.5-28.9) 0.0(1 
gm/dl =>10 
27 (25.5) 425 (85.0) 1.0 (-) 
Platelets 1x10''/litre <150 70 (66.0) 52 (10.8) 4.3 (2.6-6.9) 0.00 
=>150 36 (34.0) 448 (89.2) 1.0 (-) 
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Table B3 Characteristics of obstructed labour cases and controls 
(i) Socio-demographic characteristics 
Characteristic Stratum Cases Controls Crude odds ratio p 
N (%) N (%) (95% Cl) Value 
Distance from home 0-5 34 (31.5) 408 (81.6) 1.0 (-) 
to Mulago (km) 6-10 45 (41.7) 81 (16.2) 3.2 (1.9-5.2) 
11-15 29 (26.9) 11 (2.2) 10.1 (5.4-19.0) 0.00 
Distance to nearest 0-5 95 (88.0) 491 (98.2) 1.0 (-) 
health unit (km) >5 13 (12.0) 9 (1.8) 7.5 (3.1-18.0) 0.00 
Age (years) 14-19 41 (38.0) 155 (31.0) 1.2 (0.8-1.9) 0.00 
20-29 58 (53.7) 262 (52.4) 1.0 (-) 
30-35 5 (4.6) 52 (10.4) 0.4 (0.2-1.1) 
35+ 4 (3.7) 31 (6.2) 0.6 (0.19-1.71 
Marital status Married 87 (80.6) 425 (85.0) 1.0 (-) 
Single 21 (19.5) 75 (15.0) 1.4 (0.8-2.3) 0.27 
Tribe Bantu 
Nilotics 
42 
10 
(80.8) 
(19.2) 
454 
46 
(90.8) 
(9.2) 
1.0 
2.4 
(-) 
(1.1-5.0) 0.03 
Religion Protestant 35 (32.4) 141 (28.2) 1.0 (-) 
Catholic 36 (33.3) 173 (34.6) 0.8 (0.5-1.4) 0.57 
Muslim 30 (27.8) 160 (32.0) 0.8 (0.4-1.3) 
Other 7 (6.5) 261 (5.2) 1.3 (0.5-3.4) 
Education level of No schooling 5 (9.6) 22 (5.0) 0.3 (0.0-I. 7 
patient Primary 13 (25.0) 277 (55.4) 1.2 ((). 8-1.9) 0.19 
Secondary 23 (44.2) 186 (37.2) 1.0 (-) 
College 1 (1.9) 15 (3.0) 0.7 (0.4-4.5) 
Patients job l. mployed 32 (29.6) 128 (25.6) 1.1 (0.3-3.6) 0.99 
Peasant 76 (70.4) 372 (74.4) 1.0 (-) 
Spouse job Commerce 71 (65.7) 205 (41.0) 1.0 (-) 0.09 
Professional 12 (11.1) 106 (21.2) 0.5 (0.3- 1.0) 
Peasant 25 (23.2) 189 (37.8) 1.0 (0.6-1.7) 
Type of house Brick, plastered 59 (54.6) 417 (83.4) I. O (-) 
Brick only 38 (35.2) 69 (13.8) 3.6 (1.1-11.6) (l. OO 
Mud only II (10.2) 14 (2.8) 5.6 (2.4-12.8) 
Facility in house Electricity and 44 (40.7) 261 (52.2) I. (1 (-) 
piped v%ater 0.00 
Electricity or 47 (43.5) 140 (28.0) 1.7 (1.0-3.1) 
piped water 
Neither 27 (25.0) 99 (19.8) 2.1 (I. 2-3.0) 
Need to request Yes 25 (23.2) 47 (9.4) 3.2 (1.6-6.4) 
permission to visit No 83 (76.9) 453 (90.6) 1.0 (-I 0 00 I lealth t)nit/hospital . 
Who gives permission Spouse 20 (83.5) 41 (88.5) I. (1 (-) 
to attend I Iealth Other 05 (16.5) 06 (11.5) 1.5 (0.8-2.9) 0 2() Unit/hospital . 
Who pays lo r Self and spouse 85 (78.7) 403 (80.6) 1.0 
treatment Others 23 (21.3) 97 (19.4) 2.9 (1.7-5.2) 0.00 
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(ii) Social, family and medical history 
Characteristic Stratum Cases Controls Odds ratio P 
N (%) N (%) (95% CI) Value 
Taking alcohol Yes 28 (25.9) 137 (27.4) 0.9 (11.6-1.5) 0.75 
No 80 (74.1) 363 (72.6) I. l) (-) 
Smoking Yes 3 (2.8) Il (2.20) 0.8 (0.5-1.2) 0.12 
No 105 (97.2) 489 (97.8) 1.0 (-) 
Family hypertension Yes 5 (4.6) 194 (38.8) 2.8 (0.8-7.1) 0.49 
No 103 (95.4) 306 (61.2) I. O (-) 
Family diabetes Yes 42 (38.9) 62 (12.4) 1.0 (0.8-1.9) 0.35 
mellitus No 66 (61.1) 437 (87.6) 1.2 (-) 
hypertension (sell) Yes 4 (3.9) 2 (0.4) 9.6 (1.7-33.0) 0.01 
No 104 (96.1) 498 (95.6) 1.0 (-) 
Use of contraception Yes 7 (6.5) 219 (43.8) 1.1 (0.5-2.4) 0.23 
No 101 (93.5) 281 (56.2) 1.0 (-) 
(iii) Past obstetric p erformanc e 
Variable Stratum Cases Controls Odds ratio P 
N (%) N (%) (95% CI) Value 
Previous abortion Yc; 4 (8.11) "13 (12.3) 0.4 (0.1-1.2) 0.09 
No 46 (92.0) 307 (87.7) 1.0 (-) 
Previous evacuation of Yes 4 (3.7) 20 (4.0) 0.7 (0.2-2.5) 0.54 
uterus/dc (all women) No 104 (96.3) 480 (96.0) 1.0 (-) 
Bleeding in previous Yes 5 (10.0) 37 10.6 0.6 (0.2-1.6) 0.31 
pregnancy No 45 990.0) 313 (89.4) 1.0 (. º 
Bleeding in labour Yes 4 (8.0) 37 (10.6) 0.5 (0.1-1.4) 0.17 
No 46 (92.0) 313 (89.6) H) (-) 
Labour lasting more Yes 12 (24.0) 77 (22.0) 0.7 (0.4-1.3) 0.25 
than 18hrs No 38 (76.0) 273 (78.0) 1.0 (-) 
Still birth Yes 5 (IO. 0) 25 (7.1) 0.9 (0.3-2.4) 0.81 
No 45 990.0) 325 (92.9) 1.0 (-) 
Previous caesarean Yes 8 (16.0) 15 (4.0) 4.5 (2.0-11.9) 0.00 
section No 42 (84.0) 335 (96.0) 1.0 (-) 
Vacuum + forceps Yes 2 (4.0) 5 (1.4) 1.9 (0.4-9.8) 0.46 
No 48 (96.0) 345 (98.6) 1.0 (-) 
Post partum Yes 3 (6.0) 14 (4.0) 1.0 (0.3-3.5) 0.1O 
haemorrhage No 47 (94.0) 336 (96.0) 1.0 (-) 
* Women with previous pregnancies only 
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(iv) Characteristics and outcome of the current pregnancy 
Variable Stratum Cases Controls Odds ratio P 
N (%) N (%) (95% Cl) Value 
Number ol'pregnancy I 58 (39.8) 150 (30.0) 15 (1.6-3.8) 
2-4 43 (53.7) 237 (47.4) 1.0 (-) 0.00 
5-14 7 (6.5) 113 (22.6) 0.6 (0.3-1.3) 
Birth spacing in 1-36 21 (42.3) 216 (61.9) 1.0 () 
months* 37-60 29 (57.7) 91 (26.0) 2.1 (1.2-4.0) 0.02 
>60 - 43 (12.1) 
Attended Antenatal Yes 102 (94.4) 485 (97.0) 1.0 (-) 
care No 6 (5.6) 15 (3.0) 1.7 (0.7-5.0) 0.19 
Booking time for -28 66 (64.7) 332 (68.6) 1.0 (-) 
antenatal (weeks) 28-36 36 (35.3) 153 (31.4) 0.3 (0.2-I. I) 0.06 
Response to vaginal Go to hospital 79 (73.2) 481 (96.2) 1.0 (-) 0.00 
bleeding during Don't know 29 (26.8) 19 (3.8) 9.3 (5.0-17.4) 
pregnancy 
Referral from other Yes 31 (28.7) 84 (16.8) 2.6 (1.3-3.6) 0.00 
centres No 77 (71.3) 416 (83.2) 1.0 (-) 
Premature rupture of Yes 76 (70.4) I11 (22.3) 8.3 (5.2-13.1) 0.00 
membranes No 32 (29.6) 386 (77.7) 1.0 (-) 
Bleeding in labour Yes 6 (5.6) 6 (1.2) 4.9 (1.5-15.3) 0.00 
No 102 (94.4) 493 (98.8) 1.0 (-) 
Length of first stage <=18 16 (14.8) 43565 (87.2) 1'O (-) 
>18 92 (85.2) (12.8) 5.6 (2.4-13.0) 0.0(1 
Use ofpartograph Yes 12 (11.1) 44 (8.8) 1.0 (-) 
No 96 (88.9) 456 (91.2) 0.8 0.4-1.5 0.45 
Sex ot'baby Female 35 (32.4) 252 (50.2) 1.0 (-) 
Male 73 (67.6) 248 (49.6) 2.1 (1.4-3.8) 0.00 
Birth weight in < 2500 9 (8.4) 13 (2.6) 3.3 (1.3-8.3) 0.04 
kilograms 2500-3500 59 (54.6) 317 (63.4) 1.0 (-) 
>3500 40 (37.0) 170 (34.0) 1.3 (0.9-2.0) 
* For women with at least one previous pregnancy 
(v) Laboratory Results 
Variable Stratum Cases Controls Odds ratio p 
N (%) 
_ 
N (%) 510%/. 1) Value 
IIIV status Negative 95 (88. ()) 455 (91.0) I. )) (-) 
Positive 13 (12.0) 45 (9.0) 1.3 (0.7-2.7) 0.23 
Syphilis Negative 99 (91.7) 454 (90.8) 1.0 (-) 0.78 
Positive 9 (8.3) 46 (9.2) 0.9 (0.4-1.9) 
I laemoglobin <10 49 (45.4) 75 (15.0) 6.8 (4.3-10.7) 0. (11) 
am/dl =>10 59 (54.6) 425 (95.0) (-) I. 0 
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Table B4 Characteristics of cases of ruptured uterus and controls 
(i) Socio-demographic characteristics 
Characteristic Stratum Cases Controls Crude odds ratio p 
N (%) N (%) (95% Cl) Value 
Distance from home 0-5 18 (34.6) 408 (81.6) 1.0 (-) 
to Mulago (km) 6-10 22 (44.3) 81 (16.2) 2.9 (1.5-5.6) 0.00 
11-15 12 (23.0) Il (2.2) 8.6 (3.8-19.3) 
Distance to nearest 0-5 46 (88.5) 491 (98.2) 1.0 (-) 
health unit (km) >5 06 (11.5) 9 (1.8) 8.3 (3.0-23.3) 0.00 
Age (years) 14-19 5 (9.6) 155 (31.0) 0.1 (0.0-0.4) 0.00 
20-29 36 (69.2) 262 (52.4) 1.0 (-) 
30+ 11 (21.2) 83 (16.6) 0.9 (0.6-1.9) 
Marital status Married 47 (90.4) 425 (85.0) 1.0 (-) 
Single 5 (9.6) 75 (15.0) 0.6 (0.2-1.5) 0.28 
Tribe Bantu 42 (80.8) 454 (90.8) 1.0 (-) 
Nilotics 10 (19.2) 46 (9.2) 2.4 (1.1-5.0) 0.00 
Religion Protestant 14 (26.9) 141 (28.2) 1. (1 (-) 
Catholic 20 (38.5) 173 (34.6) 1.2 (0.6-2.5) 
Muslim 13 (25.0) 160 (32.0) 0.8 (0.4-1.8) 0.82 
Seven day 2 (3.8) 5 (1.0) 4.0 (0.7-22.7) 
Saved 3 (6.8) 21 (4.2) 1.4 (0.4-5.4) 
Education level of No schooling 5 (9.6) 22 (5.0) 0.8 (0.4-1.4) 0.24 
patient Primary 25 (48.0) 277 (55.4) 1.0 (-) 
Secondaryy 22 (42.3) 186 (37.2) 1.9 (0.7-5.6) 
College 0 (-) 15 (3.0) 
Patients. job Employed 10 (19.2) 128372 (25.6) 1.0 (-) 
Peasant 42 (81.8) (74.4) 1.2 (0.6-2.6) 0.07 
Spouse job Commerce 9 (17.0) 205 (41.0) 1.0 (-) 
Professional 10 (18.9) 106 (21.2) 0.6 (0.1-5.0) 
Peasant 23 (64.1) 189 (37.8) 0.7 (0.1-5.2) 0.89 
Type of house Brick, plastered 30 (57.7) 417 (83.4) 1.0 (-) 
Brick only 16 (30.8) 69 (13.8) 3.6 (1.1-11.6) 
Mud only 6 (11.5) 14 (2.8) 2.8 (1.4-5.3) 0.00 
Need to request Yes 15 (28.8) 47 (9.4) 3.2 (1.6-3.2) 0.00 
permission to visit No 37 (71.2) 453 (90.6) 1.0 (- ) fealth Unit/hospital I 
Who gives Spouse 13 (92.1) 42 (88.5) 1.0 (-) 
permission to attend Other 2 (7.9) 05 (11.5) 0.4 (0.1-I. 8) 0.26 I Icalth llnit/hospital 
Who pays for Self and spouse 47 (90.3) 403 (80.6) I. I) (-) 
treatment Others 5 (9.7) 97 ( 19.4)_ 
__1.8 
(0.8-4.2) 0.07 
(ii) Social, family and medical history 
Characteristic Stratum Cases Controls Odds ratio N 
N (%) N- (%) 5% Cl) Value 
Taking alcohol Yes 12 (23.1) 137 (27.4) 0.9 (0-1-I. 5) nI 
No 40 (76.9) 363 (72.6) I. 0 (-) 
Family Yes 19 (36.5) 194 (38.8) (1.9 (0.5-1.6) 0.74 
hypertension No 33 (63.5) 306 (61.2) 1.0 (-) 
Use of Yes 22 (42.3) 219 (43.8) 1.0 (-) 
contraception No 30 (57.7) 281 (56.2) 1.1 (0.6-2.0) 0.21 
222 
(iii) Past obstetric performance * 
Variable Stratum Cases Controls Odds ratio p 
N (%) N (%) (95% Cl) Value 
Previous abortion Yes 4 (8.7) 43 (12.3) 0.9 (U. 3-2.5) (1.79 
No 41 (91.3) 307 (87.7) 1.0 (-) 
Previous evacuation of Yes 2 (4.4) 20 (4.0) 2.2 (0.3-16.5) 0.46 
uterus/dc (all women) No 43 (95.6) 480 (96.0) 1.0 (-) 
Labour lasting more than Yes 14 (31.1) 77 (22.0) 2.0 (1.0-3.8) 0.02 
l8hrs No 31 (68.9) 273 (78.0) 1.0 (-) 
Still birth Yes 5 (11.1) 25 (7.1) 0.9 (0.3-2.4) 0.81 
No 40 (88.9) 325 (92.9) 1.0 (-) 
Previous caesarean section Yes 19 (42.2) 15 (4.0) 18.7 (7.7-40.9) 0.00 
No 26 (57.8) 335 (96.0) 1.0 (-) 
* Women with previous pregnancies only 
(iv) Characteristics and outcome of the current pregnancy 
Variable Stratum Cases Controls Odds ratio P 
N (°/a) N (%) (95 %-('1) Value 
Number ol'prcgnancy I 7 (13.5) I50 (30.0) (I. 3 (0. I-0.7) 0.00 
2-4 39 (75.0) 237 (47.4) 1.0 (-) 
5-14 6 (11.5) 113 (22.6) 0.5 (0.2-1.3) 
Birth spacing in months* 1-36 26 (57.8) 216 (61.9) 1.0 (-) 
37-60 8 (17.8) 91 (26.0) 0.7 ((). 3-1.6) 0.04 
>60 11 (24.4) 43 (12.1) 2.0 (1.0-4.4) 
Attended Antenatal care Yes 47 (90.4) 485 (97.0) 1.0 (-) 
No 5 (9.6) 15 (3.0) 3.4 (1.2-9.7) 0.02 
Response to vaginal Go to hospital 40 (76.9) 481 (96.2) 1.0 (-) 0.00 
bleeding during pregnancy Don't know 12 (23.1) 19 (3.8) 7.6 (3.4-16.8) 
Referral from other Yes 27 (51.9) 84 (16.8) 5.1 (2.9-9.3) 0.00 
centres No 25 (48.1) 416 (83.2) 1.0 (-) 
Bleeding in labour Yes 20 (38.5) 6 (1.20) 49.8 ( 18.7-32.4) 0.00 
No 32 (61.5) 493 (98.8) 1.0 (-) 
Use of partograph Yes 1 (1.9) 44 (8.8) 1.0 
No 51 (98.1) 456 (91.2) 0.2 (0.0-1.5) 
Length of labour first <=18 12 (23.1) 435 (87.2) 1.0 (-º 0.00 
stage in hours >18 40 (76.9) 65 (12.8) 22.2 (10.6-47.6) 
Sex of baby Female 25 (48.1) 252 (50.2) 1.0 (-) 
Male 27 (51.9) 248 (49.6) 1.1 (0.6-1.9) 0.11) 
Birth weight in kilograms 2500 3 (5.9) 13 (2.6) 1.1 (0.3-3.7) 0.02 
2500-3500 28 (54.9) 317 (63.4) 1.0 (-) 
3500 20 (39.2) 170 (34.0) 2.2 (1.2-4.0) 
* For women with at least one previous pregnancy 
(v) Laboratory Results 
Variable Stratum Cases Controls Odds ratio P 
N (%) N 0 value 
IIIV status Ncgativc 42 (8(. 8) 455 (91. () l-1 1.0 
Positive 10 (19 2) 45 (9.0) 2.4 (1.1-4.2) 0.03 
Syphilis Negative 46 (86.5) 454 (90.8) 1.0 1-1 
Positive 7 (13.5) 46 (9.2) 1.5 (0.6-3.5) 0.94 
I Iacmoglohin <10 12 (23.1 75 (15.0) 19.4 (9.7-38.5) 0.00 
gm/dl =>10 40 (76.9) 425 (85.0) 1.0 (-) 
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Table B5 Characteristics of cases of ante partum haemorrhage due to placenta 
praevia and controls 
(i) Socio-demographic characteristics 
Characteristic Stratum Cases Controls Crude odds ratio p 
N (%) N (%) (95 % Cl) Value 
Distance from home 0-5 12 (33.3) 408 (81.6) 1.00 (-) 
to Mulago (km) 6-10 II (30.6) 
81 (16.2) 2.2 (0.9-5.1) 0.00 
1-15 13 (36.1) 11 (2.2) 12.9 (5.3-30.9) 
Distance to nearest 0-5 28 (77.8) 491 (98.2) 
1.0 (-) 
health unit (km) >5 8 (22.2) 
9 (1.8) 15.6 (5.6-43.5) 0.00 
Age (years) 14-19 6 (16.7) 155 (31.0) 
0.4 (0.1 I . I) 0.06 
20-29 21 (58.3) 262 (52.4) 1.0 (-) 
30+ 9 (25.0) 83 (16.6) 1.5 (0.7-3.3) 
Marital status Married 
31 (86.1) 425 (85.0) 1.0 (-) 
Single 5 (13.9) 75 (15.0) 0.9 (0.3-0- 2.4) 0.85 
Tribe Bantu 32 (91.6) 454 (90.8) 1.0 (-) 
Nilotics 4 (8.4) 46 (9.2) 1.4 (0.5-4.0) 0.09 
Religion Protestant 18 (50.0) 141 (2X2) 1.0 (-) 
Catholic 8 (22.2) 173 (34.6) 0.4 (0.2-1.0) 0.00 
Muslim 5 (13.9) 160 (32.0) 0.3 ((). 1-11.8) 
Seven day 1 (2.8) 5 (I. 0) 3.5 (0.6-19.7) 
Saved 4 (11.1) 21 (4.2) 2.1 (0.7-6.3) 
Education level of No schooling 1 (2.9) 
22 (5.0) 0.7 (0.1-5.7) 
patient Primary 19 (52.8) 
277 (55.4) 1.1 (0.5-2.2) 0.07 
Secondary 12 (33.3) 186 (37.2) 1.0 (-) 
C'olleee 4 (11. I) 15 (3.0) 4.1 (1.2-14.4) 
Patients job Employed 
Non employed 
16 
20 
(45.5) 
(55.5) 
128 
372 
(25.6) 
(74.4) 
2.6 (-) 
I. 0 (1.3-5.2) OMI 
Spouse job Commerce 2 (5.6) 205 (41.0) 4.4 (0.8-23.8) 0.08 
Professional 8 (22.2) 106 (21.2) 1.1 (0.5-2.9) 
Peasant 15 (41.7) 199 (37.8) I. I) (-) 
9 (25.0) 1.1 (0.5-2.7) 
2 (6.6) 0.3 (0.1-1.3) 
'T'ype of house Brick. plastered 28 (80.0) 417 (83.4) I. O (-) 
Brick only 8 (20.0) 69 (13.8) I. O (0.4-2.3) 0.95 
Mud only 
Facility in house Hectricity and 23 
piped grater 
Electricity or 7 
tap only 
14 (2.8) 
(63.9) 261 (52.2) 1.0 (-) -ýý 
(19.4) 
16.7) 
140 (28.0) 1.6 (0.6-3.8) 
99 (19.9) 7. -1 (2.6-21.1 
Need to request Yes 11 (30.6) 47 (9.4) 5.4 (16-11.5) 0.00 
permission to visit 
I lealth Unit/hospital 
No 25 (69.4) 453 (911.6) 1.0 (-) 
Who gives permission 
' 
Spouse 10 (92.0) 42 (88.5) 1.0 (-) 
I o attend I lealth Other (2.0) 05 (11.5) 0.7 (0.2-2.9) l1. Il) Unit/hospital 
Who pays for Self and spouse 33 (91.6) 403 (80.6) 1.0 (-) - 
treatment Others 3 (8.4) 97 (19.4) 0.7 (0.3-3.5) 0.94 
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(ii) Social, family and medical history 
Characteristic Stratum Cases Controls Odds ratio P 
N (%) N (%) (95% Cl) value 
Taking alcohol Yes 12 (33.3) 137 (27.4) 1.3 (1). 6-2.7) 0.44 
No 24 (66.7) 363 (72.6) 1.0 (-) 
Family hypertension Yes 11 (30.6) 194 (38.8) 0.7 (0.3-1.4) 0.32 
No 25 (69.4) 306 (61.2) 1.0 (-) 
hypertension (self) Yes 2 (5.6) 2 (0.4) 7.0 (0.9-80.4 
No 34 (94.4) 498 (95.6) 1.0 (-) 0.17 
Use of contraception Yes I (2.8) 219 (43.8) 7.1 (0.6-80.4) 011 
No 35 (97.2) 281 (56.2) 1.0 (-) 
(iii) Past obstetric performance 
Variable Stratum Cases Controls Odds ratio P 
N (%) N (%) ( 95% Cl) value 
Previous abortion Yes 4 (13.3) 43 (12.3) 1.4 ((). 5-4.1) 0.35 
No 26 (86.7) 307 (87.7) 1.0 
Previous evacuation of Yes 5 (13.9) 20 (4.0) 3.9 (1.4-11.1) 0.01 
uterus/dc (all women) No 
31 (87.1) 480 (96.0) 1.0 
Bleeding in previous Yes 3 (27.8) 37 10.6 0.9 (0.2-3.5) 0.92 
pregnancy No 26 (72.2) 313 (89.4) 1.0 (-) 
Bleeding in labour Yes 2 (27.8) 37 (10.6) 0.7 (0.1-2.9) 0.53 
No 27 (72.2) 313 (89.6) 1.0 (-) 
Labour lasting more Yes 4 (13.8) 26 (7.5) 2.0 (0.5-6.9) 0.22 
than 18hrs No 25 (86.2) 324 (92.5) 1.0 (-) 
Previous caesarean Yes 10 (27.8) 15 (4.0) 12.4 (5.8-30.4) 0.00 
section No 19 (72.2) 
335 (96.0) 1.0 (-) 
Vacuum + forceps Yes I (3.4) 5 (1.4) 2.8 (0.3-24.9) 0,4() 
No 28 (96.6) 345 (98.6) 1.0 (-) 
Hypertension in Yes 1 (3.4) 19 (5.4) 09 (0.1-7.8) 0.88 
nreenancv No 28 (96.6) 331 (94.6) 1.0 (-) 
* Women with previous pregnancies only 
(iv) Characteristics and outcome of the current pregnancy 
Variable Stratum Cases Controls Odds ratio IP 
N (95% Cl) Value 
Number of pie)nancy I 7 (19. x) I5() (311. (1) (1.5 (u-2-I? ) 
2-4 25 (69.4) 237 (47.4) 1.0 (-1 029 
5-14 4 (11.1) 113 (22.6) 0.6 (0.2-1.7) 
Birth spacing 1-36 18 (69.2) 195 (61.9) 1.0 (-) 
in months* 37-60 8 (30.8) 120 (38.1) 0.7 (0.3-1.7) 0.45 
Attended Antenatal Yes 32 (88.9) 485 (97.0) I. ll (-) 
care No 4 (1I. I) 15 (3.0) 4.0 (1.3-1.7) 0.02 
Number ofantenatal 4+ 22 (66.7) 291 (59.9) 1.0 (-) 
visits 4 11 (33.3) 195 (40.1) 0.8 (0.4-1.6) 045 
Response to vaginal (; o to hospital 29 (80.8) 481 (96.2 _) 1 0 (-) bleeding during Don't know 7 (19.4) 19 . (3.8) 6.1 (2.4-I5.7) 11.00 pregnancy 
Bleeding during this Yes 6 (16.7) 3 (0.6) 30.1 (6.3-60.5) 0.00 
pregnancy No 30 (83.3) 497 (99.4) 1.0 (_) 
Referral from other Yes 13 (30.1) 84 (16.8) 2.8 (1.4-5.7) 0.00 
centres No 23 (63.9) 416 (83.2) 1.0 (-) 
Sex of bab)Female 20 (55.6) 252 (50.2) 1.0 
Male 16 (44.4) 249 (49.6) 0.8 (04-1.6) 0.49 
Birth weight in - 2500 14 (38.9) 13 (2.6) 21.3 (8.6-52.8) O. UO 
kilograms 2500-3500 16 (44.4) 317 (63.4) 1.0 (-) 
-3500 6 (16.7) 170 (34.0) 0.7 (0.2-1.8) 
* For women with at least one previous pregnancy 
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(v) Laboratory Results 
Variable Stratum Cases Controls Odds ratio p 
N (%) N (%) ( 95% CI) Value 
IIIV statu,, Negative 33 (91.7) 455 (91. (1) I. o (-ý 
Positive 3 (8.32) 45 (9.0) 0.9 (0.3-3.1) 0.68 
Syphilis Negative 33 (91.7) 454 (90.8) 1.0 (-) 
Positive 3 (8.3) 46 (9.2) 0.9 (0.3-3.0) 0.86 
Haemoglobin <10 7 (19.4) 75 (I5.0) 23.5 (9.9-55.5) 0.00 
gm/dl =>l0 29 (80.6) 425 (85.0) 1.0 (-) 
Platelets <150 8 (22.2) 52 (10.8) 2.4 (1.0-5.4) 0.04 
=>150 28 (77.8) 448 (89.2) 1.0 (-) 
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Table B6 Characteristics of cases of ante partum haemorrhage due to abruptio 
placenta and controls 
(i) Socio demographic characteristics 
Characteristic Stratum Cases Controls Crude odds ratio P 
N (%) N (%) (9 5% Cl) Value 
Distance from home 0-5 14 (31.1) 408 (81.6) 1.0 (-) 
to Mulago (kin) 6-10 21 (46.7) 81 (16.2) 3.1 (1.8-7.3) 0.00 
11-15 10 (22.2) 11 (2.2) 8.5 (3.5-20.9) 0.00 
Distance to nearest 0-5 37 (82.2) 491 (98.2) 1.0 (-) 
health unit (km) >5 8 (18.2) 9 (1.8) 11.8 (4.3-32.4) 0.00 
Age (years) 14-19 9 (20.0) 155 (31.0) 0.7 (0.3-1.5) 0.29 
20-29 25 (55.6) 262 (52.4) 1.0 (-) 
30+ 11 (23.9) 83 (16.6) 1.4 (0.7-2.9) 
Marital status Married 41 (91. l) 425 (85.0) 1.0 (-) 
Single 4 (8.9) 75 (15.0) 0.6 (0.2-1.6) 0.27 
Education level of No schooling 2 (4.4) 22 (5.0) 0.7 (0.1-5.7) 
patient Primary 26 (57.8) 277 (55.4) 1.1 (0.5-1.9) 0.20 
Secondary 16 (35.6) 186 (37.2) 1.0 (-) 
College 1 (2.2) 15 (3.0) 4.1 (1.2-14.4) 
Patients job Employed 35 (76.1) 128 (25.6) 1.0 (-) 
Peasants II (23.9) 372 (74.4) 1.15 (0.5-2.3) 
0.82 
Spouse. job Employed 36 (79.3) 
205 
(41.0) 1.0 (-) 
Not employed 10 (21.7) 
1 
189 
06 
(21.2) 1.1 (0.5-2.3) 
(37.8) 0.82 
Type of house Brick, plastered 
Brick only 
Mud only 
20 
17 
9 
(43.5) 
(37.0) 
(19.0) 
417 
69 
14 
(83.4) 
(13.8) 
(2.8) 
1.0 
5.1 
13.4 
(-) 0.00 
(2.6-10.3) 
(5.2-34.7) 
Need to request Yes 14 (31.1) 47 (9.4) 3.4 (1.7-7.0) 0.00 
permission to visit pc, ý No 31 (68.9) 453 (90.6) 1.0 (- ) Iealth Unit/hospital I 
Who gives permission Spouse 28 (87.5) 403 (88.5) . (1 
1.0 (-) health Unit/ to attend to att Other 4 (12.5) 52 (11.5) 1.1 (0.4-3.3) 0.85 
Who pays for Self and spouse 40 (87.0) 403 (80.6) 1.0 (_) 
treatment Others 6 (13.0) 97 (19.4) 1.7 (0.7-4.3) 0.26 
(ii) Social, family and medical history 
Characteristic Stratum Cases Controls Odds ratio P 
N (%) 
--- -N -_ 
(%) 
- _- __. 
(95% Cl) Value 
Taking alcohol Yes 6 (13.3) 137 (27.4) U. ") ((). 2-I. u) U(il No 39 (86.7) 363 (72.6) 1.0 (-) 
Family hypertension Yes 16 (35.6) 194 (38.8) 1.0 (0.5-1.9) 0.99 
No 25 (55.5) 306 (61.2) 1.0 (-) 
4 (8.9) 
Hypertension (sell) Yes 22 (48.9) 2 (0.4) 1.0 (0.4-1.5) 0.51 
No 23 (51.1) 498 (95.6) 0.9 (-) 
Use of contraception Yes 6 (13.3) 219 (43.8) 1. (I (-) - (I pO 
No 39 (86.9) 281 (56.2) 5.1 (2.0-13.6) 
i-I 
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(iii) Past obstetric performance * 
Variable Stratum Cases Controls Odds ratio P 
N (%) N (%) ( 95% Cl) Value 
Previous abortion Yes 4 (8.9) 43 (12.3) 2.3 (0.6-7.7) 0.12 
No 41 (91.1) 307 (87.7) 1.0 (-) 
Previous evacuation of Yes 2 (3.1) 20 (4.0) 0.5 (0. I-2. I) 0.28 
uterus/dc (all women) No 31 (96.9) 480 (96.0) 1.0 (-) 
Bleeding in previous Yes 2 (6.2) 37 (10.6) 0.6 (0.1-2.5) 0.43 
pregnancy No 30 (93.8) 313 (89.4) 1.0 (-) 
Labour lasting more Yes 4 (12.5) 77 (22.0) 0.5 (0.2-1.6) 0.20 
than 18hrs No 28 (87.5) 273 (78.0) 1.0 (-) 
Still birth Yes 6 (15.6) 25 (7.1) 2.8 (I. 1-7.0) 0.03 
No 27 (84.4) 325 (92.9) 1.0 (-) 
Previous caesarean Yes 8 (25.0) 15 (4.0) 5.0 (1.8-13.4) 0.00 
section No 24 (75.0) 335 (96.0) 1.0 (-) 
Post partum Yes 4 (2.5) 14 (4.0) 3.4 (1.0-10.8) 0.03 
hacmorrhage No 28 (97.5) 336 (96.0) 1.0 (-) 
* Women with previous pregnancies only 
(iv) Characteristics and outcome of the current pregnancy 
Variable Stratum Cases Controls Odds ratio P 
N (%) N (%) (95% CI) Value 
Parity 1 13 (28.9) 150 (30.0) 0.9 (0.5-1.8) 0.87 
2-4 26 (57.8) 237 (47.4) 1.0 (-) 
5-14 6 (13.3) 113 (22.6) 0.8 (0.3-2.0) 
Birth spacing in 1-36 16 (50.0) 195 (61.9) 1.0 (-) 
months* 37-60 9 (28.1) 82 (26.0) 1.3 (0.6-3.2) 0.41 
>60 7 (21.9) 38 (12.1) 2.3 (0.9-5.8) 
Attended Antenatal Yes 39 (86.7) 485 (97.0) 1.0 (-) 
care No 6 (13.7) 15 (3.0) 4.5 (1.8-13.5) 0.0(1 
Bleeding during this Yes 6 (15.3) 3 (0.6) 25.5 (6.1- 105.8) 0.00 
pregnancy No 39 (86.7) 497 (99.4) 1.0 (-) 
Hypertension in this Yes 16 (35.0) 7 (1.4) 22.5 (11.63-8.6) 0.00 
pregnancy No 29 (64.4) 493 (98.6) 1.0 (-) 
Referral from other Yes 27 (60.0) 84 (16.8) 7.4 (3.9-14.1) 0.00 
centres No 18 (40.0) 416 (83.2) 1.0 (-) 
Premature rupture of Yes 7 (15.6) III (22.3) 0.6 (0.3-1.5) 0.30 
membranes No 38 (84.4) 386 (77.7) 1.0 (-) 
Bleeding in labour Yes 34 (75.6) 6 (1.20) 254.0 (88.6-728.4) 0.00 
No II (24.4) 493 (98.8) 1.0 (-) 
Sex of baby Male 32 (71.1) 252 (50.2) 2.2 (1.2-4.9) 
Female 13 (28.9) 248 (49.6) 1.0 (-) 0.00 
Birth weight in -2500 21 (46.7) 13 (2.6) 30.1 (I2.9-70.2) 0.00 
kilograms 2500-3500 17 (37.8) 317 (63.4) 1.0 (-) 
=3500 7 (15.6) 170 (34.0) 0.8 (0.3-1.9) 
* For women with at least one previous pregnancy 
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(v) Laboratory Results 
Variable Stratum 
N 
Cases 
(%) 
Controls 
N (%) 
Odds ratio 
(95% Cl) 
P 
value 
IIIV status Negative 41 (91.1) 455 (91.0) I. )) (-) 0.98 
Positive 4 (8.9) 45 (9. ()) 1.0 (0.3-2.9) 
Syphilis Negative 41 (91.1) 454 (90.8) 1.0 (-) 
Positive 4 (8.9) 46 (9.2) 1.0 (0.3-2.8) 0.94 
Haemoglobin <10 36 (80.0) 75 (15.0) 22.7 0.00 (10.5-49.0) 
gn/dl =>l0 
9 (20.0) 425 (85.0) 1.0 
Platelets <150 19 (41.3) 52 (10.8) 11.7 0.00 
=>150 27 (58.7) 448 (89.2) 1.0 
(6.1-22.5) 
(-) 
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APPENDIX C: TABLES RELATING TO REFERRED AND 
NON-REFERRED CASES 
Table Cl: The primary causes of all severe maternal morbidity compared to non 
referrals 
Primary cause Number of 
referrals 
n (%) 
Number of 
non referrals 
n 
Total number of 
all cause SMM 
n (%)___. 
_. --- 
Severe pre eclampsia and eclampsia 57(45.6) 68(54.4) 125(100) 
Post partum haemorrhage 58(61.0) 37(39.0) 95(100) 
Obstructed labour 70(68.6) 32(31.4) 102(100) 
Ruptured uterus 27(51.9) 25(48.1) 52(100) 
Abruptio placenta 19(57.6) 14(42.4) 33(100) 
Placenta praevia 10(27.8) 26(72.2) 36(100) 
Puerperal sepsis 14(56.0) 11(44.0) 25(100) 
Anaemia 6(30.0) 14(70.0) 20(100) 
Other medical conditions 4(36.4) 7(63.6) 11(IOU) 
Total 263 236 236 
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Table C2: Comparing the crude odds ratios of all severe maternal morbidity to 
those who were not referred to Mulago hospital 
(i) Socio-demographic characteristics 
Characteristic Stratum Crude odds ratio p Non Non referral p 
All SMM Value referral crude odds Value 
(95% Cl) cases 
Distance from 0-5 1.0 (-) 121(51.3) 1. ) (-) 0.00 
home to Mulago 6-10 3.6 (2.7-4.9) 0.00 85(36.0) 3.7 (2.5-5.4) 
(km) 11-15 11.6 (6.1-22.3) 30(12.7) 9.4 (4.3-20.4) 
Distance to nearest 
health unit (km) 
0-5 
5.1-15 
1.0 
12.2 
(-) 
(6.1-24.4) 
212(89.8) 
0.00 24(10.2) 
1.0 
11.7 
(-) 0.00 
(4.0-34.1) 
Age (years) 14-19 0.9 (0.7-1.3) 72(30.5) 1.2 (0.8-1.7) 
20-29 1.0 (-) 127(53.8) 1.0 (-) 
30-35 0.7 ((1.4-1.2) 0.45 28(11.9) 1.0 (0.6-1.9) 0.32 
35+ 0.8 (0.6-1.4) 9(3.8) 0.6 (0.3-1.4) 
Marital status Married 1.0 (-) 195(82.6) 1.0 (-) 0.56 
Single 1.3 (0.9-1.8) 0.12 41(17.4) 1.1 (0.7-1.7) 
Tribe Bantu 1.0 (-) 209(88.6) to () 
Other 1.6 (1.1-2.5) 0.01 27(11.4) 1.2 (0.7-2.0) 0.46 
Religion Protestant 1.0 (-) 0.03 77(32.6) 1.0 (-) 
Catholic 0.8 (0.6-1.2) 75(31.8) 0.7 (0.5-1.2) 
Muslim 0.7 (0.5-0.9) 66(28.0) 0.7 (0.4-1.2) 0.42 
Seven day 1.9 (0.6-5.6) 3(1.3) 1.1 (0.2-5.2) 
Saved 1.3 (0.7-2.4) 15(6.4) 1.3 (0.6-2.6) 
Education level of No schooling 1.2 (0.1-2.2) 15(6.4) 0.9 (0.6-1.3) 
patient Primary 1.0 (0.8-1.3) 0.18 121(51.3) 1.5 (0.6-3.4) 
Secondary 1.0 (-) 89(37.7) 1.0 (-) 0.55 
College 1.9 (1.0-2.2) 11(4.6) 1.3 0.6-2.6) 
Patients Job Commerce 1.0 (0.8-1.4) 52(22.0) 0.9 (0.6-1.4) 0.21 
Professional 2.4 (1.3-4.6) 0.02 15(6.4) 2.2 (0.9-5.0) 
Peasant 1.0 (-) 169(71.6) 1.0 (-) 
Spouse job Commerce 1.0 (-) 106(44.9) 1.0 (-) 
Professional 0.7 (0.5-1.0) ((. 08 94(39.8) 0.6 (0.4-1.0) 0.16 
Peasant 0.9 ((1.7-I. I) 36(15.3) 0.9 (0.6-1.3) 
Type of house' Brick, cemented 1.0 (-) 117(49.6) 1. O (-) 0.00 
Brick only 4.1 (2.9-5.6) 0.00 94(39.8) 4.3 (2.4-6.4) 
Mud only 7.9 (4.3-14.2) 25(10.6) 6.6 (3.2-13.9) 
Facility in house Electricity and 1.0 (-) 00 65(27.5) I. 0 0 
(-) 
(111 11 
water . . 
Electricity or 1.5 (1.1-2.0) 84(35.6) 2.0 (1.3-3.0) 
water only 
Neither 2.4 (1.8-3.3) 87(36.9) 3.3 (2.2-4.9) 
Need to request 
permission to visit Yes 4.7 (3.3-6.7) 72(27.1) 5.2 (3.3-9.3) 0.0(1 
I Iealth Ilnit/ No 1.0 (-) 0.00 164(69.5) 1.0 
hospital 
Who gives 
permission to Spouse 1.0 (-) 64(85.5) I. 0 (-) ((. 71 
attend I lealth Unit/ Other 1.4 (1-0-2.2) 0.09 10(14.5) 1.1 (0.7-1.9) 
hospital 
Who pays for Selland spouse 1.0 (-) 193(81.8) 1.0 (-) 
treatment Others 2.9 (1.9-4.2) 0.0(1 43(18.2) 2.2 (1.3-3.5) 11.01 
*Brick, cemented: brick, well cemented house and floor with iron roof or tiles 
Brick only: brick, not cemented floor and walls and iron roof 
Mud only: Mud walls and floor with iron root' 
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(ii) Social, family and medical characteristics 
Characteristic Stratum Crude Odds ratio P value Non Non referral P value 
All SMM referral crude odds 
(95% Cl) cases (95% Cl) 
Faking alcohol Yes 0.7 (0.5-0.9) 0.02 50(21.2) 0.7 (0.5-1.0) 0.04 
No 1.0 (-) 186(78.8) 1.0 (-) 
Smoking Yes 0.3 (0.2-2.4) 0.75 1(0.4) 0.2 (0.0-1.2) 0.12 
No 1.0 (-) 235(99.6) 1.0 
Family Yes 1.0 (0.8-1.3) 0.87 10243.2) 1.3 (0.9-1.8) 0. II 
hypertension No 1.0 (-) 134(56.8) 1.0 
Family diabetes Yes 1.1 (0.2-1.4) 0.75 30)12.7) 1.2 (0.8-2.1) 0.35 
mellitus No 1.0 (-) 206(87.3) 1.0 (-) 
hypertension (self) Yes 12.0 (2.8-51.3) 0.00 13(5.5) 12.1 (2.7-53.9) 0.00 
No 1.0 (-) 223(94.5) 1.0 (-) 
Use of Yes 1.0 (-) 100(42.3) 1.0 (-) 0.98 
contraceptives No 1.2 (0.9-1.5) 0.26 136(57.6) 1.0 (0.7-1.4) 
(iii) Past obstetric performance * 
Characteristic Stratum Crude odds ratio P value Non Non referral P value 
All SMM referral crude odds 
(951% Cl) cases_ (95% Cl) 
Previous abortion Yes 1.1 (0.7-1.9) 0.50 25) 16.7) 1.4 (0.8-2.4) 
No 1.0 (-) 125(83.3) 1.0 (-) 0.42 
Previous evacuation Yes 1.8 (1.2-4.5) 0.00 20(13.3) 2.2 (1.1-4.2) 0.02 
of uterus and No 1.0 (-) 130(8.7) 1.0 (-) 
curettage (all women) 
Bleeding in previous Yes 1.5 (1.0-2.5) 0.07 27(18.0) 1.7 (I. 0-3.1) 0.04 
pregnancy No 1.0 (-) 123(82.0) 1.0 (-) 
Bleeding in labour Yes 1.0 (0.6-I. 6) 0.99 18(12.0) 1.1 (0.6-2.1) 0.66 
No 1.0 (-) 132(88.0) I. 0 (-) 
Labour lasting more Yes 0.7 (0.5-1.1) 0.12 26(17.3) 0.7 (0.4-1.1) 0.13 
than 18hrs No 1.0 (-) 124(82.7) 1. (1 (-) 
Still birth Yes 1.6 (0.9-2.9) 0.07 16(10.7) 1.2 ((). b-2.3) 0.60 
No 1.0 (-) 134(89.3) 1.0 (-) 
Previous caesarean Yes 5.4 (2.9-10.2) 0.00 41(27.3) 5.1 (2.9-8.7) 0.00 
section No 1.0 (-) 109(71.7) 1.0 (-) 
Vacuum or forceps Yes 1.4 (0.4-5.1) 0.62 4(2.7) 1.2 (0.3-4.2) 0. K0 
No 1.0 (-) I46(97.3) 1.0 (-) 
Post partum Yes 1.4 (0.6-3.0) 0.38 I2(8.0) 1.9 (0.7-4.1) 0.15 
haemorrhage No 1.0 (-) 138(92.0) 1.0 (-) 
Retained placenta Yes 1.0 (0.3-2.9) 0.98 6(4.0) 1.2 (0.4-3.4) 0.35 
No 1.0 (-) 144(96.0) 1.0 (-) 
I4ypertcnsion in Yes 1.4 (0.7-2.7) 0.31 I7(I 1.3) 2.2 (1.1-4.6) 0.03 
pregnancy No 1.0 (-) I33(RR. 7) 1.0 (-) 
Blood transfusion Yes 4.7 (1.4-16.6) 0.00 9(6.0) 5.4 (1.5-20.34) 0.00 
during pregnancy No 1.0 (-) 141(94.0) 1.0 (-) 
* Women with previous pregnancies only 
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(iv) Current obstetric performance 
Characteristic Stratum Crude odds ratio P value Non Non referral P value 
All SMM referral crude odds 
(95% Cl) cases (95% Cl) 
Parity I 1.3 (I. 0-1.7) 0.02 86(36.5) 1.3 ((L)-I. 9) 11.10 
2-4 1.0 (-) 102(43.2) 1.0 (-) 
5-14 0.8 (0.4-0.9) 48(20.3) 0.8 (0.6-1.4) 
Birth spacing in 1-36 1.0 (-) 87(57.8) 1.0 (-) 
months* 37-60 1.1 (0.8-1.6) 0.05 34(23.0) 1.1 (0.6-1.5) 0.07 
>60 1.8 (1.1-2.8) 29(19.2) 1.8 (1.0-3.0) 
Attended Antenatal Yes 1.0 (-) 198(83.9) 1.0 (-) 0.00 
care No 4.5 (2.5-8.0) 0.00 38(16.1) 6.4 (3.3-12.6) 
Booking time for <28 1.0 (-) 127(64.1) 1.0 (-) 0.46 
antenatal (weeks) 28-36 1.0 (0.1-1.3) 0.99 71(38.9) 1.1 (0.8-1.6) 
Number of antenatal 4+ 1.0 (-) 79(39.9) 1.0 (-) 0.13 
visits <4 1.2 (0.9-1.6) 0.13 119(60.1) 1.1 (0.8-1.6) 
having blood No 2.7 (1.7-7.6) 0.02 4(. 0) 2.6 0.00 
pressure checked Yes 1.0 (-) 194(98.0) 1.0 
(1.6-5.2) 
during antenatal 
Response to vaginal Go to hospital 1.0 (-) 180(76.3) 1.0 (-) 0.00 
bleeding during Don't know 8.7 (5.3-14.. 3) 0.00 56(23.7) 7.7 (4.3-13.9) 
pregnancy 
Bleeding during this Yes 4.8 (1.4-16.7) 0.01 41(17.4) 7.2 (1.5-34.5) 0.00 
pregnancy No 1.0 (-) 195(82.9) 1.0 (-) 
Hypertension in this Yes 16.9 (7.7-36.9) 0.00 62(27.1) 25.2 (9.9-64.1) 0.00 
pregnancy No 1.0 (-) 174(72.9) 1.0 (-) 
Anaemia in this Yes 5.0 (1.7-14.7) 0.00 12(5.1) 7.4 (2.1-26.4) 0.00 
pregnancy No 1.0 (-) 224(94.9) 1.0 (-) 
Loss of weight Yes 1.5 (1.0-2.4) 0.06 212(89.8) 1.1 (0.3-2.4) 0.14 
During pregnancy No 1.0 (-) 24(10.2) I .. o (-) 
Admission during Yes 1.4 (0.9-2.2) 
0.14 34(14.4) 2.0 (1.2-3.3) 0.00 
pregnancy No 1.0 202(85.6) 1.0 (-) 
Referral from other Yes 5.5 (4.1-7.4) 0.00 
centres No 1.0 (- ) 
Premature rupture of Yes 1.9 (1.4-2.5) 0.00 66(28.0) 1.8 (1.3-2.7) 0.0(1 
membranes No 1.0 (-) 170(72.0) 1.0 (-) 
missing 
Bleeding in labour Yes 20.1 (8.4-51.4) 0.00 8(3.3) 21.0 (8.9-49.9) 0.00 
No 1.0 (-) 228(96.6) 1.0 (-1 
(lse ofpartograph Yes 0.8 (0.5-1.3) 0.32 14(5.9) 0.9 (0.9-1.8 0.80 
No 1.0 (-) 221(94.1) 1.0 (-1 
Length of first stage ==1 Khours 1.0 (-) 182(89.0) I. 0 (-) 0.00 
in hours -18 2.7 (1.61-4.63) 0.00 25(11.8) 2.6 (1.4-4.4) 
no labour 29 
Length of third stage = <25 1.0 (-) 200(92.6) 1.0 (-) 0 00 
in minutes. ** '25 18.4 3.8 -89.6 0.00 16(7.4) 17.2 (3.4-82.1) 
Sex of baby y Female 1.0 (-) 115(48.7) 1. () (-) 0.65 
Male 1.1 (0.8-1.5) 0.33 121(51.3) 1.1 (0.7-1.5) 
missing 
Birth weight e 2500 5.9 (3.9-8.8) 0.00 76 6.8 (4.2-10.9) 0.0O 
In kilograms 2500-3500 1.0 (-) 118 1.0 (-) 
>3500 1.0 (0.7-1.4) 41 1.2 (4.2-10.9) 
missing 
Level ot'delivery y Midwife 1.0 t -) 50(21 7) 00 I 0 attendant Doctor 
" ' 
111.0 (x(1.4- 
9)0.00 2()3 
. I(, 1(70.1)) . 237 (-) 00 (84.0-663.2 ) I RA - . 19(8.3) 
Given Oxytocics ** Yes 1.0 (-) 174(98.9 1 H) 00 1-1 0 No 5.7 (2.9-11.1) 0.00 22(11.2) 6.9 . (3.0-15.87) 
* Multiparous women only r uptured uterus done hysterectomy excluded 
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(v) Laboratory results 
Characteristic Stratum Crude odds P Non Non referral P 
ratio value referral crude odds Value 
(95% Cl) cases (95% Cl) 
I{IV status Negatiýc I. O (-) 205(86.9) 1.0 (-) 0.05 
Positive 1.7 (1.1-2.5) 0.01 31(13.1) 1.6 (1.0-2.7) 
Syphilis Negative 1.0 (-) 209(8X. 6) 1.0 (-) 
Positive 0.9 (0.6-1.4) 0.75 27(11.4) 1.2 (0.7-1.9) 0.52 
Ilaemoglobin 
gm/dl 
<10 
=>IO 
1.0 
8.4 (6.3- 0.00 
11.4) 
I34(56.8) 
102(43.2) 
1.0 (-) 0.00 
7.7 (5.4-11.3) 
Mean corpuscular 
haemoglobin <33. () 1.5 (1.0-2.1) 0.03 203(86.0) 1.4 (0.9-10.2) 0.06 
concentration in >33.0 1.0 (-) 33(14.0) 1.0 
g/dI 
Platelets x109/1 <150 3.6 (2.6-5.1) 0.00 659(27.5) 3.0 (2.0-4.6) 0.00 
=>150 1.0 (-) 171(72.5) 1.0 (-) 
Table C3 Distribution of selected factors amongst referrals in severe maternal 
morbidity cases and controls 
Variable Stratum Cases Controls 
Referrals Non referrals Referrals Non referrals 
n(%) n(%) n(%) n(%) 
Distance « 5km 82(312) 75(31.8) 51(60.7) 282(67.8) 
>5-10 91(34.6) 85(36.0) 16(19.0) 65(15.6) 
>10 47(19.0) 30(12.7) 2(2.4) 9(2.2) 
Permission Yes 91(34.6) 74(30.5) 15(17.9) 32(7.7) 
No 172(65.4) 164(69.5) 69(82.1) 384(92.3) 
Paying Yes 56(21.4) 43(18.2) 2(2.4) 38(9.1) 
No 206(78.6) 193(81. ) 82(97.6) 378(90.9) 
lousing Brick, cemented 137(52.1) 121(51.3) 72(85.7) 345(83.0) 
Brick only 83(31.6) 90(38.1) 9(10.7) 60(14.4) 
Mud only 43(16.3) 25(10.6) 3(3.6) 11(2.6) 
Parity Nulliparity 99(37.6) 85(36.0) 35(29.7) 125(30.0) 
2-5 125(47.5) 103(43.6) 47(56.0) 190(45.7) 
>5 39(14.8) 48(20.3) 12(14.3) 101(24.3) 
Antenatal care Yes 231(87.8) 198(83.9) 82(97.6) 404(97.1) 
No 32(12.2) 38(16.1) 2(2.4) 12(2.9) 
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Table (4 Reason for referral among controls in stage I cases control study of 
SMM 
Reason for referral 
Numbers 
% 
No delivery facility 4 (4.8) 
Nulliparity 12(14.3) 
Big baby 16(19.0) 
Premature rupture of membranes 10(1 1.9) 
Poor progress 24(26.5) 
Breech 3(3.6) 
Medical diseases 7(8.3) 
History of infertility 5(6.0) 
Ante partum haemorrhage 3(3.6) 
Total 84(100) 
Table C5 Distribution of severe maternal morbidity and progression to mortality 
by referral 
Variable Stratum Cases Controls 
Referrals Non Referrals Non 
n(%) referrals n(%) referrals 
n(%) n (%) 
Distance 5km 5(26.3) 7(35.0) 120(49.2) I (4(52.8) 
>5-10 7(36.8) 10(50.0) 84(34.4) 75(34.7) 
>10 7(36.8) 3(15.0) 40(16.4) 27(12.5) 
Permission Yes 9(47.4) 11(55.0) 82(33.6) 61(28.2) 
No 10(52.6) 9(45.0) 162(66.4) 155(71.8) 
Paying Yes 4(21.1) 2(10.0) 52(21.4) 41(9.0) 
No 15(78.9) 18(90.0) 191(78.6) 175(81.0) 
Housing Brick, cemented 9(47.4) 13(65.0) 128(52.4) 108(50.0) 
Brick only 7(36.8) 7(35.0) 76(31.2) 83(38.4) 
Mud only 3(36.8) 0 40(16.4) 25(1 1.6) 
Parity Nulliparity 2(10.5) 8(40.0) 97(39.7) 78(36.0) 
2-5 15(79.0) 11(55.0) 110(45.1) 91(42.3) 
>5 2(10.5) 1(5.0) 37(15.2) 47(21.7) 
Antenatal care Yes 9(47.4) 13(65.0) 222(91.0) 185(85.7) 
No 10(52.6) 7(35.0) 10(9.0) 31(14.3) 
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APPENDIX D: PEOPLE INVOLVED IN THE STUDY 
The roles of the people who contributed to this study and the production of the thesis are 
listed below. 
1. Supervisors (Pat Doyle and Noreen Maconochie) and advisory committee 
(Carine Ronsmans, Jim Todd) 
" My supervisor PD was instrumental in guiding me from the beginning of the 
course to the end. Together with the statistician (NM) was instrumental in 
conceptualising the study design and guided me in preparation of upgrading 
document and main thesis. Carine Ronsmans contributed to the study design and 
the interpretation of the results. 
" PD visited me during the field work to see and check on data collection and data 
entry. 
" PD provided advice during the analysis of data and interpretation of results. 
" PD read my thesis and assisted me in English grammar 
" The advisory committee guided me on the feasibility of the study in the early 
days and later on how to focus on my study objectives during analysis and write 
up. 
2. Statistical help from Jim Todd 
" JD gave me advice on analysis whenever I asked for it, especially when 
carrying out multivariate analysis. 
3. Help with Field Work 
Assistant to PI: this was an obstetrician and gynaecologist. He: 
" Aided me in ensuring that the cases and controls satisfied the selection criteria. 
" Covered me whenever I was not available. 
Interviewers: These were two senior midwives. They: 
" Interviewed the cases and controls. 
" Took off specimens for investigations 
" Followed up of case and controls till discharge or death. 
Pathologist: He: 
" Carried out postmortems for all SMM cases who died. 
Laboratory technician: They: 
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" Carried out all laboratory investigations as requested by PI or assistant PI 
Runner 
" Was responsible for delivery of specimen to laboratories and carrying back the 
results. 
Data entry clerk: She; 
" Carried out first data entry in Uganda. 
4. My personal role. 
" Played the major role in the conceptualisation of the study design 
" Wrote the upgrading document. 
" Piloted the study 
" Supervised all staff in Uganda who participated in collection of data. 
" Supervised first data entry in Uganda. 
" Carried out second data entry at London School of Hygiene and Tropical 
Medicine 
" Carried out data cleaning and checking. 
" Carried out the data analysis 
" Interpreted the results 
" Wrote the thesis. 
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